<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cooperative Medicine</title>
	<atom:link href="http://www.cooperativemedicine.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.cooperativemedicine.com</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Sun, 25 Dec 2011 16:58:48 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>Laser therapy shown to effectively treat BRONJ</title>
		<link>http://www.cooperativemedicine.com/laser-articles/laser-therapy-effective-treats-bronj/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/laser-therapy-effective-treats-bronj/#comments</comments>
		<pubDate>Sat, 19 Nov 2011 23:41:11 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2267</guid>
		<description><![CDATA[Photomed Laser Surg. 2011 Jan 16. [Epub ahead of print] Observation of Pain Control in Patients with Bisphosphonate-Induced Osteonecrosis Using Low Level Laser Therapy: Preliminary Results. Romeo U, Galanakis A, Marias C, Vecchio AD, Tenore G, Palaia G, Vescovi P, Polimeni A. 1 Department of Oral Sciences, “Sapienza” University of Rome , Rome, Italy . [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<div>
<p>Photomed Laser Surg. 2011 Jan 16. [Epub ahead of print]</p>
<h1>Observation of Pain Control in Patients with  Bisphosphonate-Induced  Osteonecrosis Using Low Level Laser Therapy: Preliminary  Results.</h1>
<p>Romeo U, Galanakis A, Marias C, Vecchio AD, Tenore G, Palaia G, Vescovi P, Polimeni A.</p>
<p>1 Department of Oral Sciences, “Sapienza” University of Rome ,  Rome, Italy .</p>
<div>
<h3>Abstract</h3>
<p>Abstract Background: Bisphosphonate-related osteonecrosis of the jaw  (BRONJ)  is an adverse side effect associated with bisphosphonate (BP)  therapy,  especially when parenteral BP administration is used. Patients  affected by BRONJ  present wide areas of exposed necrotic bone,  particularly after surgical oral  procedures. The main symptom is pain  that is poorly controlled by common  analgesic drugs. Recently, many  studies have pointed to the beneficial effect of  low-level laser  therapy (LLLT) in pain reduction for many pathological  conditions. The  purpose of this study is to investigate whether LLLT could be  helpful  in managing BRONJ by reducing the problems associated with this   condition and the use of analgesic drugs. Methods: Twelve patients  affected by  BRONJ were monitored at the Complex Operative Unit of Oral  Pathology. Among  these patients, only seven referred to pain in  necrotic areas and were recruited  for LLLT. Laser applications were  performed with a double diode laser  simultaneously emitting at two  different wavelengths (??=?650?nm and  ??=?904-910?nm, spot  size?=?8?mm). All of the patients were irradiated with a  fluence of  0.053?J/cm(2) for 15?min five times over a period of 2 weeks, in a   non-contact mode, ?1?mm from the pathologic area. The patient’s maximum  and  minimum pain was recorded using a numeric rating scale (NRS)  evaluation before  and after the treatment. Statistical analysis was  performed using the  Kruskal-Wallis test. Results: Six patients showed  significant pain reduction,  and only one patient indicated a worsening  of the symptoms, which was probably  related to a reinfection of the  BRONJ site, which occurred during the study. A  statistically  significant difference (p?&lt;?0.05) was found between the NRS  rates  before and after the protocol. Conclusions: This pilot study suggests  that  LLLT may be a valid technique to support the treatment of  BRONJ-related pain,  even though the low number of cases in this study  does not permit any conclusive  consideration.</p>
</div>
<p>Lasers Med Sci. 2010 Jul 29. [Epub ahead of print]</p>
<h1>Low-level laser therapy supported teeth extractions of two patients receiving IV zoldendronate</h1>
<p><strong> </strong></p>
<p>Kan B, Altay MA, Ta?ar F, Akova M.</p>
<p>Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Hacettepe University, Ankara, Turkey, <a href="mailto:bahadirk@hacettepe.edu.tr">bahadirk@hacettepe.edu.tr</a>.</p>
<p>Abstract</p>
<p>BRONJ (bisphosphonate-related osteonecrosis of jaws) is a frequently  encountered disease, particularly in the maxillofacial region, and a  consequence of bisphosphonate use. Treatment of BRONJ remains  controversial, as efficiency of medical and surgical approaches as well  as a combination of these methods with supportive treatments have not  been clearly demonstrated in the literature. In recent years, laser  usage alone or in combination with the main therapy methods, has become  popular for the treatment of bisphosphonate-related osteo-necrosis of  jaws. In this article, we present the successful management of two  dental patients who had high potentials for BRONJ development as a  result of chemo and radiotherapy combined with IV zoledronic acid  application. Multiple consecutive teeth extractions followed with  primary wound closure and LLLT applications were performed under high  doses of antibiotics prophylaxis. Satisfactory wound healing in both the  surrounding soft and hard tissues was achieved. LLLT application  combined with atraumatic surgical interventions under antibiotics  prophylaxis is a preferable approach in patients with a risk of BRONJ  development. Adjunctive effect of LLLT in addition to careful infection  control on preventing BRONJ was reported and concluded.</p>
<p>Minerva Stomatol. 2010 Apr;59(4):181-213.</p>
<h1>Biphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy.  A critical review.</h1>
<p>Vescovi P, Nammour S.</p>
<p>Director of EMDOLA (European Master Degree on Oral Laser  Applications), Unit of Oral Pathology and Medicine and laser-assisted  Oral Surgery, Section of Dentistry – <a href="mailto:paolo.vescovi@unipr.it">paolo.vescovi@unipr.it</a></p>
<p>Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an area of  uncovered bone in the maxillo-facial region that did not heal within 8  weeks after identification by health care provider, in a patient who was  receiving or had been exposed to Bisphosphonate Therapy (BPT) without  previous radiation therapy to the craniofacial region. Low-grade risk of  ONJ is connected with oral BPT used in the treatment of osteopenia,  osteoporosis and Paget’s disease (from 0.01% to 0.04%) while  higher-grade risk is associated with intravenous (IV) administration in  the treatment of multiple myeloma and bone metastases (from 0.8% to  12%). The management of BRONJ currently is a dilemma. No effective  treatment has yet been developed and interrupting BPT does not seem to  be beneficial. Temporary suspension of BPs offers no short-term benefit,  whilst long term discontinuation (if systemic conditions permit it) may  be beneficial in stabilizing sites of ONJ and reducing clinical  symptoms. The use of oral antimicrobial rinses in combination with oral  systemic antibiotic therapy -penicillin, metronidazole, quinolones,  clindamycin, doxycycline, erythromycin- is indicated for Stages I and II  of Ruggiero’s Staging. The role of hyperbaric oxygen therapy is still  unclear but some benefits of this treatment have recently been described  in association with discontinuation of BPT and conventional therapy  (medical or/and surgical). Surgical treatment, in accordance to the  AAOMS Position Paper, is reserved to patients affected by Stage III of  BRONJ even if in the last version (2009) a superficial debridement is  indicated to relieve soft tissue irritation also in the stage II  (lesions being unresponsive to antibiotic treatment). Aggressive  surgical treatment may occasionally results in even larger areas of  exposed and painful infected bone. Surgical debridement or resection in  combination with antibiotic therapy may offer long-term palliation with  resolution of acute infection and pain. Mobile segments of bony  sequestrum should be removed without exposing unaffected bone. If  pathological fractures or complete mandibular involvement are observed,  if the medical condition of the patients allows it the affected bone  portion may be resected and primary bone reconstruction or  revascularization graft may be carried out. Ozone therapy in the  management of bone necrosis or in extractive sites during and after oral  surgery in patients treated with BPs may stimulate cell proliferation  and soft tissue healing. Laser applications at low intensity (Low Level  Laser Therapy – LLLT) have been reported in the literature for the  treatment of BRONJ. Biostimulant effects of laser improve reparative  process, increase inorganic matrix of bone and osteoblast mitotic index  and stimulate lymphatic and blood capillaries growth. Laser can be used  for conservative surgery, whereby necrotic bone is vaporized, until  healthy bone is reached. The Er:YAG laser wavelength has a high degree  of affinity for water and hydroxyapatite, hence both soft and bone  tissues can be easily treated. An additional advantage of the Er:YAG  laser is its bactericidal and possible biostimulatory action,  accelerating the healing of both soft and bone tissues, in comparison to  conventional treatments. Long-term, prospective studies are required to  establish the efficacy of drug holidays in reducing the risk of BRONJ  for patients receiving oral BPs even if it has been suggested that BPT  may be discontinued for three months before the surgical procedures and  bone turnover markers (CTx, NTx, PTH, 1,25-dihydroxy vitamin D) may be  checked. However it must be recognized that interindividual variability,  gender, age, physical activity, and seasonal and circadian variation  exist that can result in difficulty in interpreting these assays and  more research is needed. Laser application (LLLT and laser surgery)  nowadays appears to be a promising modality of BRONJ treatment, being  safe and well tolerated, and it permits the minimally invasive treatment  of early stages of the disease.</p>
<p>Photomed Laser Surg. 2010 Apr;28(2):179-84. <strong> </strong></p>
<h1>Effect of low-level laser irradiation on biphosphonate-induced  osteonecrosis of the jaws: preliminary results of a prospective study.</h1>
<p>Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozzati M.</p>
<p>Oral Surgery Unit, Dentistry Section, Department of Clinical Physiopathology, University of Turin, Turin, Italy.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to detail the clinical efficacy  of low-level laser therapy (LLLT) for the management of  bisphosphonate-induced osteonecrosis of the jaws (ONJ-BP).</p>
<p>BACKGROUND: ONJ-BP is the correct term, recently emerged, to describe  a significant complication in a subset of patients receiving drugs such  as zoledronic acid, pamidronate, and alendronate. No definitive  standard of care has been set for ONJ-BP and no definitively agreed  guidelines have been provided. There is currently no consensus on the  correct approach to the issue.</p>
<p>MATERIALS AND METHODS: The investigators studied a prospective cohort  of 20 patients affected by ONJ-BP, who received biostimulation with a  pulsed diode laser (GaAs). Patients were exposed to a 904-nm infrared  laser (50 kHz, 28.4 J/cm(2) energy density, 40% duty cycle, spot size  0.8 cm). Outcome variables were the size of lesions, edema, visual  analogue score of pain, presence of pus, fistulas, and halitosis.  Preoperative results were compared with the postoperative outcome and  statistically evaluated.</p>
<p>RESULTS: Four weeks after LLLT, a statistically significant  difference was observed for reported pain (p = 0.0001), clinical size (p  = 0.0034), edema (p = 0.0005), and presence of pus and fistulas (p =  0.0078 and p = 0.03, respectively).</p>
<p>CONCLUSION: This study suggests that LLLT would appear to be a  promising modality of treatment for patients with ONJ-BP, providing that  clinical efficacy is safe and well tolerated, especially by those  patients who require conservative treatment. Of course, this needs to be  addressed further in larger and randomly controlled studies in  different clinical settings.</p>
<p>Lasers Med Sci. 2010 Jan;25(1):101-13. Epub 2009 Jun 19.</p>
<h1>Surgical approach with Er:YAG laser of osteonecrosis of the jaws (ONJ) in patients under biphosphonate therapy (BPT).</h1>
<p><strong> </strong></p>
<p>Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca JP, Nammour S.</p>
<p>Oral Medicine and Laser-Assisted Surgery Unit- Section of Dentistry –  Department of ENT/Dental/Ophtalmological and Cervico-Facial Sciences,  EMDOLA (European Master Degree on Oral Laser Applications) – University  of Parma, Parma, Italy. <a href="mailto:paolo.vescovi@unipr.it">paolo.vescovi@unipr.it</a></p>
<p>Osteonecrosis of the jaw (ONJ) in patients on long-term  bisphosphonate Therapy (BPT) has been reported with increasing frequency  in literature over the past 4 years. Therapy for this condition is  still a dilemma. Temporary suspension of BPT offers no short-term  benefits; hyperbaric oxygen has no proven efficacy and therefore is not  recommended. Intermittent or continuous antibiotic therapy with surgical  debridement can be beneficial to palliate the symptoms. Er:YAG laser  can be used to eliminate necrotic bone portions by partial or total  resection as an alternative to conventional rotary devices. In our  study, 91 patients affected by ONJ-BP lesion, for a total of 115 ONJ  sites were observed between January 2004 and May 2008 (Department of  Odontostomatology, University of Parma). Fifty-five ONJ sites were  considered for this study in four different groups, retrospectively  identified on the basis of treatment performed (G1-G4). G1: 13 ONJ-BP  sites were treated with medical therapy (amoxicillin 1gr x 3/die per os  with metronidazole 250 mg x 2/die per os) for at least 2 weeks; G2: 17  ONJ-BP sites received medical treatment in association with cycles of  low-level laser therapy (LLLT) applications performed using an Nd:YAG  laser (1,064 nm) once a week for 2 months; G3: 13 ONJ-BP sites were  surgically treated (sequestrectomy of necrotic bone, debridement,  corticotomy/surgical removal of alveolar and/or cortical bone); G4: 12  ONJ-BP sites were treated with surgical therapy performed using an  Er:YAG laser (2,940 nm) in association with LLLT. Clinical success has  been defined for each treatment performed as: (a) complete mucosal  healing free from signs and symptoms (classified as stage “0″) or (b)  transition from a higher to a lower stage (Ruggiero staging) for at  least 3 months. All the ONJ-BP sites treated with Er:YAG laser (G4  group) had a clinical improvement (100%) and 87.5% of sites had a  complete mucosal healing with a mean follow-up of 13 months. The result  obtained in the G4 is extremely significant in comparison with those  obtained by medical treatment alone or in a traditional surgical  approach. Thanks to the high degree of affinity of this wavelength for  water and hydroxyapatite, both soft and bone tissues can be easily  treated. This technique can also be used for conservative operations  whereby necrotic bone is vaporized until healthy bone is reached. In  addition, an additional advantage of the Er:YAG laser is its  bactericidal and possible biostimulatory action, accelerating the  healing of both soft tissues and bone tissues, in comparison to  conventional treatments. In conclusion, from our experience, it is  possible to observe that an early conservative surgical approach with  Er:YAG laser associated with LLLT, for BP-induced ONJ could be  considered as more efficient in comparison with medical therapy or other  conventional techniques.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top">Ther Clin Risk Manag. 2009; 5: 217–227.Published online 2009 March 26.</td>
<td valign="top">PMCID: PMC2697532</td>
</tr>
</tbody>
</table>
<p>Copyright © 2009 Borgioli et al, publisher and licensee Dove Medical Press Ltd.</p>
<h1>Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.</h1>
<p>Alberto Borgioli,<sup>1</sup> Christian Viviani,<sup>1</sup> Marco Duvina,<sup>1</sup> Leila Brancato,<sup>1</sup> Giuseppe Spinelli,<sup>1</sup> Maria Luisa Brandi,<sup>2,3</sup> and Paolo Tonelli<sup>1</sup></p>
<p><sup>1</sup>Department of Odontostomatology, Dental School; <sup>2</sup>Department of Internal Medicine; <sup>3</sup>DeGene  Spin-off, Medical School, University of Florence, Florence,  ItalyCorrespondence: Maria Luisa Brandi, Department of Internal  Medicine, University of Florence, Medical School, Viale Pieraccini, 6.  50139 Florence Italy, Tel +39 0554 296 586, Fax +39 0554 296 585, Email <a href="mailto:m.brandi@dmi.unifi.it">m.brandi@dmi.unifi.it</a></p>
<p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</p>
<p><strong>Abstract</strong></p>
<p>Since osteonecrosis of the jaw was related to biphosphonate  administration by Marx, studies showing clinical symptoms, drug and  surgical therapies overwhelmed the literature. Furthermore, the  literature demonstrated the correlation between chronic biphosphonate  adsumption and osteonecrosis of the jaw onset. Nitrogen-containing  biphosphonates are widely used for the management of metastatic cancer,  for prevention and treatment of osteoporosis, for the treatment of  Paget’s disease, and for the management of acute hypercalcemia.  According to our experience, the treatment of BRON-J’s lesions is  difficult and prolonged. For this reason, in order to avoid these  complications it is mandatory to perform a risk staging in patients who  must undergo biphosphonate administration. When pharmacologic treatments  with antibiotics and local antiseptics are not able to control the  development of BRON-J’s complications, the clinicians should perform  radical surgical treatments such as the resection of the bone involved.   Keywords: osteonecrosis of the jaw, biphosphonates, BRON-J  <strong> </strong></p>
<p><strong>Introduction</strong></p>
<p>Osteonecrosis of the jaw is a chronic osteomielitis that recognizes a  multifactorial genesis, connected to both local and systemic factors.  The relevant systemic factors capable to influence development of  osteonecrosis of the jaw encompass immunosuppression, chemotherapy,  corticosteroid therapy, and endocrine diseases.  Pharmacologic-related  osteonecrosis of the jaw (BRON-J) in oncologic patients treated with  intravenous biphosphonates was an unknown clinical entity until 2003,  when Marx described 36 cases of BRON-J in patients affected by malignant  tumors.1 Biphosphonates stand as an important group of drugs for the  treatment of metabolic and oncologic pathologies involving the skeletal  system. Biphophonates act by inhibiting osteoclastic bone resorption.  The most common drugs utilized in the prevention and therapy of  osteoporosis are: alendronate, risendronate, ibandronate, and  clodronate. Pamidronate and zolendronate are utilized in the prophylaxis  of bone complications and in the hypercalcemia associated to multiple  myeloma and to metastatic bone disease due to breast and prostatic  cancer. All these chemical substances are characterized by a high power  and selectivity. Nowadays, the literature demonstrates the correlation  between chronic biphosphonate assumption and onset of osteonecrosis of  the jaw.  <strong> </strong></p>
<p><strong>BRON-J: history and definition</strong></p>
<p>Since Marx’s study other studies on BRON-J have been published. In  2004, Ruggiero and colleagues published 63 cases of BRON-J, with the  majority of cases being dependent on the use of intravenous  biphosphonate administration in cancer patients and only few patients  treated with oral biphosphonates for osteoporosis.2  In 2005, Marx  published 119 cases of BRON-J and correlated it to the type of drug  used, to the invasiveness of the oral treatments, to the dose, and to  the assumption length for a given drug.3 In the same year, Scientific  Societies published the first position paper on the topic. The American  Academy of Oral Medicine described clinical manifestations of these  lesions, suggested potential clinical ways to prevent and to treat the  affected patients.4  Several authors later reported extensive revisions  of myeloma and metastatic cancer disease treated with intravenous  biphosphonates, correlating the extension and evolution of this  complication to the type of drug and to the length of treatment.5–7   Intravenous biphosphonates became a standard therapy for the control of  complications in metastatic bone disease, such as pain, local  compression, spontaneous fractures, and hypercalcemia. In several  clinical studies, nitrogen-containing molecules (ibandronate,  pamidronate, zolendronate) showed to be more effective in controlling  manifestations of systemic malignant bone disease if compared to  clodronate, with zoledronate being the most potent drug in reducing bone  lesions extension and in delaying the development of the first bone  metastasis.8,9  Despite the high risk of BRON-J development in oncologic  patients the American Society of Clinical Oncology10 recommends the use  of zoledronic acid even in patients with asintomatic metastases or  disease in progress.11  In 2006, significant data emerged from an  American Association of Oral and Maxillofacial Surgeons position paper  that reported a consistent incidence of BRON-J, depending on prolonged  biphosphonate treatment together with other related risk factors, such  as tooth-alveolar bone pathological conditions of inflammatory nature.12  This is especially true for patients suffering from multiple myeloma,  and breast or prostatic cancer.  The American Association of Oral and  Maxillofacial Surgeons also declared a clear disease staging, from not  visible oral lesions to more severe clinical pictures, such as the  presence of bone sequestrum and jaw osteolytic complications, proposing  different therapeutic protocols based on the stage of this pathology.12   The American Association of Oral and Maxillofacial Surgeons12  established universal criteria for the BRON-J tassonomic picture that  was valid when three phenotypes were present:</p>
<ul>
<li>1) Previous or in      progress assumption of biphosphonates;</li>
<li>2) Exposed necrotic      bone of the jaws for more than eight weeks;</li>
<li>3) No history of      radiotherapy of the maxillofacial region.</li>
</ul>
<p>A strict correlation between BRON-J and chronic administration of  biphosphonates, with incidence ranging from 0.8% to 12% is a well  recognized phenomenon.13Until 2002, however, the incidence was less than  a single case out of 10,000 treated patients1 and these data refer to  patients treated with nonaminobiphosphonates, such as etidronate or  clodronate, at doses used in the therapy of osteoporosis. With the  introduction of aminobiphosphonates (risedronate, zoledronate,  ibadronate, and aledronate) more powerful in inhibiting bone resorption  and in preventing osteoporotic fractures, the incidence of this  complication grew to a relevant proportion of patients, especially in  these with cancer, with multiple myeloma or metastatic breast,  prostatic, or kidney cancer.  As suggested by the American Society of  Clinical Oncology,14 zoledronate and pamidronate show a high potency in  inhibiting bone and are the chosen therapies in the treatment of the  malignant disorders of the skeleton. The potency of these molecules  together with their intravenous administration at high dosage in  oncologic patients represent the basis for the high incidence of BRON-J  in these subjects when compared to osteoporotic patients treated for the  prevention of fragility fractures.15 Another potential factor that  plays a role in the development of BRON-J is the affinity for the  hydroxyapatite crystals by the aminobiphosphonate, with zoledronate  showing the highest affinity versus other molecules of this group.  The  American Association of Oral and Maxillofacial Surgeons12 pointed out to  other potential risk factors for BRON-J onset, such as systemic  corticosteroid therapy, smoke, alcohol, bad oral hygiene conditions,  chemotherapy, radiotherapy, diabetes, and blood clot diseases. The  permissive local factors are: oral surgical treatments, flogistic  lesions, and an excessive pressure of the removable denture on a thin  mucosa.16  There is no doubt that many factors must occur in BRON-J  development, such as intravenous prolonged biphosphonate administration,  and a chronic or an acute periodontitis, both responsible for medullary  osteomyelitis of the jaw.3  The higher incidence in females than in  males could be referred to a longer exposure to oral therapy with  biphosphonates in osteoporosis and to a higher incidence of breast  cancer17 in women versus men.  From a pathological point of view,  BRON-J, such as osteomyelitis, begins in the undifferentiated connective  bone tissue, in the Haversian wall vasa, and in the bone marrow spaces.  The process progression towards the cortical bone and the periostium  leads to the concurring presence of several anatomopathologic aspects of  the lesion: osteolysis associated to essudation or to weak growth of  granulation tissue; osteonecrosis with slow but progressive bordering of  sequestra; suppurated oral/extra-oral fistula caused by superinfection  of necrotic tissue; absence of bone remodelling, hence bone condensation  at the border of the sequestrum; and hypotrophy or atrophy following  loss of the bone sequestra with low coverage of defect by soft tissues.   According to the American Association of Oral and Maxillofacial  Surgeons position paper, one can stage BRON-J’s patients in two groups:  patients treated with aminobiphosphonates with no exposed bone segments  (patients at risk of BRON-J development); and patients presenting BRON-J  with exposed and necrotic bone segments.  Bone exposure for more than  eight weeks can worse the clinical picture. In fact, the exposed areas  located in the lower jaw and having different size (from post-extraction  socket site to larger areas or multiple areas) remain asymptomatic and  with no signs of flogosis. The necrotic bone areas and exposed bone  cause pain due to acute inflammation of surrounding soft tissues. Mucosa  is reddish, swollen, bleeding and strongly painful on light pressure.  Teeth close to the involved bone are often mobile and a local reactive  limphoadenopathy can be noticed. The clinician can still manage this  stage of pathology with conservative procedures and medical therapy;  including antibacterial agents to fight infections that involve the  exposed and necrotic bone.12  Purulent debris are present in endoral  abscessual cavities (if the purulent swelling is held by periostium and  then by perimaxillary muscels) or in extraoral cavities called perioral  phlegmon (if the osteolytic area is beyond perimaxillary muscles  insertions). In the first case purulent material drains in the oral  cavity. In the second case, purulent material drains in preconstituted  anatomical spaces delimited by connective tissue layers of the neck.  Maxillary phlegmon can involve canine or buccal spaces. Mandibular  phlegmon can involve submental, submaxillary, sublingual, submandibular  spaces. In this case the phlogosis exceeding these anatomical limits can  spread (for contiguity or through the lymphatic system) to the  secondary spaces such as pterygomandibular, lateropharyngeal, masseteric  and pterigo-maxillar spaces.18  The different thickness of the cortexes  justifies the earlier externalization if the pathologic process is  located in the upper jaw. In the lower jaw the osteolytic damage tend to  became deeper sometimes reaching the inner edge of the  mandibula  (Figures 1, ?,2).2). The involved bone can fracture spontaneously  because of its reduced elasticity. Furtheremore the purulent material  can compress nerve endings, causing local paresthesia.19,20 This phase,  often following the relapse of the oncologic disease and/or the  antiblastic treatment associated to corticosteroid therapy is defined as  “complicated phase.”</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 1</strong> <img title="Osteonecrosis Figure 1" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-1.jpg" alt="" width="102" height="58" /> Osteolytic lesion in the lower jaw of patient treated with Zometa<sup>®</sup> for 12 months (59 years old, female, breast cancer).</td>
</tr>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 2</strong> <img title="Osteonecrosis Figure 2" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-2.jpg" alt="" width="102" height="58" /> Worsening of the lesion after sequestrectomy in patient treated with   Zometa<sup>®</sup> for 12 months (59 years old, female, breast cancer).</td>
</tr>
</tbody>
</table>
<p>This phase is characterized by purulent phlogosis, by the presence of  fistulae (Figure 3), by spontaneous fractures, by compromized general  physical condition with fever, and by reactive adenopathy. In this stage  conservative treatments associated to prolonged antibiotic therapy can  be useless because of the gravity and the extension of the process, with  a radical surgery being more indicated.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 3</strong> <img title="Osteonecrosis Figure 3" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-3.jpg" alt="" width="102" height="58" /> Cutaneous fistula in patient treated with Aredia<sup>®</sup> and   Zometa<sup>®</sup> for 24 months (48 years old, female, breast cancer).</td>
</tr>
</tbody>
</table>
<p><strong>BRON-J diagnosis</strong></p>
<p>BRON-J diagnosis is quite clear if one refers to anamnesis, natural  history of the oncologic pathology and/or biphosphonates administration.  The evidence of the clinical lesion is confirmed with conventional  X-rays showing a radiopaque sequestrum usually rounded by diffused  radiolucency with a blurred contour due to the higher mineralization of  the jaw. This aspect, due to the fixation of calcium in the bone tissue,  is responsible for the patchy-ragged multilocular appearance of the  involved area and it assumes a higher definition when a radiolucent  osteolytic process with a central radiopaque mass of necrotic bone is  identified at its periphery.  Computed tomography (CT) can help allow a  higher definition of the necrotic foci and their relationships with the  surrounding anatomical structures, making possible to quantify the bone  sclerosis status. However, CT is not useful either in the staging of the  asymptomatic patients or in the differential diagnosis between a  primary tumor (with osteolytic aspect and ill-defined borders) and  metastatic spreads of prostatic or breast cancer with sclerotic aspect  (Figure 4). With CT it can be easier to detect mandibular myeloid  lesions in high vascularized areas with their “mould”, regular and well  defined characteristics. In these cases the use of a contrast medium can  help to better identify the lesions.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 4</strong> <img title="Osteonecrosis Figure 4" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-4.jpg" alt="" width="100" height="88" /> Computed tomographic scan of the bone sequestrum   in patient treated with Zometa<sup>®</sup> for 5 months (75 years old,   female, breast cancer).</td>
</tr>
</tbody>
</table>
<p>Once the sequestrum and the periosteal reactive bone deposition have  been identified by CT, magnetic resonance imaging (MRI) is useful to  evaluate the quality of overlying soft tissues and the medullary edema,  which is a sign of ischemia and bone necrosis.  The scintigraphy  (Tc99-scan) is the most sensitive diagnostic device to identify  maxillary edema with vascular alterations and to localize bone necrosis  even at early stages of the disease. Nevertheless this diagnostic  technique has a limit: Tc99-scan is not able to make a differential  diagnosis with the metastatic process.21,22  The biopsy of the bone  lesions must be carefully evaluated, because the procedure itself may  damage bone tissue by creating a wound which can hardly heal.23</p>
<p><strong>Etiopathogenesis</strong></p>
<p>Nitrogen-containing biphosphonates are used widely for the management  of metastatic cancer in bone (intravenous zoledronic acid or  pamidronate), for the prevention and treatment of osteoporosis (oral  alendronate, risedronate, and ibandronate) for the treatment of Paget’s  disease of bone (intravenous pamidronate and oral aledronate and  risedronate), and for the short-term management of acute hypercalcemia  (intravenous zoledronic acid and pamidronate).24,25 The nitrogen moiety  attached to the side chain of the middle carbon of the  phosphorus–carbon–phosphorus biphosphonate backbone renders these drugs  much more potent as inhibitors of bone resorption than the  bisphosphonates that do not contain nitrogen (etidronate and  clodronate). Bisphosphonates reduce the survival and function of  osteoclasts, the bone-resorbing cells. These antiresorptive actions  largely account for the drugs’efficacy in conditions in which the rate  of bone resorption exceeds the rate of bone formation.  Until recently,  the only adverse events of substantial consequence associated with the  nitrogen-containing bisphosphonates were upper gastrointestinal  intolerance (with oral administration) and a short-lived acute phase  reaction characterized by fever, myalgias, and an influenza-like  syndrome (with intravenous administration). Now another potential  complication of these agents–osteonecrosis of the jaw–has surfaced.26,27</p>
<p><strong>The Florence experience</strong></p>
<p>Patient’s characteristics  Based on these premises, the aim of the  present study was the description of clinical and anatomopathological  aspects of the disease, based on our experience in the management of  BRON-J.  From February 2004 to September 2006, 19 patients (14 females  and 5 males) with BRON-J undergoing intravenous biphosphonate treatments  for cancer were examined at the Oral Surgery Department of the Florence  University Hospital.28,29 The mean age was 66.4 ± 11.7.  In 14 patients  the used biphosphonate was zolendronate, in one patient pamidronate and  in four patients both drugs were administrated. The mean interval  administration was 12 months (minimum 5 months, maximum 36 months).  In  nine patients (47.4%) the oncologic disease was breast cancer, in six  patients (31.5%) myeloma, in three patients (15.8%) prostatic cancer,  and in one patient (5%) colon cancer. All the patients were chosen  following strict diagnostic criteria. The most frequent symptoms were:  spontaneous pain, swelling, odontogenic abscesses, oral fistulas, bone  exposure due to mucosal ulcer, post-extraction alveolitis, and local  limphoadenopathy.  The trigger factors were considered to be tooth  extractions in 10 patients (52.6%), local concussion (inadequate  removable total denture, edentulous ridges) in two (10.5%), root canal  treatment in two (10.5%), and surgery in three (15.7%). In some cases it  was not possible to identify a trigger factor. In 10 patients (52.6%) a  pre-existing inflammatory lesions appeared to worsen the development of  the disease.  The patients were treated with mouth rinses  (chlorhexidine gluconate 0.12% three times/daily); local or systemic  antibiotic therapy (amoxicillin 1 g three times/daily; repeated local  application of methronidazol) and, in case of mycotic overinfection,  with fluconazole 200 mg/daily. Furthermore patients underwent hyperbaric  treatment.  The treatment of this lesion is extremely difficult and  prolonged. There are no data to support any therapeutic choice: surgery  often worsens the pathology.  Surgical curettage to achieve mechanical  debridement are indicated in patients with no complications. More  invasive surgical treatment (such as deeper courettage,  sequestrectomies, large resections, and vascularized bone grafts) are  indicated after clinical changes characterized by clinical symptoms  (pain, fever), oral or extra oral fistula, necrotic tissue, pathologic  fractures and ineffective antibiotic treatment. In our study 13 patients  out of 19 were treated with curettage and two with major surgery  (segmentary mandibulectomy). Four patients were not operable.  After  one-year follow-up, in most of the cases complete healing was not  observed, although therapeutic protocol was strictly applied. All cases  of maxillary location (two out of 19) reached complete healing thanks to  secondary wound closure after two months from surgery. On the contrary  we observed only symptoms of improvement in case of mandibular location,  probably for the reduced regenerative capacity at this site.  In all  patients pharmacological biphosphonate treatment was suspended. The  interruption of biphosphonate assumption is one of the most difficult  decision and should be taken in agreement with the oncologist. According  to Migliorati and colleagues31 the suspension of biphosphonate  treatment is mandatory, even though there is no immediate clinical  improvement.  Results and discussion  The treatment of these lesions is  extremely difficult and prolonged. There are no data to prefer any  therapeutic choice over another, even though surgery appears to worsen  the disease’s course.  Surgical curettage to achieve mechanical  debridement is indicated in patients without complications. Chemical  debridement is carried out with antiseptic irrigations and with iodine  gauze. Re-infection prevention is improved by local ointment use and  0.12% chlorhexidine daily rinses. Surgical procedures to achieve a  mechanical debridement of necrotic tissue, broad spectrum antibiotic  treatment for a long period, and local antibiotic use are of benefit  before the progression to bone exposure and to small bone sequestra.  More invasive surgical treatment (such as deeper curettage,  sequestrectomies, large resections and vascularized bone grafts) are  indicated in the occurrence of systemic clinical symptoms (pain, fever),  of oral or extra-oral fistulas, of necrotic tissue, of pathologic  fractures, and of lack of response to antibiotic treatment. The necrotic  tissue curettage, sequestrectomy, sliding flap procedure (in two cases  with oro-antral communication) and peduncle vascularized bone graft (in  case of fracture) were the surgical treatments used in order to stop  osteonecrotic lesion progression (Figure 5).</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 5</strong> <img title="Osteonecrosis Figure 5" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-5.jpg" alt="" width="102" height="58" /> Spontaneous fracture of the lower jaw in patient   treated with Aredia<sup>®</sup> and Zometa<sup>®</sup> for 24 months (43   years old, female, breast cancer).</td>
</tr>
</tbody>
</table>
<p>Metastatic foci were not shown by histological examination both in  the lesion core and in the neighbouring bone tissue. Macroscopic healthy  bone samples showed cortical necrosis with well preserved lamellar  bone. Furthermore, empty osteocytic lacunae were detected and medullary  bone tissue appeared necrotic.  All cases of maxillary location reached  complete healing. In the majority of the cases of extra-maxillary  location, 14 patients (73.6%) complete healing was not achieved,  although the therapeutic protocols were strictly applied.28,29 We  observed only symptoms of improvement when the location was in the lower  jaw: five patients (26.3%), probably for the reduced regenerative  capacity at this site.  Following the American Association of Oral and  Maxillofacial Surgery’s staging and treatment criteria,12 two different  clinical courses have been identified: early clinical course, where a  small bone sequestrum was identified (Figure 6); and late clinical  course, where large neocrotic areas worsened by suppurative phlogosis  were detected (Figure 7).</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 6</strong> <img title="Osteonecrosis Figure 6" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-6.jpg" alt="" width="102" height="58" /> Early clinical picture of the lower jaw in   patient treated with Aredia<sup>®</sup> and Zometa<sup>®</sup> for 24 months   (48 years old, female, breast cancer).</td>
</tr>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 7</strong> <img title="Osteonecrosis Figure 7" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-7.jpg" alt="" width="100" height="88" /> Advanced lesion of the upper jaw in patient   treated with Zometa<sup>®</sup> for 12 months (69 years old, male, multiple   myeloma).</td>
</tr>
</tbody>
</table>
<p>The present data showed a higher incidence of BRON-J in patients  treated with intravenous zolendronate and pamidronate. Clinical pictures  varied from a more limited osteonecrosis areas with or without  suppurative phlogosis to larger osteonecrotic areas with suppurative  phlogosis, jaw fractures and extra-oral fistulae (Figure 8).</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 8</strong> <img title="Osteonecrosis Figure 8" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-8.jpg" alt="" width="102" height="58" /> Abscessual complication of necrotic bone lesion   in patient treated with Zometa<sup>®</sup> for 11 months (61 years old, male,   prostatic cancer).</td>
</tr>
</tbody>
</table>
<p>In nine patients (47.3%) we noticed a heavy odontalgia following the  extraction of teeth located in the maxillary area involved by BRON-J.  Before teeth extraction, the pain was referred to periodontitis  involving both the involved teeth and the maxillary area close to them.  The role of biphosphonates in the onset of the lesion was confirmed by  the time elapsed between drug assumption and the lesions’ development  (about 18 months for zoledronate and about six years for pamidronate),30  with reports of lesions initiated even after five months from the  beginning of treatment.31,32 All the patients of our study underwent a  drug treatment longer than six months. The length of biphosphonate  treatment represents a risk factor for BRON-J along with chemotherapy,  multiple myeloma, renal failure, corticosteroid treatment, anemia,  hypoproteinemia, infections etc.30,34 Six patients out of 14 under  chemotherapeutic and radiotherapy treatment presented larger tissue  necrosis refractory to the applied therapeutic protocols.  In our study,  preferential location of osteonecrotic lesions was in the lower jaw: in  14 patients (73.6%) the location was in the mandible, in two patients  (10.6%) was both mandible and maxillary, and in three patients (15.8%)  was only maxillary. The location in the mandible seems to be explained  by terminal vascularization, lower quantity of trabecular bone in the  lower jaw, and more frequent microinjures due to removable denture and  masticatory forces.3,20  In order to categorize patients with BRON-J,  the American Association of Oral and Maxillofacial Surgeons recognized  three stages of the disease.12 In stage 1, the bone is exposed but there  is no soft tissue inflammatory swelling. Sometimes there is pain before  bone exposure. In stage 2, bone is exposed with associated pain and  soft tissue infection. In stage 3, the patient is affected by the  pathologic fractures, oral and extra-oral fistulae.  According to  previous publications.16,35,36 and American Association of Oral and  Maxillofacial Surgeons’ guidelines, we treated patients in Stage 1 (five  patients; 26,3%) and Stage 2 (nine patients; 47.4%), with small  sequestra, using pharmacologic and conservative protocols. In Stage 3  (five patients; 26.3%), when the large suppurative necrotic area did not  heal, the conservative treatment led to poor results so a more invasive  surgical treatment should be indicated (Table 1).37</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697532/table/t1-tcrm-5-0217/"><img title="Table 1" src="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/table-icon.gif" alt="" width="100" height="76" /></a></td>
<td valign="top"><strong>Table 1</strong> Treatment of patients with osteonecrosis of the   jaw</td>
</tr>
</tbody>
</table>
<p>Under a therapeutic point of view the clinician should be paid  attention to the perimaxillary soft tissue study, and to their  vascularization since a periostium and mucosa highly vascularized are  the only possibility to try to cover the necrotic area after the removal  of the sequestrum.  Oxygen therapy with a hyperbaric chamber is useful  to prepare the patient to the surgical treatment and platelet-rich  plasma to improve soft tissue attachment (Figure 9).38–42</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top"></td>
<td valign="top"><strong>Figure 9</strong> <img title="Osteonecrosis Figure 9" src="http://www.healinglightseminars.com/wp-content/uploads/2010/09/osteonecrosis_figure-9.jpg" alt="" width="100" height="88" /> Use of platelet-rich plasma in the surgical   treatment of the lesion in patient treated with Zometa<sup>®</sup> for 12   months (59 years old, female, breast cancer).</td>
</tr>
</tbody>
</table>
<p><strong>Conclusions</strong></p>
<p>In conclusion, BRON-J shows a complex clinical picture of unclear  pathogenesis, even though it seems clearly related to intravenous  biphosphonate administration. Numerous retrospective studies confirmed  that pharmacologic and surgical therapies are not able to cure this  complication, whose consequences are extremely invalidating for the  patient. For this reason, several scientific societies underlined the  importance of a risk staging for preventing the development of the  disease in oncologic patients treated with intravenous biphosphonates as  an adjuvant intervention.4,12,23,24  In the most severe cases the  treatment should guarantee: pain relief, control of the infection,  prevention of the necrotic area spreading, and of the development of new  contiguous lesions. When pharmacologic treatments with antibiotics and  local antiseptics are not able to control the development of BRON-J’s  complications, the clinicians should perform radical surgical  treatments, such as the resection of the bone involved followed by  reconstructive surgery with vascularized bone grafts.16 Today,  prevention is mandatory in patients who have to be treated with  biphosphonates43 and in those that are under treatment for a long period  of time.  A multidisciplinary team composed by oncologists,  pathologists, bone metabolism specialists, dentists, oral surgeons, and  maxillofacial surgeons must cooperate to carefully evaluate the  patients’ clinical conditions, general and local risk factors,  radiological and biohumoral exams, are useful in the prevention and in  the staging of the disease.  <strong> </strong></p>
<p><strong>Footnotes</strong></p>
<p>Disclosure  The authors report no conflicts of interest in this work.</p>
<p>References</p>
<p>1. Marx R. Pamidronate (Aredia) and zoledonate (Zometa) induced  avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac  Surg. 2003;61:1115–1117. [PubMed]</p>
<p>2. Ruggiero SL, Mehrota B. Osteonecrosis of the jaws associated with  the use of bisphophonates; a review of 63 cases. J Oral Maxillofac Surg.  2004;62:527–534. [PubMed]</p>
<p>3. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonates-induced  exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors,  recognition, prevention and treatment. J Oral Maxillofac Surg.  2005;63:1567–1575. [PubMed]</p>
<p>4. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo  SB. Managing the care of patients with bisphosphonate-associated  osteonecrosis: an American Academy of Oral Medicine position paper. J Am  Dent Assoc. 2005;136:1658–1668. Erratum in: <em>J Am Dent Assoc</em>. 2006;137:26. [PubMed]</p>
<p>5. Badros A, Weichel D. Osteonecrosis of the jaw in multiple myeloma  patients: clinical features and risk factors. J Clin Oncol.  2006;24:945–952. [PubMed]</p>
<p>6. Dimopoulos MA, Kastritis E. Osteonecrosis of the jaw in patient  with multiple myeloma treated with bisphosphonates: evidence of  increased risk after treatment with zoledronic acid. Haematologica.  2006;91:968–971. [PubMed]</p>
<p>7. Tosi P, Zamagni E. Osteonecrosis of the jaw in newly diagnosed  multiple myeloma patient treated with zoledronic acid and  thalidomide-dexamethasone. Blood. 2006;108:3951–3952. [PubMed]</p>
<p>8. Major PP, Cook RJ. Multiple event analysis of zoledronic acid  trials in patients with cancer metastases to bone. Proc Am Soc Clin  Oncol. 2003;22:762.</p>
<p>9. Rosen LS, Gordon DH. Zoledronic acid is superior to pamidronate  for the treatment of bone metastases in breast carcinoma patients with  at least one ostelytic lesion. Cancer. 2004;100:36–43. [PubMed]</p>
<p>10. Berenson JR, Hillner BE, Kyle RA, et al. American Society of  Clinical Oncology Bisphosphonates Expert Panel. American Society of  Clinical Oncology clinical practice guidelines: the role of  bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20:3719–3736.  [PubMed]</p>
<p>11. Body JJ. Breast cancer: bisphosphonates therapy for metastatic bone disease. Clin Cancer Res. 2006;12(20 Suppl):6258–6263.</p>
<p>12. American Association of Oral and Maxillofacial Surgeons Position  paper on bisphosphonate-related osteonecrosis of the jaws, approved by  the Board of Trustees September 25, 2006 [cited on 2008 Dec 6]Available  from http://www.aaoms.org/docs/position_papers/osteonecrosis.pdf.</p>
<p>13. Durie BGM, Katz M, editors. Osteonecrosis of the jaws and  bisphosphonates N Engl J Med 2005. 35399–102.discussion 99–102. [PubMed]</p>
<p>14. Hillner BE, Ingle JN. ASCO 2003 update on the role of  Bisphosphonates and bone health issues in women with breast cancer. J  Clin Oncol. 2003;21:40–42.</p>
<p>15. Bilezikian JP. Osteonecrosis of the jaw. Do Bisphosphonates pose a risk? N Engl J Med. 2006;355:2278–2281. [PubMed]</p>
<p>16. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related  osteonecrosis of the jaw: background and guidelines for diagnosis,  staging and management. Oral Surg Oral Med Oral Path Oral Rad Endod.  2006;102:433–441.</p>
<p>17. Conte PF, Guarnieri V. Safety of intravenous and oral  bisphosphonates and compliance with dosing regimens. Oncologist.  2004;9(Suppl 4):28–37. [PubMed]</p>
<p>18. Peterson LJ, Ellis E. Contemporary oral and maxillofacial surgery. New York: Mosby; 1998. pp. 418–432.</p>
<p>19. Viale PH, Lin A. Exposed bone in oral cavities. J Clin Oncol Nurs. 2005;9:355–357.</p>
<p>20. Ficarra G, Beninati F, Rubino I, et al. Osteonecrosis of the jaws  in periodontal patients with a history of bisphosphonates treatment. J  Clin Periodontol. 2005;32:1125–1128.0</p>
<p>21. Chiandussi S, Biasiotto M, Dore F, Cavalli F, Cova MA, Di  Leonarda R. Clinical and diagnostic imaging of bisphosphonate-associated  osteonecrosis of the jaws. Dentomaxillofac Radiol. 2006;35:236–243.  [PubMed]</p>
<p>22. Hermans R, Fossion E, Ioannides C, Van de Bogaert W, Ghekiere J,  Baert AL. CT findings in osteoradionecrosis of the mandibule. Skeletal  Radiol. 1996;25:31–36. [PubMed]</p>
<p>23. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review:  bisphosphonates and osteonecrosis of the jaws. Ann Intern Med.  2006;144:753–761. [PubMed]</p>
<p>24. Resza AA, Rodan GA. Nitrogen-containing bisphosphonates mechanism of action. Mini Rev Med Chem. 2004;4:711–719. [PubMed]</p>
<p>25. Green JR. Bisphosphonates preclinical review. Oncologist. 2004;9(Suppl 4):3–13. [PubMed]</p>
<p>26. Nase JB, Suzuki JB. Osteonecrosis of the jaw and oral  bisphosphonate treatment. J Am Dent Assoc. 2006;137:1115–1119. [PubMed]</p>
<p>27. Vescovi P, Merigo E, Melet M, Manfredi M.  Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possibile  treatment? J Oral Maxillofac Surg. 2006;64:1460–1462. [PubMed]</p>
<p>28. Tonelli P, Duvina M, Brancato L, Viviani C. Osteonecrosis of the  jaw: A dramatic complication in patients with history of bisphosphonates  treatment and bone disease. Study of 19 cases. Monaco: Poster Session  in International Symposium, Osteology; May 10–12, 2007.</p>
<p>29. Borgioli A, Tonelli P, Brandi ML, Giombetti A, Duvina M, Spinelli  G, Brancato L. Osteonecrosi dei mascellari da bifosfonati. L’Esperienza  Fiorentina: Aspetti clinici e terapeuticiAlessandria: Abstract  Presentation in Workshop: BRONJ, present and future, gennaio 20, 2007.</p>
<p>30. Durie BG. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99–102. [PubMed]</p>
<p>31. Migliorati CA, Schubert MM, Peterson DE, Seneda LM.  Bisphosphonate-associated osteonecrosis of mandibular bone. Cancer.  2005;104(1):83–93. [PubMed]</p>
<p>32. Jimenez-Soriano Y, Bagan JV. Bisphosphonates as a new cause of  drug-induced jaw osteonecrosis: an update. Med Oral Patol Oral Cir  Bucal. 2005;10(Suppl 2):88–91. [PubMed]</p>
<p>33. Robinson NA. Bisphosphonates a word of caution. Ann Acad Med Singapore. 2004;33:48–49. [PubMed]</p>
<p>34. Novartis Pharmaceuticals CorporationAppendix 11: Expert panel  recommendation for the prevention, diagnosis and treatment of  osteonecrosis of the jaw. Oncologic Drugs Advisory Committee (ODAC),  Meeting March 4, 2005 [cited 2008 Dec 6]. Available from:  http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/2005-4095B2_02_12-Novartis-Zometa-App-11.pdf.</p>
<p>35. Mehrotra B, Ruggiero S. Bisphosphonates complications including  osteonecrosis of the jaw. Hematology Am Soc Hematolol Educ Program.  2006;3:356–360.</p>
<p>36. Ruggiero SL, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM.  Practical guidelines for the prevention, diagnosis and treatment of  osteonecrosis of the jaw in patients with cancer. J Clin Oncol Prac.  2006;2:7–14.</p>
<p>37. Zavras AL, Zhu S. Bisphosphonates are associated with increased  risk for jaw surgery in medical claims data: is it osteonecrosis? J Oral  Maxillofac Surg. 2006;64:917–923. [PubMed]</p>
<p>38. Martins M, Saraceni G, Koga DH, Feber O, Olivetra dos Santos M,  Zardetto C. Treatment of avascular osteonecrosis of the mandibule in  cancer patients with a history of bisphosphonate therapy by combining  bone resection and autologous platelet-rich plasma: report of 3 cases. J  Oral Maxillofac Surg. 2007;65:349–355. [PubMed]</p>
<p>39. Shimura K, Shimazaki C, Taniguchi K, et al. Hyperbaric oxygen in  addition to antibiotic therapy is effective for bisphosphonate-induced  osteonecrosis of the jaw in a patient with multiple myeloma. Int J  Hematol. 2006;84:343–345. [PubMed]</p>
<p>40. Tonelli P, Brancato L, Paggetti B, Duvina M, Borgioli A. La  terapia iperbarica nel trattamento dell’osteomielite dei mascellari.  Rome: Sessione Poster Collegio dei Docenti in Odontoiatria Roma; 2004.</p>
<p>41. Giombetti A, Borgioli A, Brancato L, Spinelli G. L’Osteomielite  farmacologica dei mascellari. Montecatini Terme: Poster Presentation,  Congresso Nazionale della Società Italiana di Chirurgia Orale (SICO): la  Pianificazione del trattamento in Chirurgia Orale; Ottobre 7–8, 2005.</p>
<p>42. Borgioli A, Duvina M, Brancato L, Duvina G, Tonelli P. Bad and  good bisphosphonates in implantology: Clinical report. Rome: Sessione  Poster Collegio dei Docenti in Odontoiatria Roma; 2007.</p>
<p>43. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of  bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral  Maxillofac Surg. 2007;65:415–423.[PubMed]</p>
<p>Lasers Med Sci. 2009 Nov;24(6):849-56. Epub 2009 Mar 11.</p>
<h1>Osteonecrosis of the jaws caused by biphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser.</h1>
<p>Angiero F, Sannino C, Borloni R, Crippa R, Benedicenti S, Romanos GE.   Pathological Anatomy, University of Milan-Bicocca, Ospedale S Gerardo  Monza, Milan, Italy. <a href="mailto:f.angiero@teos.it">f.angiero@teos.it</a></p>
<p>A series of 49 patients diagnosed with osteonecrosis and all treated  with latest-generation bisphosphonates was reviewed retrospectively to  evaluate the use of erbium-doped: yttrium, aluminum, and garnet laser  (Er:YAG) in terms of clinical outcome, and examine current trends from  the clinical-therapeutic standpoint. Pathology reports on specimens  submitted over the previous 7 years from either the mandible or the  maxilla were reviewed; 49 patients were identified as having  osteonecrosis of the jaws. For each of these cases, the medical history  and profile were evaluated; 19 were treated with conservative therapy,  20 with radical surgery, and 10 with Er:YAG laser (2,940 nm). Of the 20  patients treated surgically (bone baquette, curettage, sequestrectomy of  the necrotic bone), some required re-treatment, which resulted in bone  fracturing. None of the patients were treated successfully. The 19 cases  treated conservatively produced an improvement in symptoms, but not  remission of the lesions. Of the ten patients treated with Er:YAG laser,  six achieved total remission of signs and symptoms, four an  improvement, and re-treatment was required in one case. Our present  approach is to recommend intensive prophylactic care before the  administration of bisphosphonates, and great caution is advised even in  simple maneuvers like curettage, because this may exacerbate the  avascular process. The use of Er:YAG laser appears to be promising  (within the limits of our experience). It can be concluded that at 1  year of laser surgery, the treatment led to significant improvements in  clinical parameters, and may represent a valid alternative, although  studies on a larger scale are needed.</p>
<p>Lasers Surg Med. 2009 Jan;41(1):26-30.  <strong> </strong></p>
<h1>A preliminary report about treatment of biphosphonate related osteonecrosis of the jaw with Er:YAG laser ablation.</h1>
<p><strong> </strong> Stübinger S, Dissmann JP, Pinho NC, Saldamli B,  Seitz O, Sader R.  Hightech Research Center of Cranio-Maxillofacial  Surgery, University of Basel, Basel, Switzerland. <a href="mailto:sstuebinger@uhbs.ch">sstuebinger@uhbs.ch</a></p>
<p>BACKGROUND AND OBJECTIVES: This preliminary report describes a new  laser-assisted treatment option for the emerging complication of  bisphosphonate related osteonecrosis (BON) of the jaw.</p>
<p>MATERIALS AND METHODS: In eight tumour patients (three women, five  men) ten bony lesions in the maxilla and mandible in the course of  intravenous bisphosphonate therapy were treated with a variable square  pulsed (VSP) Er:YAG laser. For the treatment, the Er:YAG laser was  applied with a pulse energy of 1,000 mJ, a pulse duration of 300  microseconds, and a frequency of 12 Hz (energy density 157 J/cm(2)). The  spot size was 0.9 mm and the handpiece was kept at a distance of about  10 mm from the bone surface. The diseased bone was ablated exclusively  with the Er:YAG laser by subsequently sweeping the bone surface in a  well directed scanning mode.</p>
<p>RESULTS: The surgical procedure and postoperative wound healing were  without any complications and a complete soft tissue recovering was  achieved within 4 weeks. During follow-up examinations over 12 months  soft tissue conditions were stable. The pulsed laser ablation caused a  characteristic microstructured and craggy bone surface without a  condensation or a smear layer on the laser rims.</p>
<p>CONCLUSION: The bone ablation technique using a VSP Er:YAG laser  yielded promising clinical results without impairment of wound healing. A  further analyse of the chemical, physical and pharmacological aspects  of laser assisted treatment of BON lesions is necessary to get a safe  and reliable treatment protocol for bisphosphonate-related osteonecrosis  of the jaw.</p>
<p>Rev Belge Med Dent. 2009;64(2):87-95.</p>
<h1>Surgical treatment of maxillary osteonecrosis due to biphosphonates  using an Er:YAG (2940 nm) laser.  Discussion of 17 clinical cases</h1>
<p>[Article in French]</p>
<p>Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca EP, De Moor RJ, Nammour S.</p>
<p>Department of ENT/Dental/Ophthalmological and Cervico-Facial  Sciences, Università degli Studi di Parma, Via Gramsci 14, 43100 Parma,  Italy. <a href="mailto:paolo.vescovi@unipr.it">paolo.vescovi@unipr.it</a></p>
<p>Reports of cases of ONJ are significantly increased during the last  five years as a iatrogenic complication of therapy with bisphosphonates  (BPT). The aim of this work is to present the advantages of surgery  using Er:YAG laser for treatment of ONJ. Er:YAG laser can gradually  reach the healthy bone without causing any heating damage of tissues.  This device results very versatile and gives the possibility of choose  among different surgical techniques depending by the case (e.g.:  vaporization or ostectomy). Moreover, different studies have  demonstrated the presence of both bactericidal and biomodulating effect  on bone and surrounding tissues, with biostimulation of microcirculation  and neoangiogenesis. Seventeen sites of ONJ, classified according to  the staging system developed by Ruggiero and observed in 12 patients  with multiple myeloma (9 patients), bone metastases (2 patients) and  osteoporosis (1 patient), were treated with Er:YAG laser (Fidelis Plus,  Fotona-Slovenia). Laser device was used in non-contact or near-contact  way (VSP, 300 m3 30 Hz, Fluence 60 J/cm2) on 17 sites (4 Stage I and 13  Stage II) on 3 different types of surgery: sequestrectomy + debridement,  sequestrectomy + corticotomy and vaporization. For an average follow-up  of 9 months (SD +/- 6 months), complete healing of ONJ (Stage 0) was  obtained for 13 sites (76.5%) and resolution of symptoms was obtained  (Stage 1) for 3 sites (17.5%). For one site at Stage II (6%), recovery  was obtained but this result was not maintained over 3 months. Positive  results were independent by the anatomical area (mandible or maxilla),  primary disease (osteoporosis, multiple myelomas or metastasis) and  discontinuation of BPT before surgery. Er:YAG laser (2940 nm), in our  experience, represents a valid therapeutic option for ONJ-BP related,  especially in early stages of the disease.</p>
<p>Photomed Laser Surg. 2008 Feb;26(1):37-46</p>
<h1>Nd:YAG laser biostimulation in the treatment of  biphosphonate-associated osteonecrosis of the jaw: clinical experience  in 28 cases.</h1>
<p>Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S.</p>
<p>Unit of Oral Pathology and Medicine, Section of Dentistry, Department  of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University  of Parma, Parma, Italy. <a href="mailto:paolo.vescovi@unipr.it">paolo.vescovi@unipr.it</a></p>
<p>OBJECTIVE: To research an efficient treatment for the management of bisphosphonate-associated osteonecrosis.</p>
<p>BACKGROUND DATA: Necrosis of the jawbone has recently been described  in association with systemic bisphosphonate therapy with drugs including  zoledronic acid, pamidronate, and alendronate. The extent and clinical  characteristics of bisphosphonate-associated osteonecrosis (BON) of the  jaw are extremely variable, and range from the presence of fistulae in  the oral mucosa or orofacial tissues, to large exposed areas of necrotic  bone within the oral cavity. Clinical signs and symptoms commonly  reported include pain, swelling, the presence of pus, loose teeth,  ill-fitting dentures, and paresthesias of the inferior alveolar nerve  when the necrosis affects the mandible. Fractures have also been  reported. The treatment of BON of the jaw is still controversial since  no therapy has proven to be efficacious as shown by the literature on  the subject.</p>
<p>MATERIALS AND METHODS: In this study we report results achieved with  28 patients affected by BON of the jaw, who received treatment with the  Nd:YAG laser alone or in combination with conventional medical or  surgical treatment. Clinical variables such as severity of symptoms,  presence of pus, and closure of mucosal flaps before and after therapy  were evaluated to establish the effectiveness of laser irradiation. The  28 patients with BON were subdivided into four groups: eight patients  were treated with medical therapy only (antibiotics with or without  antimycotics and/or antiseptic rinses), six patients were treated with  medical and surgical therapy (necrotic bone removal and bone curettage),  six patients were treated with medical therapy associated with laser  biostimulation, and eight patients were treated with medical therapy  associated with both surgical therapy and laser biostimulation.</p>
<p>RESULTS: Of the 14 patients who underwent laser biostimulation, nine  reported complete clinical success (no pain, symptoms of infection, or  exposed bone or draining fistulas), and three improved their  symptomatology only, with a follow-up of between 4 and 7 mo.  CONCLUSIONS: While the results reported in this study are not  conclusive, they indicate that laser therapy has potential to improve  management of BON.</p>
<p>Acta Biomed. 2006 Aug;77(2):109-17.  <strong> </strong></p>
<h1>Bone necrosis of the jaws associated with biphosphonate treatment: a report of twenty-nine cases.</h1>
<p>Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E,  D’Aleo P, Corradi D, Corcione L, Sesenna E, Ferrari S, Poli T,  Bonaninil M, Vescovi P.</p>
<p>Unit of Oral Pathology and Medicine, Section of Odontostomatology,  Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences,  University of Parma, Parma, Italy.<a href="mailto:elisabetta.merigo@unipr.it">elisabetta.merigo@unipr.it</a></p>
<p>Bone necrosis of the jaws is often related to head and neck  radiotherapy, to surgical procedures at maxillary or mandibular level  but also to various local and systemic factors such as haematological  diseases, haemoglobinopathies and systemic lupus eritematosus; its  pathogenesis maybe associated with defects of vascularization.  Bisphosphonate are synthetic analogues of pyrophosphate used for the  treatment of hypercalcemia in patients with malignancies and bone  metastasis and for the treatment of many other disorders such as  metabolic bone diseases, Paget’s disease, and osteoporosis; their  pharmacological activity is related to the inhibition of the  osteoclastic function which leads to resorption and reduction of bone  vascularization. Since the end of 2003 Bisphosphonate-associated  Osteonecrosis (BON) has become an increasing problem and the test of  that is the increase of the relative published case report and case  series. Here we report 29 cases of bone necrosis of the jaws in patients  treated with pamidronate (Aredia), zoledronate (Zometa) and  alendronate: 15 underwent surgical procedures and 14 occurred  spontaneously. Among these patients (21 females, 8 males; mean age  between 45 and 83 years); 14 were treated for bone metastasis, 12 for  multiple myeloma and 3 for osteoporosis. Bone necrosis involved only  maxilla in 7 patients, only mandible in 20 patients and both in 2  patients. Six patients had multiple osteonecrotic lesions, 3  contemporary lesions and 3 non contemporary. In these patients we  performed 3 kinds of therapy, associated or not: medical therapy (with  antibiotic drugs, antimycotics and antiseptic mouthwashes), surgical  therapy with curettage or sequestrectomy and Nd:YAG laser  biostimulation.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/laser-therapy-effective-treats-bronj/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bio-electromagnetic therapy in osteoporosis and bone healing</title>
		<link>http://www.cooperativemedicine.com/bioelectromagnetic-articles/bio-electromagnetic-therapy-in-osteoporosis-and-bone-healing/</link>
		<comments>http://www.cooperativemedicine.com/bioelectromagnetic-articles/bio-electromagnetic-therapy-in-osteoporosis-and-bone-healing/#comments</comments>
		<pubDate>Sat, 19 Nov 2011 22:54:44 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Bioelectromagnetic Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2250</guid>
		<description><![CDATA[Int J Immunopathol Pharmacol.  2011 Jan-Mar;24(1 Suppl 2):17-20. Stimulation of bone formation and fracture healing with pulsed electromagnetic fields: biologic responses and clinical implications. Chalidis B, Sachinis N, Assiotis A, Maccauro G. Source Interbalkan Medical Center, Orthopaedic Department, Thessaloniki, Greece. Abstract Pulsed electromagnetic fields (PEMF) have been used for several years to supplement bone healing. [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<div>
<div>Int J Immunopathol Pharmacol.  2011 Jan-Mar;24(1 Suppl 2):17-20.</div>
<h1>Stimulation of bone formation and fracture healing with pulsed  electromagnetic fields: biologic responses and clinical implications.</h1>
<div>Chalidis B, Sachinis N, Assiotis A, Maccauro G.</div>
<div>
<p><strong>Source</strong></p>
<p>Interbalkan Medical Center, Orthopaedic Department, Thessaloniki, Greece.</p>
</div>
<div>
<p><strong>Abstract</strong></p>
<p>Pulsed electromagnetic fields (PEMF) have been used for several years  to supplement bone healing. However, the mode of action of this  non-invasive method is still debated and quantification of its effect on  fracture healing is widely varied. At cellular and molecular level,  PEMF has been advocated to promote the synthesis of extracellular matrix  proteins and exert a direct effect on the production of proteins that  regulate gene transcription. Electromagnetic fields may also affect  several membrane receptors and stimulate osteoblasts to secrete several  growth factors such as bone morphogenic proteins 2 and 4 and TGF-beta.  They could also accelerate intramedullary angiogenesis and improve the  load to failure and stiffness of the bone. Although healing rates have  been reported in up to 87 % of delayed unions and non-unions, the  efficacy of the method is significantly varied while patient or fracture  related variables could not be clearly associated with a successful  outcome.</p>
</div>
<p>MC Musculoskelet Disord. 2010 Aug 23;11(1):188. [Epub ahead of print]</p>
<h1>Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study.</h1>
<p>Jansen JH, van der Jagt OP, Punt BJ, Verhaar JA, van Leeuwen JP, Weinans H, Jahr H.</p>
<h3>Abstract</h3>
<p>ABSTRACT:</p>
<p>BACKGROUND: Although pulsed electromagnetic field (PEMF) stimulation  may be clinically beneficial during fracture healing and for a wide  range of bone disorders, there is still debate on its working mechanism.  Mesenchymal stem cells are likely mediators facilitating the observed  clinical effects of PEMF. Here, we performed in vitro experiments to  investigate the effect of PEMF stimulation on human bone marrow-derived  stromal cell (BMSC) metabolism and, specifically, whether PEMF can  stimulate their osteogenic differentiation.</p>
<p>METHODS: BMSCs derived from four different donors were cultured in  osteogenic medium, with the PEMF treated group being continuously  exposed to a 15 Hz, 1 Gauss EM field, consisting of 5-millisecond bursts  with 5-microsecond pulses. On culture day 1, 5, 9, and 14, cells were  collected for biochemical analysis (DNA amount, alkaline phosphatase  activity, calcium deposition), expression of various osteoblast-relevant  genes and activation of extracellular signal-regulated kinase (ERK)  signaling. Differences between treated and control groups were analyzed  using the Wilcoxon signed rank test, and considered significant when p  &lt; 0.05.</p>
<p>RESULTS: Biochemical analysis revealed significant, differentiation  stage-dependent, PEMF-induced differences: PEMF increased mineralization  at day 9 and 14, without altering alkaline phosphatase activity. Cell  proliferation, as measured by DNA amounts, was not affected by PEMF  until day 14. Here, DNA content stagnated in PEMF treated group,  resulting in less DNA compared to control. Quantitative RT-PCR revealed  that during early culture, up to day 9, PEMF treatment increased mRNA  levels of bone morphogenetic protein 2, transforming growth factor-beta  1, osteoprotegerin, matrix metalloproteinase-1 and -3, osteocalcin, and  bone sialoprotein. In contrast, receptor activator of NF-kappaB ligand  expression was primarily stimulated on day 14. ERK1/2 phosphorylation  was not affected by PEMF stimulation.</p>
<p>CONCLUSIONS: PEMF exposure of differentiating human BMSCs enhanced  mineralization and seemed to induce differentiation at the expense of  proliferation. The osteogenic stimulus of PEMF was confirmed by the  up-regulation of several osteogenic marker genes in the PEMF treated  group, which preceded the deposition of mineral itself. These findings  indicate that PEMF can directly stimulate osteoprogenitor cells towards  osteogenic differentiation. This supports the theory that PEMF treatment  may recruit these cells to facilitate an osteogenic response in vivo.</p>
<p>Electrophoresis. 2010 Jul 21. [Epub ahead of print]</p>
<h1>A microfluidic magnetic bead impact generator for physical stimulation of osteoblast cell.</h1>
<p>Song SH, Choi J, Jung HI.</p>
<p>Laboratory of Biochip Technology, School of Mechanical Engineering Yonsei University, Seoul, South Korea.</p>
<h3>Abstract</h3>
<p>We developed a novel microfluidic cell culture device in which  magnetic beads repetitively collide with osteoblast cells, MC3T3-E1,  owing to attractive forces generated by pulsed electromagnetic fields  and consequently the cells were physically stimulated by bead impacts.  Our device consists of an on-chip microelectromagnet and a microfluidic  channel which were fabricated by a microelectromechanical system  technique. The impact forces and stresses acting on a cell were  numerically analyzed and experimentally generated with different sizes  of bead (4.5, 7.6 and 8.4 mum) and at various pulse frequencies (60 Hz, 1  kHz and 1 MHz). Cells were synchronized at each specific phase of the  cell cycle before stimulation in order to determine the most susceptible  phase against bead impacts. The cells were stimulated with different  sizes of bead at various pulse frequencies for 1 min at G1, S and G2  phases, respectively, and then counted immediately after one doubling  time. The growth rate of cells was highly accelerated when they were  stimulated with 4.5 mum beads at G1 phase and a pulse frequency of 1  MHz. Almost all of the cells were viable after stimulation, indicating  that our cell stimulator did not cause any cellular damage and is  suitable for use in new physical stimulus modalities.</p>
<p>Clin Orthop Relat Res. 2010 Aug;468(8):2260-77. Epub 2010 Apr 13.</p>
<h1>Effects of pulsed electromagnetic fields on human osteoblastlike cells (MG-63): a pilot study.</h1>
<p>Sollazzo V, Palmieri A, Pezzetti F, Massari L, Carinci F.</p>
<p>Istituto di Clinica Ortopedica Università di Ferrara, Corso Giovecca 203, 44100 Ferrara, Italy. <a href="mailto:slv@unife.it">slv@unife.it</a></p>
<h3>Abstract</h3>
<p>BACKGROUND: Although pulsed electromagnetic fields (PEMFs) are used  to treat delayed unions and nonunions, their mechanisms of action are  not completely clear. However, PEMFs are known to affect the expression  of certain genes.</p>
<p>QUESTIONS/PURPOSES: We asked (1) whether PEMFs affect gene expression  in human osteoblastlike cells (MG63) in vitro, and (2) whether and to  what extent stimulation by PEMFs induce cell proliferation and  differentiation in MG-63 cultures.</p>
<p>METHODS: We cultured two groups of MG63 cells. One group was treated  with PEMFs for 18 hours whereas the second was maintained in the same  culture condition without PEMFs (control). Gene expression was evaluated  throughout cDNA microarray analysis containing 19,000 genes spanning a  substantial fraction of the human genome.</p>
<p>RESULTS: PEMFs induced the upregulation of important genes related to  bone formation (HOXA10, AKT1), genes at the transductional level  (CALM1, P2RX7), genes for cytoskeletal components (FN1, VCL), and  collagenous (COL1A2) and noncollagenous (SPARC) matrix components.  However, PEMF induced downregulation of genes related to the degradation  of extracellular matrix (MMP-11, DUSP4).</p>
<p>CONCLUSIONS AND CLINICAL RELEVANCE: PEMFs appear to induce cell  proliferation and differentiation. Furthermore, PEMFs promote  extracellular matrix production and mineralization while decreasing  matrix degradation and absorption. Our data suggest specific mechanisms  of the observed clinical effect of PEMFs, and thus specific approaches  for use in regenerative medicine.</p>
<p>Bioelectromagnetics. 2010 May;31(4):277-85.</p>
<h1>EMF acts on rat bone marrow mesenchymal stem cells to promote  differentiation to osteoblasts and to inhibit differentiation to  adipocytes.</h1>
<p>Yang Y, Tao C, Zhao D, Li F, Zhao W, Wu H.</p>
<p>Department of Orthopedics, Tongji Hospital, Medical College, Huazhong University of Science and Technology, Wuhan, China.</p>
<h3>Abstract</h3>
<p>The use of electromagnetic fields (EMFs) to treat nonunion fractures  developed from observations in the mid-1900s. Whether EMF directly  regulates the bone marrow mesenchymal stem cells (MSCs), differentiating  into osteoblasts or adipocytes, remains unknown. In the present study,  we investigated the roles of sinusoidal EMF of 15 Hz, 1 mT in  differentiation along these separate lineages using rat bone marrow  MSCs. Our results showed that EMF promoted osteogenic differentiation of  the stem cells and concurrently inhibited adipocyte formation. EMF  increased alkaline phosphatase (ALP) activity and mineralized nodule  formation, and stimulated osteoblast-specific mRNA expression of RUNX2,  ALP, BMP2, DLX5, and BSP. In contrast, EMF decreased adipogenesis and  inhibited adipocyte-specific mRNA expression of adipsin, AP-2, and  PPARgamma2, and also inhibited protein expression of PPARgamma2. These  observations suggest that commitment of MSCs into osteogenic or  adipogenic lineages is influenced by EMF.</p>
<p>Stem Cells Dev. 2010 May;19(5):731-43.</p>
<h1>Static electromagnetic fields induce vasculogenesis and  chondro-osteogenesis of mouse embryonic stem cells by reactive oxygen  species-mediated up-regulation of vascular endothelial growth factor.</h1>
<p>Bekhite MM, Finkensieper A, Abou-Zaid FA, El-Shourbagy IK, Omar KM, Figulla HR, Sauer H, Wartenberg M.</p>
<p>Department of Internal Medicine I, Cardiology Division, Friedrich Schiller University Jena, Germany.</p>
<h3>Abstract</h3>
<p>Electromagnetic fields (EMFs) are used to treat bone diseases.  Herein, the effects of static EMFs on chondroosteogenesis and  vasculogenesis of embryonic stem (ES) cells and bone mineralization of  mouse fetuses were investigated. Treatment of differentiating ES cells  with static EMFs (0.4-2 mT) stimulated vasculogenesis and  chondro-osteogenesis and increased reactive oxygen species (ROS), which  was abolished by the free radical scavengers trolox, 1,10-phenanthroline  (phen), and the NAD(P)H oxidase inhibitor diphenylen iodonium (DPI). In  contrast, EMFs of 10 mT field strength exerted inhibitory effects on  vasculogenesis and chondro-osteogenesis despite robust ROS generation.  EMFs of 1 mT and 10 mT increased and decreased vascular endothelial  growth factor (VEGF) expression, respectively, which was abolished by  DPI and radical scavengers. EMFs activated extracellular-regulated  kinase 1/2 (ERK1/2), p38, and c-jun N-terminal kinase (JNK), which was  sensitive to DPI treatment. The increase in VEGF by EMFs was inhibited  by the ERK1/2 inhibitor U0126 but not by SB203580 and SP600125, which  are p38 and JNK inhibitors, respectively, suggesting VEGF regulation by  ERK1/2. Chondroosteogenesis and vasculogenesis of ES cells was blunted  by trolox, DPI, and the VEGF receptor-2 (flk-1) antagonist SU5614. In  mouse fetuses 1 mT EMFs increased and 10 mT EMFs decreased bone  mineralization, which was abolished in the presence of trolox. Hence,  EMFs induced chondro-osteogenesis and vasculogenesis in ES cells and  bone mineralization of mouse fetuses by a ROS-dependent up-regulation of  VEGF expression.</p>
<p>Bioelectromagnetics. 2010 Apr;31(3):209-19.</p>
<h1>Pulsed electromagnetic fields accelerate proliferation and  osteogenic gene expression in human bone marrow mesenchymal stem cells  during osteogenic differentiation.</h1>
<p>Sun LY, Hsieh DK, Lin PC, Chiu HT, Chiou TW.</p>
<p>Department of Biological Science and Technology, National Chiao Tung University, No. 75 Po-Ai Street, Hsinchu, Taiwan, ROC.</p>
<h3>Abstract</h3>
<p>Osteogenesis is a complex series of events involving the  differentiation of mesenchymal stem cells to generate new bone. In this  study, we examined the effect of pulsed electromagnetic fields (PEMFs)  on cell proliferation, alkaline phosphatase (ALP) activity,  mineralization of the extracellular matrix, and gene expression in bone  marrow mesenchymal stem cells (BMMSCs) during osteogenic  differentiation. Exposure of BMMSCs to PEMFs increased cell  proliferation by 29.6% compared to untreated cells at day 1 of  differentiation. Semi-quantitative RT-PCR indicated that PEMFs  significantly altered temporal expression of osteogenesis-related genes,  including a 2.7-fold increase in expression of the key osteogenesis  regulatory gene cbfa1, compared to untreated controls. In addition,  exposure to PEMFs significantly increased ALP expression during the  early stages of osteogenesis and substantially enhanced mineralization  near the midpoint of osteogenesis. These results suggest that PEMFs  enhance early cell proliferation in BMMSC-mediated osteogenesis, and  accelerate the osteogenesis.</p>
<p>Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Mar;41(2):296-8, 311.</p>
<h1>Effect of pulsed electromagnetic fields on biomechanical properties of femur in ovariectomized rats.</h1>
<p>[Article in Chinese]</p>
<p>Xiao D, Yang L, Lei ZJ, Yang YH, Qiang G, He CQ.</p>
<p>Department of Physical Medicine &amp; Rehabilitation, the First  Affiliated Hospital of Chongqing Medical University, Chongqing 400016,  China.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: To test the effect of pulsed electromagnetic fields  (PEMFs) with different length of treatment on the biomechanical  properties of femurs in ovariectomized rats.</p>
<p>METHODS: Fifty female SD rats were randomly divided into five groups:  (1) SHAM control (no PEMFs treatment), (2) OVXo control (no PEMFs  treatment), (3) OVX(I) (PEMFs treatment at 8 Hz frequency with 3.8 mT  intensity, 20 min daily for 30 days), (4) OVX(II) (PEMFs treatment at 8  Hz frequency with 3. 8 mT intensity, 40 min daily for 30 days), and (5)  OVX(III) (PEMFs treatment at 8 Hz frequency with 3.8 mT intensity, 60  min daily for 30 days). All of the rats were subject to bilateral  overiectomy except those in the SHAM control group. The biomechanical  properties of the femurs were assessed at the end of the PEMFs  treatment.</p>
<p>RESULTS: The rats in the OVX0 control group had significantly lower  values in the biomechanical properties than the rats in the other four  groups (P &lt; 0.05 or P &lt; 0.01). The rats treated with PEMFs showed  no significant differences in the biomechanical properties compared with  the sham controls (P &gt; 0.05).</p>
<p>CONCLUSION: PEMFs therapy at 8 Hz and 3.8 mT magnetic intensity for  20 to 60 min everyday prevents decline in biomechanical properties of  femurs in ovariectomized rat</p>
<p>Spinal Cord. 2009 Jul;47(7):508-18. Epub 2009 Jan 27.</p>
<h1>Non-pharmacological treatment and prevention of bone loss after spinal cord injury: a systematic review.</h1>
<p>Biering-Sørensen F, Hansen B, Lee BS.</p>
<p>Clinic for Spinal Cord Injuries, Rigshospitalet, Hornbaek, Denmark. <a href="mailto:finbs@rh.regionh.dk">finbs@rh.regionh.dk</a></p>
<h3>Abstract</h3>
<p>OBJECTIVE: Review the literature on non-pharmacological prevention and treatment of osteoporosis after spinal cord injury (SCI).</p>
<p>METHODS: PubMed, EMBASE and the Cochrane Controlled Trials Register  were searched. All identified papers were read by title, abstract and  full-length article when relevant. Hand search of the articles’ sources  identified additional papers. For included studies, the level of  evidence was determined.</p>
<p>RESULTS: No studies conclusively showed an effective intervention.  However, there are few randomized controlled trials (RCTs), and those  that exist assess interventions and outcome measures that could be  improved. Five studies on weight-bearing early post-injury are  conflicting, but standing or walking may help retain bone mineral. In  the chronic phase, there was no effect of weight bearing (12 studies).  One study found that an early commencement of sports after SCI improved  bone mineral, and the longer the period of athletic career, the higher  the (leg) bone mineral. Early after SCI, there may be some effects of  electrical stimulation (ES) (five studies). Chronic-phase ES studies  vary (14 studies, including mixed periods after injury), but improvement  is seen with longer period of training, or higher frequency or stimulus  intensity. Improvements correspond to trabecular bone in the distal  femur or proximal tibia. Impact vibration and pulsed electromagnetic  fields may have some positive effects, whereas pulsed ultrasound does  not. Six studies on the influence of spasticity show inconsistent  results.</p>
<p>CONCLUSIONS: Bone mineral should be measured around the knee; the  length and intensity of the treatment should be sufficiently long and  high, respectively, and should commence early after SCI. If bone mineral  is to remain, the stimulation has to be possibly continued for long  term. In addition, RCTs are necessary.</p>
<p>J Orthop Res. 2009 Sep;27(9):1169-74.</p>
<h1>Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation.</h1>
<p>Tsai MT, Li WJ, Tuan RS, Chang WH.</p>
<p>Department of Biomedical Engineering, Chung Yuan Christian University, Chung-Li City, Taiwan.</p>
<h3>Abstract</h3>
<p>Human mesenchymal stem cells (hMSCs) are a promising candidate cell  type for regenerative medicine and tissue engineering applications by  virtue of their capacity for self-renewal and multipotent  differentiation. Our intent was to characterize the effect of pulsed  electromagnetic fields (PEMFs) on the proliferation and osteogenic  differentiation of hMSCs in vitro. hMSCs isolated from the bone marrow  of adult patients were cultured with osteogenic medium for up to 28 days  and exposed to daily PEMF stimulation with single, narrow 300 micros  quasi-rectangular pulses with a repetition rate of 7.5 Hz. Relatively  greater cell numbers were observed at late stages of osteogenic culture  with PEMF exposure. The production of alkaline phosphatase (ALP), an  early marker of osteogenesis, was significantly enhanced at day 7 with  PEMF treatment in both basal and osteogenic cultures as compared to  untreated controls. Furthermore, the expressions of other early  osteogenic genes, including Runx2/Cbfa1 and ALP, were also partially  modulated by PEMF exposure, indicating that osteogenesis in hMSCs was  associated with the specific PEMF stimulation. Based on ALP and alizarin  red S staining, the accumulation of ALP protein produced by the hMSCs  as well as calcium deposits reached their highest levels at day 28. Our  results indicate that extremely low-frequency PEMF stimulation may play a  modulating role in hMSC osteogenesis. Taken together, these findings  provide insights on the development of PEMF as an effective technology  for regenerative medicine.</p>
<p>Bioelectromagnetics. 2009 May;30(4):251-60.</p>
<h1>Effect of pulsed electromagnetic field on the proliferation and  differentiation potential of human bone marrow mesenchymal stem cells.</h1>
<p>Sun LY, Hsieh DK, Yu TC, Chiu HT, Lu SF, Luo GH, Kuo TK, Lee OK, Chiou TW.</p>
<p>Department of Life Science and Graduate Institute of Biotechnology,  National Dong Hwa University, Hualien, Taiwan, Republic of China.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields (PEMFs) have been used clinically to  slow down osteoporosis and accelerate the healing of bone fractures for  many years. The aim of this study is to investigate the effect of PEMFs  on the proliferation and differentiation potential of human bone marrow  mesenchymal stem cells (BMMSC). PEMF stimulus was administered to BMMSCs  for 8 h per day during culture period. The PEMF applied consisted of  4.5 ms bursts repeating at 15 Hz, and each burst contained 20 pulses.  Results showed that about 59% and 40% more viable BMMSC cells were  obtained in the PEMF-exposed cultures at 24 h after plating for the  seeding density of 1000 and 3000 cells/cm2, respectively. Although,  based on the kinetic analysis, the growth rates of BMMSC during the  exponential growth phase were not significantly affected, 20-60% higher  cell densities were achieved during the exponentially expanding stage.  Many newly divided cells appeared from 12 to 16 h after the PEMF  treatment as revealed by the cell cycle analysis. These results suggest  that PEMF exposure could enhance the BMMSC cell proliferation during the  exponential phase and it possibly resulted from the shortening of the  lag phase. In addition, according to the cytochemical and  immunofluorescence analysis performed, the PEMF-exposed BMMSC showed  multi-lineage differentiation potential similar to the control group.</p>
<p>Int J Nanomedicine. 2009;4:133-44. Epub 2009 Sep 10.</p>
<h1>Synergistic role of hydroxyapatite nanoparticles and pulsed  electromagnetic field therapy to prevent bone loss in rats following  exposure to simulated microgravity.</h1>
<p>Prakash D, Behari J.</p>
<p>School of Environmental Sciences, Jawaharlal Nehru University, New Delhi–110067, India.</p>
<h3>Abstract</h3>
<p>The purpose of the present study was to use capacitive coupling of  pulsed electromagnetic field (CC-PEMF) and hydroxyapatite nanoparticles  (HAp) as a countermeasure to prevent osteoporosis induced by simulated  microgravity. We used the hind-limb suspension (HLS) rat model to  simulate microgravity-induced bone losses for 45 days. In order to  compare the resulting changes, mineralogical (bone mineral density  [BMD], calcium [Ca], and phosphorus [P]), biochemical (osteocalcin,  alkaline phosphatase [ALP], and type I collagen), and histological  (scanning electron microscopy) parameters were adopted. As a  countermeasure to the above, the effect of PEMF and HAp application were  examined. Three-month-old female Wistar rats were randomly divided into  control (n = 8), HLS (n = 8), HLS with PEMF (n = 8), HLS with HAp  nanoparticles (n = 8), and HLS with HAp and PEMF (n = 8). We observed:  1) significant decrease (p &lt; 0.01) in BMD, Ca, P, type I collagen,  and ALP activity in femur and tibia in hind-limb bone and serum  osteocalcin in HLS rats as compared with the ground control. 2)  Nonsignificant increase in BMD (p &lt; 0.1), Ca (p &lt; 0.1), P (p &lt;  0.5), type I collagen (p &lt; 0.1), and ALP activity (p &lt; 0.5) in  femur and tibia in hind-limb bone and serum osteocalcin (p &lt; 0.5) in  HLS + PEMF rats compared with HLS rats. 3) Significant increase in BMD  (p &lt; 0.02), Ca (p &lt; 0.05), P (p &lt; 0.05), type I collagen (p  &lt; 0.02), and ALP activity (p &gt; 0.02) in femur and tibia in  hind-limb bone with a nonsignificant increase in serum osteocalcin (p  &gt; 0.1) in HLS + HAp rats compared to HLS rats. 4) Significant  increase in BMD (p &gt; 0.01). Ca (p &gt; 0.01). P (p &gt; 0.01). type I  collagen (p &gt; 0.01). and ALP activity (p &gt; 0.01) in femur and  tibia in hind-limb bone and serum osteocalcin (p &gt; 0.02) were also  observed. Results suggest that a combination of low level PEMF and Hap  nanoparticles has potential to control bone loss induced by simulated  microgravity.</p>
<p>Clin Orthop Relat Res. 2009 Apr;467(4):1083-91. Epub 2008 Oct 15.</p>
<h1>Extremely small-magnitude accelerations enhance bone regeneration: a preliminary study.</h1>
<p>Hwang SJ, Lublinsky S, Seo YK, Kim IS, Judex S.</p>
<p>Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, Seoul, South Korea.</p>
<h3>Abstract</h3>
<p>High-frequency, low-magnitude accelerations can be anabolic and  anticatabolic to bone. We tested the hypothesis that application of  these mechanical signals can accelerate bone regeneration in scaffolded  and nonscaffolded calvarial defects. The cranium of experimental rats (n  = <img src='http://www.cooperativemedicine.com/wp-includes/images/smilies/icon_cool.gif' alt='8)' class='wp-smiley' /> in which the 5-mm bilateral defects either contained a collagen  scaffold or were left empty received oscillatory accelerations (45 Hz,  0.4 g) for 20 minutes per day for 3 weeks. Compared with scaffolded  defects in the untreated control group (n = 6), defects with a scaffold  and subject to oscillatory accelerations had a 265% greater fractional  bone defect area 4 weeks after the surgery. After 8 weeks of healing  (1-week recovery, 3 weeks of stimulation, 4 weeks without stimulation),  the area (181%), volume (137%), and thickness (53%) of the regenerating  tissue in the scaffolded defect were greater in experimental than in  control animals. In unscaffolded defects, mechanical stimulation induced  an 84% greater bone volume and a 33% greater thickness in the defect.  These data provide preliminary evidence that extremely low-level,  high-frequency accelerations can enhance osseous regenerative processes,  particularly in the presence of a supporting scaffold.</p>
<p>Ann Biomed Eng. 2009 Mar;37(3):437-44. Epub 2009 Jan 13.</p>
<h1>Osteoprotegerin (OPG) production by cells in the osteoblast lineage  is regulated by pulsed electromagnetic fields in cultures grown on  calcium phosphate substrates.</h1>
<p>Schwartz Z, Fisher M, Lohmann CH, Simon BJ, Boyan BD.</p>
<p>Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, GA 30332-0363, USA.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields (PEMF) used clinically to stimulate  bone formation enhance the osteogenic effects of BMP-2 on human  mesenchymal stem cells (MSCs) if the MSCs are grown in osteogenic medium  and are cultured on calcium phosphate (CaP) surfaces rather than tissue  culture polystyrene plastic (TCPS). This study tested if PEMF’s effects  on cells in the osteoblast lineage are substrate dependent and if  factors produced by osteoblasts that regulate osteoclastic bone  resorption, might also be regulated by PEMF. Human MSCs treated with  BMP-2 and human osteoblast-like cells (normal human osteoblasts [NHOst  cells], MG63 cells, SaOS-2 cells) were cultured on CaP or TCPS and their  response to PEMF (4.5 ms bursts of 20 pulses repeating at 15 Hz for 8  h/day) determined as a function of decoy receptor osteoprotegerin (OPG)  and RANK ligand (RANKL) production, both of which are associated with  regulation of osteoclast differentiation. The results showed that when  osteoblast-like cells were cultured on CaP, PEMF decreased cell number  and increased production of paracrine factors associated with reduced  bone resorption like OPG. RANKL was unaffected, indicating that the  OPG/RANKL ratio was increased, further supporting a surface-dependent  osteogenic effect of PEMF. Moreover, effects of estrogen were surface  dependent and enhanced by PEMF, demonstrating that PEMF can modulate  osteogenic responses to anabolic regulators of osteoblast function.  These effects of PEMF would not be evident in models examining cells in  traditional culture on plastic.</p>
<p>Chin Med J (Engl). 2008 Oct 20;121(20):2095-9.</p>
<h1>Clinical update of pulsed electromagnetic fields on osteoporosis.</h1>
<p>Huang LQ, He HC, He CQ, Chen J, Yang L.</p>
<p>Department of Rehabilitation Medicine, West China Hospital Affiliated to Sichuan University, Chengdu, Sichuan 610041, China.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: To understand the effects of low-frequency pulsed  electromagnetic fields (PEMFs) on chronic bony pain, bone mineral  density (BMD), bone strength and biochemical markers of bone metabolism  in the patients of osteoporosis.</p>
<p>DATA SOURCES: Using the key words “pulsed electromagnetic fields” and  “osteoporosis”, we searched the PubMed for related studies published in  English from January 1996 to December 2007. We also searched the China  National Knowledge Infrastructure (CNKI) for studies published in  Chinese from January 1996 to December 2007.</p>
<p>STUDY SELECTION: Inclusion criteria: (1) all articles which referred  to the effects of low-frequency pulsed magnetic fields on osteoporosis  either in primary osteoporosis or secondary osteoporosis; (2) either  observational studies or randomized controlled studies. Exclusion  criteria: (1) articles on experimental studies about osteoporosis; (2)  repetitive studies; (3) case reports; (4) meta analysis.</p>
<p>RESULTS: Totally 111 related articles were collected, 101 of them  were published in Chinese, 10 were in English. Thirty-four were included  and the remaining 84 were excluded.</p>
<p>CONCLUSIONS: Low-frequency PEMFs relieves the pain of primary  osteoporosis quickly and efficiently, enhances bone formation and  increases BMD of secondary osteoporosis. But the effects of PEMFs on  bone mineral density of primary osteoporosis and bone resorption were  controversial.</p>
<p>J Orthop Res. 2008 Sep;26(9):1250-5.</p>
<h1>Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells.</h1>
<p>Schwartz Z, Simon BJ, Duran MA, Barabino G, Chaudhri R, Boyan BD.</p>
<p>Petit Institute of Bioengineering and Bioscience, Georgia Institute  of Technology, 315 Ferst Drive NW, Atlanta, Georgia 30332, USA.</p>
<h3>Abstract</h3>
<p>Mesenchymal stem cells (MSCs) express an osteoblastic phenotype when  treated with BMP-2, and BMP-2 is used clinically to induce bone  formation although high doses are required. Pulsed electromagnetic  fields (PEMF) also promote osteogenesis in vivo, in part through direct  action on osteoblasts. We tested the hypothesis that PEMF enhances  osteogenesis of MSCs in the presence of an inductive stimulus like  BMP-2. Confluent cultures of human MSCs were grown on calcium phosphate  disks and were treated with osteogenic media (OM), OM containing 40  ng/mL rhBMP-2, OM + PEMF (8 h/day), or OM + BMP-2 + PEMF. MSCs  demonstrated minor increases in alkaline phosphatase (ALP) during 24  days in culture and no change in osteocalcin. OM increased ALP and  osteocalcin by day 6, but PEMF had no additional effect at any time.  BMP-2 was stimulatory over OM, and PEMF + BMP-2 synergistically  increased ALP and osteocalcin. PEMF also enhanced the effects of BMP-2  on PGE2, latent and active TGF-beta1, and osteoprotegerin. Effects of  PEMF on BMP-2-treated cells were greatest at days 12 to 20. These  results demonstrate that PEMF enhances osteogenic effects of BMP-2 on  MSCs cultured on calcium phosphate substrates, suggesting that PEMF will  improve MSC response to BMP-2 in vivo in a bone environment.</p>
<p>Plast Reconstr Surg. 2008 May;121(5):1554-66; discussion 1567-9.</p>
<h1>Nitric oxide stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells.</h1>
<p>Lin IC, Smartt JM Jr, Nah HD, Ischiropoulos H, Kirschner RE.</p>
<p>Division of Plastic Surgery and the Department of Neonatology, The  Children’s Hospital of Philadelphia and the University of Pennsylvania  School of Medicine, Pa. 19104-4399, USA.</p>
<h3>Abstract</h3>
<p>BACKGROUND: Infant dura mater plays a critical role in calvarial  development. This investigation examines the expression of nitric oxide  synthase isoforms in the craniofacial skeleton and the influence of  nitric oxide signaling on the growth and differentiation of fetal dural  and calvarial bone cells.</p>
<p>METHODS: Sections of fetal and adult calvaria were evaluated for  endothelial and inducible nitric oxide synthase expression by  immunohistochemistry. Primary fetal (E18) murine dural cell and  calvarial osteoblast cultures were treated with 1 microM or 10 microM  DETA-NONOate, a nitric oxide donor compound, or 1 mM  N-monomethyl-l-arginine (l-NMMA), a nitric oxide synthase inhibitor.  Controls were left untreated. Cell proliferation was measured at 48  hours, and mRNA transcripts for Runx2, alkaline phosphatase, and  osteopontin were measured by reverse transcription and quantitative  real-time polymerase chain reaction at 2 to 18 days. Experiments were  performed in triplicate.</p>
<p>RESULTS: Fetal, but not adult, dural cells express endothelial nitric  oxide synthase. DETA-NONOate stimulated osteoblast mitogenesis by 16  percent (p &lt; 0.05) but did not affect proliferation of dural cells.  l-NMMA inhibited proliferation of dural cells and calvarial osteoblasts  by 35 percent (p &lt; 0.01) and 17 percent (p = 0.05), respectively.  Exogenous nitric oxide increased dural cell transcription of Runx2,  alkaline phosphatase (p = 0.03), and osteopontin (p = 0.09) and  calvarial osteoblast transcription of Runx2 (p = 0.02) and osteopontin  (p &lt; 0.01). Fetal calvarial osteoblasts and dural cells treated with  l-NMMA demonstrated reduced transcription of Runx2 and alkaline  phosphatase (p &lt; 0.05).</p>
<p>CONCLUSIONS: Fetal dural cells and calvarial osteoblasts express  endothelial nitric oxide synthase. Nitric oxide enhances proliferation  and differentiation of fetal dural cells and calvarial osteoblasts.  These results suggest that endothelial nitric oxide synthase-derived  nitric oxide may play an important role in development of the fetal  craniofacial skeleton.</p>
<p>Spine J. 2008 May-Jun;8(3):436-42. Epub 2007 Jul 17.</p>
<h1>Randomized, prospective, and controlled clinical trial of pulsed electromagnetic field stimulation for cervical fusion.</h1>
<p>Foley KT, Mroz TE, Arnold PM, Chandler HC Jr, Dixon RA, Girasole GJ,  Renkens KL Jr, Riew KD, Sasso RC, Smith RC, Tung H, Wecht DA, Whiting  DM.</p>
<p>Department of Neurosurgery, University of Tennessee Health Science  Center and Semmes-Murphey Neurologic and Spine Institute, Memphis,  Tennessee 38104, USA. <a href="mailto:kfoley@usit.net">kfoley@usit.net</a></p>
<h3>Abstract</h3>
<p>BACKGROUND CONTEXT: Multilevel fusions, the use of allograft bone,  and smoking have been associated with an increased risk of nonunion  after anterior cervical discectomy and fusion (ACDF) procedures. Pulsed  electromagnetic field (PEMF) stimulation has been shown to increase  arthrodesis rates after lumbar spine fusion surgery, but there are  minimal data concerning the effect of PEMF stimulation on cervical spine  fusion.</p>
<p>PURPOSE: To determine the efficacy and safety of PEMF stimulation as  an adjunct to arthrodesis after ACDF in patients with potential risk  factors for nonunion.</p>
<p>STUDY DESIGN: A randomized, controlled, prospective multicenter clinical trial.</p>
<p>PATIENT SAMPLE: Three hundred and twenty-three patients with  radiographic evidence (computed tomography-myelogram [CT-myelo] or  magnetic resonance imaging [MRI]) of a compressed cervical nerve root  and symptomatic radiculopathy appropriate to the compressed root that  had failed to respond to nonoperative management were enrolled in the  study. The patients were either smokers (more than one pack per day)  and/or were undergoing multilevel fusions. All patients underwent ACDF  using the Smith-Robinson technique. Allograft bone and an anterior  cervical plate were used in all cases.</p>
<p>OUTCOME MEASURES: Measurements were obtained preoperatively and at  each postoperative interval and included neurologic assessment, visual  analog scale (VAS) scores for shoulder/arm pain at rest and with  activity, SF-12 scores, the neck disability index (NDI), and radiographs  (anteroposterior, lateral, and flexion-extension views). Two orthopedic  surgeons not otherwise affiliated with the study and blinded to  treatment group evaluated the radiographs, as did a blinded radiologist.  Adverse events were reported by all patients throughout the study to  determine device safety.</p>
<p>METHODS: Patients were randomly assigned to one of two groups: those  receiving PEMF stimulation after surgery (PEMF group, 163 patients) and  those not receiving PEMF stimulation (control group, 160 patients).  Postoperative care was otherwise identical. Follow-up was carried out at  1, 2, 3, 6, and 12 months postoperatively.</p>
<p>RESULTS: The PEMF and control groups were comparable with regard to  age, gender, race, past medical history, smoking status, and litigation  status. Both groups were also comparable in terms of baseline diagnosis  (herniated disc, spondylosis, or both) and number of levels operated  (one, two, three, or four). At 6 months postoperatively, the PEMF group  had a significantly higher fusion rate than the control group (83.6% vs.  68.6%, p=.0065). At 12 months after surgery, the stimulated group had a  fusion rate of 92.8% compared with 86.7% for the control group  (p=.1129). There were no significant differences between the PEMF and  control groups with regard to VAS pain scores, NDI, or SF-12 scores at 6  or 12 months. No significant differences were found in the incidence of  adverse events in the groups.</p>
<p>CONCLUSIONS: This is the first randomized, controlled trial that  analyzes the effects of PEMF stimulation on cervical spine fusion. PEMF  stimulation significantly improved the fusion rate at 6 months  postoperatively in patients undergoing ACDF with an allograft and an  anterior cervical plate, the eligibility criteria being patients who  were smokers or had undergone multilevel cervical fusion. At 12 months  postoperatively, however, the fusion rate for PEMF patients was not  significantly different from that of the control group. There were no  differences in the incidence of adverse events in the two groups,  indicating that the use of PEMF stimulation is safe in this clinical  setting.</p>
<p>J Huazhong Univ Sci Technolog Med Sci. 2008 Apr;28(2):152-5. Epub 2008 May 15.</p>
<h1>Electromagnetic field change the expression of osteogenesis genes in murine bone marrow mesenchymal stem cells.</h1>
<p>Zhao D, Wu H, Li F, Li R, Tao C.</p>
<p>Department of Orthopedics, Tongji Hospital, Tongji Medical College,  Huazhong University of Science and Technology, Wuhan 430030, China. <a href="mailto:zhaodongming33@yahoo.com.cn">zhaodongming33@yahoo.com.cn</a></p>
<h3>Abstract</h3>
<p>In order to identify the differentially expressing gene of bone  marrow mesenchymal stem cells (MSCs) stimulated by electromagnetic field  (EMF) with osteogenesis microarray analysis, the bone marrow MSCs of SD  rats were isolated and cultured in vitro. The third-passage cells were  stimulated by EMFs and total RNA was extracted, purified and then used  for the synthesis of cDNA and cRNA. The cRNA of stimulated group and the  control group was hybridized with the rat oligo osteogenesis microarray  respectively. The hybridization signals were acquired by using X-ray  film after chemiluminescent detection and the data obtained were  analyzed by employing the web-based completely integrated GEArray  Expression Analysis Suite. RT-PCR was used to identify the target genes:  Bmp1, Bmp7, Egf and Egfr. The results showed that 19 differentially  expressing genes were found between the stimulated group and the control  group. There were 6 up-regulated genes and 13 down-regulated genes in  the stimulated group. Semi-quantitative RT-PCR confirmed that the  expressions of Bmp1, Bmp7 mRNA of the stimulated group were up-regulated  (P&lt;0.05) and those of Egf, Egfr were down-regulated (P&lt;0.05). It  was suggested that the gene expression profiles of osteogenesis of the  bone marrow MSCs were changed after EMF treatment. It is concluded that  the genes are involved in skeletal development, bone mineral metabolism,  cell growth and differentiation, cell adhesion etc.</p>
<p>Electromagn Biol Med. 2008;27(3):298-311.</p>
<h1>Effects of extremely low-frequency-pulsed electromagnetic field on different-derived osteoblast-like cells.</h1>
<p>Wei Y, Xiaolin H, Tao S.</p>
<p>Bioelectromagnetic Lab, Institute of Electrical Engineering, Chinese Academy of Sciences, Beijing, China.</p>
<h3>Abstract</h3>
<p>The aim of this study is to investigate the effects of extremely  low-frequency pulsed electromagnetic field (PEMF) on osteoblast-like  cells. PEMF with a magnetic flux density of 1.55 mT at 48 Hz was  employed to stimulate the MC3T3-E1 cell and the primary osteoblast cell  derived from 2-day-old Sprague Dawley (SD) rat calvaria for different  time. MTS method was applied to analyze cell proliferation and flow  cytometry to detect cell cycle. The intracellular alkaline phosphatase  (ALP) activity was measured by colorimetry. Our results demonstrated  that PEMF of 1.55 mT at 48 Hz did not affect cell number of MC3T3-E1  cell, whereas the cell percentage of S and G(2)M phase decreased  significantly. Although the cell number of the primary osteoblast cell  did not alter by MTS assay after being exposed to PEMF for 24 h  continuously, the cell percentage of S and G(2)M phase increased  significantly. When culture time extended to 48 h, the cell number  increased greatly and the cell percentage of S and G(2)M phase decreased  significantly despite of the exposure type. After the primary  osteoblast cell was exposed to PEMF for 24 h continuously, the ALP  activity decreased significantly, whereas it increased significantly  when being exposed to PEMF for 48 h continuously. From the results we  concluded that PEMF of 1.55 mT at 48 Hz did not affect proliferation and  differentiation of MC3T3-E1 cell, but it promoted proliferation,  inhibited differentiation at proliferation stage, and promoted  differentiation at differentiation stage of primary osteoblast cells.</p>
<p>Ann Biomed Eng. 2008 Feb;36(2):195-203. Epub 2007 Nov 27.</p>
<h1>Why do electromagnetic pulses enhance bone growth?</h1>
<p>Bowen SP, Mancini JD, Fessatidis V, Grabiner M.</p>
<p>Department of Chemistry and Physics, Chicago State University, Chicago, IL 60628, USA. <a href="mailto:sbowen@csu.edu">sbowen@csu.edu</a></p>
<h3>Abstract</h3>
<p>The excitation probability of substrate molecules involved in the  production of growth factors influencing the division of chondrocytes in  the growth layer of bone under the influence of pulsed electromagnetic  fields is studied theoretically in a quantum mechanical model  calculation. In this model matrix elements and anti-bonding energy  levels are assumed known and the dynamics of the interaction with pulsed  electromagnetic fields is derived. The derivation makes it clear that  continuous pulsing or large driving currents can overwhelm local  diffusive transport to the growth plane resulting in a loss of its  enhancement properties. Optimal locations within a pair of Helmholtz  coils for enhancement of bone growth are also investigated and found to  be close to the coils. The work presented here is believed to be the  first derivation in a model calculation of a physical basis for the  effects of pulsed electromagnetic fields on bone growth and fusion.</p>
<p>Bioelectromagnetics. 2007 Oct;28(7):519-28.</p>
<h1>Pulsed electromagnetic fields affect osteoblast proliferation and differentiation in bone tissue engineering.</h1>
<p>Tsai MT, Chang WH, Chang K, Hou RJ, Wu TW.</p>
<p>Department of Biomedical Engineering, Chung Yuan Christian University, Chung-Li, Taiwan.</p>
<h3>Abstract</h3>
<p>Bone tissue engineering is an interdisciplinary field involving both  engineers and cell biologists, whose main purpose is to repair bone  anatomical defects and maintain its functions. A novel system that  integrates pulsed electromagnetic fields (PEMFs) and bioreactors was  applied to bone tissue engineering for regulating osteoblast  proliferation and differentiation in’vitro. Osteoblasts were acquired  from the calvaria of newborn Wistar rats and isolated after sequential  digestion. Poly(DL-lactic-co-glycolic acid) (PLGA) scaffolds were made  by the solvent merging/particulate leaching method. Osteoblasts were  seeded into porous PLGA scaffolds with 85% porosity and cultured in  bioreactors for the 18-day culture period. Cells were exposed to PEMF  pulsed stimulation with average (rms) amplitudes of either 0.13, 0.24,  or 0.32 mT amplitude. The resulting induced electric field waveform  consisted of single, narrow 300 micros quasi-rectangular pulses with a  repetition rate of 7.5′Hz. The results showed that PEMF stimulation for 2  and 8 h at .13 mT increased the cell number on days 6 and 12, followed  by a decrease on day 18 using 8 h stimulation. However, ALP activity was  decreased and then increased on days 12 and 18, respectively. On the  other hand, PEMF-treated groups (irrespective of the stimulation time)  at 0.32 mT inhibited cell proliferation but enhanced ALP activity during  the culture period. These findings suggested that PEMF stimulation with  specific parameters had an effect on regulating the osteoblast  proliferation and differentiation. This novel integrated system may have  potential in bone tissue engineering.</p>
<p>J Orthop Res. 2007 Jul;25(7):933-40.</p>
<h1>Pulsed electromagnetic fields rapidly modulate intracellular  signaling events in osteoblastic cells: comparison to parathyroid  hormone and insulin.</h1>
<p>Schnoke M, Midura RJ.</p>
<p>Department of Biomedical Engineering and The Orthopaedic Research  Center, Lerner Research Institute, ND20, Cleveland Clinic, 9500 Euclid  Avenue, Cleveland, Ohio 44195, USA.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic field (PEMF) devices are approved for the  healing of bone nonunions, but there is a lack of understanding as to  their mechanism of action at the cell and molecular level. Intermittent  parathyroid hormone (PTH) therapy is currently utilized for treatment of  osteoporosis, and is also being investigated for the purpose of  augmenting fracture healing. Insulin and IGF-1 are also thought to play  important anabolic roles in osteogenesis. In this report, signaling  pathways activated by acute PTH or insulin treatments were compared to  those activated by PEMF treatment in osteoblast-like cells. Some  signaling molecules like the extracellular response kinases 1/2 (Erk1/2)  and the cAMP response element binding protein (CREB) were activated by  insulin and PTH, respectively, but not by PEMF treatment. Other  signaling molecules like the insulin receptor substrate-1 (IRS-1), the  S6 ribosomal subunit kinase, and the endothelial nitric oxide synthase  (eNOS) were phosphorylated by PTH, insulin, and PEMF to the same  relative extent and within the same time frame. IRS-1, eNOS, and S6 have  been implicated in bone anabolism, and our results suggest that the  anabolic effects of PEMF may be mediated, in part, through the  activation of these proteins.</p>
<p>J Altern Complement Med. 2007 Jun;13(5):485-90.</p>
<h1>The biologic effects and the therapeutic mechanism of action of  electric and electromagnetic field stimulation on bone and cartilage:  new findings and a review of earlier work.</h1>
<p>Haddad JB, Obolensky AG, Shinnick P.</p>
<p>San Jose Orthopedic Medical Group, San Jose, CA 95136, USA. <a href="mailto:jackd16@yahoo.com">jackd16@yahoo.com</a></p>
<h3>Abstract</h3>
<p>BACKGROUND: Muscle, ligament, bone, cartilage, blood, and adult  stem-cell production all respond to electric and electromagnetic fields,  and these biophysical field agents can be applied in therapeutic  contexts. Postulated mechanisms at the cellular, subcellular, and  molecular level are discussed. Electric and electromagnetic field  stimulation enhance the repair of bone through the mediation of three  areas at the cellular level: (1) the complex interplay of the physical  environment; (2) growth factors; and (3) the signal transduction  cascade. Studies of electric and electromagnetic fields suggest that an  intermediary mechanism of action may be an increase in morphogenetic  bone proteins, transforming growth factor-beta, and the insulin-like  growth factor II, which results in an increase of the extracellular  matrix of cartilage and bone. Investigations have begun to clarify how  cells respond to biophysical stimuli by means of transmembrane signaling  and gene expression for structural and signaling proteins.</p>
<p>METHODS: Review of meta-analysis trials of electrical stimulation of all types.</p>
<p>CONCLUSIONS: Further research in the form of methodologically sound,  randomized, controlled studies are needed. Inter alia, resolutions are  needed for the significant disparities between clinical targets, types  of electrical stimulation, and clinical outcomes.</p>
<p>Electromagn Biol Med. 2007;26(3):167-77.</p>
<h1>Effects of different extremely low-frequency electromagnetic fields on osteoblasts.</h1>
<p>Zhang X, Zhang J, Qu X, Wen J.</p>
<p>Department of Physics, Fourth Military Medical University, Shanxi, China.</p>
<h3>Abstract</h3>
<p>It is well known that the extremely low-frequency electromagnetic  field (EMF) can promote the healing of bone fractures, but its mechanism  remains poorly understood. The purpose of this study was to examine the  response of neonatal rat calvarial bone cells to the rectangular  electromagnetic field (REMF), triangular electromagnetic field (TEMF),  sinusoidal electromagnetic field (SEMF), and pulsed electromagnetic  field (PEMF). The stimulatory effects of EMF were evaluated by the  proliferation (methyltetrazolium colorimetric assay), differentiation  (alkaline phosphatase (ALP) activity), and mineralization (area of  mineralized nodules of the cells). REMF treatment of osteoblasts  increased cellular proliferation and decreased ALP activity (p &lt;  0.05). TEMF had an accelerative effect on the cellular mineralized  nodules (p &lt; 0.05). SEMF treatment of osteoblasts decreased the  cellular proliferation, increased ALP activity, and suppressed  mineralized nodules formation (p &lt; 0.05). PEMF promoted the  proliferation of osteoblasts, inhibited their differentiation, and  increased the mineralized nodules formation (p &lt; 0.05). Moreover, the  effects of PEMF on osteoblasts were concerned with the extracellular  calcium, P2 receptor on the membrane, and PLC pathway, but the response  of osteoblasts on SEMF was only related to PLC pathway. The results  suggested that the waveforms of EMF were the crucial parameters to  induce the response of osteoblasts.</p>
<p>Electromagn Biol Med. 2007;26(3):153-65.</p>
<h1>Cytokine release from osteoblasts in response to different intensities of pulsed electromagnetic field stimulation.</h1>
<p>Li JK, Lin JC, Liu HC, Chang WH.</p>
<p>Bone Tissue Engineering Research Lab, Center for Nano Bioengineering,  Chung Yuan Christian University, Chung Li, Taiwan, Republic of China.</p>
<h3>Abstract</h3>
<p>We use an in-vitro osteoblast cell culture model to investigate the  effects of low-frequency (7.5 Hz) pulsed electromagnetic field (PEMF)  stimulation on osteoblast population, cytokines (prostaglandin E(2)  (PGE(2)), transforming growth factor beta1(TGFbeta1), and alkaline  phosphatase (ALP) activity to find the optimal intensity of PEMF for  osteoblast growth. The results demonstrate that PEMF can stimulate  osteoblast growth, release of TGFbeta1, and, in addition, an increase of  ALP activity. The synthesis and release of PGE(2) in the culture medium  are reduced with increasing numbers of cells. Higher intensity does not  necessarily mean increased osteoblast growth, and the most efficient  intensity is about 2 mV/cm in this case. Although the lower intensities  of the PEMF are yet to be determined, the results of this study can shed  light on the mechanisms of PEMF stimulation on non union fracture  therapy and osteoporosis prevention in the future.</p>
<p>Eur J Histochem. 2006 Jul-Sep;50(3):199-204.</p>
<h1>Stimulation of osteoblast growth by an electromagnetic field in a model of bone-like construct.</h1>
<p>Icaro Cornaglia A, Casasco M, Riva F, Farina A, Fassina L, Visai L, Casasco A.</p>
<p>Department of Experimental Medicine, Histology and Embryology Unit, via Forlanini 10, University of Pavia, Pavia, Italy. <a href="mailto:icaro@unipv.it">icaro@unipv.it</a></p>
<h3>Abstract</h3>
<p>The histogenesis of bone tissue is strongly influenced by physical  forces, including magnetic fields. Recent advances in tissue engineering  has permitted the generation of three dimensional bone-like constructs.  We have investigated the effects of electromagnetic stimulation on  human osteoblast cells grown in a hydrophobic polyurethane scaffold.  Bone-like constructs were stimulated by pulsed electromagnetic fields in  a bioreactor. Proliferation, bone protein expression and calcified  matrix production by osteoblasts were measured using histochemical  methods. In stimulated cultures, the number of cells was significantly  higher compared to static (control) cultures. In both stimulated and  control cultures, cells were immunoreactive to osteoblast markers,  including type-I collagen, osteocalcin and osteopontin, thus suggesting  that the expression of bone-related markers was maintained throughout  the in vitro experiments. Morphometric analysis of von Kossa-stained  sections revealed that stimulation with electromagnetic field  significantly increased matrix calcification. The data lend support to  the view that the application of a magnetic field can be used to  stimulate cell growth in bone-like constructs in vitro. This finding may  be of interest for the production of biomaterials designed for clinical  applications.</p>
<p>Ann N Y Acad Sci. 2006 Apr;1068:513-31.</p>
<h1>Clinical biophysics: the promotion of skeletal repair by physical forces.</h1>
<p>Aaron RK, Ciombor DM, Wang S, Simon B.</p>
<p>Department of Orthopaedic Surgery, Brown Medical School, 100 Butler Drive, Providence, RI 02906, USA. <a href="mailto:Roy_Aaron@Brown.edu">Roy_Aaron@Brown.edu</a></p>
<h3>Abstract</h3>
<p>Skeletal tissues respond to the physical demands of their environment  by altering the synthesis and organization of the extracellular matrix.  These observations have major implications for how physical  environmental demands result in the clinical observations of atrophy and  hypertrophy, and how manipulation of the physical environment can be  used therapeutically to stimulate repair. Electrical stimulation will be  considered as a paradigm of how musculoskeletal tissues respond to  physical stimuli. A model of demineralized bone matrix-induced  endochondral ossification has been used because it epitomizes the cell  biology of endochondral bone formation in a temporally consistent way.  We have studied cartilage and bone matrix production, the temporal locus  of cell responsiveness, signal dosimetry, and the synthesis of  signaling cytokines (TGF-beta) using biochemical, immunohistochemical,  and molecular techniques. Exposure to certain electrical environments  enhances chondrocyte differentiation reflected as a temporal  acceleration and quantitative increase of cartilage extracellular  matrix, earlier onset of osteogenesis, and more mature trabecular bone.  The cell pool competent to respond resides in the mesenchymal stage. The  enhancement in chondrogenesis is associated with an increase in  TGF-beta synthesis mediated at least in part by binding of the  transcription factor AP-1 and may be modulated specifically by  phosphorylation of JNK. The clinical practice of orthopedics has  empirically created a variety of biophysical environments in attempts to  optimize skeletal repair. We are beginning to understand the biological  effects of biophysical stimulation and are now poised to replace  empiricism with treatment paradigms based upon physiologic  understandings of dose and biologic response.</p>
<p>Bioelectromagnetics. 2005 Dec;26(8):670-6.</p>
<h1>Timing of pulsed electromagnetic field stimulation does not affect the promotion of bone cell development.</h1>
<p>Hannay G, Leavesley D, Pearcy M.</p>
<p>School of Engineering Systems &amp; Institute of Health and  Biomedical Innovation, Queensland University of Technology, Brisbane,  Australia. <a href="mailto:g.hannay@qut.edu.au">g.hannay@qut.edu.au</a></p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic field (PEMF) devices have been used clinically  to promote the healing of surgically resistant fractures in vivo.  However, there is a sparsity of data on how the timing of an applied  PEMF effects the osteogenic cells that would be present within the  fracture gap. The purpose of this study was to examine the response of  osteoblast-like cells to a PEMF stimulus, mimicking that of a clinically  available device, using four protocols for the timing of the stimulus.  The PEMF signal consisted of a 5 ms pulse burst (containing 20 pulses)  repeated at 15 Hz. Cultures of a human osteosarcoma cell line, SaOS-2,  were exposed to the four timing protocols, each conducted over 3 days.  Protocol one stimulated the cells for 8 h each day, protocol two  stimulated the cells for 24 h on the first day, protocol three  stimulated the cells for 24 h on the second day, and protocol four  stimulated the cells for 24 h on the third day. Cells were seeded with  either 25,000 or 50,000 cells/well (24-well cell culture plates). All  assays showed reduced proliferation and increased differentiation  (alkaline phosphatase activity) in the PEMF stimulated cultures compared  with the control cultures, except for protocol four alkaline  phosphatase measurements. No clear trend was observed between the four  protocols; however this may be due to cell density. The results  indicated that an osteoblast-like cell line is responsive to a 15 Hz  PEMF stimulus, which will stimulate the cell line to into an increasing  state of maturity.</p>
<p>Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Dec;22(6):1168-70.</p>
<h1>Effects of the PEMFs of different intensity on BMD and biomechanical properties of rabbits’ femur.</h1>
<p>[Article in Chinese]</p>
<p>Luo E, Jiao L, Shen G, Wu XM, Xu Q, Lu L.</p>
<p>Research Center of Intelligent Information Processing, School of  Electronic Engineering, Xidian University, Xi’an 710071, China. <a href="mailto:luoerping@fmmu.edu.cn">luoerping@fmmu.edu.cn</a></p>
<h3>Abstract</h3>
<p>The effects of the pulsed electromagnetic fields (PEMFs) of different  intensity on bone mineral density (BMD) and biomechanical properties of  rabbits’ femur had been studied. Twenty-seven female white big ear  rabbits were randomly divided into three groups. The magnetic groups  were fed in 15 Hz PEMFs, which pulse duration was set to be 5 ms (6 h x  d(-1)), the magnetic intensity was 10 x 10(-4) T and the other was 20 x  10(-4) T. Control group were just fed in coils, and the instrument of  PEMFs was powered off. After six weeks, by examine BMD and biomechanical  properties of the rabbits’ femur, the effects of these PEMFs were  studied. Compared with control group, the values of BMD, maximum load  and structural rigidity of magnetic group were significantly increased  (P &lt; 0.05). In addition, there was significant increase in values of  BMD and structural rigidity in group 10 x 10(-4) T in comparison with  group 20 x 10(-4) T (P &lt; 0.05). PEMFs is effective in improving BMD  and biomechanical properties. The experiment indicated that there was  evident “window-effect” during the treatment by PEMFs. It is favorable  to the treatment and prevention of osteoporosis.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="575"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="575">Arq Bras Endocrinol Metabol. 2005 Dec;49(6):891-6. Epub 2006 Mar 16.</td>
<td width="2">
<p lang="sv-SE">
</td>
</tr>
</tbody>
</table>
<h1>Evidences of physical agents action on bone metabolism and their potential clinical use.</h1>
<p><strong> </strong>[Article in Portuguese]<br />
<strong> </strong></p>
<p>Lirani AP, Lazaretti-Castro M.</p>
<p>Departamento de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP. <a href="mailto:analirani@fcr.epm.br">analirani@fcr.epm.br</a></p>
<p>The action of physical agents such as low level laser therapy,  low-intensity pulsed ultrasound and electrical and electromagnetic  fields on bone have been often studied, showing that they are able to  promote osteogenesis, accelerate fracture consolidation and augment bone  mass. The use of these therapeutic modalities was first based on the  finding that bone is a piezoelectric material, that means it can  generate polarization when deformed, transforming mechanical energy into  electric energy, and this has widen therapeutic possibilities to bony  tissue. The present work aims to present evidences of physiologic  effects and mechanisms of action of these physical agents on bone  metabolism, based on articles published in international scientific  literature in the relationship between waveform characteristics and  biological outcomes.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="575"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="575"></td>
<td width="2"></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">J Orthop Res. 2005 Jun 2; [Epub ahead of print]</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>Pulsed electromagnetic field treatments enhance the healing of fibular osteotomies.</h1>
<p>Midura RJ, Ibiwoye MO, Powell KA, Sakai Y, Doehring T, Grabiner MD, Patterson TE, Zborowski M, Wolfman A.</p>
<p>Department of Biomedical Engineering, The Orthopaedic Research  Center, Lerner Research Institute of The Cleveland Clinic Foundation,  Cleveland, OH 44195, USA.</p>
<p>This study tested the hypothesis that pulsed electromagnetic field  (PEMF) treatments augment and accelerate the healing of bone trauma. It  utilized micro-computed tomography imaging of live rats that had  received bilateral 0.2mm fibular osteotomies ( approximately 0.5% acute  bone loss) as a means to assess the in vivo rate dynamics of hard callus  formation and overall callus volume. Starting 5days post-surgery,  osteotomized right hind limbs were exposed 3h daily to Physio-Stim((R))  PEMF, 7days a week for up to 5weeks of treatment. The contralateral hind  limbs served as sham-treated, within-animal internal controls. Although  both PEMF- and sham-treatment groups exhibited similar onset of hard  callus at approximately 9days after surgery, a 2-fold faster rate of  hard callus formation was observed thereafter in PEMF-treated limbs,  yielding a 2-fold increase in callus volume by 13-20days after surgery.  The quantity of the new woven bone tissue within the osteotomy sites was  significantly better in PEMF-treated versus sham-treated fibulae as  assessed via hard tissue histology. The apparent modulus of each callus  was assessed via a cantilever bend test and indicated a 2-fold increase  in callus stiffness in the PEMF-treated over sham-treated fibulae.  PEMF-treated fibulae exhibited an apparent modulus at the end of 5-weeks  that was approximately 80% that of unoperated fibulae. Overall, these  data indicate that Physio-Stim((R)) PEMF treatment improved osteotomy  repair. These beneficial effects on bone healing were not observed when a  different PEMF waveform, Osteo-Stim((R)), was used. This latter  observation demonstrates the specificity in the relationship between  waveform characteristics and biological outcomes.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">J Orthop Res. 2005 May 20; [Epub ahead of print]</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>Pulsed electromagnetic fields stimulation affects osteoclast  formation by modulation of osteoprotegerin, RANK ligand and macrophage  colony-stimulating factor.</h1>
<p>Chang K, Chang WH, Huang S, Huang S, Shih C.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Chung-Li 32023, Taiwan.</p>
<p>Electromagnetic stimulation has been documented to treat recalcitrant  problems of musculoskeletal system. Yet, the underlying mechanisms are  not completely understood. In this study, we investigated effect of  pulsed electromagnetic fields (PEMF) with parameters modified from  clinical bone growth stimulator on osteoclast formation, bone  resorption, and cytokines associated with osteoclastogenesis. Marrow  cells were harvested from both femora and tibiae of 6 week-old mice and  cultured in 8-well chamber slides or 16-well calcium phosphate  apatite-coated multitest slides. After 1-day incubation, marrow cells  were exposed to PEMF at different electric field intensities for 2h/day  and continued for 9 days. Osteoprotegerin (OPG), receptor activator of  NFkappaB-ligand (RANKL) and macrophage colony-stimulating factor (M-CSF)  concentrations of each group were determined after PEMF stimulation.  Osteoclast identity was confirmed by both tartrate resistant acid  phosphatase (TRAP) stain and bone resorption assay. A statistically  significant increase and decrease of osteoclastogenesis and bone  resorption areas were found when exposed to PEMF with different  intensities. Besides, consistent correlations among OPG, RANKL, M-CSF,  osteoclast numbers, and bone resorption after exposure to different  intensities of PEMF were observed. These data demonstrated that PEMF  with different intensities could regulate osteoclastogenesis, bone  resorption, OPG, RANKL, and M-CSF concentrations in marrow culture  system.</p>
<p>Bioelectromagnetics. 2005 Apr;26(3):207-14.</p>
<h1>Changes in polyamines, c-myc and c-fos gene expression in osteoblast-like cells exposed to pulsed electromagnetic fields.</h1>
<p>De Mattei M, Gagliano N, Moscheni C, Dellavia C, Calastrini C, Pellati A, Gioia M, Caruso A, Stabellini G.</p>
<p>Department of Morphology and Embryology, Section of Histology and Embryology, University of Ferrara, Italy.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic field (PEMF) stimulation promotes the healing  of fractures in humans, though its effect is little known. The processes  of tissue repair include protein synthesis and cell differentiation.  The polyamines (PA) are compounds playing a relevant role in both  protein synthesis processes and cell differentiation through c-myc and  c-fos gene activation. Since several studies have demonstrated that PEMF  acts on embryonic bone cells, human osteoblast-like cells and  osteosarcoma TE-85 cell line, in this study we analyzed the effect on  cell PAs, proliferation, and c-myc and c-fos gene expression of MG-63  human osteoblast-like cell cultures exposed to a clinically useful PEMF.  The cells were grown in medium with 0.5 or 10% fetal calf serum (FCS).  c-myc and c-fos gene expressions were determined by RT-PCR. Putrescine  (PUT), spermidine (SPD), or spermine (SPM) levels were evaluated by  HPLC. [(3)H]-thymidine was added to cultures for DNA analysis. The PEMF  increased [(3)H]-thymidine incorporation (P &lt; or = .01), while PUT  decreased after treatment (P &lt; or = .01); SPM and SPD were not  significantly affected. c-myc was activated after 1 h and downregulated  thereafter, while c-fos mRNA levels increased after 0.5 h and then  decreased. PUT, SPD, SPM trends, and [(3)H]-thymidine incorporation were  significantly related to PEMF treatment. These results indicate that  exposure to PEMF exerts biological effects on the intracellular PUT of  MG-63 cells and DNA synthesis, influencing the genes encoding c-myc and  c-fos gene expression. These observations provide evidence that in vitro  PEMF affects the mechanisms involved in cell proliferation and  differentiation.</p>
<p>J Orthop Res. 2004 Sep;22(5):1086-93.</p>
<h1>Bone mass is preserved in a critical-sized osteotomy by low energy  pulsed electromagnetic fields as quantitated by in vivo micro-computed  tomography.</h1>
<p>Ibiwoye MO, Powell KA, Grabiner MD, Patterson TE, Sakai Y, Zborowski M, Wolfman A, Midura RJ.</p>
<p>Department of Biomedical Engineering, Lerner Research Institute of  The Cleveland Clinic Foundation, ND20, 9500 Euclid Avenue, Cleveland, OH  44195, USA.</p>
<h3>Abstract</h3>
<p>The effectiveness of non-invasive pulsed electromagnetic fields  (PEMF) on stimulating bone formation in vivo to augment fracture healing  is still controversial, largely because of technical ambiguities in  data interpretation within several previous studies. To address this  uncertainty, we implemented a rigorously controlled, blinded protocol  using a bilateral, mid-diaphyseal fibular osteotomy model in aged rats  that achieved a non-union status within 3-4 weeks post-surgery.  Bilateral osteotomies allowed delivery of a PEMF treatment protocol on  one hind limb, with the contralateral limb representing a within-animal  sham-treatment. Bone volumes in both PEMF-treated and sham-treated  fibulae were assessed simultaneously in vivo using highly sensitive,  high-resolution micro-computed tomography (microCT) over the course of  treatment. We found a significant reduction in the amount of  time-dependent bone volume loss in PEMF-treated, distal fibular segments  as compared to their contralateral sham-treated bones. Osteotomy gap  size was significantly smaller in hind limbs exposed to PEMF over  sham-treatment. Therefore, our data demonstrate measurable biological  consequences of PEMF exposure on in vivo bone tissue.</p>
<p>Bioelectromagnetics. 2004 Sep;25(6):457-65.</p>
<h1>Effect of pulse-burst electromagnetic field stimulation on osteoblast cell activities.</h1>
<p>Chang WH, Chen LT, Sun JS, Lin FH.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Zhong-Li, Tao-Yuan, Taiwan, China.</p>
<h3>Abstract</h3>
<p>Electric stimulation has been used successfully to treat a wide range  of bone disorders. However, the mechanism by which the electric fields  can influence the bone cells behavior remains poorly understood. The  purpose of this research was to assess the possible mechanism of the  stimulatory effect of pulsed electromagnetic field (PEMF) on bone cells.  A PEMF with a frequency of 15 Hz (1 G [0.1 mT]; electric field strength  2 mV/cm) were applied to neonatal mouse calvarial bone cell cultures  for 14 days. The temporal effects of PEMF on the osteoblasts were  evaluated by the status of proliferation, differentiation,  mineralization, and gene expression on the 3rd, 5th, 7th, and 14th days  of culture. Our results demonstrated that PEMF stimulation significantly  increased the osteoblasts’ proliferation by 34.0, 11.5, and 13.3% over  the control group after 3, 5, and 7 days’ culture. Although the alkaline  phosphatase (ALP) staining and the mineralization nodules formation did  not change, the ALP activity of the bone cells decreased significantly  after PEMF stimulation. Under the PEMF stimulation, there was no effect  on the extracellular matrix synthesis, while the osteoprotegerin (OPG)  mRNA expression was up regulated and the receptor activator of NF-kappaB  ligand (RANKL) mRNA expression were down regulated, compared to the  control. In conclusion, the treatment by PEMF of osteoblasts may  accelerate cellular proliferation, but did not affect the cellular  differentiation. The effect of PEMF stimulation on the bone tissue  formation was most likely associated with the increase in the number of  cells, but not with the enhancement of the osteoblasts’ differentiation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">
<p lang="fr-FR">Int J Artif Organs. 2004 Aug;27(8):681-90.</p>
</td>
<td width="3">
<p lang="fr-FR">
</td>
</tr>
</tbody>
</table>
<h1>Current trends in the enhancement of biomaterial osteointegration: biophysical stimulation.</h1>
<h1><strong> </strong></h1>
<p>Fini M, Giavaresi G, Setti S, Martini L, Torricelli P, Giardino R.</p>
<p>Department of Experimental Surgery, Research Institute Codivilla-Putti, Rizzoli Orthopedic Institute, Bologna, Italy.</p>
<p>To enhance bone implant osteointegration, many strategies for  improving biomaterial properties have been developed which include  optimization of implant material, implant design, surface morphology and  osteogenetic coatings. Other methods that have been attempted to  enhance endogenous bone healing around biomaterials are different forms  of biophysical stimulations such as pulsed electromagnetic fields  (PEMFs) and low intensity pulsed ultrasounds (LIPUS), which were  initially developed to accelerate fracture healing. To aid in the use of  adjuvant biophysical therapies in the management of bone-implant  osteointegration, the present authors reviewed experimental and clinical  studies published in the literature over the last 20 years on the  combined use of biomaterials and PEMFs or LIPUS, and summarized the  methodology, and the possible mechanism of action and effectiveness of  the different biophysical stimulations for the enhancement of bone  healing processes around bone implanted biomaterials.</p>
<p>Bioelectromagnetics. 2004 Sep;25(6):457-65.</p>
<h1>Effect of pulse-burst electromagnetic field stimulation on osteoblast cell activities.</h1>
<p>Chang WH, Chen LT, Sun JS, Lin FH.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Zhong-Li, Tao-Yuan, Taiwan, China.</p>
<h3>Abstract</h3>
<p>Electric stimulation has been used successfully to treat a wide range  of bone disorders. However, the mechanism by which the electric fields  can influence the bone cells behavior remains poorly understood. The  purpose of this research was to assess the possible mechanism of the  stimulatory effect of pulsed electromagnetic field (PEMF) on bone cells.  A PEMF with a frequency of 15 Hz (1 G [0.1 mT]; electric field strength  2 mV/cm) were applied to neonatal mouse calvarial bone cell cultures  for 14 days. The temporal effects of PEMF on the osteoblasts were  evaluated by the status of proliferation, differentiation,  mineralization, and gene expression on the 3rd, 5th, 7th, and 14th days  of culture. Our results demonstrated that PEMF stimulation significantly  increased the osteoblasts’ proliferation by 34.0, 11.5, and 13.3% over  the control group after 3, 5, and 7 days’ culture. Although the alkaline  phosphatase (ALP) staining and the mineralization nodules formation did  not change, the ALP activity of the bone cells decreased significantly  after PEMF stimulation. Under the PEMF stimulation, there was no effect  on the extracellular matrix synthesis, while the osteoprotegerin (OPG)  mRNA expression was up regulated and the receptor activator of NF-kappaB  ligand (RANKL) mRNA expression were down regulated, compared to the  control. In conclusion, the treatment by PEMF of osteoblasts may  accelerate cellular proliferation, but did not affect the cellular  differentiation. The effect of PEMF stimulation on the bone tissue  formation was most likely associated with the increase in the number of  cells, but not with the enhancement of the osteoblasts’ differentiation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">J Foot Ankle Surg. 2004 Mar-Apr;43(2):93-6.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>The effect of pulsed electromagnetic fields on hindfoot arthrodesis: a prospective study.</h1>
<p>Dhawan SK, Conti SF, Towers J, Abidi NA, Vogt M.</p>
<p>Department of Orthopaedic Surgery, Interfaith Medical Center, Brooklyn, NY 11213, USA.<a href="mailto:drdhawan@hotmail.com">drdhawan@hotmail.com</a></p>
<p>The aim of this study was to evaluate the effect of pulsed  electromagnetic fields in a consecutive series of 64 patients undergoing  hindfoot arthrodesis (144 joints). All patients who underwent elective  triple/subtalar arthrodesis were randomized into control and pulsed  electromagnetic field study groups. Subjects in the study group had an  external pulsed electromagnetic fields device applied over the cast for  12 hours a day. Radiographs were taken pre- and postoperatively until  radiographic union occurred. A senior musculoskeletal radiologist,  blinded to the treatment scheme, evaluated the radiographic parameters.  The average time to radiographic union in the control group was 14.5  weeks in 33 primary subtalar arthrodeses. There were 4 nonunions. The  study group consisted of 22 primary subtalar arthrodeses and 5  revisions. The average time to radiographic union was 12.9 weeks (P  =.136). The average time to fusion of the talonavicular joint in the  control group was 17.6 weeks in 19 primary procedures. In the pulsed  electromagnetic fields group of 20 primary and 3 revision talonavicular  arthrodeses, the average time to radiographic fusion was 12.2 weeks (P  =.003). For the 21 calcaneocuboid arthrodeses in control group, the  average time to radiographic fusion was 17.7 weeks; it was 13.1 weeks (P  =.010) for the 19 fusions in the study group. This study suggests that,  if all parameters are equal, the adjunctive use of a pulsed  electromagnetic field in elective hindfoot arthrodesis may increase the  rate and speed of radiographic union of these joints.</p>
<p>Clin Orthop Relat Res. 2004 Feb;(419):30-7.</p>
<h1>Stimulation of growth factor synthesis by electric and electromagnetic fields.</h1>
<p>Aaron RK, Boyan BD, Ciombor DM, Schwartz Z, Simon BJ.</p>
<p>Department of Orthopaedics, Brown Medical School, Providence, RI, USA. <a href="mailto:Roy_Aaron@Brown.edu">Roy_Aaron@Brown.edu</a></p>
<h3>Abstract</h3>
<p>Biophysical input, including electric and electromagnetic fields,  regulate the expression of genes in connective tissue cells for  structural extracellular matrix (ECM) proteins resulting in an increase  in cartilage and bone production. In in vivo models and clinical  situations, this can be manifested as enhanced repair and a gain in  mechanical properties of the repairing tissues. The mechanisms by which  cell functions are regulated by biophysical input is the subject of this  review. Biophysical interactions of electric and electromagnetic fields  at the cell membrane are not well understood and require considerable  additional study. We review information on transmembrane signaling,  channel activation and receptor stimulation or blockade. Understanding  physical interactions and transmembrane signaling will most likely be  necessary to establish dosing paradigms and improve therapeutic  efficacy. Considerable information has been generated on an intermediary  mechanism of activity – growth factor stimulation. Electric and  electromagnetic fields increase gene expression for, and synthesis of,  growth factors and this may function to amplify field effects through  autocrine and paracrine signaling. Electric and electromagnetic fields  can produce a sustained upregulation of growth factors, which enhance,  but do not disorganize endochondral bone formation. Progress in the  areas of signal transduction and growth factor synthesis is very rapid  and future directions are suggested.</p>
<p>Bioelectromagnetics. 2004 Feb;25(2):134-41.</p>
<h1>Pulsed electromagnetic field stimulation of bone marrow cells  derived from ovariectomized rats affects osteoclast formation and local  factor production.</h1>
<p>Chang K, Hong-Shong Chang W, Yu YH, Shih C.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Chung-Li, Taiwan, Republic of China.</p>
<h3>Abstract</h3>
<p>This study examined the effects of a specific pulsed electromagnetic  field (PEMF) stimulation on osteoclast formation in bone marrow cells  from ovariectomized rats and to determine if the signal modulates the  production of cytokines associated with osteoclast formation. Adult  female Wistar rats were subjected to bilateral or sham ovariectomy, and  primary bone marrow cells were harvested at 4 days (Subgroup I) and 7  days (Subgroup II) after surgery. Primary bone marrow cells were  subsequently placed in chamber slides and set inside solenoids powered  by a pulse generator (300 micros, 7.5 Hz) for 1 h per day for 9 days  (OVX + PEMF group). Others (INT, SHAM, and OVX groups) were cultured  under identical conditions, but no signal was applied. Recruitment and  authentication of osteoclast-like cells were evaluated by determining  multinuclear, tartrate-resistant acid phosphatase (TRAP) positive cells  on day 10 of culture and by pit formation assay, respectively. The PEMF  signal caused significant reductions in osteoclast formation in both  Subgroups I (-55%) and II (-43%). Tumor necrosis factor-alpha  (TNF-alpha), interleukin 1beta (IL-1beta), and interleukin 6 (IL-6) in  OVX + PEMF group of Subgroup I were significantly reduced at 5, 7, and 9  days as compared to OVX group. The results found in this study suggest  that osteoclastogenesis can be inhibited by PEMF stimulation, putatively  due to a concomitant decrease in local factor production.</p>
<p>Clin Orthop Relat Res. 2004 Feb;(419):21-9.</p>
<h1>Treatment of nonunions with electric and electromagnetic fields.</h1>
<p>Aaron RK, Ciombor DM, Simon BJ.</p>
<p>Department of Orthopaedics, Brown Medical School, Providence, RI, USA. <a href="mailto:Roy_Aaron@Brown.edu">Roy_Aaron@Brown.edu</a></p>
<h3>Abstract</h3>
<p>Electric and electromagnetic fields are, collectively, one form of  biophysical technique which regulate extracellular matrix (ECM)  synthesis and may be useful in clinically stimulating repair of  fractures and nonunions. Preclinical studies have shown that electric  and electromagnetic fields regulate proteoglycan (PG) and collagen  synthesis in models of endochondral ossification, and increase bone  formation in vivo and in vitro. A substantial number of clinical studies  have been done that suggest acceleration of bone formation and healing,  particularly osteotomies and spine fusions, by electric and  electromagnetic fields. Many of these studies have used randomized,  placebo controlled designs. In osteotomy trials, greater bone density,  trabecular maturation, and radiographic healing were observed in  actively treated, compared with placebo-treated patients. In spine  fusions, average union rates of 80% to 90% were observed in actively  treated patients across numerous studies compared with 65% to 75% in  placebo-treated patients. Uncontrolled, longitudinal cohort studies of  delayed and nonunions report mean union rates of approximately 75% to  85% in fractures previously refractory to healing. The few randomized  controlled studies in delayed and nonunions suggest improved results  with electric and electromagnetic fields compared with placebo  treatment, and equivalent to bone grafts.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">Am J Orthop. 2004 Jan;33(1):27-30.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<h1>Pseudoarthrosis after lumbar spine fusion: nonoperative salvage with pulsed electromagnetic fields.</h1>
<p>Simmons JW Jr, Mooney V, Thacker I.</p>
<p>UTMB, Galveston, Texas, USA.</p>
<p>We studied 100 patients in whom symptomatic pseudarthrosis had been  established at more than 9 months after lumbar spine fusion. All  patients were treated with a pulsed electromagnetic field device worn  consistently 2 hours a day for at least 90 days. Solid fusion was  achieved in 67% of patients. Effectiveness was not statistically  significantly different for patients with risk factors such as smoking,  use of allograft, absence of fixation, or multilevel fusions. Treatment  was equally effective for posterolateral fusions (66%) as with interbody  fusions (69%). For patients with symptomatic pseudarthrosis after  lumbar spine fusion, pulsed electromagnetic field stimulation is an  effective nonoperative salvage approach to achieving fusion.</p>
<p>J Dent Res. 2003 Dec;82(12):962-6.</p>
<h1>Effects of static magnetic fields on bone formation in rat osteoblast cultures.</h1>
<p>Yamamoto Y, Ohsaki Y, Goto T, Nakasima A, Iijima T.</p>
<p>Department of Orthodontics, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.</p>
<h3>Abstract</h3>
<p>Although the promotional effects on osteoblasts of pulsed  electromagnetic fields have been well-demonstrated, the effects of  static magnetic fields (SMF) remain unclear; nevertheless, magnets have  been clinically used as a ‘force source’ in various orthodontic  treatments. We undertook the present investigation to study the effects  of SMF on osteoblastic differentiation, proliferation, and bone nodule  formation using a rat calvaria cell culture. During a 20-day culture,  the values of the total area and the number and average size of bone  nodules showed high levels in the presence of SMF. In the matrix  development and mineralization stages, the calcium content in the matrix  and two markers of osteoblastic phenotype (alkaline phosphatase and  osteocalcin) also showed a significant increase. Accordingly, these  findings suggest that SMF stimulates bone formation by promoting  osteoblastic differentiation and/or activation.</p>
<p>Eur Cell Mater. 2003 Dec 31;6:72-84; discussion 84-5.</p>
<h1>Biophysical stimulation of bone fracture repair, regeneration and remodelling.</h1>
<p>Chao EY, Inoue N.</p>
<p>Biomechanics Laboratory, Department of Orthopaedic Surgery Johns  Hopkins University, School of Medicine, Baltimore, Maryland 21205-2196,  USA. <a href="mailto:echao@jhmi.edu">echao@jhmi.edu</a></p>
<h3>Abstract</h3>
<p>Biophysical stimulation to enhance bone fracture repair and bone  regenerate maturation to restore its structural strength must rely on  both the biological and biomechanical principle according to the local  tissue environment and the type of mechanical stress to be born by the  skeletal joint system. This paper reviews the possible interactions  between biophysical stimuli and cellular responses in healing bone  fractures and proceeds to speculate the prospects and limitations of  different experimental models in evaluating and optimising such  non-invasive interventions. It is important to realize that bone  fracture repair has several pathways with various combinations of bone  formation mechanisms, but there may only be one bone remodeling  principle regulated by the hypothesis proposed by Wolff. There are  different mechanical and biophysical stimuli that could provide  effective augmentation of fracture healing and bone regenerate  maturation. The key requirements of establishing these positive  interactions are to define the precise cellular response to the  stimulation signal in an in vitro environment and to use  well-established animal models to quantify and optimise the therapeutic  regimen in a time-dependent manner. This can only be achieved through  research collaboration among different disciplines using scientific  methodologies. In addition, the specific forms of biophysical  stimulation and its dose effect and application timing must be carefully  determined and validated. Technological advances in achieving focalized  stimulus delivery with adjustable signal type and intensity, in the  ability to monitor healing callus mechanical property non-invasively,  and in the establishment of a robust knowledge base to develop effective  and reliable treatment protocols are the essential pre-requisites to  make biophysical stimulation acceptable in the main arena of health  care. Finally, it is important to bear in mind that successful fracture  repair or bone regeneration through callus distraction without adequate  remodeling process through physiological loading would seriously  undermine the value of biophysical stimulation in meeting the  biomechanical demand of a long bone.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="574">J Am Acad Orthop Surg. 2003 Sep-Oct;11(5):344-54.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>Use of physical forces in bone healing.</h1>
<p>Nelson FR, Brighton CT, Ryaby J, Simon BJ, Nielson JH, Lorich DG, Bolander M, Seelig J.</p>
<p>Henry Ford Hospital, Detroit, MI, USA.</p>
<p>During the past two decades, a number of physical modalities have  been approved for the management of nonunions and delayed unions.  Implantable direct current stimulation is effective in managing  established nonunions of the extremities and as an adjuvant in achieving  spinal fusion. Pulsed electromagnetic fields and capacitive coupling  induce fields through the soft tissue, resulting in low-magnitude  voltage and currents at the fracture site. Pulsed electromagnetic fields  may be as effective as surgery in managing extremity nonunions.  Capacitive coupling appears to be effective both in extremity nonunions  and lumbar fusions. Low-intensity ultrasound has been used to speed  normal fracture healing and manage delayed unions. It has recently been  approved for the management of nonunions. Despite the different  mechanisms for stimulating bone healing, all signals result in increased  intracellular calcium, thereby leading to bone formation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">Wiad Lek. 2003;56(9-10):434-41.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<h1>Application of variable magnetic fields in medicine–15 years experience.</h1>
<p>[Article in Polish]</p>
<p>Sieron A, Cieslar G.</p>
<p>Katedra i Klinika Chorob Wewnetrznych, Angiologii i Medycyny Fizykalnej SAM, ul. Batorego 15, 41-902 Bytom. <a href="mailto:sieron@mediclub.pl">sieron@mediclub.pl</a></p>
<p>The results of 15-year own experimental and clinical research on  application of variable magnetic fields in medicine were presented. In  experimental studies analgesic effect (related to endogenous opioid  system and nitrogen oxide activity) and regenerative effect of variable  magnetic fields with therapeutical parameters was observed. The  influence of this fields on enzymatic and hormonal activity, free oxygen  radicals, carbohydrates, protein and lipid metabolism, dielectric and  rheological properties of blood as well as behavioural reactions and  activity of central dopamine receptor in experimental animals was  proved. In clinical studies high therapeutic efficacy of magnetotherapy  and magnetostimulation in the treatment of osteoarthrosis, abnormal  ossification, osteoporosis, nasosinusitis, multiple sclerosis,  Parkinson’s disease, spastic paresis, diabetic polyneuropathy and  retinopathy, vegetative neurosis, peptic ulcers, colon irritable and  trophic ulcers was confirmed.</p>
<p>Bioelectromagnetics. 2003 Sep;24(6):431-9.</p>
<h1>Effects of different intensities of extremely low frequency pulsed electromagnetic fields on formation of osteoclast-like cells.</h1>
<p>Chang K, Chang WH, Wu ML, Shih C.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Chung-Li, Taiwan, Republic of China.</p>
<h3>Abstract</h3>
<p>Over the past 30 years, the beneficial therapeutic effects of  selected low energy, time varying electromagnetic fields (EMF) have been  documented with increasing frequency to treat therapeutically resistant  problems of the musculoskeletal system. However, the underlying  mechanisms at a cellular level are still not completely understood. In  this study, the effects of extremely low frequency pulsed  electromagnetic fields (ELF-PEMF) on osteoclastogenesis, cultured from  murine bone marrow cells and stimulated by 1,25(OH)(2)D(3), were  examined. Primary bone marrow cells were cultured from mature Wistar  rats and exposed to ELF-PEMF stimulation daily for 7 days with different  intensities of induced electric field (4.8, 8.7, and 12.2 micro V/cm  rms) and stimulation times (0.5, 2, and 8 h/day). Recruitment and  authentication of osteoclast-like cells were evaluated, respectively, by  determining multinuclear, tartrate resistant acid phosphatase (TRAP)  positive cells on day 8 of culture and by the pit formation assay.  During the experiments, cytokines such as tumor necrosis factor-alpha  (TNF-alpha), interleukin 1-beta (IL-1beta), and prostaglandin-E(2)  (PGE(2)) were assayed using the enzyme linked immunosorbent assay  (ELISA). These findings suggest that ELF-PEMF can both enhance  (approximately 50%) and suppress (approximately 27%) the formation of  osteoclast-like cells in bone marrow culture, depending on the induced  electric field intensity. In addition, consistent correlations were  observed between TNF-alpha, IL-1beta, and osteoclast-like cell number  after exposure to different induced electric field intensities of  ELF-PEMF. This in vitro study could be considered as groundwork for in  vivo ELF-PEMF clinical applications on some osteoclast-associated bone  diseases.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">J Pediatr Orthop. 2003 Jul-Aug;23(4):478-83.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>Effects of pulsed electromagnetic field stimulation on distraction osteogenesis in the rabbit tibial leg lengthening model.</h1>
<p>Fredericks DC, Piehl DJ, Baker JT, Abbott J, Nepola JV.</p>
<p>Bone Healing Research Laboratory, Department of Orthopaedic Surgery,  University of Iowa College of Medicine, Iowa City, Iowa 52242, USA. <a href="mailto:douglas-fredericks@uiowa.edu">douglas-fredericks@uiowa.edu</a></p>
<p>The purpose of this study was to determine whether exposure to pulsed  electromagnetic field (PEMF) would shorten the healing time of  regenerate bone in a rabbit tibial distraction model. Beginning 1 day  after surgery, mid-shaft tibial osteotomies, stabilized with external  fixators, were distracted 0.25 mm twice daily for 21 days and received  either no exposure (sham control) or 1 hour per day exposure to  low-amplitude, low-frequency PEMF. Tibiae were tested for torsional  strength after 9, 16, and 23 days post-distraction. PEMF-treated tibiae  were significantly stronger than shams at all three time points. By 16  days post-distraction, the PEMF group had achieved biomechanical  strength essentially equivalent to intact bone. Shams did not achieve  normal biomechanical strength even after 23 days post-distraction. In  this tibial distraction model, short daily PEMF exposures accelerated  consolidation of regenerate bone. Clinical usefulness awaits testing.</p>
<p>Osteoarthritis Cartilage. 2003 Jun;11(6):455-62.</p>
<h1>Modification of osteoarthritis by pulsed electromagnetic field–a morphological study.</h1>
<p><strong> </strong>Ciombor DM, Aaron RK, Wang S, Simon B.</p>
<p>Department of Orthopaedics, Brown Medical School, Providence, RI 02906, USA.</p>
<p>OBJECTIVE: Hartley guinea pigs spontaneously develop arthritis that  bears morphological, biochemical, and immunohistochemical similarities  to human osteoarthritis. It is characterized by the appearance of  superficial fibrillation by 12 months of age and severe cartilage  lesions and eburnation by 18 months of age. This study examines the  effect of treatment with a pulsed electromagnetic field (PEMF) upon the  morphological progression of osteoarthritis in this animal model.</p>
<p>DESIGN: Hartley guinea pigs were exposed to a specific PEMF for  1h/day for 6 months, beginning at 12 months of age. Control animals were  treated identically, but without PEMF exposure. Tibial articular  cartilage was examined with histological/histochemical grading of the  severity of arthritis, by immunohistochemistry for cartilage  neoepitopes, 3B3(-) and BC-13, reflecting enzymatic cleavage of  aggrecan, and by immunoreactivity to collagenase (MMP-13) and  stromelysin (MMP-3). Immunoreactivity to TGFbeta, interleukin  (IL)-1beta, and IL receptor antagonist protein (IRAP) antibodies was  examined to suggest possible mechanisms of PEMF activity.</p>
<p>RESULTS: PEMF treatment preserves the morphology of articular  cartilage and retards the development of osteoarthritic lesions. This  observation is supported by a reduction in the cartilage neoepitopes,  3B3(-) and BC-13, and suppression of the matrix-degrading enzymes,  collagenase and stromelysin. Cells immunopositive to IL-1 are decreased  in number, while IRAP-positive cells are increased in response to  treatment. PEMF treatment markedly increases the number of cells  immunopositive to TGFbeta.</p>
<p>CONCLUSIONS: Treatment with PEMF appears to be disease-modifying in  this model of osteoarthritis. Since TGFbeta is believed to upregulate  gene expression for aggrecan, downregulate matrix metalloprotease and  IL-1 activity, and upregulate inhibitors of matrix metalloprotease, the  stimulation of TGFbeta may be a mechanism through which PEMF favorably  affects cartilage homeostasis.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="573"></td>
<td width="3"></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574"></td>
<td width="2"></td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="586"></col>
</colgroup>
<tbody>
<tr>
<td width="586" valign="top"><strong>Journal of Bone and Mineral Metabolism</strong>Publisher: Springer-Verlag Tokyo Inc.ISSN: 0914-8779 (Paper) 1435-5604 (Online)</p>
<p>DOI: 10.1007/s007740200050</p>
<p>Issue: Volume 20, Number 6</p>
<p>Date:  November 2002</p>
<p>Pages: 345 – 349</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="586"></col>
</colgroup>
<tbody>
<tr>
<td width="586">
<h1>The preventative effect on bone loss of 50-Hz, 1-mT electromagnetic field on ovariectomized rats.</h1>
<p>Cemil Sert <sup>A1</sup>, Mustafa Denz <sup>A2</sup>, M. Zahir Düz <sup>A3</sup>, Feyzan Ak?en <sup>A4</sup>, Abdurrahman Kaya <sup>A4</sup></p>
<p><sup>A1</sup> Department of Biophysics, Medical School, Harran University, 63300, Yeni?ehir Kampüsü ?anl?urfa, Turkey<br />
<sup>A2</sup> Department of Anatomy, Medical School, Harran University, ?anl?urfa, Turkey<br />
<sup>A3</sup> Department of Chemistry, School of Art and Sciences, Dicle University, Campus, 21280, Diyarbak?r, Turkey<br />
<sup>A4</sup> Department of Biophysics, Medical School, Dicle University, Campus, 21280, Diyarbak?r, Turkey</p>
<p><strong>Abstract:</strong></p>
<p>Abstract. Osteoporosis is a common health problem, especially in the  elderly and in women after menopause. Although there are some treatment  methods, they impose serious side effects. Recently, the use of an  electromagnetic field (EMF) has been a promising candidate for better  treatment of osteoporosis. In the present study, we investigated the  preventive effects of low-frequency (50 Hz), low-intensity (1 mT), and  long-term (6 weeks) EMF on bone loss in ovariectomized rats. We used 18  female albino Wistar rats (8 unexposed and 10 exposed) to assess the  effect of EMF. We examined the mineralization and the morphology of the  tibia in control and EMF-exposed rats. The cortical thickness of the  tibia was increased in EMF-exposed rats (P &lt; 0.002). The levels of Na  and K in the tibia were significantly increased in rats exposed to EMF  (P &lt; 0.001; P &lt; 0.002, respectively). We also observed an  increased blood alkaline phosphatase (ALP) level after EMF exposure (P  &lt; 0.05). No significant differences in the levels of Ca, Mg, Li, or  creatine were found between the exposed and unexposed groups. Our data  support the notion that an EMF may prove to be an effective treatment  method for osteoporosis and other abnormalities related to bone loss.</td>
</tr>
</tbody>
</table>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">Int J Low Extrem Wounds. 2002 Sep;1(3):152-60.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<h1>Electromagnetic fields for bone healing.</h1>
<p>Pickering SA, Scammell BE.</p>
<p>Department of Orthopaedic and Accident Surgery, University Hospital, Queen’s Medical Centre, Nottingham, UK. <a href="mailto:simonpickering@tiscali.co.uk">simonpickering@tiscali.co.uk</a></p>
<p>Electrical stimulation has been applied in a number of different ways  to influence tissue healing. Most of the early work was carried out by  orthopedic surgeons looking for new ways of enhancing fracture healing,  particularly those fractures that had developed into nonunions.  Electrical energy can be supplied to a fracture by direct application of  electrodes or inducing current by use of pulsed electromagnetic field  or capacitive coupling. Many of these techniques have not been  standardized, so interpretation of the literature can be difficult and  misleading. Despite this, there have been a few good laboratory and  clinical studies to investigate the effect of electrical stimulation on  fracture healing, which are reviewed. These do not permit recommendation  or rejection of the technique per se; however, there is some room for  optimism. The authors present some of the guidelines for using this  treatment modality but suggest that all treatment should be carried out  as part of a clinical trial in order to generate reliable data.</p>
<p>Bioelectromagnetics. 2003 Apr;24(3):189-98.</p>
<h1>Pulsed electromagnetic fields prevent osteoporosis in an ovariectomized female rat model: a prostaglandin E2-associated process.</h1>
<p>Chang K, Chang WH.</p>
<p>Department of Biomedical Engineering, Chung-Yuan Christian University, Chung-Li, Taiwan, Republic of China.</p>
<h3>Abstract</h3>
<p>With the use of Helmholtz coils and pulsed electromagnetic field  (PEMF) stimulators to generate uniform time varying electromagnetic  fields, the effects of extremely low frequency electromagnetic fields on  osteoporosis and serum prostaglandin E(2) (PGE(2)) concentration were  investigated in bilaterally ovariectomized rats. Thirty-five 3 month old  female Sprague-Dawley rats were randomly divided into five different  groups: intact (INT), ovariectomy (OVX), aspirin treated (ASP), PEMF  stimulation (PEMF + OVX), and PEMF stimulation with aspirin (PEMF + ASP)  groups. All rats were subjected to bilateral ovariectomy except those  in INT group. Histomorphometric analyses showed that PEMF stimulation  augmented and restored proximal tibial metaphyseal trabecular bone mass  (increased hard tissue percentage, bone volume percentage, and  trabecular number) and architecture (increased trabecular perimeter,  trabecular thickness, and decreased trabecular separation) in both PEMF +  OVX and PEMF + ASP. Trabecular bone mass of PEMF + OVX rats after PEMF  stimulation for 30 days was restored to levels of age matched INT rats.  PEMF exposure also attenuated the higher serum PGE(2) concentrations of  OVX rats and restored it to levels of INT rats. These experiments  demonstrated that extremely low intensity, low frequency, single pulse  electromagnetic fields significantly suppressed the trabecular bone loss  and restored the trabecular bone structure in bilateral ovariectomized  rats. We, therefore, conclude that PEMF may be useful in the prevention  of osteoporosis resulting from ovariectomy and that PGE(2) might relate  to these preventive effects.</p>
<p>Nitric Oxide. 2002 Aug;7(1):18-23.</p>
<h1>Nitric oxide mediates the effects of pulsed electromagnetic field  stimulation on the osteoblast proliferation and differentiation.</h1>
<p>Diniz P, Soejima K, Ito G.</p>
<p>Department of Orthodontics, Kagoshima University Dental School, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.</p>
<h3>Abstract</h3>
<p>The purpose of this research was to investigate whether the effects  of pulsed electromagnetic field (PEMF) stimulation on the osteoblast  proliferation and differentiation are mediated by the increase in the  nitric oxide (NO, nitrogen monoxide) synthesis. The osteoblasts  (MC3T3-E1 cell line) were cultured in the absence (-NMMA group) or in  the presence (+NMMA group) of the NO synthase inhibitor L-NMMA. First,  osteoblasts were subjected to PEMF stimulation (15 Hz and 0.6 mT) up to  15 days. The DNA content and the NO concentration in the conditioned  medium were determined on the 3rd, 7th, and 15th days of culture.  Following, osteoblasts were stimulated in the proliferation (P-NMMA and  P+NMMA groups) or in the differentiation (D-NMMA and D+NMMA groups)  stages of maturation, and the alkaline phosphatase (AlPase) activity was  determined on the 15th day of culture for all groups. PEMF stimulation  increased significantly the nitrite concentration in the -NMMA group on  the 3rd, 7th, and 15th days of culture. However, this effect was  partially blocked in the +NMMA group. The DNA content in the -NMMA  group, but not in the +NMMA group, increased significantly on the 3rd  and 7th days of culture. The AlPase activity in the P-NMMA and D-NMMA  groups, but not in the P+NMMA and D+NMMA groups, also increased  significantly. In conclusion, the PEMF stimulatory effects on the  osteoblasts proliferation and differentiation were mediated by the  increase in the NO synthesis.</p>
<p>Bioelectromagnetics. 2002 Jul;23(5):398-405.</p>
<h1>Effects of pulsed electromagnetic field (PEMF) stimulation on bone  tissue like formation are dependent on the maturation stages of the  osteoblasts.</h1>
<p>Diniz P, Shomura K, Soejima K, Ito G.</p>
<p>Department of Orthodontics, Kagoshima University Dental School, Kagoshima, Japan.</p>
<h3>Abstract</h3>
<p>The effects of pulsed electromagnetic field (PEMF, 15 Hz pulse burst,  7 mT peak) stimulation on bone tissue-like formation on osteoblasts  (MC3T3-E1 cell line) in different stages of maturation were assessed to  determine whether the PEMF stimulatory effect on bone tissue-like  formation was associated with the increase in the number of cells and/or  with the enhancement of the cellular differentiation. The cellular  proliferation (DNA content), differentiation (alkaline phosphatase  activity), and bone tissue-like formation (area of mineralized matrix)  were determined at different time points. PEMF treatment of osteoblasts  in the active proliferation stage accelerated cellular proliferation,  enhanced cellular differentiation, and increased bone tissue-like  formation. PEMF treatment of osteoblasts in the differentiation stage  enhanced cellular differentiation and increased bone tissue-like  formation. PEMF treatment of osteoblasts in the mineralization stage  decreased bone tissue-like formation. In conclusion, PEMF had a  stimulatory effect on the osteoblasts in the early stages of culture,  which increased bone tissue-like formation. This stimulatory effect was  most likely associated with enhancement of the cellular differentiation,  but not with the increase in the number of cells.</p>
<p>J Vet Med A Physiol Pathol Clin Med. 2002 Feb;49(1):33-7.</p>
<h1>The effect of short-duration, high-intensity electromagnetic pulses on fresh ulnar fractures in rats.</h1>
<p>Leisner S, Shahar R, Aizenberg I, Lichovsky D, Levin-Harrus T.</p>
<p>Veterinary Teaching Hospital, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovat, Israel. <a href="mailto:leisner@agri.huji.ac.il">leisner@agri.huji.ac.il</a></p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields (PEMFs) have been found to be  beneficial to a wide variety of biological phenomena. In particular,  PEMFs have been shown to be useful in the promotion of healing of  ununited fractures. Conflicting information exists regarding the benefit  of using PEMFs to accelerate the healing of fresh fractures. This paper  reports on the evaluation of the effect of a new PEMF generator (PAP  IMI) on the healing of fresh ulnar fractures in rats. This device is  unique by virtue of the extremely high power output of each of the  pulses it generates. Ulnar fractures were created in rats by using a  bone cutter, thus producing a 2-3 mm bone defect. Rats were then  randomly divided into treatment and control groups. The treatment group  underwent periodic treatments with the PAP IMI, and the control group  received no treatment. Radiographs of rats from both groups were taken  at 1-week intervals. Histological evaluation was performed at the end of  the study. Radiographic and histopathological evaluations were scored,  and scores were used to assess both rate and quality of healing. The  radiographic results demonstrated gradual bridging callus formation in  both control and treatment groups, however, the healing process was  faster in rats that were not treated by PEMF. Histological evaluation  demonstrated that the fibrous content of the callus in rats belonging to  the treatment group was significantly higher than that in rats  belonging to the control group. The results of this study do not support  the claim that PEMF generated by the PAP-IMI stimulate osteogenesis and  bone healing after the creation of fresh ulnar fractures in rats.</p>
<p>Clin Orthop Relat Res. 2001 Mar;(384):265-79.</p>
<h1>Pulsed electromagnetic fields increase growth factor release by nonunion cells.</h1>
<p>Guerkov HH, Lohmann CH, Liu Y, Dean DD, Simon BJ, Heckman JD, Schwartz Z, Boyan BD.</p>
<p>Department of Orthopaedics, University of Texas Health Science Center at San Antonio, 78229-3900, USA.</p>
<h3>Abstract</h3>
<p>The mechanisms involved in pulsed electromagnetic field stimulation  of nonunions are not known. Animal and cell culture models suggest  endochondral ossification is stimulated by increasing cartilage mass and  production of transforming growth factor-beta 1. For the current study,  the effect of pulsed electromagnetic field stimulation on cells from  human hypertrophic (n = 3) and atrophic (n = 4) nonunion tissues was  examined. Cultures were placed between Helmholtz coils, and an  electromagnetic field (4.5-ms bursts of 20 pulses repeating at 15 Hz)  was applied to 1/2 of them 8 hours per day for 1, 2, or 4 days. There  was a time-dependent increase in transforming growth factor-beta 1 in  the conditioned media of treated hypertrophic nonunion cells by Day 2  and of atrophic nonunion cells by Day 4. There was no effect on cell  number, [3H]-thymidine incorporation, alkaline phosphatase activity,  collagen synthesis, or prostaglandin E2 and osteocalcin production. This  indicates that human nonunion cells respond to pulsed electromagnetic  fields in culture and that transforming growth factor-beta 1 production  is an early event. The delayed response of hypertrophic and atrophic  nonunion cells (&gt; 24 hours) suggests that a cascade of regulatory  events is stimulated, culminating in growth factor synthesis and  release.</p>
<p>Clin Oral Implants Res. 2000 Aug;11(4):354-60.</p>
<h1>Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits.</h1>
<p>Matsumoto H, Ochi M, Abiko Y, Hirose Y, Kaku T, Sakaguchi K.</p>
<p>Department of Fixed Prosthodontics, School of Dentistry, Health  Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293  Japan.</p>
<h3>Abstract</h3>
<p>The present study examined the effect of applying a pulsed  electromagnetic field (PEMF) on bone formation around a rough-surfaced  dental implant. A dental implant was inserted into the femur of Japanese  white rabbits bilaterally. A PEMF with a pulse width of 25 microseconds  and a pulse frequency of 100 Hz was applied. PEMF stimulation was  applied for 4 h or 8 h per day, at a magnetic intensity of 0.2 mT, 0.3  mT or 0.8 mT. The animals were sacrificed 1, 2 or 4 weeks after  implantation. After staining the resin sections with 2% basic fuchsin  and 0.1% methylene blue, newly formed bone around the implant on tissue  sections was evaluated by computer image analysis. The bone contact  ratios of the PEMF-treated femurs were significantly larger than those  of the control groups. Both the bone contact ratio and bone area ratio  of the 0.2 mT- and 0.3 mT-treated femurs were significantly larger than  the respective value of the 0.8 mT-treated femurs (P &lt; 0.001). No  significant difference in bone contact ratio or bone area ratio was  observed whether PEMF was applied for 4 h/day or 8 h/day. Although a  significantly greater amount of bone had formed around the implant of  the 2-week treated femurs than the 1-week treated femurs, no significant  difference was observed between the 2-week and 4-week treated femurs.  These results suggest that PEMF stimulation may be useful for promoting  bone formation around rough-surfaced dental implants. It is important to  select the proper magnetic intensity, duration per day, and length of  treatment.</p>
<p>J Orthop Res. 2000 Jul;18(4):637-46.</p>
<h1>Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production.</h1>
<p>Lohmann CH, Schwartz Z, Liu Y, Guerkov H, Dean DD, Simon B, Boyan BD.</p>
<p>Department of Orthopaedics, The University of Texas Health Science Center at San Antonio, 78229-3900, USA.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic field stimulation has been used to promote the  healing of chronic nonunions and fractures with delayed healing, but  relatively little is known about its effects on osteogenic cells or the  mechanisms involved. The purpose of this study was to examine the  response of osteoblast-like cells to a pulsed electromagnetic field  signal used clinically and to determine if the signal modulates the  production of autocrine factors associated with differentiation.  Confluent cultures of MG63 human osteoblast-like cells were placed  between Helmholtz coils and exposed to a pulsed electromagnetic signal  consisting of a burst of 20 pulses repeating at 15 Hz for 8 hours per  day for 1, 2, or 4 days. Controls were cultured under identical  conditions, but no signal was applied. Treated and control cultures were  alternated between two comparable incubators and, therefore, between  active coils; measurement of the temperature of the incubators and the  culture medium indicated that application of the signal did not generate  heat above the level found in the control incubator or culture medium.  The pulsed electromagnetic signal caused a reduction in cell  proliferation on the basis of cell number and [3H]thymidine  incorporation. Cellular alkaline phosphatase-specific activity increased  in the cultures exposed to the signal, with maximum effects at day 1.  In contrast, enzyme activity in the cell-layer lysates, which included  alkaline phosphatase-enriched extracellular matrix vesicles, continued  to increase with the time of exposure to the signal. After 1 and 2 days  of exposure, collagen synthesis and osteocalcin production were greater  than in the control cultures. Prostaglandin E2 in the treated cultures  was significantly reduced at 1 and 2 days, whereas transforming growth  factor-beta1 was increased; at 4 days of treatment, however, the levels  of both local factors were similar to those in the controls. The results  indicate enhanced differentiation as the net effect of pulsed  electromagnetic fields on osteoblasts, as evidenced by decreased  proliferation and increased alkaline phosphatase-specific activity,  osteocalcin synthesis, and collagen production. Pulsed electromagnetic  field stimulation appears to promote the production of matrix vesicles  on the basis of higher levels of alkaline phosphatase at 4 days in the  cell layers than in the isolated cells, commensurate with osteogenic  differentiation in response to transforming growth factor-beta1. The  results indicate that osteoblasts are sensitive to pulsed  electromagnetic field stimulation, which alters cell activity through  changes in local factor production.</p>
<p>Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2000 Jun;17(2):218-22.</p>
<h1>The mechanism of bone formation promoted by mechano-electrical environments–current studies on local bone factors.</h1>
<p lang="de-DE">[Article in Chinese]</p>
<p>Zheng L, Wang Q, Pei G.</p>
<p>Department of Orthopedics and Traumatology, Nanfang Hospital, First Military Medical University, Guangzhou 510510.</p>
<h3>Abstract</h3>
<p>The mechanism for promoting bone formation under the mechanical and  the electromagnetical fields stimulation is not yet quite clear. In  recent years, it has been found the mechanical and electromagnetical  environments may induce the osteogenic cells to produce some local bone  factors, such as prostaglandin E2(PGE2), insultine-like growth  factors-II (IGF-II), bone morphogenetic protein (BMP) and transforming  growth factor beta (TGF-beta). These factors play an important role in  bone formation and remodeling. This article introduces current studies  on some of these local bone factors under the stimulation of the  mechanical and electromagnetical environments.</p>
<p>Acta Med Austriaca. 2000;27(3):61-8.</p>
<h1>Clinical effectiveness of magnetic field therapy–a review of the literature.</h1>
<p lang="de-DE">[Article in German]</p>
<p>Quittan M, Schuhfried O, Wiesinger GF, Fialka-Moser V.</p>
<p>Universitätsklinik für Physikalische Medizin und Rehabilitation, Wien. <a href="mailto:michael.quittan@akh-wien.ac.at">michael.quittan@akh-wien.ac.at</a></p>
<p><strong>Abstract</strong></p>
<p>To verify the efficacy of electromagnetic fields on various diseases  we conducted a computer-assisted search of the pertinent literature. The  search was performed with the aid of the Medline and Embase database  (1966-1998) and reference lists. Clinical trials with at least one  control group were selected. The selection criteria were met by 31  clinical studies. 20 trials were designed double-blind, randomised and  placebo-controlled. The studies were categorised by indications.  Electromagnetic fields were applied to promote bone-healing, to treat  osteoarthritis and inflammatory diseases of the musculoskeletal system,  to alleviate pain, to enhance healing of ulcers and to reduce  spasticity. The action on bone healing and pain alleviation of  electromagnetic fields was confirmed in most of the trials. In the  treatment of other disorders the results are contradictory. Application  times varied between 15 minutes and 24 hours per day for three weeks up  to eighteen months. There seems to be a relationship between longer  daily application time and positive effects particular in bone-healing.  Patients were treated with electromagnetic fields of 2 to 100 G (0.2 mT  to 10 mT) with a frequency between 12 and 100 Hz. Optimal dosimetry for  therapy with electromagnetic fields is yet not established.</p>
<p>J Spinal Cord Med. 1999 Winter;22(4):239-45.</p>
<h1>The effect of pulsed electromagnetic fields on osteoporosis at the knee in individuals with spinal cord injury.</h1>
<p>Garland DE, Adkins RH, Matsuno NN, Stewart CA.</p>
<p>Rancho Los Amigos Medical Center, Downey, California 90242, USA.</p>
<h3>Abstract</h3>
<p>The purpose of this study was to determine the effects of pulsed  electromagnetic fields on osteoporotic bone at the knee in individuals  with chronic spinal injury. The study consisted of 6 males with complete  spinal cord injury at a minimum of 2 years duration. Bone mineral  density (BMD) was obtained at both knees at initiation, 3 months, 6  months, and 12 months using dual energy X-ray absorptiometry. In each  case, 1 knee was stimulated using The Bone Growth Stimulator Model 3005  from American Medical Electronics, Incorporated and the opposite knee  served as the control. Stimulation ceased at 6 months. At 3 months BMD  increased in the stimulated knees 5.1% and declined in the control knees  6.6% (p &lt; .05 and p &lt; .02, respectively). By 6 months the BMD  returned to near baseline values and at 12 months both knees had lost  bone at a similar rate to 2.4% below baseline for the stimulated knee  and 3.6% below baseline for the control. There were larger effects  closer to the site of stimulation. While the stimulation appeared useful  in retarding osteoporosis, the unexpected exaggerated decline in the  control knees and reversal at 6 months suggests underlying mechanisms  are more complex than originally anticipated. The authors believe a  local as well as a systemic response was created.</p>
<p>Bangladesh Med Res Counc Bull. 1999 Apr;25(1):6-10.</p>
<h1>Pulsed electromagnetic fields for the treatment of bone fractures.</h1>
<p>Satter Syed A, Islam MS, Rabbani KS, Talukder MS.</p>
<p>Industrial Physics Division, BCSIR Laboratories, Dhaka.</p>
<h3>Abstract</h3>
<p>The effectiveness of electrical stimulation and Pulsed Electro  Magnetic Field (PEMF) stimulation for enhancement of bone healing has  been reported by many workers. The mechanism of osteogenesis is not  clear, therefore, studies look for empirical evidence. The present study  involved a clinical trial using low amplitude PEMF on 19 patients with  non-union or delayed union of the long bones. The pulse system used was  similar in shape to Bassett’s single pulse system where the electric  voltage pulse was 0.3 mSec wide repeating every 12 mSec making a  frequency of about 80 Hz. The peak magnetic fields were of the order of  0.01 to 0.1 m Tesla, hundred to thousand times smaller than that of  Bassett. Among the 13 who completed this treatment schedule the history  of non-union was an average of 41.3 weeks. Within an average treatment  period of 14 weeks, 11 of the 13 patients had successful bone healing.  The two unsuccessful cases had bone gaps greater than 1 cm following  removal of dead bone after infection. However, use of such a low field  negates Bassett’s claim for a narrow window for shape and amplitude of  wave form, and justifies further experimental study and an attempt to  understand the underlying mechanism.</p>
<p>Clin Orthop Relat Res. 1998 Oct;(355 Suppl):S90-104.</p>
<h1>Effects of electromagnetic fields in experimental fracture repair.</h1>
<p>Otter MW, McLeod KJ, Rubin CT.</p>
<p>Program in Biomedical Engineering, State University of New York at Stony Brook 11794-8181, USA.</p>
<h3>Abstract</h3>
<p>The clinical benefits of electromagnetic fields have been claimed for  20 centuries, yet it still is not clear how they work or in what  circumstances they should be used. There is a large body of evidence  that steady direct current and time varying electric fields are  generated in living bone by metabolic activity and mechanical  deformation, respectively. Externally supplied direct currents have been  used to treat nonunions, appearing to trigger mitosis and recruitment  of osteogenic cells, possibly via electrochemical reactions at the  electrode-tissue interface. Time varying electromagnetic fields also  have been used to heal nonunions and to stabilize hip implants, fuse  spines, and treat osteonecrosis and osteoarthritis. Recent research into  the mechanism(s) of action of these time varying fields has  concentrated on small, extremely low frequency sinusoidal electric  fields. The osteogenic capacity of these fields does not appear to  involve changes in the transmembrane electric potential, but instead  requires coupling to the cell interior via transmembrane receptors or by  mechanical coupling to the membrane itself.</p>
<p>Biochem Biophys Res Commun. 1998 Sep 18;250(2):458-61.</p>
<h1>Pulsed electromagnetic fields simultaneously induce osteogenesis and  upregulate transcription of bone morphogenetic proteins 2 and 4 in rat  osteoblasts in vitro.</h1>
<p>Bodamyali T, Bhatt B, Hughes FJ, Winrow VR, Kanczler JM, Simon B, Abbott J, Blake DR, Stevens CR.</p>
<p>School of Postgraduate Medicine, University of Bath, Claverton Down, United Kingdom.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields (PEMF) are successfully employed in the  treatment of a variety of orthopaedic conditions, particularly delayed  and nonunion fractures. In this study, we examined PEMF effects on in  vitro osteogenesis by bone nodule formation and on mRNA expression of  bone morphogenetic proteins 2 and 4 by reverse-transcriptase polymerase  chain reaction (RT-PCR) in cultured rat calvarial osteoblasts. PEMF  exposure induced a significant increase in both the number (39% over  unexposed controls) and size (70% larger compared to unexposed controls)  of bone-like nodules formed. PEMF also induced an increase in the  levels of BMP-2 and BMP-4 mRNA in comparison to controls. This effect  was directly related to the duration of PEMF exposure. This study shows  that clinically applied PEMF have a reproducible osteogenic effect in  vitro and simultaneously induce BMP-2 and -4 mRNA transcription. This  supports the concept that the two effects are related.</p>
<p>Artif Cells Blood Substit Immobil Biotechnol. 1998 May;26(3):309-15.</p>
<h1>In vitro osteoinduction of demineralized bone.</h1>
<p>Torricelli P, Fini M, Giavaresi G, Giardino R.</p>
<p>Department of Experimental Surgery, Orthopaedic Institutes Rizzoli, Bologna, Italy.</p>
<h3>Abstract</h3>
<p>Among numerous available materials for osseous repair and  reconstruction, those presenting osteoinductive characteristics and  promoting bone regeneration are preferable. Fresh autologous bone is one  of the most effective, but it has some disadvantages and risks.  Demineralized bone matrix (DBM) is considered to be a valid alternative,  because it seems to show osteogenic potential, ascribed to the presence  of bone morphogenetic proteins. In addition it can be prepared without  difficulty and preserved without losing osteoinductive properties. The  aim of the study was to evaluate the osteoinductive ability of xenogenic  DBM, by testing DBM powder obtained from rabbit long bones, in cell  culture of murine fibroblasts, alone or associated with electromagnetic  field (EMF), that are known to exhibit biologic effects on cells: in  particular they are used in orthopedics to improve bone formation. At  the end of experiment, alkaline phosphatase (ALP) activity, calcium  levels and cell proliferation and morphology were evaluated. A  statistically significant stimulation of ALP activity and cell  proliferation and a morphological change of fibroblasts were found. The  results obtained show how DBM and EMF have different effects on cells,  and that together they have synergic action toward bone induction.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">Bioelectromagnetics. 1998;19(2):75-8.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<h1>Clinical report on long-term bone density after short-term EMF application.</h1>
<p>Tabrah FL, Ross P, Hoffmeier M, Gilbert F Jr.</p>
<p>University of Hawaii School of Medicine, Department of Physiology, Straub Clinic and Hospital, Honolulu 96813, USA. <a href="mailto:hbo@aloha.net">hbo@aloha.net</a></p>
<p>A 1984 study determined the effect of a 72 Hz pulsating  electromagnetic field (PEMF) on bone density of the radii of  post-menopausal (osteoporosis-prone) women, during and after treatment  of 10 h daily for 12 weeks. Bone mineral densities of the treated radii  increased significantly in the immediate area of the field during the  exposure period and decreased during the following 36 weeks. Bone  density determination of the radii of these women, remeasured after  eight years, suggests no long-term changes. The bone density-enhancing  effect of PEMFs should be further studied, alone and in combination with  exercise and pharmacologic agents such as the bisphosphonates and  hormones, as prophylaxis in the osteoporosis-prone postmenopausal woman  and as a possible block to the demineralization effect of microgravity.</p>
<p>Clin Orthop Relat Res. 1997 May;(338):262-70.</p>
<h1>Electromagnetic fields can affect osteogenesis by increasing the rate of differentiation.</h1>
<p>Landry PS, Sadasivan KK, Marino AA, Albright JA.</p>
<p>Department of Orthopaedic Surgery, Louisiana State University Medical Center, Shreveport 71130-3932, USA.</p>
<h3>Abstract</h3>
<p>Electromagnetic fields of various kinds can alter osteogenesis in  animals with osteotomies and patients with nonunions, but the underlying  cellular mechanisms are unknown. The aims of this study were to  determine whether I gauss at 60 Hz affected periosteal proliferation and  differentiation in either the normal rat tibia or 1 to 14 days after a  surgically induced defect. In the injured rats, using histologic study,  autoradiography, and morphometry, it was found that exposure for 1 or 3  days had no effect on proliferation but that it produced an increase in  osteoblasts 3 days after the injury. Proliferation and differentiation  were unaffected by exposure in the absence of injury. The results  suggest that the primary effect of the fields was to promote  differentiation but not proliferation. Because fields can stimulate  proliferation of osteoblastlike cells in vitro, the results of this  study may indicate the presence of an in vivo factor that antagonizes  the tendency of fields to increase mitotic activity.</p>
<p>Bioelectromagnetics. 1997;18(3):193-202.</p>
<h1>Mechanical and electrical interactions in bone remodeling.</h1>
<p>Spadaro JA.</p>
<p>Department of Orthopedic Surgery, State University of New York, Syracuse 13210, USA. <a href="mailto:spadaroj@vax.cs.hscyr.edu">spadaroj@vax.cs.hscyr.edu</a></p>
<h3>Abstract</h3>
<p>The natural remodeling and adaptation of skeletal tissues in response  to mechanical loading is a classic example of physical regulation in  biology. It is largely because it involves forces that do not seem to  fit into the familiar schemes of biochemical controls that bone  adaptation mechanisms have intrigued us for at least a century. The  effect of electromagnetic fields on organisms is another example of  this, and the two have become linked in an attempt to explain bone  remodeling (“Yasuda’s hypothesis”). This paper re-examines the roles of  endogenous and exogenous electromagnetic fields in the response of bone  to mechanical forces. A series of experiments is reviewed in which  mechanical and electrical stimuli were applied to implants in the  medullary canal of rabbit long bones. The results suggest that  endogenously generated electrical currents are not required to initiate  mechanically stimulated bone formation, but that direct mechanical  effects on bone cells is the more likely scenario. Based on this and  other evidence from the literature, it is suggested that when exogenous  electromagnetic stimuli are applied, bone cells respond by modulating  the activity of more primary activators such as hormones, growth  factors, cytokines, and mechanical forces.</p>
<p>Int J Adult Orthodon Orthognath Surg. 1997;12(1):43-53.</p>
<h1>Effects of static magnetic and pulsed electromagnetic fields on bone healing.</h1>
<p>Darendeliler MA, Darendeliler A, Sinclair PM.</p>
<p>Discipline of Orthodontics, Faculty of Dentistry, University of Sydney, Australia.</p>
<h3>Abstract</h3>
<p>The purpose of the present study was to evaluate the healing pattern  of an experimentally induced osteotomy in Hartley guinea pigs in the  presence of static magnetic and pulsed electromagnetic fields. The  sample consisted of 30 Hartley guinea pigs 2 weeks of age divided into 3  groups: pulsed electromagnetic, static magnetic, and control. An  osteotomy was performed in the mandibular postgonial area in all groups  under general anesthesia. During the experimental period of 9 days, the  animals were kept in experiment cages 8 hours per day, the first two  groups being in the presence of pulsed electromagnetic and static  magnetic field, respectively. Based on histologic results, both static  and pulsed electromagnetic fields seemed to accelerate the rate of bone  repair when compared to the control group. The osteotomy sites in the  control animals consisted of connective tissue, while new bone had  filled the osteotomy areas in both magnetic field groups.</p>
<p>J Orthop Res. 1996 Jul;14(4):582-9.</p>
<h1>Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool.</h1>
<p>Aaron RK, Ciombor DM.</p>
<p>Department of Orthopaedics, Brown University, Providence, Rhode Island, USA.</p>
<h3>Abstract</h3>
<p>Endochondral ossification can be modulated by a number of biochemical  and biophysical stimuli. This study uses the experimental model of  decalcified bone matrix-induced endochondral ossification to examine the  effect of one biophysical stimulus, an electromagnetic field, on  chondrogenesis, calcification, and osteogenesis. A temporal acceleration  and quantitative increase in sulfate incorporation, glycosaminoglycan  content, and calcification suggests that the stimulation of endochondral  ossification is due to an increase in extracellular matrix synthesis.  The locus of that stimulation is identified in the mesenchymal stage of  endochondral bone development, and stimulation at this stage is  essential for accelerated bone formation. The data suggest that enhanced  differentiation of mesenchymal stem cells present at this stage is most  likely responsible for the increase in extracellular matrix synthesis  and bone maturation.</p>
<p>Bone. 1996 Jun;18(6):505-9.</p>
<h1>Effect of pulsed electromagnetic fields on bone formation and bone loss during limb lengthening.</h1>
<p>Eyres KS, Saleh M, Kanis JA.</p>
<p>WHO Collaborating Centre for Metabolic Bone Disease, University of Sheffield Medical School, UK.</p>
<h3>Abstract</h3>
<p>We examined the effect of pulsed electromagnetic fields (PEMFs) on  bone formation and disuse osteoporosis sustained during limb lengthening  in a double-blind study. Seven males (mean age 13 years, range 11-19  years) and six females (mean age 12 years, range 9-19 years) were  randomly allocated to receive either an active or an inactive PEMF coil.  Limb lengthening was performed by the Villarubbias technique using  either a unilateral or circular frame system. Sequential bone density  measurements were made using dual energy X-ray absorptiometry and  compared to traditional radiographs. Ten segments (eight tibial and two  femoral) in seven patients were lengthened under the influence of active  coils and eight segments (six tibial and two femoral) in six patients  using inactive coils. There was no difference in the rate nor the amount  of new bone formed at the site of distraction between the two groups.  Bone loss in the segments of bone distal to the lengthening sites was  observed in both groups but was significantly more marked using inactive  coils (BMD reduced by 23% +/- SEM 3% and 33% +/- 4% control values  after one and two months, respectively; p &lt; 0.0001) than using active  coils (BMD reduced by 10% +/- 2% at 2 months). These differences were  greater at 12 months after surgery (reduced by 54% +/- 5% and 13% +/-  4%, respectively; p &lt; 0.0001). Stimulation with pulsed  electromagnetic fields has no effect on the regenerate bone, but does  prevent bone loss adjacent to the distraction gap.</p>
<p>In Vivo. 1996 May-Jun;10(3):351-6.</p>
<h1>Osteogenesis by pulsing electromagnetic fields (PEMFs): optimum stimulation setting.</h1>
<p>Matsunaga S, Sakou T, Ijiri K.</p>
<p>Department of Orthopaedic Surgery, Faculty of Medicine, Kagoshima University, Japan.</p>
<h3>Abstract</h3>
<p>The optimum setting for electromagnetic stimulation was examined by  histologically assessing the degree of osteogenesis at different  settings of electromagnetic stimulation, and comparing alkaline  phosphatase (ALP) activity in the bone marrow. For this experiment, an  electromagnetic field generator manufactured by the Institute of  Physical and Chemical Research was used. The intensity of the magnetic  field was set at eight levels; 0.1, 0.2, 0.4, 1, 2, 4, 6 and 8 gauss  (G). The frequencies used were 5, 10, 20, 50, 100 and 200 Hz. Pulse  durations were 6, 12, 25, 50 and 100 micro sec. Significant ALP  elevation and osteogenesis were observed at magnetic field intensities  of 0.4, 1, and 2G. ALP activity did not differ between different  frequencies. ALP activity at pulse durations of 25 and 50 micro sec were  significantly higher than at the other pulse durations. The effect of  electromagnetic stimulation on osteogenesis greatly depends on the  intensity and pulse duration of the stimulation.</p>
<p>J Bone Miner Res. 1993 Dec;8 Suppl 2:S573-81.</p>
<h1>Optimization of electric field parameters for the control of bone  remodeling: exploitation of an indigenous mechanism for the prevention  of osteopenia.</h1>
<p>Rubin CT, Donahue HJ, Rubin JE, McLeod KJ.</p>
<p>Department of Orthopaedics, State University of New York, Stony Brook.</p>
<p>Abstract</p>
<p>The discovery of piezoelectric potentials in loaded bone was  instrumental in developing a plausible mechanism by which functional  activity could intrinsically influence the tissue’s cellular environment  and thus affect skeletal mass and morphology. Using an in vivo model of  osteopenia, we have demonstrated that the bone resorption that normally  parallels disuse can be prevented or even reversed by the exogenous  induction of electric fields. Importantly, the manner of the response  (i.e., formation, turnover, resorption) is exceedingly sensitive to  subtle changes in electric field parameters. Fields below 10 microV/cm,  when induced at frequencies between 50 and 150 Hz for 1 h/day, were  sufficient to maintain bone mass even in the absence of function.  Reducing the frequency to 15 Hz made the field extremely osteogenic.  Indeed, this frequency-specific sinusoidal field initiated more new bone  formation than a more complex pulsed electromagnetic field (PEMF),  though inducing only 0.1% of the electrical energy of the PEMF. The  frequencies and field intensities most effective in the exogenous  stimulation of bone formation are similar to those produced by normal  functional activity. This lends strong support to the hypothesis that  endogenous electric fields serve as a critical regulatory factor in both  bone modeling and remodeling processes. Delineation of the field  parameters most effective in retaining or promoting bone mass will  accelerate the development of electricity as a unique and site-specific  prophylaxis for osteopenia. Because fields of these frequencies and  intensities are indigenous to bone tissue, it further suggests that such  exogenous treatment can promote bone quantity and quality with minimal  risk or consequence.</p>
<p>J Orthop Res. 1993 Sep;11(5):664-70.</p>
<h1>Pulsed magnetic fields improve osteoblast activity during the repair of an experimental osseous defect.</h1>
<p>Canè V, Botti P, Soana S.</p>
<p>Institutes of Human Anatomy, University of Modena, Italy.</p>
<p>Abstract</p>
<p>The influence of pulsed low-frequency electromagnetic fields (PEMFs)  on bone formation was investigated in studies of the healing process of  transcortical holes, bored at the diaphyseal region of metacarpal bones  of six adult horses, exposed for 30 days to PEMFs (28 G peak amplitude,  1.3 ms rise time, and 75 Hz repetition rate). A pair of Helmholtz coils,  continuously powered by a pulse generator, was applied for 30 days to  the left metacarpal bone, through which two holes, of equal diameter and  depth, had been bored at the diaphyseal region. Two equal holes, bored  at the same level in the right metacarpal and surrounded by an inactive  pair of Helmholtz coils, were used as controls. All horses were given an  intravenous injection of 25-30 mg/kg of tetracycline chloride on the  15th and again on the 25th day after the operation and were killed 5  days later. The histomorphometric analysis indicated that both the  amount of bone formed during 30 days and the mineral apposition rate  during 10 days (deduced from the interval between the two tetracycline  labels) were significantly greater (p &lt; 0.01 and p &lt; 0.0001,  respectively) in the PEMF-treated holes than in the controls. As did a  previous investigation, these preliminary findings indicate that PEMFs  at low frequency not only stimulate bone repair but also seem to improve  the osteogenic phase of the healing process, at least in our  experimental conditions.</p>
<p>Boll Soc Ital Biol Sper. 1993 Jul-Aug;69(7-8):469-75.</p>
<h1>Effects of pulsed magnetic fields in the therapy of osteoporosis induced by ovariectomy in the rat.</h1>
<p>Zati A, Gnudi S, Mongiorgi R, Giardino R, Fini M, Valdrè G, Galliani I, Montagnani AM.</p>
<p>Institute Orthopaedic Rizzoli, University of Bologna.</p>
<h3>Abstract</h3>
<p>This paper presents preliminary results on the effects of pulsed  electromagnetic fields (EMF) in the therapy of post menopausal  osteoporosis induced by ovariectomy in female rats aged ten months. In  particular, the effects of the intensity of pulsed EMF applied at  constant frequency has been studied. Magnetic fields pulsed at 50 Hz  were used having a positive sinusoidal wave form with a maximum  intensity of 30 and 70 Gauss. Treatment lasting one hour per day for 4  months showed that the pulsed EMF with 30 Gauss of maximum intensity are  able to slow down the bone mass loss, keeping it within some 10%; with  pulsed EMF with 70 Gauss of maximum intensity, instead, no significant  bone mass loss was observed.</p>
<p>J Cell Biochem. 1993 May;52(1):37-41.</p>
<h1>Influence of electromagnetic fields on endochondral bone formation.</h1>
<p>Ciombor DM, Aaron RK.</p>
<p>Department of Orthopaedics, Brown University, Providence, Rhode Island 00928.</p>
<h3>Abstract</h3>
<p>Endochondral ossification is a basic physiological process in limb  development and is central to bone repair and linear growth. Factors  which regulate endochondral ossification include several biophysical and  biochemical agents and are of interest from clinical and biological  perspectives. One of these agents, electric stimulation, has been shown  to result in enhanced synthesis of extracellular matrix, calcification,  and bone formation in a number of experimental systems and is the  subject of this review. The effects of electric stimulation have been  studied in embryonic limb rudiments, growth plates, and experimental  endochondral ossification induced with decalcified bone matrix and, in  all these models, endochondral ossification has been enhanced. It is not  known definitively whether electric fields stimulate cell  differentiation or modulate an increased number of molecules synthesized  by committed cell population and this is a fertile area of current  study.</p>
<p>Arch Oral Biol. 1993 Jan;38(<br />
<strong> </strong></p>
<h1>Autoradiographic study of the effects of pulsed electromagnetic fields on bone and cartilage growth in juvenile rats.</h1>
<p>Wilmot JJ, Chiego DJ Jr, Carlson DS, Hanks CT, Moskwa JJ.</p>
<p>Department of Orthodontics and Pediatric Dentistry, University of Michigan, School of Dentistry, Ann Arbor 48109.</p>
<p>Application of pulsed electromagnetic fields (PEMF) has been used in  growth and repair of non-union bone fractures. The similarities between  the fibrocartilage callus in non-union bone fractures and the secondary  cartilage in the mandibular condyle, both histologically and  functionally, lead naturally to study the effects of PEMFs on growth in  the condyle. The purposes of this study were: (1) to describe the  effects of PEMFs on the growth of the condyle using autoradiography,  [3H]-proline and [3H]-thymidine, and (2) to differentiate between the  effects of the magnetic and electrical components of the field. Male  pre-adolescent Sprague-Dawley rats (28 days old) were divided into three  experimental groups of five animals each: (1) PEMF-magnetic (M), (2)  PEMF-electrical (E) and (3) control, and were examined at three  different times-3, 7 and 14 days of exposure. Each animal was exposed to  the field for 8 h per day. Histological coronal sections were processed  for quantitative autoradiography to determine the mitotic activity of  the condylar cartilage and the amount of bone deposition. The PEMF  (magnetic or electrical) had statistically significant effects only on  the thickness of the articular zone, with the thickness in the PEMF-M  group being the most reduced. Length of treatment was associated with  predictable significant changes in the thickness of the condylar  cartilage zones and the amount of bone deposition.(ABSTRACT TRUNCATED AT  250 WORDS)</p>
<p>J Dent Res. 1992 Dec;71(12):1920-5.</p>
<h1>Effect of a pulsing electromagnetic field on demineralized  bone-matrix-induced bone formation in a bony defect in the premaxilla of  rats.</h1>
<p>Takano-Yamamoto T, Kawakami M, Sakuda M.</p>
<p>Department of Orthodontics, Osaka University, Faculty of Dentistry, Japan.</p>
<h3>Abstract</h3>
<p>A 2-mm non-healing bony defect was prepared in the premaxilla of male  Wistar rats weighing about 180 g as a simulation of an alveolar cleft,  for determination of whether a pulsing electromagnetic field (PEMF)  could promote regeneration of bone induced by demineralized bone matrix  (DBM). The defect was either treated with 7 mg DBM or was left as a  non-grafted control. The rats were exposed to a PEMF with a frequency of  100 Hz, a 10-ms-wide burst with 100 microseconds-wide quasi-rectangular  pulses, repeating at 15 Hz, and magnetic field strength of 1.5-1.8 G.  Alkaline phosphatase activity increased significantly from day 7 in the  DBM-graft-plus-PEMF group and from day 10 in the DBM-graft group,  reaching a maximum on day 14. A greater-than-two-fold rise in alkaline  phosphatase activity and a three-fold rise in the amount of 45Ca  incorporation in the DBM-graft-plus-PEMF group were attained compared  with those of the DBM-graft group. The DBM-graft-plus-PEMF group  produced more bone with almost complete osseous bridging in the defect  sites than did the group treated with DBM only on day 35. The findings  indicate that PEMF had an enhancing effect on the bone-inductive  properties of the DBM through the stimulation of osteoblast  differentiation induced by DBM.</p>
<p>J Bone Joint Surg Am. 1992 Jul;74(6):920-9.</p>
<h1>The effect of low-frequency electrical fields on osteogenesis.</h1>
<p>McLeod KJ, Rubin CT.</p>
<p>Department of Orthopaedics, School of Medicine, State University of New York, Stony Brook 11794-8181.</p>
<p>Erratum in:</p>
<ul>
<li>J Bone Joint Surg Am 1992 Sep;74(8):1274.</li>
</ul>
<h3>Abstract</h3>
<p>An in vivo animal model of disuse osteopenia was used to determine  the osteogenic potential of specific components of electrical fields.  The ability of a complex pulsed electrical field to inhibit loss of bone  was compared with the remodeling response generated by extremely  low-power, low-frequency (fifteen, seventy-five, and 150-hertz)  sinusoidal electrical fields. The left ulnae of thirty adult male  turkeys were functionally isolated by creation of distal and proximal  epiphyseal osteotomies and then were exposed, for one hour each day, to  an electrical field that had been induced exogenously by means of  magnetic induction. After a fifty-six-day protocol, the remodeling  response was quantified by a comparison of the cross-sectional area of  the mid-part of the diaphysis of the functionally isolated ulna with  that of the intact contralateral ulna. Disuse resulted in a 13 per cent  mean loss of osseous tissue, which was not significantly different than  the 10 per cent loss that was caused by disuse treated with inactive  coils. Exposure to the pulsed electrical fields prevented this  osteopenia and stimulated a 10 per cent mean increase in the bone area.  The osteogenic influence of the sinusoidal electrical fields was  strongly dependent on the frequency; the 150, seventy-five, and  fifteen-hertz sinusoidal fields, respectively, generated a -3 per cent, +  5 per cent, and + 20 per cent mean change in the bone area. These  results suggest a tissue sensitivity that is specific to very  low-frequency sinusoidal electrical fields, and they imply that the  induced electrical fields need not have complex waveforms to be  osteogenic. Since the frequency and intensity range of the sinusoidal  fields producing the greatest osteogenic response are similar to the  levels produced intrinsically by normal functional activity, these  results support the hypothesis that electricity plays a role in the  retention of the normal remodeling balance within mature bone.</p>
<p>Rev Hosp Clin Fac Med Sao Paulo. 1992 May-Jun;47(3):128-30.</p>
<h1>Effect of electromagnetic fields on osteogenesis: an experimental study on rats.</h1>
<p>[Article in Portuguese]</p>
<p>de Barros Filho TE, Rossi JD, Lage Lde A, Rodrigues CJ, de Oliveira AS, Pinto FC, dos Reis GM, Rodrigues Júnior AJ.</p>
<p>LIM-41, Instituto de Ortopedia e Traumatologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo.</p>
<h3>Abstract</h3>
<p>The authors studied experimentally the electromagnetic pulsing field  effects in an experimental model in rats, for evaluation of the velocity  of consolidation of tibial and fibular fractures. The animals were  followed for a period of three weeks under continuous stimulation and  there were done radiological evaluation weekly and histological study at  the end of the study. There were no histological, clinical or  radiological differences between the group of rats submitted to  electromagnetic pulsing fields and the control group.</p>
<p>J Orthop Res. 1991 Nov;9(6):908-17.</p>
<h1>Electromagnetic stimulation of bone repair: a histomorphometric study.</h1>
<p>Canè V, Botti P, Farneti D, Soana S.</p>
<p>Institutes of Human Anatomy, University of Modena, Italy.</p>
<p>Abstract</p>
<p>The effect of pulsing electromagnetic fields (PEMFs) on bone repair  was studied in principal metacarpal bones of eight adult male horses:  Six horses were treated with PEMFs, and two horses were untreated. In  treated horses, Helmholtz coils were applied during a 60-day period to  the left metacarpal bones, bored with eight holes of equal diameter and  depth, from the middiaphysis toward the distal metaphysis. Eight equal  holes bored in the right metacarpal, surrounded by unactivated Helmholtz  coils, were taken as controls. The two untreated horses were taken as  additional control. The results of computer-assisted histomorphometric  analysis indicate that (a) in diaphyseal levels, the amount of bone  formed during 60 days is significantly greater (p less than 0.01) in  PEMF-treated holes than in contralateral ones and those in control  horses; (b) in metaphyseal levels, PEMF-treated holes are sometimes more  closed, sometimes less, as compared with contralateral holes and those  in control horses; in any case the statistical analysis indicates that  the symmetry in the rate of hole repair, found between the two antimeres  of control horses, is not appreciable at metaphyseal levels also; (c)  there was no statistically significant difference between untreated  holes in PEMF-treated horses and holes in control horses, neither at  diaphyseal nor at metaphyseal levels. These preliminary findings  indicate that PEMFs at low frequency influence the process of bone  repair on both diaphysis and metaphysis, and seem to improve the process  of bone repair in skeletal regions normally having a lower osteogenetic  activity, i.e., in diaphyses as against metaphyses.</p>
<p>Int Orthop. 1991;15(4):341-6.</p>
<h1>Effects of pulsing electromagnetic fields on cultured cartilage cells.</h1>
<p>Sakai A, Suzuki K, Nakamura T, Norimura T, Tsuchiya T.</p>
<p>Department of Orthopaedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.</p>
<p>In order to evaluate the effects of pulsing electromagnetic fields  (PEMFs) on cell proliferation and glycosaminoglycan (GAG) synthesis and  to study the action site of PEMF stimulation in the cells, we performed a  series of experiments on rabbit costal growth cartilage cells and human  articular cartilage cells in culture. A PEMF stimulator was made using a  Helmholz coil. Repetitive pulse burst electric currents with a burst  width of 76 ms, a pulse width of 230 microseconds and 6.4 Hz were passed  through this coil. The magnetic field strength reached 0.4 mT (tesla)  on the average. The syntheses of DNA and GAG were measured by  3H-thymidine and 35S-sulfuric acid incorporations. The effects on the  cells treated with lidocaine, adriamycin and irradiation were also  measured using a colony forming assay. The PEMF stimulation for the  duration of 5 days promoted both cell proliferation and GAG synthesis in  growth cartilage cells and intermittent stimulation on and off  alternatively every 12 h increased them most significantly, while, in  articular cartilage cells, the stimulation promoted cell proliferation,  but did not enhance GAG synthesis. PEMF stimulation promoted cells  treated with lidocaine more significantly than with other agents. These  results present evidence that intermittent PEMF stimulation is more  effective on both cell proliferation and GAG synthesis of cartilage  cells than continuous stimulation, and that the stimulation could exert  effects not by nucleus directly, but by the cellular membrane-dependent  mechanism. This study provides further basic data to encourage the  clinical application of PEMF stimulation on bone and cartilage  disorders.</p>
<p>Med Biol Eng Comput. 1991 Mar;29(2):113-20.</p>
<h1>Comparative study of bone growth by pulsed electromagnetic fields.</h1>
<p>Gupta TD, Jain VK, Tandon PN.</p>
<p>Department of Electrical Engineering, Harcourt Butler Technological Institute, Kanpur, India.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields have been widely used for treatment of  non-united fractures and congenital pseudarthrosis. Several electrical  stimulation systems such as air-cored and iron-cored coils and solenoids  have been used the world over and claimed to be effective. Electrical  parameters such as pulse shape, magnitude and frequency differ widely,  and the exact bone-healing mechanism is still not clearly understood.  The study attempts to analytically investigate the effectiveness of  various parameters and suggests an optimal stimulation waveform.  Mathematical analysis of electric fields inside the bone together with  Fourier analysis of induced voltage waveforms produced by commonly used  electrical stimulation wave-forms has been performed. A hypothesis based  on assigning different weightings to different frequencies for  osteogenic response has been proposed. Using this hypothesis  astonishingly similar effective values of electric fields have been  found in different systems. It is shown that effective electric field  rather than peak electric field is the main parameter responsible for  osteogenesis. The results are in agreement with experimental findings  made on human beings by different investigators.</p>
<p>Biomed Sci Instrum. 1991;27:205-17.</p>
<h1>Low magnetic field effects on embryonic bone growth.</h1>
<p>McCleary VL, Akers TK, Aasen GH.</p>
<p>Dept. of Phys., UND School of Medicine, Grand Forks 58202.</p>
<h3>Abstract</h3>
<p>Pulsed electromagnetic fields [EMF] and electric fields have been  demonstrated to promote osteogenesis and wound healing. Pulsed EMF’s  have been approved since 1979 by the FDA, and are highly effective in  the treatment of non-union fractures. Increased linear growth, cellular  proliferation, cAMP and uptake of tritiated thymidine have been  documented on short term exposure. Yet the mechanisms and the changes  that occur have been difficult to quantify. Fluorescence, light, and  electron microscopy were utilized in this study to assess any  histological changes in bone. During incubation chick embryos were  exposed to magnets oriented in various positions. Controls were oriented  similarly using galvanized steel plugs. Field density in the center of  the field was measure by a gaussmeter with a transverse probe. Each  chick embryo in its magnetic field was isolated from the magnetic fields  of others by being encased in a steel box. Intramembranous [calvaria]  and endochondral [tibia] ossification were studied. Fluorescent dyes  were micropipetted intravascularly at various stages of chick  development. The tissues were fixed in methacrylate and stained for  histomorphological study.</p>
<p>Anat Anz. 1991;172(2):143-7.</p>
<h1>Augmentation of bone repair by pulsed elf magnetic fields in rats.</h1>
<p>Ottani V, De Pasquale V, Govoni P, Castellani PP, Ripani M, Gaudio E, Morocutti M.</p>
<p lang="sv-SE">Istituto di Anatomia Umana Normale, Bologna, Italy.</p>
<h3>Abstract</h3>
<p>Tibial osteotomies in rats were exposed for 2, 3, 5 and 8 weeks to a  pulsed extremely low frequency magnetic field. The shape of the pulse  was a double halfwave (50 Hz, 70 G). The rate of bone healing was  evaluated by light and electron microscopy. An increase of bone healing  was found in rats treated with magnetic fields persisting throughout the  tested time. The accelerated healing process produced a sequence of  morphological appearances identical to those of a normal fracture callus  being the enhancement of osteogenesis produced by an acceleration of  preliminary ossification.</p>
<p>Bioelectromagnetics. 1991;12(2):101-16.</p>
<h1>Effect of localized pulsed electromagnetic fields on tail-suspension osteopenia in growing mice.</h1>
<p>Simske SJ, Wachtel H, Luttges MW.</p>
<p>Department of Electrical Engineering, University of Colorado, Boulder 80309-0425.</p>
<h3>Abstract</h3>
<p>Pulsed magnetic fields (PEMFs) have been used effectively to treat  bone fractures and sciatic-nerve-section-induced osteopenias. Properly  applied PEMFs are presumed to stimulate osteogenesis. Mouse-tail  suspension has been implemented as a means of inducing an osteopenic  response in the long bones of the hind limbs. To evaluate localized PEMF  effects, the mouse-suspension model was modified to accommodate the use  of miniature wire coils affixed directly to the rear legs. Laterally  and axially orientated PEMF effects were compared. Three test groups of  mice included (C) control mice, (S) tail-suspended mice with treatment  apparatus attached, and (SF) tail-suspended mice with apparatus attached  and PEMFs delivered. The SF group was divided into mice receiving axial  or lateral PEMFs. Significant bone changes occurred in suspended as  compared with control mice after a 2-week test period. The PEMF mice  showed significantly fewer osteopenic effects than did untreated,  suspended mice. These findings are based on biomechanical measures of  stiffness, strength, ductility, and energy as well as whole-bone mass  and porosity. The effects of PEMFs on these properties differ for axial  and lateral exposures. The results are discussed in terms of mechanisms  underlying PEMF effects.</p>
<p>Z Orthop Ihre Grenzgeb. 1991 Jan-Feb;129(1):118-25.</p>
<h1>Biophysical foundations in the application of electromagnetic fields in the modification of osteogenesis.</h1>
<p lang="de-DE">[Article in German]</p>
<p>Werhahn C.</p>
<p lang="de-DE">Orthopädische Abteilung Ev. Waldkrankenhaus Spandau.</p>
<h3>Abstract</h3>
<p>The interactions between bone-forming cells and the extracellular  processes determining the mineralisation of the osteoid with electric  and/or magnetic fields is the elementary prerequisite. The magnetic or  electric field or the combination of both, as well as their time related  intensity are discussed as the stimulating factors. When using electric  current there is a physical process to be considered. This process  consists of changes of metabolites caused by the cathodic electrode  reaction which may gain influence on the metabolism of bone-forming  cells and the mineralisation. According to the results of this  investigation the bone-producing effect of the cathodic electrode  reaction saturates+ at a geometric current density of about 0.4  microA/mm2. Apart from the changes of metabolites produced by the  electric current there are electric polarizations in front of interfaces  and cell membranes due to local ion concentrations caused by even very  weak electric fields.</p>
<p>J Biomed Eng. 1990 Sep;12(5):410-4.</p>
<h1>Influence of magnetic fields on calcium salts crystal formation: an  explanation of the ‘pulsed electromagnetic field’ technique for bone  healing.</h1>
<p>Madroñero A.</p>
<p>C.E.N.I.M., Madrid, Spain.</p>
<h3>Abstract</h3>
<p>In the search for a mechanism by means of which a magnetic field  deparalyses non-unions and enhances bone tissue formation, the influence  of continuous magnetic fields on the formation of calcium phosphate  crystal seeds has been investigated. From this perspective, an  explanation is given of a working mode in conventional equipment for  pulsed electromagnetic field treatment; this is compared with  multifunction equipment.</p>
<p>J Bone Miner Res. 1990 May;5(5):437-42.</p>
<h1>Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs).</h1>
<p>Tabrah F, Hoffmeier M, Gilbert F Jr, Batkin S, Bassett CA.</p>
<p>University of Hawaii School of Medicine, Straub Clinic and Hospital, Honolulu.</p>
<h3>Abstract</h3>
<p>To determine the effect of a 72 Hz pulsating electromagnetic field  (PEMF) on bone density of the radii of osteoporosis-prone women, the  nondominant forearms of 20 subjects were exposed to PEMF 10 h daily for a  period of 12 weeks. Bone density before, during, and after the exposure  period was determined by use of a Norland-Cameron bone mineral  analyzer. Bone mineral densities of the treated radii measured by  single-photon densitometry increased significantly in the immediate area  of the field during the exposure period and decreased during the  following 36 weeks. A similar but weaker response occurred in the  opposite arm, suggesting a “cross-talk” effect on the nontreated radii,  from either possible arm proximity during sleep or very weak general  field effects. The data suggest that properly applied PEMFs, if scaled  for whole-body use, may have clinical application in the prevention and  treatment of osteoporosis.</p>
<p>Acta Orthop Belg. 1990;56(3-4):545-56.</p>
<h1>The value of electromagnetic waves in delayed union. Apropos of 21 cases.</h1>
<p>[Article in French]</p>
<p>Beguin JM, Debelle M, Poilvache G.</p>
<p lang="fr-FR">Département Orthopédie-Traumatologie, Institut des Deux Alice, Bruxelles, Belgique.</p>
<h3>Abstract</h3>
<p>Healing was obtained in 21 fractures with delayed union or  pseudarthrosis by stimulation of the bone with electromagnetic waves.  The interest of this method lies in a number of factors: the apparatus  Centicure is miniaturized and very easy to handle; the daily treatment  is performed by the patient himself; and application may be split,  allowing normal and even professional activity. The method requires no  immobilization nor surgical electrode implantation, the cost of the  treatment is low and the apparatus can be used for several patients.  Bone healing was seen in 15 cases of the 19 reviewed after a brief  treatment period. Stimulation by means of magnetic fields, on the other  hand, has obvious drawbacks, including high costs.</p>
<p>J Bone Miner Res. 1989 Apr;4(2):227-33.</p>
<h1>Stimulation of experimental endochondral ossification by low-energy pulsing electromagnetic fields.</h1>
<p><strong> </strong>Aaron RK, Ciombor DM, Jolly G.</p>
<p>Department of Biochemistry and Biophysics, University of Rhode Island, Providence.</p>
<p>Pulsed electromagnetic fields (PEMFs) of certain configuration have  been shown to be effective clinically in promoting the healing of  fracture nonunions and are believed to enhance calcification of  extracellular matrix. In vitro studies have suggested that PEMFs may  also have the effect of modifying the extracellular matrix by promoting  the synthesis of matrix molecules. This study examines the effect of one  PEMF upon the extracellular matrix and calcification of endochondral  ossification in vivo. The synthesis of cartilage molecules is enhanced  by PEMF, and subsequent endochondral calcification is stimulated.  Histomorphometric studies indicate that the maturation of bone  trabeculae is also promoted by PEMF stimulation. These results indicate  that a specific PEMF can change the composition of cartilage  extracellular matrix in vivo and raises the possibility that the effects  on other processes of endochondral ossification (e.g., fracture healing  and growth plates) may occur through a similar mechanism.</p>
<p>J Bone Joint Surg Am. 1989 Mar;71(3):411-7.</p>
<h1>Prevention of osteoporosis by pulsed electromagnetic fields.</h1>
<p>Rubin CT, McLeod KJ, Lanyon LE.</p>
<p>Musculo-Skeletal Research Laboratory, Department of Orthopaedics, State University of New York, Stony Brook 11794.</p>
<h3>Abstract</h3>
<p>Using an animal model, we examined the use of pulsed electromagnetic  fields, induced at a physiological frequency and intensity, to prevent  the osteoporosis that is concomitant with disuse. By protecting the left  ulnae of turkeys from functional loading, we noted a loss of bone of  13.0 per cent compared with the intact contralateral control ulnae over  an eight-week experimental period. Using a treatment regimen of one hour  per day of pulsed electromagnetic fields, we observed an osteogenic  dose-response to induced electrical power, with a maximum osteogenic  effect between 0.01 and 0.04 tesla per second. Pulse power levels of  more or less than these levels were less effective. The maximum  osteogenic response was obtained by a decrease in the level of  intracortical remodeling, inhibition of endosteal resorption, and  stimulation of both periosteal and endosteal new-bone formation. These  data suggest that short daily periods of exposure to appropriate  electromagnetic fields can beneficially influence the behavior of the  cell populations that are responsible for bone-remodeling, and that  there is an effective window of induced electrical power in which bone  mass can be controlled in the absence of mechanical loading.</p>
<p>J Postgrad Med. 1989 Jan;35(1):43-8.</p>
<h1>Role of pulsed electromagnetic fields in recalcitrant non-unions.</h1>
<p>Delima DF, Tanna DD.</p>
<h3>Abstract</h3>
<p>Twenty-nine patients of recalcitrant nonunion of long bones were  treated by pulsed electromagnetic fields in an attempt to bring about  osteogenesis. The pulse used was rectangular, equal mark space wave in  the astable, continuous mode operating at a frequency of 40 Hertz. The  success rate was 82.5%. The result was not dependent on the age, sex,  time of nonunion or the presence of infection. However, the results were  uniformly poor when infection and fracture instability were coexistent  in the same patient.</p>
<p>Equine Vet J. 1987 Mar;19(2):120-4.</p>
<h1>Preliminary study of quantitative aspects and the effect of pulsed  electromagnetic field treatment on the incorporation of equine  cancellous bone grafts.</h1>
<p>Kold SE, Hickman J, Meisen F.</p>
<p lang="fi-FI">
<p lang="de-DE">Abstract</p>
<p lang="de-DE">The quantitative aspects of equine cancellous bone graft  incorporation and the possibility of influencing graft incorporation by  daily exposure to a pulsed electromagnetic field (PEMF) was studied in  eight yearling ponies. In order to be able to quantify formative aspects  of graft remodelling, a double and treble tetracycline intravital  labelling technique was used. Intravital radiographs were obtained at  regular intervals throughout the trial, but were found to be of little  assistance in assessing any differences between stimulated and  non-stimulated grafts. The ponies were humanely destroyed at regular  intervals between nine and 241 days after installation of the graft.  Light microscopy and fluorescent light microscopy were used to evaluate  quantitative aspects of graft incorporation and to compare  PEMF-stimulated grafts with control grafts. There was a small but  statistically significant effect of PEMF-stimulation on cancellous bone  graft incorporation. In view of this, these observations can only be  considered as indicative of a possible trend, but should encourage  further studies using different signal modalities.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">J Cell Biochem. 1993 Apr;51(4):387-93.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Beneficial effects of electromagnetic fields.</h1>
<p>Bassett CA.</p>
<p>Bioelectric Research Center, Columbia University, Riverdale, New York 10463.</p>
<p>Selective control of cell function by applying specifically  configured, weak, time-varying magnetic fields has added a new, exciting  dimension to biology and medicine. Field parameters for therapeutic,  pulsed electromagnetic field (PEMFs) were designed to induce voltages  similar to those produced, normally, during dynamic mechanical  deformation of connective tissues. As a result, a wide variety of  challenging musculoskeletal disorders have been treated successfully  over the past two decades. More than a quarter million patients with  chronically ununited fractures have benefitted, worldwide, from this  surgically non-invasive method, without risk, discomfort, or the high  costs of operative repair. Many of the athermal bioresponses, at the  cellular and subcellular levels, have been identified and found  appropriate to correct or modify the pathologic processes for which  PEMFs have been used. Not only is efficacy supported by these basic  studies but by a number of double-blind trials. As understanding of  mechanisms expands, specific requirements for field energetics are being  defined and the range of treatable ills broadened. These include nerve  regeneration, wound healing, graft behavior, diabetes, and myocardial  and cerebral ischemia (heart attack and stroke), among other conditions.  Preliminary data even suggest possible benefits in controlling  malignancy</p>
<h1>How can pulsed electromagnetic field therapy assist in the healing of bones and ligaments?</h1>
<p>Dr. D. C. Laycock, Ph.D. Med. Eng. Westville Consultants.</p>
<p>Bone is essentially calcium structure which contains trace elements.  One particular element recently identified is Alpha Quartz. This is the  same type of material used in computers and digital or electronic  watches. When this material is compressed, it develops a voltage across  its two compressive faces, a phenomenon known as the piezoelectric  effect. The old crystal pickups on record players used this effect to  generate electrical sound signals. Gas appliances and some cigar  lighters also utilize the same effect to generate a spark for ignition.<br />
In bone, areas of stress generate small electric charges which are  greater than those of less stressed areas, so that polarized bone-laying  cells (osteoblasts) are believed to be attracted to these areas and  begin to build up extra bone material to counter the stress.<br />
With bone injuries, bleeding occurs to form a haematoma in which  capillaries quickly form, transporting enriched blood to the injury  site. Pulsed Magnetic Field therapy of a base frequency of 50Hz, pulsed  at above 12Hz, causes vasodilatation and capillary dilatation, so  helping to speed up the process of callus formation. Within the bone  itself, pulsed electromagnetism causes the induction of small eddy  currents in the trace elements, which in turn purify and strengthen the  crystal structures. These have the same effect as the stress-induced  voltages caused by the alpha quartz and as such, attract bone cells to  the area under treatment. This can, therefore, accelerate the bone  healing process to allow earlier mobilization and eventual full union.  Ligaments and tendons are affected in similar ways to solid bone by  pulsed electromagnetic therapy, since they are uncalcified bone  structures in themselves.</p>
<p>J Bone Joint Surg Am. 1992 Jul;74(6):920-9.</p>
<h1>The effect of low-frequency electrical fields on osteogenesis.</h1>
<p>McLeod KJ, Rubin CT.</p>
<p>Department of Orthopaedics, School of Medicine, State University of New York, Stony Brook 11794-8181.</p>
<h3>Abstract</h3>
<p>An in vivo animal model of disuse osteopenia was used to determine  the osteogenic potential of specific components of electrical fields.  The ability of a complex pulsed electrical field to inhibit loss of bone  was compared with the remodeling response generated by extremely  low-power, low-frequency (fifteen, seventy-five, and 150-hertz)  sinusoidal electrical fields. The left ulnae of thirty adult male  turkeys were functionally isolated by creation of distal and proximal  epiphyseal osteotomies and then were exposed, for one hour each day, to  an electrical field that had been induced exogenously by means of  magnetic induction. After a fifty-six-day protocol, the remodeling  response was quantified by a comparison of the cross-sectional area of  the mid-part of the diaphysis of the functionally isolated ulna with  that of the intact contralateral ulna. Disuse resulted in a 13 per cent  mean loss of osseous tissue, which was not significantly different than  the 10 per cent loss that was caused by disuse treated with inactive  coils. Exposure to the pulsed electrical fields prevented this  osteopenia and stimulated a 10 per cent mean increase in the bone area.  The osteogenic influence of the sinusoidal electrical fields was  strongly dependent on the frequency; the 150, seventy-five, and  fifteen-hertz sinusoidal fields, respectively, generated a -3 per cent, +  5 per cent, and + 20 per cent mean change in the bone area. These  results suggest a tissue sensitivity that is specific to very  low-frequency sinusoidal electrical fields, and they imply that the  induced electrical fields need not have complex waveforms to be  osteogenic. Since the frequency and intensity range of the sinusoidal  fields producing the greatest osteogenic response are similar to the  levels produced intrinsically by normal functional activity, these  results support the hypothesis that electricity plays a role in the  retention of the normal remodeling balance within mature bone.</p>
<p>J Orthop Res. 1991 Jul;9(4):600-8.</p>
<h1>Modulation of bone loss during disuse by pulsed electromagnetic fields.</h1>
<p>Skerry TM, Pead MJ, Lanyon LE.</p>
<p>Department of Anatomy, University of Bristol, U.K.</p>
<h3>Abstract</h3>
<p>The effect of pulsed electromagnetic fields (PEMFs) on bone loss  associated with disuse was investigated by applying 1.5 Hz repetitions  of 30 ms bursts of asymmetric pulses, varying from +2.5 to -135 mV, to  bones deprived of their normal functional loading. The proximal portion  of one fibula in each of a group of ovariectomised adult female beagle  dogs was isolated from functional loading in vivo by proximal and distal  osteotomies. Comparison of these prepared bones with their intact  contralateral controls after 12 weeks, showed a 23% reduction in  cross-sectional area. In similarly prepared bones exposed to PEMFs for 1  h per day, 5 days per week, this bone loss was substantially and  significantly reduced to 9% (p = 0.029). There was no evidence of any  new bone formation on the periosteal surface of prepared fibulae in  treated or untreated situations. PEMF treatment was not associated with  any significant change in number of osteons per mm2 formed within the  cortex of the bones, their radial closure rate, or their degree of  closure. The modulation in loss of bone area associated with exposure to  PEMFs can, therefore, be inferred to be due to a reduction in  resorption on the bone surface.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">Med Biol Eng Comput. 1991 Mar;29(2):113-20.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Comparative study of bone growth by pulsed electromagnetic fields.</h1>
<p>Gupta TD, Jain VK, Tandon PN.</p>
<p>Department of Electrical Engineering, Harcourt Butler Technological Institute, Kanpur, India.</p>
<p>Pulsed electromagnetic fields have been widely used for treatment of  non-united fractures and congenital pseudarthrosis. Several electrical  stimulation systems such as air-cored and iron-cored coils and solenoids  have been used the world over and claimed to be effective. Electrical  parameters such as pulse shape, magnitude and frequency differ widely,  and the exact bone-healing mechanism is still not clearly understood.  The study attempts to analytically investigate the effectiveness of  various parameters and suggests an optimal stimulation waveform.  Mathematical analysis of electric fields inside the bone together with  Fourier analysis of induced voltage waveforms produced by commonly used  electrical stimulation wave-forms has been performed. A hypothesis based  on assigning different weightings to different frequencies for  osteogenic response has been proposed. Using this hypothesis  astonishingly similar effective values of electric fields have been  found in different systems. It is shown that effective electric field  rather than peak electric field is the main parameter responsible for  osteogenesis. The results are in agreement with experimental findings  made on human beings by different investigators.</p>
<p>Bioelectromagnetics. 1991;12(2):101-16.</p>
<h1>Effect of localized pulsed electromagnetic fields on tail-suspension osteopenia in growing mice.</h1>
<p>Simske SJ, Wachtel H, Luttges MW.</p>
<p>Department of Electrical Engineering, University of Colorado, Boulder 80309-0425.</p>
<h3>Abstract</h3>
<p>Pulsed magnetic fields (PEMFs) have been used effectively to treat  bone fractures and sciatic-nerve-section-induced osteopenias. Properly  applied PEMFs are presumed to stimulate osteogenesis. Mouse-tail  suspension has been implemented as a means of inducing an osteopenic  response in the long bones of the hind limbs. To evaluate localized PEMF  effects, the mouse-suspension model was modified to accommodate the use  of miniature wire coils affixed directly to the rear legs. Laterally  and axially orientated PEMF effects were compared. Three test groups of  mice included (C) control mice, (S) tail-suspended mice with treatment  apparatus attached, and (SF) tail-suspended mice with apparatus attached  and PEMFs delivered. The SF group was divided into mice receiving axial  or lateral PEMFs. Significant bone changes occurred in suspended as  compared with control mice after a 2-week test period. The PEMF mice  showed significantly fewer osteopenic effects than did untreated,  suspended mice. These findings are based on biomechanical measures of  stiffness, strength, ductility, and energy as well as whole-bone mass  and porosity. The effects of PEMFs on these properties differ for axial  and lateral exposures. The results are discussed in terms of mechanisms  underlying PEMF effects.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">J Bone Joint Surg Am. 1989 Mar;71(3):411-7.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Prevention of osteoporosis by pulsed electromagnetic fields.</h1>
<p>Rubin CT, McLeod KJ, Lanyon LE.</p>
<p>Musculo-Skeletal Research Laboratory, Department of Orthopaedics, State University of New York, Stony Brook 11794.</p>
<p>Using an animal model, we examined the use of pulsed electromagnetic  fields, induced at a physiological frequency and intensity, to prevent  the osteoporosis that is concomitant with disuse. By protecting the left  ulnae of turkeys from functional loading, we noted a loss of bone of  13.0 per cent compared with the intact contralateral control ulnae over  an eight-week experimental period. Using a treatment regimen of one hour  per day of pulsed electromagnetic fields, we observed an osteogenic  dose-response to induced electrical power, with a maximum osteogenic  effect between 0.01 and 0.04 tesla per second. Pulse power levels of  more or less than these levels were less effective. The maximum  osteogenic response was obtained by a decrease in the level of  intracortical remodeling, inhibition of endosteal resorption, and  stimulation of both periosteal and endosteal new-bone formation. These  data suggest that short daily periods of exposure to appropriate  electromagnetic fields can beneficially influence the behavior of the  cell populations that are responsible for bone-remodeling, and that  there is an effective window of induced electrical power in which bone  mass can be controlled in the absence of mechanical loading.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="572"></col>
<col span="1" width="4"></col>
</colgroup>
<tbody>
<tr>
<td width="572">Spine. 1990 Jul;15(7):708-12.</td>
<td width="4"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>A randomized double-blind prospective study of pulsed electromagnetic fields for interbody lumbar fusions.</h1>
<p>Mooney V.</p>
<p>Division of Orthopaedic Surgery, University of California, Irvine.</p>
<p>A randomized double-blind prospective study of pulsed electromagnetic  fields for lumbar interbody fusions was performed on 195 subjects.  There were 98 subjects in the active group and 97 subjects in the  placebo group. A brace containing equipment to induce an electromagnetic  field was applied to patients undergoing interbody fusion in the active  group, and a sham brace was used in the control group. In the active  group there was a 92% success rate, while the control group had a 65%  success rate (P greater than 0.005). The effectiveness of bone graft  stimulation with the device is thus established.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">J Bone Miner Res. 1990 May;5(5):437-42.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs).</h1>
<p>Tabrah F, Hoffmeier M, Gilbert F Jr, Batkin S, Bassett CA.</p>
<p>University of Hawaii School of Medicine, Straub Clinic and Hospital, Honolulu.</p>
<p>To determine the effect of a 72 Hz pulsating electromagnetic field  (PEMF) on bone density of the radii of osteoporosis-prone women, the  nondominant forearms of 20 subjects were exposed to PEMF 10 h daily for a  period of 12 weeks. Bone density before, during, and after the exposure  period was determined by use of a Norland-Cameron bone mineral  analyzer. Bone mineral densities of the treated radii measured by  single-photon densitometry increased significantly in the immediate area  of the field during the exposure period and decreased during the  following 36 weeks. A similar but weaker response occurred in the  opposite arm, suggesting a “cross-talk” effect on the nontreated radii,  from either possible arm proximity during sleep or very weak general  field effects. The data suggest that properly applied PEMFs, if scaled  for whole-body use, may have clinical application in the prevention and  treatment of osteoporosis.</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="573"></col>
<col span="1" width="3"></col>
</colgroup>
<tbody>
<tr>
<td width="573">Crit Rev Biomed Eng. 1989;17(5):451-529.</td>
<td width="3"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Fundamental and practical aspects of therapeutic uses of pulsed electromagnetic fields (PEMFs).</h1>
<p>Bassett CA.</p>
<p>Department of Orthopedic Surgery, Columbia University, New York, New York.</p>
<p>The beneficial therapeutic effects of selected low-energy,  time-varying magnetic fields, called PEMFs, have been documented with  increasing frequency since 1973. Initially, this form of athermal energy  was used mainly as a salvage for patients with long-standing juvenile  and adult nonunions. Many of these individuals were candidates for  amputation. Their clearly documented resistance to the usual forms of  surgical treatment, including bone grafting, served as a reasonable  control in judging the efficacy of this new therapeutic method,  particularly when PEMFs were the sole change in patient management. More  recently, the biological effectiveness of this approach in augmenting  bone healing has been confirmed by several highly significant  double-blind and controlled prospective studies in less challenging  clinical circumstances. Furthermore, double-blind evidence of  therapeutic effects in other clinical disorders has emerged. These data,  coupled with well-controlled laboratory findings on pertinent  mechanisms of action, have begun to place PEMFs on a therapeutic par  with surgically invasive methods but at considerably less risk and cost.  As a result of these clinical observations and concerns about  electromagnetic “pollution”, interactions of nonionizing electromagnetic  fields with biological processes have been the subject of increasing  investigational activity. Over the past decade, the number of  publications on these topics has risen exponentially. They now include  textbooks, speciality journals, regular reviews by government agencies,  in addition to individual articles, appearing in the wide spectrum of  peer-reviewed, scientific sources. In a recent editorial in Current  Contents, the editor reviews the frontiers of biomedical engineering  focusing on Science Citation Index methods for identifying core research  endeavors. Dr. Garfield chose PEMFs from among other biomedical  engineering efforts as an example of a rapidly emerging discipline.  Three new societies in the bioelectromagnetics, bioelectrochemistry, and  bioelectrical growth and repair have been organized during this time,  along with a number of national and international committees and  conferences. These activities augment a continuing interest by the IEEE  in the U.S. and the IEE in the U.K. This review focuses on the  principles and practice behind the therapeutic use of “PEMFs”. This term  is restricted to time-varying magnetic field characteristics that  induce voltage waveform patterns in bone similar to those resulting from  mechanical deformation. These asymmetric, broad-band pulses affect a  number of biologic processes athermally. Many of these processes appear  to have the ability to modify selected pathologic states in the  musculoskeletal and other systems.(ABSTRACT TRUNCATED AT 400 WORDS)</p>
<table border="0" cellspacing="0" cellpadding="0">
<colgroup span="1">
<col span="1" width="574"></col>
<col span="1" width="2"></col>
</colgroup>
<tbody>
<tr>
<td width="574">Vestn Khir Im I I Grek. 1989 Feb;142(2):63-6.</td>
<td width="2"></td>
</tr>
</tbody>
</table>
<p lang="de-DE">
<h1>Rehabilitation treatment of patients with uncomplicated fractures of the spine at a hospital rehabilitation center.</h1>
<p>[Article in Russian]</p>
<p>Bagaturiia GO, Chanov VL, Kutushev FKh.</p>
<p>The authors make an analysis of treatment of 188 patients with  noncomplicated compressive fractures of the vertebral column in the  thoracolumbar part performed at the stationary rehabilitation center.  The course of restorative treatment was as long as 31-40 days and  included individual and group trainings of exercise therapy, massage,  hydrokinesotherapy, thermo-, electro-, photo- and magnetotherapy.  Results of the treatment were followed in 81 patients. Excellent and  good results were obtained in 43 patients (53%), unsatisfactory–in 7  patients (8.6%). The period of follow-up observation was from 1 month to  1 year.</p>
<p>Orthop Clin North Am. 1984 Jan;15(1):61-87.</p>
<h1>The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses.</h1>
<p>Bassett CA.</p>
<h3>Abstract</h3>
<p>This article deals with the rational and practical use of surgically  noninvasive pulsed electromagnetic fields (PEMFs) in treating ununited  fractures, failed arthrodeses, and congenital pseudarthroses (infantile  nonunions). The method is highly effective (more than 90 per cent  success) in adult patients when used in conjunction with good management  techniques that are founded on biomechanical principles. When union  fails to occur with PEMFs alone after approximately four months, their  proper use in conjunction with fresh bone grafts insures a maximum  failure rate of 1 to 1.5 per cent. Union occurs because the weak  electric currents induced in tissues by the time-varying fields effect  calcification of the fibrocartilage in the fracture gap, thereby setting  the stage for the final phases of fracture healing by endochondral  ossification. The efficacy, safety, and simplicity of the method has  prompted its use by the majority of orthopedic surgeons in this country.  In patients with delayed union three to four months postfracture, PEMFs  appear to be more successful and healing, generally, is more rapid than  in patients managed by other conservative methods. For more challenging  problems such as actively infected nonunions, multiple surgical  failures, long-standing (for example, more than two years postfracture)  atrophic lesions, failed knee arthrodeses after removal of infected  prostheses, and congenital pseudarthroses, success can be expected in a  large majority of patients in whom PEMFs are used. Finally, as  laboratory studies have expanded knowledge of the mechanisms of PEMF  action, it is clear that different pulses affect different biologic  processes in different ways. Selection of the proper pulse for a given  pathologic entity has begun to be governed by rational processes  similar, in certain respects, to those applied to pharmacologic agents.</p>
<p>Langenbecks Arch Chir. 1976;Suppl:276-80.</p>
<h1>Behavior of reactive shaft pseudarthroses of the canine radius in the electric and electromagnetic fields.</h1>
<p lang="de-DE">[Article in German]</p>
<p>Blömer J, Oestern HJ, Suren EG, Achinger R, Schmit-Neuerburg KP, Creutzig H, Fröhlich H.</p>
<h3>Abstract</h3>
<p>In 27 beagles, 19 radius shaft pseudarthroses and 8 tibia were  stimulated either by directly applied alternating current of low  frequency and strength, delivered from an implanted battery source, or  by a pulsing electromagnetic field inductively coupled to bone. Increase  of periosteal callus was only found beneath parallel sling electrodes  placed on pseudarthroses parallel to the radius shaft. Stimulation by  transverse electrodes implanted into bone produced no significant  increase of osteogenesis and bone healing, evaluated by x-rays,  scintigrams, and morphometry when compared with contralateral leg  controls</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/bioelectromagnetic-articles/bio-electromagnetic-therapy-in-osteoporosis-and-bone-healing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low intensity laser therapy in bone healing and osteoporosis</title>
		<link>http://www.cooperativemedicine.com/laser-articles/low-intensity-laser-therapy-in-bone-healing-and-osteoporosis/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/low-intensity-laser-therapy-in-bone-healing-and-osteoporosis/#comments</comments>
		<pubDate>Sat, 19 Nov 2011 22:50:26 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2248</guid>
		<description><![CDATA[Lasers Med Sci.  2011 Nov 18. [Epub ahead of print] Effects of the combination of low-level laser irradiation and recombinant human bone morphogenetic protein-2 in bone repair. Rosa AP, de Sousa LG, Regalo SC, Issa JP, Barbosa AP, Pitol DL, de Oliveira RH, de Vasconcelos PB, Dias FJ, Chimello DT, Siéssere S. Source Department of [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<div>
<div>
<div>
<div>
<div>
<div>
<div>Lasers Med Sci.  2011 Nov 18. [Epub ahead of print]</div>
<h1>Effects of the combination of low-level laser irradiation and recombinant human bone morphogenetic protein-2 in bone repair.</h1>
<div>Rosa AP, de Sousa LG, Regalo SC, Issa JP, Barbosa AP, Pitol DL, de  Oliveira RH, de Vasconcelos PB, Dias FJ, Chimello DT, Siéssere S.</div>
<div>
<p><strong>Source</strong></p>
<p>Department of Morphology, Stomatology and Physiology, School of  Dentistry at Ribeirão Preto, University of São Paulo, Avenida do Café,  s/n – Bairro – Monte Alegre, 14040-904, Ribeirão Preto, São Paulo,  Brazil.</p>
</div>
<div>
<p>Abstract</p>
<p>Low-level laser irradiation (LLLI) and recombinant human bone  morphogenetic protein type 2 (rhBMP-2) have been used to stimulate bone  formation. LLLI stimulates proliferation of osteoblast precursor cells  and cell differentiation and rhBMP-2 recruits osteoprogenitor cells to  the bone healing area. This in vivo study evaluated the effects of LLLI  and rhBMP-2 on the bone healing process in rats. Critical bone defects  were created in the parietal bone in 42 animals, and the animals were  divided into six treatment groups: (1) laser, (2) 7 ?g of rhBMP-2, (3)  laser and 7 ?g of rhBMP-2, (4) 7 ?g of rhBMP-2/monoolein gel, (5) laser  and 7 ?g rhBMP-2/monoolein gel, and (6) critical bone defect controls. A  gallium-aluminum-arsenide diode laser was used (wavelength 780 nm,  output power 60 mW, beam area 0.04 cm(2), irradiation time 80 s, energy  density 120 J/cm(2), irradiance 1.5 W/cm(2)). After 15 days, the  calvarial tissues were removed for histomorphometric analysis. Group 3  defects showed higher amounts of newly formed bone (37.89%) than the  defects of all the other groups (P?&lt;?0.05). The amounts of new bone  in defects of groups 1 and 4 were not significantly different from each  other (24.00% and 24.75%, respectively), but were significantly  different from the amounts in the other groups (P?&lt;?0.05). The  amounts of new bone in the defects of groups 2 and 5 were not  significantly different from each other (31.42% and 31.96%,  respectively), but were significantly different from the amounts in the  other groups (P?&lt;?0.05). Group 6 defects had 14.10% new bone  formation, and this was significantly different from the amounts in the  other groups (P?&lt;?0.05). It can be concluded that LLLI administered  during surgery effectively accelerated healing of critical bone defects  filled with pure rhBMP-2, achieving a better result than LLLI alone or  the use of rhBMP-2 alone.</p>
</div>
<p>Lasers Med Sci.  2011 Nov 9. [Epub ahead of print]</p>
</div>
<h1>Development of a minimally invasive laser needle system: effects on cortical bone of osteoporotic mice.</h1>
<div>Kang H, Ko CY, Ryu Y, Seo DH, Kim HS, Jung B.</div>
<div>
<p><strong>Source</strong></p>
<p>Department of Biomedical Engineering, Yonsei University, 234 Maeji-ri, Heungup-myun, Wonju-si, Gangwon-do, 220-710, Korea.</p>
</div>
<div>
<p><strong>Abstract</strong></p>
<p>Many studies have shown the positive effects of low-level laser  therapy in the treatment of bone disease. However, laser radiation is  scattered in the skin surface which reduces the initial photon density  for tissue penetration and consequently the therapeutic efficacy. We  developed a minimally invasive laser needle system (MILNS) to avoid  laser scattering in tissue and investigated its stimulatory effects in  the cortical bone of osteoporotic mice. The MILNS was designed to  stimulate cortical bone directly by employing fine hollow needles to  guide 100 ?m optical fibers. The study animals comprised 12 mice which  were subjected to sciatic denervation of the right hind limb and were  randomly divided into two groups, a sham group and a laser group which  were treated using the MILNS for 2 weeks without and with laser  irradiation, respectively. In vivo micro-CT images were taken to analyze  the structural parameters and bone mineral density. After 2 weeks of  treatment with the MILNS, the relative changes in mean polar moment  inertia, cross-section thickness, and periosteal perimeter were  significantly higher in the laser group than in the sham group.  Moreover, the distribution of bone mineral density index was higher in  the laser group. The MILNS was developed as a minimally invasive  treatment modality for bone disease and resulted in positive therapeutic  efficacy in the cortical bone of osteoporotic mice.</p>
</div>
<p>Lasers Med Sci.  2011 Aug 13. [Epub ahead of print]</p>
</div>
<h1>Effect of low-level laser therapy after rapid maxillary expansion on proliferation and differentiation of osteoblastic cells.</h1>
<div>da Silva AP, Petri AD, Crippa GE, Stuani AS, Stuani AS, Rosa AL, Stuani MB.</div>
<div>
<h3>Source</h3>
<p>Department of Pediatric Dentistry and Othodontic, School of Dentistry  of Ribeirao Preto, University of Sao Paulo, Av do Cafe, s/n, 14040-904,  Ribeirao Preto, SP, Brazil.</p>
</div>
<div>
<h3>Abstract</h3>
<p>The aim of this study was to investigate the osteoblastic activity of  cells derived from the midpalatal suture upon treatment with low-level  laser therapy (LLLT) after rapid maxillary expansion (RME). A total of  30 rats were divided into two groups: experimental I (15 rats with RME  without LLLT) and experimental II (15 rats with RME + LLLT). The rats  were euthanized at 24 h, 48 h, and 7 days after RME, when the  osteoblastic cells derived from the rats’ midpalatal suture were  explanted. These cells were cultured for periods up to 17 days, and then  in vitro osteogenesis parameters and gene expression markers were  evaluated. The cellular doubling time in the proliferative stage  (3-7 days) was decreased in cultured cells harvested from the midpalatal  suture at 24 and 48 h after RME + LLLT, as indicated by the increased  growth of the cells in a culture. Alkaline phosphatase activity at days 7  and 14 of the culture was increased by LLLT in cells explanted from the  midpalatal suture at 24 and 48 h and 7 days after RME. The  mineralization at day 17 was increased by LLLT after RME in all periods.  Results from the real-time PCR demonstrated that cells harvested from  the LLLT after RME group showed higher levels of ALP, Runx2,  osteocalcin, type I collagen, and bone sialoprotein mRNA than control  cells. More pronounced effects on ALP activity, mineralization, and gene  expression of bone markers were observed at 48 h after RME and LLLT.  These results indicate that the LLLT applied after RME is able to  increase the proliferation and the expression of an osteoblastic  phenotype in cells derived from the midpalatal suture.</p>
</div>
<p>Endocr Regul.  2010 Oct;44(4):155-63.</p>
</div>
<h1>Possible role of <strong>low</strong> <strong>level</strong> <strong>laser</strong> therapy on bone turnover in ovariectomized rats.</h1>
<div>Saad A, El Yamany M, Abbas O, Yehia M.</div>
<div>
<h3>Source</h3>
<p>Physiology Department, Medical Research Institute, Alexandria University, Egypt.</p>
</div>
<div>
<h3>Abstract</h3>
<h6>OBJECTIVE:</h6>
<p>The aim of this study was to assess the effect of <strong>low</strong> <strong>level</strong> <strong>laser</strong> therapy (LLLT) on bone turnover markers in ovariectomized rats.</p>
<h6>METHODS:</h6>
<p>Thirty adult female albino rats were divided into three groups; Group  1: 10 sham- operated control rats; Group 2: 10 bilaterally  ovariectomized rats (OVX); Group 3: 10 OVX rats exposed to LLLT. LLLT  was applied on the neck and shaft of femur, five times per week for 8  weeks. The dose applied on each point was 1000 Hertz, 5 Watts for 30  seconds with a total dose of 15 mJoule/cm². At the end of experiment,  blood samples were collected and sera were separated for determination  of serum calcium (Ca), inorganic phosphorus (Pi), osteocalcin and  alkaline phosphatase (ALP). In addition, a 24 hour urine sample was also  collected from each rat for the determination of urinary calcium,  phosphorous and deoxypyridinoline (U-DPD)/creatinine.</p>
<h6>RESULTS:</h6>
<p>Significant increase in serum Ca, Pi , ALP, osteocalcin and  significant decrease in U-DPD/creatinine in LLLT exposed group was found  as compared to the other two groups. Bone morphological findings  revealed the increase in calcium deposition and alkaline phosphatase of  femoral bones in LLLT exposed group as compared to sham-operated and OVX  rats. The software image analysis showed increased osteoblast numbers,  decreased osteoclast numbers and increased compact bone thickness in  LLLT exposed group. Significant positive correlations was obtained  between osteoblast numbers and serum Ca , Pi, ALP and osteocalcin in  LLLT exposed group ,while a significant negative correlation was noticed  with U-DPD.</p>
<h6>CONCLUSION:</h6>
<p>The use of LLLT was found effective in enhancing bone formation and  decreasing bone resorption in the osteoporotic OVX rats. Further studies  are necessary to investigate the effect of different parameters of LLLT  as wave length, duration and also numbers of sessions. The potential  use of LLLT in postmenopausal women with osteoporosis is needed to be  verified.</p>
</div>
<p>J Biomed Opt.  2011 Jul;16(7):078001.</p>
</div>
<h1>Low-level laser therapy, at 60 J/cm(2) associated with a  Biosilicate(®) increase in bone deposition and indentation biomechanical  properties of callus in osteopenic rats.</h1>
<div>Fangel R, Se?rgio Bossini P, Cla?udia Renno A, Araki Ribeiro D,  Chenwei Wang C, Luri Toma R, Okino Nonaka K, Driusso P, Antonio  Parizotto N, Oishi J.</div>
<div>
<h3>Source</h3>
<p>Federal University of Sa?o Carlos, Department of Physiotherapy, Rod.  Washington Luiz, km 235, Sa?o Carlos, Sao Paulo 13600-970 BrazilFederal  University of Sao Paulo, Department of Bioscience, Av. Ana Costa, 95,  Santos, Sao Paulo 11050240, BrazilFederal University of Sa?o Carlos,  Department of Biology, Rod. Washington Luiz, km 235, Sa?o Carlos, Sao  Paulo 13600-970 BrazilFederal University of Sao Paulo, Department of  Physiotherapy, Av. Ana Costa, 95, Santos, Sao Paulo 11050240,  BrazilFederal University of Sa?o Carlos, Department of Statistics, Rod.  Washington Luiz, km 235, Sao Carlos, Sao Paulo 13565-2081, Brazil.</p>
</div>
<div>
<h3>Abstract</h3>
<p>We investigate the effects of a novel bioactive material  (Biosilicate(®)) and low-level laser therapy (LLLT), at 60 J/cm(2), on  bone-fracture consolidation in osteoporotic rats. Forty female Wistar  rats are submitted to the ovariectomy, to induce osteopenia. Eight weeks  after the ovariectomy, the animals are randomly divided into four  groups, with 10 animals each: bone defect control group; bone defect  filled with Biosilicate group; bone defect irradiated with laser at 60  J/cm(2) group; bone defect filled with Biosilicate and irradiated with  LLLT, at 60 J/cm(2) group. Laser irradiation is initiated immediately  after surgery and performed every 48 h for 14 days. Histopathological  analysis points out that bone defects are predominantly filled with the  biomaterial in specimens treated with Biosilicate. In the 60-J/cm(2)  laser plus Biosilicate group, the biomaterial fills all bone defects,  which also contained woven bone and granulation tissue. Also, the  biomechanical properties are increased in the animals treated with  Biosilicate associated to lasertherapy. Our results indicate that laser  therapy improves bone repair process in contact with Biosilicate as a  result of increasing bone formation as well as indentation biomechanical  properties.</p>
</div>
<p>Lasers Med Sci.  2011 May 20. [Epub ahead of print]</p>
</div>
<h1>The effects of low-level laser irradiation on differentiation and  proliferation of human bone marrow mesenchymal stem cells into neurons  and osteoblasts-an in vitro study.</h1>
<div>Soleimani M, Abbasnia E, Fathi M, Sahraei H, Fathi Y, Kaka G.</div>
<div>
<h3>Source</h3>
<p>Department of Hematology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran, <a href="mailto:soleim_m@modares.ac.ir">soleim_m@modares.ac.ir</a>.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Bone marrow-derived mesenchymal stem cells (BMSCs) are promising for  use in regenerative medicine. Several studies have shown that low-level  laser irradiation (LLLI) could affect the differentiation and  proliferation of MSCs. The aim of this study was to examine the  influence of LLLI at different energy densities on BMSCs differentiation  into neuron and osteoblast. Human BMSCs were cultured and induced to  differentiate to either neuron or osteoblast in the absence or presence  of LLLI. Gallium aluminum arsenide (GaAlAs) laser irradiation (810 nm)  was applied at days 1, 3, and 5 of differentiation process at energy  densities of 3 or 6 J/cm(2) for BMSCs being induced to neurons, and 2 or  4 J/cm(2) for BMSCs being induced to osteoblasts. BMSCs proliferation  was evaluated by MTT assay on the seventh day of differentiation. BMSCs  differentiation to neurons was assessed by immunocytochemical analysis  of neuron-specific enolase on the seventh day of differentiation. BMSCs  differentiation to osteoblast was tested on the second, fifth, seventh,  and tenth day of differentiation via analysis of alkaline phosphatase  (ALP) activity. LLLI promoted BMSCs proliferation significantly at all  energy densities except for 6 J/cm(2) in comparison to control groups on  the seventh day of differentiation. LLLI at energy densities of 3 and  6 J/cm(2) dramatically facilitated the differentiation of BMSCs into  neurons (p?&lt;?0.001). Also, ALP activity was significantly enhanced in  irradiated BMSCs differentiated to osteoblast on the second, fifth,  seventh, and tenth day of differentiation (p?&lt;?0.001 except for the  second day). Using LLLI at 810 nm wavelength enhances BMSCs  differentiation into neuron and osteoblast in the range of 2-6 J/cm(2),  and at the same time increases BMSCs proliferation (except for  6 J/cm(2)). The effect of LLLI on differentiation and proliferation of  BMSCs is dose-dependent. Considering these findings, LLLI could improve  current in vitro methods of differentiating BMSCs prior to  transplantation.</p>
</div>
<p>Photomed Laser Surg. 2011 Feb 9. [Epub ahead of print]</p>
<h1>Low-Level Laser Therapy Induces Differential Expression of Osteogenic Genes During Bone Repair in Rats.</h1>
<p>Fávaro-Pípi E, Ribeiro DA, Ribeiro JU, Bossini P, Oliveira P, Parizotto NA, Tim C, de Araújo HS, Renno AC.</p>
<p>1 Department of Physiotherapy, Federal University of São Carlos , São Carlos, SP-Brazil .</p>
<div>
<h3>Abstract</h3>
<p>Abstract Objectives: The aim of this study was to measure the  temporal pattern of the expression of osteogenic genes after low-level  laser therapy during the process of bone healing. We used quantitative  real-time polymerase chain reaction (qPCR) along with histology to  assess gene expression following laser irradiation on created bone  defects in tibias of rats.</p>
<p>Material and Methods: The animals were randomly distributed into two  groups: control or laser-irradiated group. Noncritical size bone defects  were surgically created at the upper third of the tibia. Laser  irradiation started 24 h post-surgery and was performed for 3, 6, and 12  sessions, with an interval of 48?h. A 830?nm laser, 50?J/cm(2), 30 mW,  was used. On days 7, 13, and 25 post-injury, rats were sacrificed  individually by carbon dioxide asphyxia. The tibias were removed for  analysis.</p>
<p>Results: The histological results revealed intense new bone formation  surrounded by highly vascularized connective tissue presenting slight  osteogenic activity, with primary bone deposition in the group exposed  to laser in the intermediary (13 days) and late stages of repair (25  days). The quantitative real-time PCR showed that laser irradiation  produced an upregulation of BMP-4 at day 13 post-surgery and an  upregulation of BMP4, ALP, and Runx 2 at day 25 after surgery.</p>
<p>Conclusion: Our results indicate that laser therapy improves bone  repair in rats as depicted by differential histopathological and  osteogenic genes expression, mainly at the late stages of recovery.</p>
</div>
<p>Photomed Laser Surg. 2011 Feb 8. [Epub ahead of print]</p>
<h1>Application of Low-Level Laser Irradiation (LLLI) and rhBMP-2 in  Critical Bone Defect of Ovariectomized Rats: Histomorphometric  Evaluation.</h1>
<p>Siéssere S, Sousa LG, Issa JP, Iyomasa MM, Pitol DL, Barbosa AP, Semprini M, Sebald W, Bentley MV, Regalo SC.</p>
<p>1 Facultie of Dentistry, University of São Paulo , Ribeirão Preto, São Paulo, Brazil .</p>
<div>
<h3>Abstract</h3>
<p>Abstract Objectives: The aim of this study was to evaluate the  osteogenic potential of recombinant human bone morphogenetic protein-2  (rhBMP-2) and low-level laser irradiation (LLLI), isolated or combined  in critical bone defects (5?mm) in parietal bone using ovariectomized  female rats as an experimental animal model. Materials and</p>
<p>Methods: Forty-nine female Wistar rats, bilaterally ovariectomized  (OVX), were divided into seven treatment groups of seven animals each:  (I) laser in a single application, (II) 7??g of pure rhBMP-2, (III)  laser and 7??g of pure rhBMP-2, (IV) 7??g of rhBMP-2/monoolein gel, (V)  laser and 7??g of rhBMP-2/monoolein gel, (VI) laser and pure monoolein  gel, and (VII) critical bone defect controls. The low-level laser source  used was a gallium aluminum arsenide semiconductor diode laser device  (??=?780?nm, D?=?120?J/cm(2)).</p>
<p>Results: Groups II and III presented higher levels of newly formed  bone than all other groups with levels of 40.57% and 40.39%,  respectively (p?&lt;?0.05). The levels of newly formed bone of groups I,  IV, V, and VI were similar with levels of 29.67%, 25.75%, 27.75%, and  30.64%, respectively (p?&gt;?0.05). The area of new bone formation in  group VII was 20.96%, which is significantly lower than groups I, II,  III, and VI.</p>
<p>Conclusions: It was concluded that pure rhBMP-2 and a single dose of  laser application stimulated new bone formation, but the new bone  formation area was significantly increased when only rhBMP-2 was used.  Additionally, the laser application in combination with other treatments  did not influence the bone formation area.</p>
</div>
<p>Lasers Med Sci. 2011 Jan 19. [Epub ahead of print]</p>
<h1>Evaluation of the osteogenic effect of low-level laser therapy  (808 nm and 660 nm) on bone defects induced in the femurs of female rats  submitted to ovariectomy.</h1>
<p>Ré Poppi R, Da Silva AL, Nacer RS, Vieira RP, de Oliveira LV, Santos de Faria Júnior N, de Tarso Camilo Carvalho P.</p>
<p>Postgraduate Program in Health and Development in the West Central  Region, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.</p>
<div>
<h3>Abstract</h3>
<p>The present study aimed to evaluate the effects of LLLT (660- and  808-nm wavelengths) on the process of repairing bone defects induced in  the femurs of female rats submitted to ovariectomy. Bilateral  ovariectomies were performed on 18 female Wistar rats, which were  divided into control and irradiated groups after the digital analysis of  bone density showed decreased bone mass and after standardized drilling  of the femurs. The irradiated groups received 133 J/cm(2) of AsGaAl  (660-nm) and InGaAlP (880-nm) laser radiation. The animals were  euthanized on days 14 and 21 after the bone defects were established.  Detailed descriptive histological evaluations were performed, followed  by semi-quantitative histomorphometry. The results from days 14 and 21  showed that the irradiated groups presented increased density of  osteoblasts, fibroblasts, and immature osteocytes on the tissue surface  compared with the control (non-irradiated) groups (p?&lt;?0.05).  Additionally, inflammatory infiltrate evaluations showed that LLLT  decreased the accumulation of leukocytes when compared to the control  treatment (p?&lt;?0.05). We concluded that, in our experimental model,  both wavelengths (660-nm and 880-nm) inhibited the inflammatory process  and induced the proliferation of cells responsible for bone remodeling  and repair.</p>
</div>
<p>Photomed Laser Surg.  2010 Dec;28(6):823-30.</p>
<h1>Laser-induced alveolar bone changes during orthodontic movement: a histological study on rodents.</h1>
<p>Habib FA, Gama SK, Ramalho LM, Cangussú MC, Santos Neto FP, Lacerda JA, Araújo TM, Pinheiro<a href="http://www.healinglightseminars.com/laser-research-library/laser-research-library/pubmed?term=%22Pinheiro%20AL%22%5BAuthor%5D"> AL</a>.</p>
<p>Centro de Ortodontia e Ortopedia Facial Prof. José Edimo Soares  Martins, School of Dentistry, Federal University of Bahia (UFBA),  Salvador, Brazil.</p>
<div>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to assess by light microscopy changes in alveolar bone during orthodontic movement in rats.</p>
<p>BACKGROUND: Orthodontic movement causes both removal and deposition  of bone tissue. The use of laser phototherapy (LPT) is considered an  enhancement factor for bone repair.</p>
<p>METHODS: Thirty Wistar rats were divided into two groups (n?=?15) and  subdivided according to animal death (7,13, and 19 days). Half of the  animals in each group were treated with LPT during orthodontic movement.  After animal death, specimens were processed and underwent histological  and semi-quantitative analyses (HE and Sirius red).</p>
<p>RESULTS: LPT-irradiated specimens showed significantly higher numbers  of osteoclasts when compared with controls at both 7 (p?=?0.015) and 19  (p?=?0.007) days, as well as significant increases in the number of  osteoblasts (p?=?0.015) between days 7 and 13. The amount of collagen  matrix was significantly reduced between days 7 and 13 at both pressure  and tension sites in controls (p?=?0.015) but not in LPT-treated  animals. LPT-treated subjects showed significantly greater deposition of  collagen matrix at the pressure site at both the thirteenth (p?=?0.007)  and nineteenth days (p?=?0.001). At the tension site, a significant  increase in the amount of collagen matrix was observed in non-irradiated  specimens (p?=?0.048) between days 7 and 19.</p>
<p>CONCLUSIONS: LPT caused significant histological changes in the  alveolar bone during induced tooth movement, including alterations in  the number of both osteoclasts and osteoblasts and in collagen  deposition in both pressure and tension areas.</p>
</div>
<p>Photomed Laser Surg. 2010 Oct;28 Suppl 2:S89-97. Epub 2010 Oct 7.</p>
<h1>Raman spectroscopy validation of DIAGNOdent-assisted fluorescence  readings on tibial fractures treated with laser phototherapy, BMPs,  guided bone regeneration, and miniplates.</h1>
<p>Pinheiro AL, Lopes CB, Pacheco MT, Brugnera A Jr, Zanin FA, Cangussú MC, Silveira L Jr.</p>
<p>Center of Biophotonics, School of Dentistry, Federal University of Bahia, Salvador, BA, Brazil. albp@ufba.br</p>
<div>
<h3>Abstract</h3>
<p>OBJECTIVES: We aimed to assess through Raman spectroscopy and  fluorescence the levels of calcium hydroxyapatite (CHA) and lipids and  proteins in complete fractures treated with internal rigid fixation  (IRF) treated or not with laser phototherapy (LPT) and associated or not  with bone morphogenetic proteins (BMPs) and guided bone regeneration  (GBR).</p>
<p>BACKGROUND: Fractures have different etiologies and treatments and  may be associated with bone losses. LPT has been shown to improve bone  healing.</p>
<p>METHODS: Tibial fractures were created on 15 animals and divided into  five groups. LPT started immediately after surgery, repeated at 48-h  intervals. Animal death occurred after 30 days.</p>
<p>RESULTS: Raman spectroscopy and fluorescence were performed at the  surface. Fluorescence data of group IRF + LPT + Biomaterial showed  similar readings to those of the group IRF-no bone loss. Significant  differences were seen between groups IRF + LPT + Biomaterial and IRF +  LPT; IRF + LPT + Biomaterial; and IRF + Biomaterial; and between IRF +  LPT + Biomaterial and IRF. CH groups of lipids and proteins readings  showed decreased levels of organic components in subjects treated with  the association of LPT, biomaterial, and GBR. Pearson correlation showed  that fluorescence readings of both CHA and CH groups of lipids and  proteins correlated negatively with the Raman data.</p>
<p>CONCLUSIONS: The use of both methods indicates that the use of the  biomaterials associated with infrared LPT resulted in a more-advanced  and higher quality of bone repair in fractures treated with miniplates  and that the DIAGNOdent may be used to perform optical biopsy on bone.</p>
</div>
<p>Endocr Regul 2010 Oct;44(4):155-63.</p>
<p><strong> </strong></p>
<h1>Possible role of low level laser therapy on bone turnover in ovariectomized rats.</h1>
<p>Saad A, Yamany ME, Abbas O, Yehia M.</p>
<p>Abstract</p>
<p>Objective. The aim of this study was to assess the effect of low  level laser therapy (LLLT) on bone turnover markers in ovariectomized  rats. &lt;br /&gt;Methods. Thirty adult female albino rats were divided  into three groups; Group 1: 10 sham- operated control rats; Group 2: 10  bilaterally ovariectomized rats (OVX); Group 3: 10 OVX rats exposed to  LLLT. LLLT was applied on the neck and shaft of femur, five times per  week for 8 weeks. The dose applied on each point was 1000 Hertz, 5 Watts  for 30 seconds with a total dose of 15 mJoule/cm2. At the end of  experiment, blood samples were collected and sera were separated for  determination of serum calcium (Ca), inorganic phosphorus (Pi),  osteocalcin and alkaline phosphatase (ALP). In addition, a 24 hour urine  sample was also collected from each rat for the determination of  urinary calcium, phosphorous and deoxypyridinoline (U-DPD)/creatinine.  &lt;br /&gt;Results. Significant increase in serum Ca, Pi , ALP,  osteocalcin and significant decrease in U-DPD/creatinine in LLLT exposed  group was found as compared to the other two groups. Bone morphological  findings revealed the increase in calcium deposition and alkaline  phosphatase of femoral bones in LLLT exposed group as compared to  sham-operated and OVX rats. The software image analysis showed increased  osteoblast numbers, decreased osteoclast numbers and increased compact  bone thickness in LLLT exposed group. Significant positive correlations  was obtained between osteoblast numbers and serum Ca , Pi, ALP and  osteocalcin in LLLT exposed group ,while a significant negative  correlation was noticed with U-DPD.&lt;br /&gt;Conclusion. The use of  LLLT was found effective in enhancing bone formation and decreasing bone  resorption in the osteoporotic OVX rats. Further studies are necessary  to investigate the effect of different parameters of LLLT as wave  length, duration and also numbers of sessions. The potential use of LLLT  in postmenopausal women with osteoporosis is needed to be verified.  Keywords: Ovariectomy – Laser – Calcium – Phosphorus – Alkaline  phosphatase – Osteocalcin – Osteoporosis.</p>
<p>Photomed Laser Surg. 2010 Oct 12. [Epub ahead of print]</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<h1>Comparison of the Effects of Electrical Stimulation and Low-Level  Laser Therapy on Bone Loss in Spinal Cord&amp;#x2013;Injured Rats.</h1>
<p>Medalha CC, Amorim BO, Ferreira JX, Ol iveira P, Pereira RM, Tim C, Lirani-Galy Xooe3 O AP, da Silva Ol, Renno AC,</p>
<p>1 Department of Bioscience, Federal University of S&amp;#x00E3;o Paulo (UNIFESP) , Santos, SP, Brazil .</p>
<p><strong>Abstract</strong></p>
<p>Abstract Objective: This study investigated the effects of low-level  laser therapy (LLLT) and electrical stimulation (ES) on bone loss in  spinal cord&amp;#x2013;injured rats. Materials and Methods: Thirty-seven  male Wistar rats were divided into four groups: standard control group  (CG); spinal cord&amp;#x2013;injured control (SC); spinal  cord&amp;#x2013;injured treated with laser (SCL; GaAlAs,  830&amp;#x2009;nm, CW, 30&amp;#x2009;mW/cm,  250&amp;#x2009;J/cm&lt;sup&gt;2&lt;/sup&gt;); and spinal  cord&amp;#x2013;injured treated with electrical field stimulation (SCE;  1.5&amp;#x2009;MHz, 1:4 duty cycles, 30 mW, 20&amp;#x2009;min).  Biomechanical, densitometric, and morphometric analyses were performed.  Results: SC rats showed a significant decrease in bone mass,  biomechanical properties, and morphometric parameters (versus CG). SCE  rats showed significantly higher values of inner diameter and internal  and external areas of tibia diaphyses; and the SCL group showed a trend  toward the same result (versus SC). No increase was found in either  mechanical or densitometric parameters. Conclusion: We conclude that the  mentioned treatments were able to initiate a positive bone-tissue  response, maybe through stimulation of osteoblasts, which was able to  determine the observed morphometric modifications. However, the evoked  tissue response could not determine either biomechanical or  densitometric modifications.</p>
<p>Lasers Med Sci. 2010 Sep;25(5):727-32. Epub 2010 Jun 3.</p>
<h1>Comparative study of the effects of low-intensity pulsed ultrasound  and low-level laser therapy on bone defects in tibias of rats.</h1>
<p>Fávaro-Pípi E, Feitosa SM, Ribeiro DA, Bossini P, Oliveira P, Parizotto NA, Renno AC.</p>
<p>Department of Physiotherapy, Federal University of São Carlos, Rodovia Washington Luís (SP-310), Km 235, São Carlos, SP, Brazil.</p>
<h3>Abstract</h3>
<p>The aim of this study was to investigate and to compare the effects  of low intensity ultra-sound (LIPUS) and low-level laser therapy (LLLT)  during the process of bone healing by means of histopathological and  morphometric analysis. The animals were randomly distributed into three  groups of 30 animals each: the control group (bone defect without  treatment); the laser-treated group: (bone defect treated with laser),  and the LIPUS-treated (bone defect treated with ultrasound). Each group  was further divided into three different subgroups (n = 10) and on days  7, 13, and 25 post-injury, rats were killed with an intra-peritoneal  injection of general anesthetic. The rats were treated with a  30-mW/cm(2) low-intensity pulsed ultrasound and a 830-nm laser at 50  J/cm(2). The results showed intense new bone formation surrounded by  highly vascularized connective tissue presenting a slight osteogenic  activity, with primary bone deposition being observed in the group  exposed to laser in the intermediary (13 days) and late stages of repair  (25 days). This was confirmed by morphometric analysis in which  significant statistical differences (p &lt; 0.05) were noticed when  compared to the control. No remarkable differences were noticed in the  specimens treated with ultrasound with regard to the amount of newly  formed bone in comparison to the control group. Taken together, our  results indicate that laser therapy improves bone repair in rats as  depicted by histopathological and morphometric analysis, mainly at the  late stages of recovery. Moreover, it seems that this therapy was more  effective than US to accelerate bone healing.</p>
<p>Photomed Laser Surg. 2010 Aug;28 Suppl 1:S157-65.</p>
<h1>Red-light light-emitting diode irradiation increases the  proliferation and osteogenic differentiation of rat bone marrow  mesenchymal stem cells.</h1>
<p>Li WT, Leu YC, Wu JL.</p>
<p>Department of Biomedical Engineering, Chung Yuan Christian University, Chung-Li, Taiwan, Republic of China. wtli@cycu.edu.tw</p>
<div>
<h3>Abstract</h3>
<p>OBJECTIVE: The objective of this study was to investigate the effects  on the proliferation and osteogenic differentiation of rat mesenchymal  stem cells (MSCs) by using red-light light-emitting diode (LED)  irradiation.</p>
<p>BACKGROUND DATA: Low-level light irradiation (LLLI) has been shown to  enhance proliferation and cytokine secretion of a number of cells. MSCs  are capable of regenerating various mesenchymal tissues and are  essential in supporting the growth and differentiation of hematopoietic  stem cells within the bone marrow.</p>
<p>MATERIALS AND METHODS: Rat bone marrow MSCs were treated with single  or multiple doses of LLLI from an LED array (630 nm) at the irradiances  of 5 and 15 mW/cm(2), and radiant exposures of 2 and 4 J/cm(2). The  proliferation, clonogenic potential, and osteogenic differentiation of  MSCs were evaluated after illumination.</p>
<p>RESULTS: The growth of MSCs was enhanced by red-light LLLI, and the  effect became more obvious at low cell density. A single dose of LLLI  led only to a short-term increase in MSCs proliferation. A maximal  increase in cell proliferation was observed with multiple exposures of  LLLI at 15 mW/cm(2) and 4 J/cm(2). The number of colony-forming unit  fibroblasts increased when cells were illuminated under the optimal  parameter. During osteogenesis, significant increases (p &lt; 0.01) in  both alkaline phosphatase and osteocalcin expressions were found in the  MSCs that received light irradiation.</p>
<p>CONCLUSION: Our data demonstrated that MSCs proliferation was  enhanced by multiple exposures to LLLI from 630-nm LEDs, and cell growth  depended on the plating density. Furthermore, multiple dose of LLLI  could enhance the osteogenic potential of rat MSCs.</p>
</div>
<p>Lasers Med Sci. 2010 Jul;25(4):559-69. Epub 2010 Feb 26.</p>
<h1>Low-level Er:YAG laser irradiation enhances osteoblast proliferation through activation of MAPK/ERK.</h1>
<p>Aleksic V, Aoki A, Iwasaki K, Takasaki AA, Wang CY, Abiko Y, Ishikawa I, Izumi Y.</p>
<p>Section of Periodontology, Department of Hard Tissue Engineering,  Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima,  Bunkyo-ku, Tokyo, 113-8549, Japan.</p>
<h3>Abstract</h3>
<p>Although the use of high-level Er:YAG laser irradiation has been  increasing in periodontal and peri-implant therapy, the effects of  low-level Er:YAG laser on surrounding tissues and cells remain unclear.  In the present study, the effects of low-level Er:YAG laser irradiation  on osteoblast proliferation were investigated. Cells of the osteoblastic  cell line MC3T3-E1 were treated with low-level Er:YAG laser irradiation  with various combinations of laser settings (fluence 0.7-17.2 J/cm(2))  and in the absence or presence of culture medium during irradiation. On  day 1 and/or day 3, cell proliferation and death were determined by cell  counting and by measurement of lactate dehydrogenase (LDH) levels.  Further, the role of mitogen-activated protein kinase (MAPK) pathways in  laser-enhanced cell proliferation was investigated by inhibiting the  MAPK pathways and then measuring MAPK phosphorylation by Western  blotting. Higher proliferation rates were found with various  combinations of irradiation parameters on days 1 and 3. Significantly  higher proliferation was also observed in laser-irradiated MC3T3-E1  cells at a fluence of approximately 1.0-15.1 J/cm(2), whereas no  increase in LDH activity was observed. Further, low-level Er:YAG  irradiation induced the phosphorylation of extracellular  signal-regulated protein kinase (MAPK/ERK) 5 to 30 min after  irradiation. Although MAPK/ERK 1/2 inhibitor U0126 significantly  inhibited laser-enhanced cell proliferation, activation of  stress-activated protein kinases/Jun N-terminal kinase (SAPK/JNK) and  p38 MAPK was not clearly detected. These results suggest that low-level  Er:YAG laser irradiation increases osteoblast proliferation mainly by  activation of MAPK/ERK, suggesting that the Er:YAG laser may be able to  promote bone healing following periodontal and peri-implant therapy.</p>
<p>Photomed Laser Surg. 2010 Jul 22. [Epub ahead of print]</p>
<h1>Low-Level Laser Therapy Stimulates Mineralization Via Increased Runx2 Expression and ERK Phosphorylation in Osteoblasts.</h1>
<p><strong> </strong></p>
<p>Kiyosaki T, Mitsui N, Suzuki N, Shimizu N.</p>
<p>1 Department of Orthodontics, Nihon University School of Dentistry , Chiyoda-ku, Tokyo, Japan .</p>
<p>Abstract</p>
<p>Abstract Objective: This study examined the effects of low-level  laser therapy (LLLT) on osteoblasts via insulin-like growth factor I  (IGF-I) signal transduction. Background: Because orthodontic treatment  is usually accompanied by bone formation, if bone formation can be  promoted, the treatment and retention periods will be shorter. Recently,  we reported the stimulatory effects of LLLT on bone formation. It was  dependent on increased IGF-I, which plays an essential role in the  anabolic regulation of bone metabolism. However, the signal transduction  of IGF-I stimulated by LLLT was not elucidated. Materials and Methods:  Mouse osteoblastic MC3T3-E1 cells were cultured with or without LLLT  (0.96-3.82 J/cm(2)), and the expression of IGF-I and Runt-related  transcription factor 2 (Runx2) and the phosphorylation of  extracellular-signal-regulated kinase (ERK) were determined by using  real-time PCR and Western blot analysis. Results: LLLT at 1.91 J/cm(2)  significantly increased the expression of IGF-I and Runx2 and of ERK  phosphorylation. Cyclolignan picropodophyllin (PPP; an IGF-I receptor  inhibitor) partly inhibited the LLLT-induced expression of these  factors. Moreover, when conditioned medium from the LLLT (1.91 J/cm(2))  cells was added to the MC3T3-E1 culture, the calcium content in the  mineralized nodules increased significantly. PPP or noggin [a bone  morphogenetic protein (BMP) antagonist] partly inhibited the  LLLT-induced change in calcium content, and the addition of both PPP and  noggin inhibited most of the LLLT-induced change in calcium content.  Conclusion: These results suggest that LLLT stimulates in vitro  mineralization through increased IGF-I and BMP production, through Runx2  expression and ERK phosphorylation in osteoblasts.</p>
<p>Med Oral Patol Oral Cir Bucal. 2010 Jul 1;15(4):e616-8.</p>
<h1>Histological evaluation of the effect of low-level laser on distraction osteogenesis in rabbit mandibles.</h1>
<p><strong> </strong></p>
<p>Kreisner PE, Blaya DS, Gaião L, Maciel-Santos ME, Etges A, Santana-Filho M,</p>
<p>de Oliveira MG. School of Dentistry, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</p>
<p>Abstract</p>
<p>OBJECTIVES: This study evaluated the action of low level laser  therapy (LLLT) on the percentage of newly formed bone in rabbit  mandibles that underwent distraction osteogenesis (DO). STUDY DESIGN:  Ten rabbits underwent bone lengthening according to the following  protocol: Latency – 3 days; Activation – 7 days 0.7 mm/d; and  Consolidation – 10 days. The control group was composed of 4 rabbits.  The experimental group, composed of 6 rabbits, received infrared GaAlAs  LLLT (wavelength=830 nm, P=40 mW) according to the following protocol:  point dose of 10 J/cm(2) applied directly on the bone site that  underwent DO during bone consolidation at 48-hour intervals. RESULTS:  The percentage of newly formed bone was greater in the LLLT group  (57.89%) than in the control group (46.75%) (p=0.006). CONCLUSION: The  results suggest that LLLT had a positive effect on the percentage of  newly formed bone. Better-quality bone sites may allow early removal of  the osteogenic distractors, thus shortening total treatment time.</p>
<p>Photomed Laser Surg. 2010 Jun;28(3):411-6.</p>
<h1>Effect of biostimulation on healing of bone defects in diabetic rats.</h1>
<p>Akyol UK, Güngörmü? M.</p>
<p>Ataturk University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Erzurum, Turkey. utkanakyol@yahoo.com</p>
<h3>Abstract</h3>
<p>BACKGROUND AND OBJECTIVE: The aim of this study was to investigate  the effects of biostimulation on healing of bone defects in diabetic  rats. STUDY DESIGN/</p>
<p>MATERIAL AND METHODS: Twenty-eight Wistar rats weighting 250 to 300 g  were used for this study. Diabetes was chemically induced with  streptozotocin, and 14 nondiabetic and 14 diabetic rats were included in  the study. The distal epiphysis of the right and left femurs of the  diabetic rats were perforated with a surgical bone drill. This surgical  procedure was performed on the left femurs of normal rats too. The wound  on the right side of each diabetic rat received laser stimulation. The  left femur of each nondiabetic (normal) rat served as a control. The  rats were assigned to three experimental groups: (1) normal bur (control  group); (2) diabetic bur; (3) diabetic bur + biostimulation.</p>
<p>RESULTS: There was a significant difference among all groups in  substantia spongiosa formation on day 10. According to the Mann-Whitney U  test, there was a difference between Groups 1 and 2. A significant  difference was noted between Groups 2 and 3 as well as between Groups 1  and 3 and between Groups 2 and 3 in union at 20 d of healing.</p>
<p>CONCLUSIONS: Substantia spongiosa formation was slightly more evident  in Groups 1 and 3 than in Group 2. Also, there was more union in Group 3  than in the other groups on day 20. As a result, it can be concluded  that low-level laser therapy (808 nm laser at 10 J/cm(2)) can have a  beneficial effect on spongiosa in diabetic bone repair when five  treatments are administered with 2 d intervals between treatments.</p>
<p>Lasers Med Sci. 2010 Jun 3. [Epub ahead of print]</p>
<h1>Comparative study of the effects of low-intensity pulsed ultrasound  and low-level laser therapy on bone defects in tibias of rats.</h1>
<p><strong> </strong></p>
<p>Fávaro-Pípi E, Feitosa SM, Ribeiro DA, Bossini P, Oliveira P, Parizotto NA, Renno AC.</p>
<p>Department of Physiotherapy, Federal University of São Carlos, Rodovia Washington Luís (SP-310), Km 235, São Carlos, SP, Brazil.</p>
<p>Abstract</p>
<p>The aim of this study was to investigate and to compare the effects  of low intensity ultra-sound (LIPUS) and low-level laser therapy (LLLT)  during the process of bone healing by means of histopathological and  morphometric analysis. The animals were randomly distributed into three  groups of 30 animals each: the control group (bone defect without  treatment); the laser-treated group: (bone defect treated with laser),  and the LIPUS-treated (bone defect treated with ultrasound). Each group  was further divided into three different subgroups (n = 10) and on days  7, 13, and 25 post-injury, rats were killed with an intra-peritoneal  injection of general anesthetic. The rats were treated with a  30-mW/cm(2) low-intensity pulsed ultrasound and a 830-nm laser at 50  J/cm(2). The results showed intense new bone formation surrounded by  highly vascularized connective tissue presenting a slight osteogenic  activity, with primary bone deposition being observed in the group  exposed to laser in the intermediary (13 days) and late stages of repair  (25 days). This was confirmed by morphometric analysis in which  significant statistical differences (p &lt; 0.05) were noticed when  compared to the control. No remarkable differences were noticed in the  specimens treated with ultrasound with regard to the amount of newly  formed bone in comparison to the control group. Taken together, our  results indicate that laser therapy improves bone repair in rats as  depicted by histopathological and morphometric analysis, mainly at the  late stages of recovery. Moreover, it seems that this therapy was more  effective than US to accelerate bone healing.</p>
<p>Biol Trace Elem Res. 2010 Mar;133(3):342-9. Epub 2009 Jul 4.</p>
<h1>Therapeutic effect of organic gallium on ovariectomized osteopenic  rats by decreased serum minerals and increased bone mineral content.</h1>
<p>Ma Z, Fu Q.</p>
<p>Department of Orthopaedics, Sheng Jing Hospital, China Medical University, Shenyang, 110004, People’s Republic of China.</p>
<h3>Abstract</h3>
<p>The purpose of this study was to verify the effect of organic gallium  on ovariectomized osteopenic rats. Thirty Wistar female rats used were  divided into three groups: (1) sham-operation rats (control), (2)  ovariectomized (OVX) rats with osteopenia, and (3) OVX rats with  osteopenia treated with organic gallium. Treatments were performed over  an 8-week period. At sacrifice, the fifth lumbar vertebral body, one  tibia, one femur, and the fourth lumbar vertebrae were removed,  subjected to micro-CT for determination of trabecular bone structure,  and then processed for histomorphometry to assess bone turnover. The  femoral neck was used for mechanical compression testing. Treatment with  organic gallium increased bone volume in OVX animals. Organic  gallium-treated animals had significant increases in trabecular and  cortical thickness and bone strength. The plasma total calcium and  inorganic phosphate concentrations in OVX rats decreased and bone  mineral content in the lumbar vertebrae and femur increased after  treatment with organic gallium. These data provide an important proof of  concept that organic gallium may represent a powerful approach to  treating or reversing severe osteoporosis in humans.</p>
<p>Osteoporos Int. 2010 Mar 4. [Epub ahead of print]</p>
<h1>Laser 904 nm action on bone repair in rats with osteoporosis.</h1>
<p>Pires-Oliveira DA, Oliveira RF, Amadei SU, Pacheco-Soares C, Rocha RF.</p>
<p>Programa de Pós Graduação-Unicastelo, Departamento Curso de  Odontologia, Universidade Camilo Castelo Branco-Unicastelo São Paulo,  Rua Carolina Fonseca 584, Itaquera, São Paulo, São Paulo,  CEP-08.230-030, Brazil, deisepyres@yahoo.com.br.</p>
<p>The aim of the present study was to determine the action of AsGA  laser irradiation on bone repair in the tibia of osteopenic rats. The  animals were randomly divided into eight experimental groups according  to the presence of ovarian hormone (sham group) or the absence of the  hormone (OVX group), as well as being irradiated or non-irradiated.  Low-level 904-nm laser (50 mJ/cm(2)) accelerated the repair process of  osteopenic fractures, especially in the initial phase of bone  regeneration. INTRODUCTION: The development of new techniques to speed  the process of bone repair has provided significant advances in the  treatment of fractures. Some attention recently focused on the effects  of biostimulation on bone. METHODS: Forty-eight adult rats were randomly  divided into eight experimental groups (six animals in each group)  according to the presence of ovarian hormone (sham group) or absence of  the hormone (ovariectomized (OVX) group) as well as being irradiated or  non-irradiated. For the application of low-level laser therapy, the  animals were anesthetized with one third of the dose sufficient to  immobilize the animal and irradiated with AsGa laser (904 nm, 50  mJ/cm(2) for 2 s, point form and in contact). The control animals  received the same type of manipulation as the irradiated animals, but  with the laser turned off. Half of the animals were killed 7 days  following the confection of the bone defect, and the other half were  killed 21 days after the surgery. After complete demineralization, the  tibias were cut cross-sectionally in the central region of the bone  defect and embedded in paraffin blocks. The blocks were then cut in  semi-seriated slices and stained with hematoxylin and eosin. RESULTS:  There was new bone formation in the animals in the OVX group with laser  treatment killed after 7 days (p &lt; 0.001). The lowest percentage of  bone formation was observed in the OVX without laser killed after 7 days  (p &gt; 0.05). All animals killed after 21 days exhibited linear  closure of the lesion. CONCLUSION: Low-level 904-nm laser (50 mJ/cm(2))  accelerated the repair process of osteopenic fractures, especially in  the initial phase of bone regeneration.</p>
<p>Photomed Laser Surg. 2010 Feb;28(1):45-9.</p>
<h1>Effect of low-level laser therapy and calcitonin on bone repair in castrated rats: a densitometric study.</h1>
<p>Nascimento SB, Cardoso CA, Ribeiro TP, Almeida JD, Albertini R, Munin E, Arisawa EA.</p>
<p>Biomedical Vibrational Spectroscopy Laboratory, Universidade do Vale do Paraíba, São José dos Campos, São Paulo, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: To investigate the healing of bone defects in male rats  treated with salmon calcitonin, low-level laser therapy (LLLT), or both.</p>
<p>BACKGROUND: Healing of bone defects still represents a challenge to  health professionals in several areas. In this article, the effect of  calcitonin in combination with LLLT on bone repair was studied.  Densitometry was used as a valuable tool for the measurement of bone  regeneration.</p>
<p>METHODS: Sixty male Wistar rats underwent bilateral castration  surgery before the creation of a surgical bone defect. The animals were  randomly divided into four groups: control, treated with calcitonin  (Ca), treated with LLLT (La), and treated with calcitonin and LLLT  (CaLa). Groups Ca and CaLa received 2 IU/kg of synthetic salmon  calcitonin intramuscularly three times a week. Groups La and CaLa  received laser therapy using a gallium-aluminum-arsenide laser (10 mW,  20 J/cm(2), wavelength 830 nm). Control animals were submitted to sham  irradiation. The animals were sacrificed 7, 14, and 21 days after  surgery, and bone defects were analyzed using densitometry.</p>
<p>RESULTS: The CaLa group had a higher degree of bone regeneration 14 and 21 days after surgery.</p>
<p>CONCLUSIONS: The La and CaLa had significantly higher bone mineral density than the control and Ca groups.</p>
<p>J Orthop Surg Res. 2010 Jan 4;5(1):1. [Epub ahead of print]</p>
<h1>Effects of low power laser irradiation on bone healing in animals: a meta-analysis.</h1>
<p>Bashardoust Tajali S, Macdermid JC, Houghton P, Grewal R.</p>
<p>ABSTRACT: Purpose: The meta-analysis was performed to identify animal  research defining the effects of low power laser irradiation on  biomechanical indicators of bone regeneration and the impact of dosage.  Methods: We searched five electronic databases (MEDLINE, EMBASE, PubMed,  CINAHL, and Cochrane Database of Randomised Clinical Trials) for  studies in the area of laser and bone healing published from 1966 to  October 2008. Included studies had to investigate fracture healing in  any animal model, using any type of low power laser irradiation, and use  at least one quantitative biomechanical measures of bone strength.  There were 880 abstracts related to the laser irradiation and bone  issues (healing, surgery and assessment). Five studies met our inclusion  criteria and were critically appraised by two raters independently  using a structured tool designed for rating the quality of animal  research studies. After full text review, two articles were deemed  ineligible for meta-analysis because of the type of injury method and  biomechanical variables used, leaving three studies for meta-analysis.  Maximum bone tolerance force before the point of bone fracture during  the biomechanical test, 4 weeks after bone deficiency was our main  biomechanical bone properties for the Meta analysis. Results: Studies  indicate that low power laser irradiation can enhance biomechanical  properties of bone during fracture healing in animal models. Maximum  bone tolerance was statistically improved following low level laser  irradiation (average random effect size 0.726, 95% CI 0.08 – 1.37, p  0.028). While conclusions are limited by the low number of studies,  there is concordance across limited evidence that laser improves the  strength of bone tissue during the healing process in animal models.</p>
<p>Lasers Med Sci. 2010 Jan;25(1):73-7. Epub 2009 Apr 28.</p>
<h1>Effect of low-level laser therapy on the fracture healing process.</h1>
<p>Kazem Shakouri S, Soleimanpour J, Salekzamani Y, Oskuie MR.</p>
<p>Tabriz University of Medical Sciences, Tabriz, Iran. sk0531ir@yahoo.com</p>
<h3>Abstract</h3>
<p>Low-level laser therapy (LLLT) is a biophysical form of intervention  in the fracture-repair process, which, through several mechanisms,  accelerates the healing of fractures and enhances callus formation. The  effect of laser on fracture healing is controversial. Some authors  affirm that LLLT can accelerate bone formation by increasing  osteoblastic activity. The objective of our study was to evaluate the  effect of laser therapy on fracture healing. Thirty rabbits were  subjected to tibial bone open osteotomies that were stabilized with  external fixators. The animals were divided into two study groups: laser  group and control group. Callus development and bone mineral density  were quantitatively evaluated by CT; the animals were then killed and  the fractures were assessed for biomechanical properties. The results  demonstrated that the increasing rate of bone mineral density was higher  in the laser (L) group than in the control (C) group. CT at 5 weeks  revealed a mean callus density of 297 Hounsfield units (HU) for the  control group and 691 HU for the L group, which was statistically  significant (P = 0.001). In the L group, the mean recorded fracture  tension was 190.5 N and 359.3 N for healed and intact bones,  respectively, which was statistically significant (P &lt; 0.001). The  result of the study showed that the use of laser could enhance callus  development in the early stage of the healing process, with doubtful  improvement in biomechanical properties of the healing bone; therefore,  laser therapy may be recommended as an additional treatment in non-union  fractures in humans.</p>
<p>Med Oral Patol Oral Cir Bucal. 2009 Dec 29. [Epub ahead of print]</p>
<h1>Histological evaluation of the effect of low-level laser on distraction osteogenesis in rabbit mandibles.</h1>
<p>Kreisner PE, Blaya D, Gaião L, Maciel-Santos ME, Etges A, Santana-Filho M, de Oliveira MG.</p>
<p>Av. Cel. Lucas de Oliveira, 1841/203, Petrópolis CEP: 90460-001 – Porto Alegre, RS, Brazil, mogerhardt@yahoo.com.br.</p>
<p>Objectives: This study evaluated the action of low level laser  therapy (LLLT) on the percentage of newly formed bone in rabbit  mandibles that underwent distraction osteogenesis (DO). Study design:  Ten rabbits underwent bone lengthening according to the following  protocol: Latency – 3 days; Activation – 7 days 0.7 mm/d; and  Consolidation – 10 days. The control group was composed of 4 rabbits.  The experimental group, composed of 6 rabbits, received infrared GaAlAs  LLLT (wavelength=830 nm, 40 mW) according to the following protocol:  point dose of 10 J/cm(2) applied directly on the bone site that  underwent DO during bone consolidation at 48-hour intervals. Results:  The percentage of newly formed bone was greater in the LLLT group  (57.89%) than in the control group (46.75%) (p=0.006). Conclusion: The  results suggest that LLLT had a positive effect on the percentage of  newly formed bone. Better-quality bone sites may allow early removal of  the osteogenic distractors, thus shortening total treatment time.</p>
<p>J Mater Sci Mater Med. 2009 Nov 27. [Epub ahead of print]</p>
<h1>Low level laser therapy does not modulate the outcomes of a highly  bioactive glass-ceramic (Biosilicate((R))) on bone consolidation in  rats.</h1>
<p>Oliveira P, Ribeiro DA, Pipi EF, Driusso P, Parizotto NA, Renno AC.</p>
<p>Department of Physiotherapy, Federal University of São Carlos, Rodovia Washington Luís (SP-310), Km 235, São Carlos, SP, Brazil.</p>
<p>The main purpose of the present work was to evaluate if low level  laser therapy (LLLT) can improve the effects of novel fully-crystallized  glass-ceramic (Biosilicate((R))) on bone consolidation in tibial  defects of rats. Forty male Wistar rats with tibial bone defects were  used. Animals were divided into four groups: group bone defect control  (CG); group bone defect filled with Biosilicate((R)) (BG); group bone  defect filled with Biosilicate((R)), irradiated with LLLT, at 60 J  cm(-2) (BG 60) and group bone defect filled with Biosilicate((R)),  irradiated with LLLT, at 120 J cm(-2) (BG 120). A low-energy GaAlAs 830  nm, CW, 0.6 mm beam diameter, 100 W cm(-2), 60 and 120 J cm(-)(2) was  used in this study. Laser irradiation was initiated immediately after  the surgery procedure and it was performed every 48 h for 14 days.  Fourteen days post-surgery, the three-point bending test revealed that  the structural stiffness of the groups CG and BG was higher than the  values of the groups BG60 and BG120. Morphometric analysis revealed no  differences between the control group and the Biosilcate((R)) group.  Interestingly, the groups treated with Biosilicate((R)) and laser (BG 60  and BG120) showed statistically significant lower values of newly  formed bone in the area of the defect when compared to negative control  (CG) and bone defect group filled with Biosilicate (CB). Our findings  suggest that although Biosilicate((R)) exerts some osteogenic activity  during bone repair, laser therapy is not able to modulate this process.</p>
<p>Photomed Laser Surg. 2009 Oct 27. [Epub ahead of print]</p>
<h1>Effect of Biostimulation on Healing of Bone Defects in Diabetic Rats.</h1>
<p>Akyol UK, Güngörmü? M.</p>
<p>Ataturk University , Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Erzurum, Turkey .</p>
<p>Abstract Background and Objective: The aim of this study was to  investigate the effects of biostimulation on healing of bone defects in  diabetic rats. Study Design/Material and Methods: Twenty-eight Wistar  rats weighting 250 to 300 g were used for this study. Diabetes was  chemically induced with streptozotocin, and 14 nondiabetic and 14  diabetic rats were included in the study. The distal epiphysis of the  right and left femurs of the diabetic rats were perforated with a  surgical bone drill. This surgical procedure was performed on the left  femurs of normal rats too. The wound on the right side of each diabetic  rat received laser stimulation. The left femur of each nondiabetic  (normal) rat served as a control. The rats were assigned to three  experimental groups: (1) normal bur (control group); (2) diabetic bur;  (3) diabetic bur + biostimulation. Results: There was a significant  difference among all groups in substantia spongiosa formation on day 10.  According to the Mann-Whitney U test, there was a difference between  Groups 1 and 2. A significant difference was noted between Groups 2 and 3  as well as between Groups 1 and 3 and between Groups 2 and 3 in union  at 20 d of healing. Conclusions: Substantia spongiosa formation was  slightly more evident in Groups 1 and 3 than in Group 2. Also, there was  more union in Group 3 than in the other groups on day 20. As a result,  it can be concluded that low-level laser therapy (808 nm laser at 10  J/cm(2)) can have a beneficial effect on spongiosa in diabetic bone  repair when five treatments are administered with 2 d intervals between  treatments.</p>
<p>Lasers Med Sci. 2009 Sep;24(5):689-95. Epub 2008 Sep 12.</p>
<h1>Morphometric and histological analysis of low-power laser influence on bone morphogenetic protein in bone defects repair.</h1>
<p>Denadai AS, de Carvalho Pde T, dos Reis FA, Belchior AC, Pereira DM, Dourado DM, Silva IS, de Oliveira LV.</p>
<p>Postgraduate Program on Health and Development in West Central  Region, Federal University of Mato Grosso do Sul, Campo Grande, Mato  Grosso do Sul, Brazil.</p>
<h3>Abstract</h3>
<p>Bone morphogenetic proteins (BMPs) are secreted signaling molecules  belonging to the transforming growth factor-beta (TGF-beta) superfamily.  The objective of this study was to determine how  gallium-aluminum-arsenium (GaAlAs) 650 nm laser influenced the action of  BMPs on bone defects created in rat femurs. The sample consisted of 24  male albino Wistar rats. Group 1 was composed of rats with bone defects  filled with bone-inducing substance, with the application of low-power  laser. Group 2 contained rats with bone defects filled with a  bone-inducing substance, without the application of low-power laser.  Group 3 rats had bone defects not filled with a bone-inducing substance,  with the application of low-power laser. Group 4 rats had bone defects  and no treatment (control group). A bone defect was produced with  drills. In groups 1 and 2 the defects were filled with a bone-inducing  substance. The animals were treated with GaAlAs (50 mW) laser, energy  density 4 J/cm(2), for 80 ss on a 1 cm(2) area. Groups 2 and 4 were used  as control. Bone samples were removed for histological procedures and  morphometric analysis on the 7th, 14th and 21st days after surgery.  Results obtained were subjected to statistical analysis. Rejection level  for the null hypothesis was 0.05. Statistical differences were found in  the comparison between group 1 (G1), G2, G3 and G4 [analysis of  variance (ANOVA); P &lt; 0.0134]. There was a statistically significant  correlation between groups 1 and 4 (P &lt; 0.01). The results of other  correlations by Tukey’s post-hoc test were: group 1 vs group 3 (P =  0.341), group 1 vs group 2 (P = 0.862), group 2 vs group 4 (P = 0.061),  group 2 vs group 3 (P = 0.744), and group 3 vs group 4 (P = 0.249). We  concluded that the association of low-power laser with a bone-inducing  substance produced better results than when low-power laser or BMPs were  used alone.</p>
<p>Photomed Laser Surg. 2009 Aug;27(4):641-6.</p>
<h1>The effects of infrared low-level laser therapy on healing of  partial osteotomy of tibia in streptozotocin-induced diabetic rats.</h1>
<p>Javadieh F, Bayat M, Abdi S, Mohsenifar Z, Razi S.</p>
<p>Anatomy Department, Medical Faculty, Shahid Beheshti University, MC, Tehran, Iran.</p>
<p>OBJECTIVE: The effects of low-level laser therapy (LLLT) on a bone  defect model in streptozotocin-induced diabetic (STZ-D) rats was  examined. BACKGROUND DATA: LLLT accelerates bone fracture repair in  healthy animals, but its effect in diabetic animals is unclear. METHODS:  Twenty-eight rats were divided into five groups: 1 (diabetes, no LLLT),  2 (diabetes, LLLT high dose), 3 (diabetes, LLLT low dose), 4 (no  diabetes, no LLLT), and 5 (no diabetes, LLLT low dose) Diabetes was  induced by a single injection of STZ in rats of groups 1, 2, and 3. A  bone defect was made in the right tibia of rats in all groups. The  defect in groups 2, 3, and 5 was treated with LLLT (890 nm, 70 W, 3000  Hz, circular beam shape, and 1 cm(2) spot size). Doses of 23.3 J/cm(2)  (530 s) for group 2 and 11.6 J/cm(2) (265 s) for groups 3 and 5 were  applied three times a week. The right tibias were collected 42 days  after surgery and subjected to three-point bending test on a material  testing machine (MTM) until fracture occurred. Data was automatically  recorded on the MTM formed the load-deformation curve. RESULTS:  Mann-Whitney test showed that LLLT with 11.6 J/cm(2) significantly  increased bending stiffness and maximum force in diabetic rats compared  with group 1 (both p = 0.041). CONCLUSION: LLLT in an experimental  diabetic model enhanced bone repair with a higher bending stiffness and  maximum force compared to the control group.</p>
<p>Lasers Med Sci. 2009 Jul;24(4):527-33. Epub 2008 Jul 15</p>
<h1>Effect of soft laser and bioactive glass on bone regeneration in the treatment of bone defects (an experimental study).</h1>
<p>AboElsaad NS, Soory M, Gadalla LM, Ragab LI, Dunne S, Zalata KR, Louca C.</p>
<p>Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.</p>
<p>This study aimed to investigate the influence of low-power  gallium-aluminium-arsenide (GaAlAs) laser [830 nm, continuous wave (CW),  40 mW and fluence 4 J/cm(2)] on the healing of surgically created bone  defects in rats treated with bioactive glass graft material. Surgical  bone defects were created in the mandibles of 36 Wistar rats divided  into two groups, each consisting of 18 rats. Group I was treated with  bioactive glass plus laser irradiation. Group II was treated with graft  material only. The animals were killed at 4 weeks, 8 weeks and 12 weeks  postoperatively for histological examination. Laser irradiation had  significantly accelerated bone healing at 4 weeks and 8 weeks in  comparison with that at the sites not irradiated. However at 12 weeks,  complete healing of the defects had occurred with no difference  detected. Our results have confirmed the positive effect of soft laser  in accelerating bone regeneration.</p>
<p>Lasers Med Sci. 2009 Jun 23. [Epub ahead of print</p>
<h1>Effects of low-level laser therapy on bone formation after distraction osteogenesis.</h1>
<p>Hübler R, Blando E, Gaião L, Kreisner PE, Post LK, Xavier CB, de Oliveira MG.</p>
<p>School of Physics, Pontifícia Universidade Católica do Rio Grande do  Sul (PUCRS), Av. Ipiranga, 6681, Prédio 10, sala 222, Caixa Postal 1429,  90619-900, Porto Alegre, RS, Brazil.</p>
<p>This study evaluated the effect of low-level laser therapy (LLLT) on  the chemical composition, crystallinity and crystalline structure of  bone at the site of distraction osteogenesis. Five rabbits were  subjected to distraction osteogenesis (latency = 3 days; rate and  frequency = 0.7 mm/day for 7 days; consolidation = 10 days), and three  were given LLLT with arsenide-gallium-aluminum (AsGaAl; 830 nm, 40 mW):  10 J/cm(2) dose per spot, applied directly to the distraction  osteogenesis site during the consolidation stage at 48 h intervals.  Samples were harvested at the end of the consolidation stage. X-ray  fluorescence and X-ray diffraction were used to analyze chemical  composition, crystallinity and crystalline structure of bone at the  distraction osteogenesis site. The analysis of chemical composition and  calcium (Ca) and phosphorus (P) ratios revealed greater mineralization  in the LLLT group. Diffractograms showed that the crystalline structure  of the samples was similar to that of hydroxyapatites. Crystallinity  percentages were greater in rabbits that were given LLLT. Crystallinity  (41.14% to 54.57%) and the chemical composition of the bone at the  distraction osteogenesis site were similar to the that of the control  group (42.37% to 49.29%). The results showed that LLLT had a positive  effect on the biomodulation of newly formed bone.</p>
<p>Lasers Med Sci. 2009 May;24(3):347-52. Epub 2008 Jul 22.</p>
<h1>Effect of low-power gallium-aluminum-arsenium laser therapy (830 nm)  in combination with bisphosphonate treatment on osteopenic bone  structure: an experimental animal study.</h1>
<p>Diniz JS, Nicolau RA, de Melo Ocarino N, do Carmo Magalhães F, de Oliveira Pereira RD, Serakides R.</p>
<p>Instituto de Pesquisa e Desenvolvimento, Universidade do Vale do Paraíba, São José dos Campos, SP, Brazil.</p>
<h3>Abstract</h3>
<p>Laser therapy is able to modulate cell metabolism and accelerate the  repair of fracture. Little attention has been given to the effect of  laser on bone with osteopenia or osteoporosis. The purpose of our study  was to verify the effect of laser therapy in combination with  bisphosphonate on osteopenic bone structure. The 35 Wistar female rats  used were divided into five groups: (1) sham-operation rats (control),  (2) ovariectomized (OVX'd) rats with osteopenia, (3) OVX'd rats with  osteopenia treated with laser, (4) OVX'd rats with osteopenia treated  with bisphosphonate and (5) OVX'd rats with osteopenia treated with  bisphosphonate and laser. Groups 3 and 5 were given daily 6 mg doses of  bisphosphonate orally. Groups 4 and 5 underwent low level laser therapy  [gallium-aluminum-arsenium (GaAlAs) laser, 830 nm, 50 mW and 4 J/cm(2)]  on the femoral neck and vertebral segments (T13-L2). Both treatments  were performed over an 8-week period. Rats from the osteopenic control  and osteopenic + laser groups presented marked osteopenia. In the  osteopenic + bisphosphonate group, the trabecular bone volume in  vertebra L2 was significantly greater than in the osteopenic control  group. Notably, in the association between laser and bisphosphonate, the  trabecular bone volume was significantly greater in vertebrae L2 and  T13 and was similar to that in the sham-operation control group. It was  concluded that the laser therapy associated with bisphosphonate  treatment was the best method for reversing vertebral osteopenia caused  by the ovariectomy.</p>
<p>Lasers Surg Med. 2009 Apr;41(4):298-304.</p>
<h1>Superpulsed laser irradiation increases osteoblast activity via modulation of bone morphogenetic factors.</h1>
<p>Saracino S, Mozzati M, Martinasso G, Pol R, Canuto RA, Muzio G.</p>
<p>Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello 30, 10125 Turin, Italy.</p>
<h3>Abstract</h3>
<p>BACKGROUND AND OBJECTIVE: Laser therapy is a new approach applicable  in different medical fields when bone loss occurs, including orthopedics  and dentistry. It has also been used to induce soft-tissue healing, for  pain relief, bone, and nerve regeneration. With regard to bone  synthesis, laser exposure has been shown to increase osteoblast activity  and decrease osteoclast number, by inducing alkaline phosphatase (ALP),  osteopontin, and bone sialoprotein expression. Studies have  investigated the effects of continuous or pulsed laser irradiation, but  no data are yet available on the properties of superpulsed laser  irradiation. This study thus aimed to investigate the effect of  superpulsed laser irradiation on osteogenic activity of human  osteoblast-like cells, paying particular attention to investigating the  molecular mechanisms underlying the effects of this type of laser  radiation.</p>
<p>STUDY DESIGN/MATERIALS AND METHODS: Human osteoblast-like MG-63 cells  were exposed to 3, 7, or 10 superpulsed laser irradiation (pulse width  200 nanoseconds, minimum peak power 45 W, frequency 30 kHz, total energy  60 J, exposure time 5 minutes). The following parameters were  evaluated: cell growth and viability (light microscopy, lactate  dehydrogenase release), calcium deposits (Alizarin Red S staining),  expression of bone morphogenetic factors (real-time PCR).</p>
<p>RESULTS: Superpulsed laser irradiation decreases cell growth, induces  expression of TGF-beta2, BMP-4, and BMP-7, type I collagen, ALP, and  osteocalcin, and increases the size and the number of calcium deposits.  The stimulatory effect is maximum on day 10, that is, after seven  applications.</p>
<p>CONCLUSIONS: Reported results show that superpulsed laser  irradiation, like the continuous and pulsed counterparts, possesses  osteogenic properties, inducing the expression of molecules known to be  important mediators of bone formation and, as a consequence, increasing  calcium deposits in human MG-63 cells. Moreover, the data suggest a new  potential role for PPARgamma as a regulator of osteoblast proliferation.</p>
<p>Photomed Laser Surg. 2009 Apr;27(2):309-15.</p>
<h1>Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells.</h1>
<p>Xu M, Deng T, Mo F, Deng B, Lam W, Deng P, Zhang X, Liu S.</p>
<p>School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. xumin@hkbu.edu.hk</p>
<h3>Abstract</h3>
<p>OBJECTIVE: This study aimed to investigate the effect of  low-intensity pulsed laser (LIPL; 650 nm, 2 mW) irradiation on mRNA  expression of receptor activator of NF-kappaB ligand (RANKL) and  osteoprotegerin (OPG) in rat calvarial cells.</p>
<p>MATERIALS AND METHODS: Cultured cells were treated with LIPL  irradiation of 1.14 J/cm(2) (group A) or 2.28 J/cm(2) (group B), and  non-irradiated cells (group C) were used as controls. The changes in  cell numbers, alkaline phosphatase (ALP) activity, RANKL, and OPG mRNA  expression in the three study groups was determined using MTT, UV/VIS  spectrophotometry, and RT-PCR analyses.</p>
<p>RESULTS: The cell numbers in groups A and B increased significantly  (7.52% and 8.80%, respectively), as did ALP activity (71.95% and 88.20%,  respectively), compared with group C (p &lt; 0.001). Meanwhile, RANKL  and OPG mRNA expression in group A were 51.06% lower and 3.35 times  higher, respectively, than those seen in the controls (p &lt; 0.05), and  the RANKL:OPG mRNA ratio in group A was 81.82% lower than that in group  C (p &lt; 0.005).</p>
<p>CONCLUSION: LIPL irradiation may directly promote osteoblast  proliferation and differentiation, and indirectly inhibit osteoclast  differentiation, by downregulating the RANKL:OPG mRNA ratio in  osteoblasts. Thus LIPL irradiation may play an important role in bone  remodeling, and should be valuable for the treatment of bone diseases  such as osteoporosis.</p>
<p>Lasers Med Sci.s 2009 Mar;24(2):234-40. Epub 2008 Apr 17.</p>
<h1>Bone repair following bone grafting hydroxyapatite guided bone  regeneration and infra-red laser photobiomodulation: a histological  study in a rodent model.</h1>
<p>Pinheiro AL, Martinez Gerbi ME, de Assis Limeira F Jr, Carneiro Ponzi  EA, Marques AM, Carvalho CM, de Carneiro Santos R, Oliveira PC, Nóia M,  Ramalho LM.</p>
<p>Department of Propedeutica and Clínica Integrada, Laser Center,  School of Dentistry, Federal University of Bahia, Salvador, BA, Brazil.  albp@ufba.br</p>
<h3>Abstract</h3>
<p>The aim of the investigation was to assess histologically the effect  of laser photobiomodulation (LPBM) on a repair of defects surgically  created in the femurs of rats. Forty-five Wistar rats were divided into  four groups: group I (control); group II (LPBM); group III  (hydroxyapatite guided bone regeneration; HA GBR); group IV (HA GBR  LPBM). The animals in the irradiated groups were subjected to the first  irradiation immediately after surgery, and it was repeated every day for  2 weeks. The animals were killed 15 days, 21 days and 30 days after  surgery. When the groups irradiated with implant and membrane were  compared, it was observed that the repair of the defects submitted to  LPBM was also processed faster, starting from the 15th day. At the 30th  day, the level of repair of the defects was similar in the irradiated  groups and those not irradiated. New bone formation was seen inside the  cavity, probably by the osteoconduction of the implant, and, in the  irradiated groups, this new bone formation was incremental. The present  preliminary data seem to suggest that LPMB therapy might have a positive  effect upon early wound healing of bone defects treated with a  combination of HA and GBR.</p>
<p>Lasers Med Sci. 2009 Mar;24(2):195-201. Epub 2008 Feb 29.</p>
<h1>Low-level laser therapy modulates cyclo-oxygenase-2 expression during bone repair in rats.</h1>
<p>Matsumoto MA, Ferino RV, Monteleone GF, Ribeiro DA.</p>
<p>Department of Oral Maxillofacial Surgery, School of Dentistry, University of the Sacred Heart (USC), Bauru, SP, Brazil.</p>
<h3>Abstract</h3>
<p>The goal of this study was to analyze the role of cyclo-oxygenase-2  following bone repair in rats submitted to low-level laser therapy. A  total of 48 rats underwent surgery to inflict bone defects in their  tibias having been randomly distributed into two groups: negative  control and laser exposed group, i.e., the animals were treated with  low-level laser therapy by means of gallium arsenide laser at 16  J/cm(2). The animals were killed after 48 h, 7 days, 14 days, or 21  days. The tibias were removed for morphological, morphometric, and  immunohistochemistry analysis for cyclo-oxygenase-2. Statistical  significant differences (P &lt; 0.05) were observed in the quality of  bone repair and quantity of formed bone between groups 14 days after  surgery in the laser exposed group. In the same way, cyclo-oxygenase-2  immunoreactivity was more intense in bone cells for intermediate periods  evaluated in this group. Taken together, such results suggest that  low-level laser therapy is able to improve bone repair in the tibia of  rats after 14 days of surgery as a result of an up-regulation for  cyclo-oxygenase-2 expression in bone cells.</p>
<p>Wien Klin Wochenschr. 2008;120(3-4):112-7.</p>
<h1>Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells.</h1>
<p>Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D, Baghestanian M, Turhani D.</p>
<p>Department of Cranio-Maxillofacial and Oral Surgery, Medical University of Vienna, Austria.</p>
<h3>Abstract</h3>
<p>Low-level laser therapy is a clinically well established tool for  enhancement of wound healing. In vitro studies have also shown that low  level laser therapy has a biostimulatory effect on cells of different  origin. The aim of this in vitro study was to investigate the initial  effect of low-level laser therapy on growth and differentiation of human  osteoblast-like cells. SaOS-2 cells were irradiated with laser doses of  1 J/cm2 and 2 J/cm2 using a diode laser with 670 nm wave length and an  output power of 400 mW. Untreated cells were used as controls. At 24 h,  48 h and 72 h post irradiation, cells were collected and assayed for  viability of attached cells and alkaline phosphatase specific activity.  In addition, mRNA expression levels of osteopontin and collagen type I  were assessed using semi-quantitative RT-PCR. Over the observation  period, cell viability, alkaline phosphatase activity and the expression  of osteopontin and collagen type I mRNA were slightly enhanced in cells  irradiated with 1 J/cm2 compared with untreated control cells.  Increasing the laser dose to 2 J/cm2 reduced cell viability during the  first 48 h and resulted in persistently lower alkaline phosphatase  activity compared with the other two groups. The expression of  osteopontin and collagen type I mRNA slightly decreased with time in  untreated controls and cells irradiated with 1 J/cm2, but their  expression was increased by treatment with 2 J/cm2 after 72 h. These  results indicate that low-level laser therapy has a biostimulatory  effect on human osteoblast-like cells during the first 72 h after  irradiation. Further studies are needed to determine the potential of  low-level laser therapy as new treatment concept in bone regeneration.</p>
<p>J Contemp Dent Pract. 2008 Sep 1;9(6):41-8.</p>
<h1>Histologic study of the effect of laser therapy on bone repair.</h1>
<p>Blaya DS, Guimarães MB, Pozza DH, Weber JB, de Oliveira MG.</p>
<p>Centro Universitário Franciscano, Santa Maria, RS, Brazil.</p>
<h3>Abstract</h3>
<p>AIM: This study used histologic analysis and HE staining to evaluate  laser biomodulation of bone repair in cavities made in the femurs of  rats that underwent non-ablative laser irradiation.</p>
<p>METHODS AND MATERIALS: Eighteen male Wistar rats weighing 300 to 400  grams were randomly assigned to three groups of six animals each. A  surgical defect site was produced with a trephine about 2 mm in diameter  under abundant irrigation. In Group I the complete surgical protocol to  produce a bone defect was followed but without laser radiation  (control). In Group II a continuous wave 830 nm infrared laser was used  at 10 J/cm2 and 50 mW at each point of the surgical site. In Group III a  continuous wave 685 nm infrared laser at 10J/cm2 and 35 mW was used at  each point of surgical site. The animals were irradiated at intervals of  48 hours beginning immediately after the preparation of the defect and  were sacrificed on the 15th, 21st, and 30th days. Slides were studied by  means of descriptive analysis.</p>
<p>RESULTS: Greater degrees of new bone formation and vertical  regeneration were found in the irradiated groups than in the control  group.</p>
<p>CONCLUSION: Laser therapy in this study protocol was efficient in promoting bone repair.</p>
<p>CLINICAL SIGNIFICANCE: The use of laser technology has been used to  improve the clinical results of bone surgeries and to promote a more  comfortable postoperative period and quicker healing.</p>
<p>Photomed Laser Surg. 2008 Aug;26(4):301-6.</p>
<h1>Laser-needle therapy for spontaneous osteonecrosis of the knee.</h1>
<p>Banzer W, Hübscher M, Schikora D.</p>
<p>Department of Sports Medicine, Goethe-University Frankfurt/Main, University of Paderborn, Frankfurt/Main, Germany. <a href="mailto:banzer@sport.uni-frankfurt.de">banzer@sport.uni-frankfurt.de</a></p>
<h3>Abstract</h3>
<p>OBJECTIVE: This case report describes the treatment of a 63-year-old patient with spontaneous osteonecrosis of the knee (SONK).</p>
<p>BACKGROUND DATA: SONK usually appears in the elderly patient without  the typical risk factors for osteonecrosis. It is characterized by acute  and sudden pain, mostly occurring at the medial side of the knee joint.  Symptoms usually worsen with physical activity and improve with rest.  Besides physical therapy, limited weight-bearing and the use of  analgesics and nonsteroidal anti-inflammatory drugs, we propose  low-level laser therapy (LLLT) as a conservative treatment option.</p>
<p>METHODS: LLLT was carried out using laser needles emitting radiation  with wavelengths of 685 and 885 nm, and a power density of 17.8 W/cm(2).  Therapy sessions lasted 60 min and were performed daily over a period  of 3 mo. The total irradiation dose emitted by 8 laser needles in 60 min  of treatment was 1008 J.</p>
<p>RESULTS: Magnetic resonance imaging revealed distinct restitution of  the spongiosa edema 5 wk after treatment onset, and the final check-up  at 35 wk demonstrated complete restoration of integrity.</p>
<p>CONCLUSION: The present case report provides the first indication  that laser-needle therapy may be a promising tool for complementary and  alternative therapeutic intervention for those with SONK.</p>
<p>Photomed Laser Surg. 2008 Aug;26(4):401-4.</p>
<h1>Evaluation of low-level laser therapy of osteoblastic cells.</h1>
<p>Pires Oliveira DA, de Oliveira RF, Zangaro RA, Soares CP.</p>
<p>Laboratório de Dinâmica de Compartimentos Celulares, Instituto de  Pesquisa e Desenvolvimento, UNIVAP, São José dos Campos, São Paulo,  Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The purpose of the present study was to evaluate the  effect of biomodulation on osteoblastic cells using a  gallium-aluminium-arsenide diode laser.</p>
<p>BACKGROUND DATA: Low-level laser therapy (LLLT) is a  non-pharmacological therapeutic resource to which biological tissues  respond well, producing such effects as the acceleration of bone  formation and bone repair.</p>
<p>MATERIALS AND METHODS: Osteoblastic cell cultures (OFCOL II) were  irradiated with a gallium-aluminium-arsenide diode laser (GaAlAs lambda =  830 nm; 50 mW; 3 J/cm(2); 600-microm-diameter optical fiber) and  divided into two groups: group 1–irradiated cells, and group  2–non-irradiated cells. Irradiation occurred at 24-h intervals for a  total of 3 d. After each interval, the cells were marked with Mito  Tracker Orange dye to assess the biostimulatory effect on mitochondrial  activity and cell proliferation using an MTT assay.</p>
<p>RESULTS: Intense grouping of mitochondria in the perinuclear region  was observed at 24 h and 48 h following irradiation. Changes from a  filamentous to a granular appearance in mitochondrial morphology and  mitochondria distributed throughout the cytoplasm were observed 72 h  following proliferation. Such changes led to an in vitro proliferation  process, as confirmed by the MTT assay.</p>
<p>CONCLUSION: LLLT has shown itself capable of altering mitochondrial activity and the population of OFCOL II cells.</p>
<p>Photomed Laser Surg. 2008 Feb;26(1):55-60.</p>
<h1>Infrared laser light further improves bone healing when associated  with bone morphogenic proteins: an in vivo study in a rodent model.</h1>
<p>Gerbi ME, Marques AM, Ramalho LM, Ponzi EA, Carvalho CM, Santos Rde C, Oliveira PC, Nóia M, Pinheiro AL.</p>
<p>School of Dentistry, Federal University of Pernambuco, Recife, PE, Salvador.</p>
<p>OBJECTIVE: This study assessed histologically the effect of laser  photobiomodulation (LPBM) on the repair of surgical defects created in  the femurs of Wistar rats treated or not treated with bone morphogenic  proteins (BMPs) and organic bovine bone graft. BACKGROUND DATA: This  paper is part of an ongoing series of works in which biomaterials are  used in association with LPBM. Several previous reports by our group  have shown that the use of laser photobiomodulation improves the  treatment of bone defects. MATERIALS AND METHODS: Forty-eight adult male  Wistar rats were divided into four randomized groups: group I (control,  n = 12); group II (LPBM, n = 12); group III (BMPs + organic bovine bone  graft, n = 12); and group IV (BMPs + organic bovine bone graft + LPBM, n  = 12). The irradiated groups received seven irradiations every 48 h,  beginning immediately after the surgical procedure. The laser therapy  (lambda = 830 nm, 40 mW CW, varphi = 0.6 mm) consisted of 16 J/cm(2) per  session divided equally over four points (4 J/cm(2) each) around the  defect. The subjects were sacrificed after 15, 21, and 30 d, and the  specimens were routinely embedded in wax, stained with hematoxylin and  eosin and sirius red, and analyzed under light microscopy. RESULTS: The  results showed histological evidence of increased deposition of collagen  fibers (at 15 and 21 d), as well as an increased amount of  well-organized bone trabeculae at the end of the experimental period (30  d) in the irradiated animals versus the non-irradiated controls.  CONCLUSION: The use of LPBM with BMPs and organic bovine bone grafts  increases the positive biomodulating effects of laser light.</p>
<p>J Oral Rehabil. 2008 Dec;35(12):925-33.</p>
<h1>Low-level laser therapy improves bone repair in rats treated with anti-inflammatory drugs.</h1>
<p>Ribeiro DA, Matsumoto MA.</p>
<p>Department of Biosciences, Federal University of Sao Paulo, UNIFESP, Santos, SP, Brazil. daribeiro@unifesp.br</p>
<h3>Abstract</h3>
<p>Nowadays, selective cyclooxygenase-2 non-steroidal anti-inflammatory  drugs have been largely used in surgical practice for reducing oedema  and pain. However, the association between these drugs and laser therapy  is not known up to now. Herein, the aim of this study was to evaluate  the action of anti-COX-2 selective drug (celecoxib) on bone repair  associated with laser therapy. A total of 64 rats underwent surgical  bone defects in their tibias, being randomly distributed into four  groups: Group 1) negative control; Group 2) animals treated with  celecoxib; Group 3) animals treated with low-level power laser and Group  4) animals treated with celecoxib and low-level power laser. The  animals were killed after 48 h, 7, 14 and 21 days. The tibias were  removed for morphological, morphometric and immunohistochemistry  analysis for COX-2. Statistical significant differences (P &lt; 0.05)  were observed in the quality of bone repair and quantity of formed bone  between groups at 14 days after surgery for Groups 3 and 4. COX-2  immunoreactivity was more intense in bone cells for intermediate periods  evaluated in the laser-exposed groups. Taken together, such results  suggest that low-level laser therapy is able to improve bone repair in  the tibia of rats as a result of an up-regulation for cyclooxygenase-2  expression in bone cells.</p>
<p>Photomed Laser Surg. 2008 Aug;26(4):371-7.</p>
<h1>Does the use of laser photobiomodulation, bone morphogenetic  proteins, and guided bone regeneration improve the outcome of autologous  bone grafts? An in vivo study in a rodent model.</h1>
<p>Torres CS, dos Santos JN, Monteiro JS, Amorim PG, Pinheiro AL.</p>
<p>Centro Baiano de Estudos Odontológicos, Especialização em Cirurgia e  Traumatologia Bucomaxilofaciais, Universidade Federal da Bahia,  Salvador, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of the present investigation was to histologically  assess the effect of laser photobiomodulation (LBPM) on the repair of  autologous bone grafts in a rodent model.</p>
<p>BACKGROUND DATA: A major problem in modern dentistry is the recovery  of bone defects caused by trauma, surgical procedures, or pathologies.  Several types of biomaterials have been used to improve the repair of  these defects. These materials are often associated with procedures of  guided bone regeneration (GBR).</p>
<p>MATERIALS AND METHODS: Twenty four animals were divided into four  groups: group I (control); group II (LPBM of the bone graft); group III  (bone morphogenetic proteins [BMPs] + bone graft); and group IV (LPBM of  the bed and the bone graft + BMPs). When appropriate the bed was filled  with lyophilized bovine bone and BMPs used with or without GBR. The  animals in the irradiated groups received 10 J/cm(2) per session divided  over four points around the defect (4 J/cm(2)), with the first  irradiation immediately after surgery, and then repeated seven times  every other day. The animals were humanely killed after 40 d. Results:  The results showed that in all treatment groups, new bone formation was  greater and qualitatively better than the untreated subjects. Control  specimens showed a less advanced repair after 40 d, and this was  characterized by the presence of medullary tissue, a small amount of  bone trabeculi, and some cortical repair.</p>
<p>CONCLUSION: We conclude that LPBM has a positive biomodulatory effect  on the healing of bone defects, and that this effect was more evident  when LPBM was performed on the surgical bed intraoperatively, prior to  the placement of the autologous bone graft.</p>
<p>Lasers Med Sci. 2008 Jul;23(3):313-7. Epub 2007 Sep 20.</p>
<h1>Effect of IR laser photobiomodulation on the repair of bone defects grafted with organic bovine bone.</h1>
<p>Márquez Martínez ME, Pinheiro AL, Ramalho LM.</p>
<p>School of Dentistry, Pernambuco University, Camaragibe, Pernambuco, Brazil.</p>
<h3>Abstract</h3>
<p>A major problem on modern dentistry is the recovery of bone defects  of different etiologies. Biomaterials are used to improve the repair of  these defects. Previous studies have shown positive effects of Laser  Photobiomodulation (LPBM) on the repair of both soft and bone tissues.  This study assessed histologically the effect of LPBM on the repair of  surgical defects on the femur of rats filled with lyophilized bovine  bone. The animals were divided into three groups: group I (control);  group II (graft); group III (graft + LPBM). The animals on the  irradiated groups received 16 J/cm(2) per session divided into four  points around the defect being the first irradiation immediately after  surgery and repeated at every 48 h during 2 weeks. Animal death occurred  15, 21, and 30 days after surgery. The specimens were routinely  processed and stained with H/E and Sirius red and analyzed by light  microscopy. There was histological evidence of improved collagen fiber  deposition at early stages of the healing; increased amount of  well-organized bone trabeculae at the end of the experimental period on  irradiated animals. It is concluded that LPBM has positive biomodulative  effect on the healing process bone defects.</p>
<p>Lasers Med Sci. 2008 Jul;23(3):313-7. Epub 2007 Sep 20.</p>
<h1>Effect of IR photobiomodulation on the repair of bone defects grafted with organic bovine bone.</h1>
<p>Márquez Martínez ME, Pinheiro AL, Ramalho LM.</p>
<p>School of Dentistry, Pernambuco University, Camaragibe, Pernambuco, Brazil.</p>
<p>A major problem on modern dentistry is the recovery of bone defects  of different etiologies. Biomaterials are used to improve the repair of  these defects. Previous studies have shown positive effects of Laser  Photobiomodulation (LPBM) on the repair of both soft and bone tissues.  This study assessed histologically the effect of LPBM on the repair of  surgical defects on the femur of rats filled with lyophilized bovine  bone. The animals were divided into three groups: group I (control);  group II (graft); group III (graft + LPBM). The animals on the  irradiated groups received 16 J/cm(2) per session divided into four  points around the defect being the first irradiation immediately after  surgery and repeated at every 48 h during 2 weeks. Animal death occurred  15, 21, and 30 days after surgery. The specimens were routinely  processed and stained with H/E and Sirius red and analyzed by light  microscopy. There was histological evidence of improved collagen fiber  deposition at early stages of the healing; increased amount of  well-organized bone trabeculae at the end of the experimental period on  irradiated animals. It is concluded that LPBM has positive biomodulative  effect on the healing process bone defects.</p>
<p>Photomed Laser Surg. 2008 Feb;26(1):37-46</p>
<h1>Nd:YAG laser biostimulation in the treatment of  biphosphonate-associated osteonecrosis of the jaw: clinical experience  in 28 cases.</h1>
<p>Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S.</p>
<p>Unit of Oral Pathology and Medicine, Section of Dentistry, Department  of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University  of Parma, Parma, Italy. <a href="mailto:paolo.vescovi@unipr.it">paolo.vescovi@unipr.it</a></p>
<p>OBJECTIVE: To research an efficient treatment for the management of bisphosphonate-associated osteonecrosis.</p>
<p>BACKGROUND DATA: Necrosis of the jawbone has recently been described  in association with systemic bisphosphonate therapy with drugs including  zoledronic acid, pamidronate, and alendronate. The extent and clinical  characteristics of bisphosphonate-associated osteonecrosis (BON) of the  jaw are extremely variable, and range from the presence of fistulae in  the oral mucosa or orofacial tissues, to large exposed areas of necrotic  bone within the oral cavity. Clinical signs and symptoms commonly  reported include pain, swelling, the presence of pus, loose teeth,  ill-fitting dentures, and paresthesias of the inferior alveolar nerve  when the necrosis affects the mandible. Fractures have also been  reported. The treatment of BON of the jaw is still controversial since  no therapy has proven to be efficacious as shown by the literature on  the subject.</p>
<p>MATERIALS AND METHODS: In this study we report results achieved with  28 patients affected by BON of the jaw, who received treatment with the  Nd:YAG laser alone or in combination with conventional medical or  surgical treatment. Clinical variables such as severity of symptoms,  presence of pus, and closure of mucosal flaps before and after therapy  were evaluated to establish the effectiveness of laser irradiation. The  28 patients with BON were subdivided into four groups: eight patients  were treated with medical therapy only (antibiotics with or without  antimycotics and/or antiseptic rinses), six patients were treated with  medical and surgical therapy (necrotic bone removal and bone curettage),  six patients were treated with medical therapy associated with laser  biostimulation, and eight patients were treated with medical therapy  associated with both surgical therapy and laser biostimulation.</p>
<p>RESULTS: Of the 14 patients who underwent laser biostimulation, nine  reported complete clinical success (no pain, symptoms of infection, or  exposed bone or draining fistulas), and three improved their  symptomatology only, with a follow-up of between 4 and 7 mo.</p>
<p>CONCLUSIONS: While the results reported in this study are not  conclusive, they indicate that laser therapy has potential to improve  management of BON.</p>
<p>Lasers Surg Med. 2007 Dec;39(10):788-96.</p>
<h1>Effect of low-level laser therapy on bone repair: histological study in rats.</h1>
<p>Pretel H, Lizarelli RF, Ramalho LT.</p>
<p>Department of Orthodontics and Pediatric Dentistry, School of  Dentistry of Araraquara, São Paulo State University, Rua Humaitá 1680,  Araraquara, SP, Brazil. <a href="mailto:hpretel@hotmail.com">hpretel@hotmail.com</a></p>
<h3>Abstract</h3>
<p>BACKGROUND AND OBJECTIVES: Bone remodeling is characterized as a  cyclic and lengthy process. It is currently accepted that not only this  dynamics is triggered by a biological process, but also biochemical,  electrical, and mechanical stimuli are key factors for the maintenance  of bone tissue. The hypothesis that low-level laser therapy (LLLT) may  favor bone repair has been suggested. The purpose of this study was to  evaluate the bone repair in defects created in rat lower jaws after  stimulation with infrared LLLT directly on the injured tissue.</p>
<p>STUDY DESIGN/MATERIALS AND METHODS: Bone defects were prepared on the  mandibles of 30 Holtzman rats allocated in two groups (n = 15), which  were divided in three evaluation period (15, 45, and 60 days), with five  animals each. control group-no treatment of the defect; laser  group-single laser irradiation with a GaAlAs semiconductor diode laser  device (lambda = 780 nm; P = 35 mW; t = 40 s; Theta = 1.0 mm; D = 178  J/cm(2); E = 1.4 J) directly on the defect area. The rats were  sacrificed at the pre-established periods and the mandibles were removed  and processed for staining with hematoxylin and eosin, Masson’s  Trichrome and picrosirius techniques.</p>
<p>RESULTS: The histological results showed bone formation in both  groups. However, the laser group exhibited an advanced tissue response  compared to the control group, abbreviating the initial inflammatory  reaction and promoting rapid new bone matrix formation at 15 and 45 days  (P&lt;0.05). On the other hand, there were no significant differences  between the groups at 60 days.</p>
<p>CONCLUSION: The use of infrared LLLT directly to the injured tissue  showed a biostimulating effect on bone remodeling by stimulating the  modulation of the initial inflammatory response and anticipating the  resolution to normal conditions at the earlier periods. However, there  were no differences between the groups at 60 days.</p>
<p>Photomed Laser Surg. 2007 Dec;25(6):487-94.</p>
<h1>Effect of lower-level laser therapy on rabbit tibial fracture.</h1>
<p>Liu X, Lyon R, Meier HT, Thometz J, Haworth ST.</p>
<p>Musculoskeletal Functional Assessment Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53201, USA. <a href="mailto:xcliu@mcw.edu">xcliu@mcw.edu</a></p>
<h3>Abstract</h3>
<p>OBJECTIVE: The purpose of the study was to demonstrate the biological  effects of low-level laser therapy (LLLT) on tibial fractures using  radiographic, histological, and bone density examinations.</p>
<p>METHODS: Fourteen New Zealand white rabbits with surgically induced  mid-tibial osteotomies were included in the study. Seven were assigned  to a group receiving LLLT (LLLT-A) and the remaining seven served as a  sham-treated control group (LLLT-C). A low-energy laser apparatus with a  wavelength of 830 nm, and a sham laser (a similar design without laser  diodes) were used for the study. Continuous outflow irradiation with a  total energy density of 40 J/cm(2) and a power level of 200 mW/cm(2) was  directly delivered to the skin for 50 seconds at four points along the  tibial fracture site. Treatment commenced immediately postsurgery and  continued once daily for 4 weeks.</p>
<p>RESULTS: Radiographic findings revealed no statistically significant  fracture callus thickness difference between the LLLT-A and LLLT-C  groups (p &gt; 0.05). However, the fractures in the LLLT-A group showed  less callus thickness than those in LLLT-C group 3 weeks after  treatment. The average tibial volume was 14.5 mL in the LLLT-A group,  and 11.25 mL in the LLLT-C group. The average contralateral normal  tibial volume was 7.1 mL. Microscopic changes at 4 weeks revealed an  average grade of 5.5 and 5.0 for the LLLT-A group and the LLLT-C group,  respectively. The bone mineral density (BMD) as ascertained using a grey  scale (graded from 0 to 256) showed darker coloration in the LLLT-A  group (138) than in the LLLT-C group (125).</p>
<p>CONCLUSION: The study suggests that LLLT may accelerate the process  of fracture repair or cause increases in callus volume and BMD,  especially in the early stages of absorbing the hematoma and bone  remodeling. Further study is necessary to quantify these findings.</p>
<p>Lasers Med Sci. 2007 Oct 31; [Epub ahead of print]</p>
<h1>Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures.</h1>
<p>Haxsen V, Schikora D, Sommer U, Remppis A, Greten J, Kasperk C.</p>
<p>Faculty of Science, Biophotonics Group, University of Paderborn, Paderborn, Germany, <a href="mailto:volker.haxsen@urz.uni-heidelberg.de">volker.haxsen@urz.uni-heidelberg.de</a>.</p>
<p>Induction of matrix synthesis by low-level laser has been  demonstrated extensively. However, the question of dose- or power  intensity-dependency is under-investigated. To address this issue we  chose human osteoblast cell cultures and measured their alkaline  phosphatase (ALP) activity after laser irradiation. The cell cultures  were irradiated periodically by 690 nm radiation via optical  transmission fiber-based laser needles, reaching into the culture  dishes. The osteoblasts showed no induction of ALP activity when we used  a single laser needle stimulation with a laser irradiance of 51  mW/cm(2), an increase of approximately 43% at 102 mW/cm(2) irradiance  (two needles per well) and a ninefold increase at 204 mW/cm(2)  irradiance (four needles per well), leaving the temperature of the  culture medium unaffected. We concluded that the osteoblastic response  in ALP activity to a laser stimulus shows a logarithmic relationship,  with a distinct threshold, rather than a linear dose-dependency.  Secondly, the laser irradiance, rather than the dose, is relevant for  the impact of the laser.</p>
<p>Photomed Laser Surg. 2007 Aug;25(4):275-80.</p>
<h1>The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro.</h1>
<p>Renno AC, McDonnell PA, Parizotto NA, Laakso EL.</p>
<p>Physical Therapy Department, Federal University of Sao Carlos, Sao Carlos, Brazil. <a href="mailto:a.renno@unifesp.br">a.renno@unifesp.br</a></p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to investigate the effects of  670-nm, 780-nm, and 830-nm laser irradiation on cell proliferation of  normal primary osteoblast (MC3T3) and malignant osteosarcoma (MG63) cell  lines in vitro.</p>
<p>BACKGROUND: Some studies have shown that laser phototherapy is able  to stimulate the osteogenesis of bone tissue, increasing osteoblast  proliferation and accelerating fracture consolidation. It has been  suggested that laser light may have a biostimulatory effect on tumor  cells. However, the mechanism by which the laser acts on cells is not  fully understood.</p>
<p>MATERIALS AND METHODS: Neonatal, murine, calvarial, osteoblastic, and  human osteosarcoma cell lines were studied. A single laser irradiation  was performed at three different wavelengths, at the energies of 0.5, 1,  5, and 10 J/cm(2). Twenty-four hours after laser irradiation, cell  proliferation and alkaline phosphatase assays were assessed.</p>
<p>RESULTS: Osteoblast proliferation increased significantly after  830-nm laser irradiation (at 10 J/cm(2)) but decreased after 780-nm  laser irradiation (at 1, 5, and 10 J/cm(2)). Osteosarcoma cell  proliferation increased significantly after 670-nm (at 5 J/cm(2)) and  780-nm laser irradiation (at 1, 5, and 10 J/cm(2)), but not after 830-nm  laser irradiation. Alkaline phosphatase (ALP) activity in the  osteoblast line was increased after 830-nm laser irradiation at 10  J/cm(2), whereas ALP activity in the osteosarcoma line was not altered,  regardless of laser wavelength or intensity.</p>
<p>CONCLUSION: Based on the conditions of this study, we conclude that  each cell line responds differently to specific wavelength and dose  combinations. Further investigations are required to investigate the  physiological mechanisms responsible for the contrasting outcomes  obtained when using laser irradiation on cultured normal and malignant  bone cells.</p>
<p>J Photochem Photobiol B. 2007 Jul 27;88(1):11-5. Epub 2007 May 1.</p>
<h1>The therapeutic effect of low-level laser on repair of osteochondral defects in rabbit knee.</h1>
<p>Kamali F, Bayat M, Torkaman G, Ebrahimi E, Salavati M.</p>
<p>Department of Physical Therapy, University of Social Welfare and Rehabilitation, Tehran, Iran. <a href="mailto:fahimehkamali@hotmail.com">fahimehkamali@hotmail.com</a></p>
<h3>Abstract</h3>
<p>INTRODUCTION: Low level laser therapy (LLLT) has been shown to  enhance collagen production and wound healing but its effect on  cartilage repair from biomechanical point of view is not known yet. The  aim of present study was to evaluate the biomechanical behaviour of  repairing osteochondral defect in rabbits which received a pulsed  low-level gallium-arsenide (Ga-As) laser irradiation.</p>
<p>MATERIALS AND METHODS: Osteochondral defects with 5mm diameter and  4mm in depth induced by drilling in right femoral patellar grooves of 41  adolescent male rabbits. They were divided into experimental and  control groups. Experimental group received pulsed Ga-As (890nm) laser  irradiation with energy density of 4.8J/cm(2). The rabbits in control  group received placebo LLLT with shut-down equipment. The control  defects were allowed to heal spontaneously. Each group were divided into  three subgroups: A, B and C. Subgroups A, B and C were sacrificed on 4,  8, and 16 weeks after surgery. The knee joint were removed, and the  defects were examined biomechanically by in situ-indentation method. The  thickness, instantaneous and equilibrium indentation stiffness was  measured during the test. Data were analysed using ANOVA and independent  sample t-test.</p>
<p>RESULT: While no difference was observed in the repaired cartilage  biomechanical properties among 4th, 8th, 16th weeks in study groups. The  equilibrium indentation stiffness of experimental group was  significantly higher in 8th week in comparison with control group.</p>
<p>CONCLUSION: LLLT significantly enhances the stiffness of repairing  tissue in the 8th week post injury in osteochondral defects in rabbits.</p>
<p>Implant Dent. 2007 Jun;16(2):204-11.</p>
<h1>Histologic comparison of light emitting diode phototherapy-treated  hydroxyapatite-grafted extraction sockets: a same-mouth case study.</h1>
<p>Brawn PR, Kwong-Hing A.</p>
<p>343 Railway Street, Vancouver, British Columbia, Canada. <a href="mailto:brawn_peter@yahoo.ca">brawn_peter@yahoo.ca</a></p>
<h3>Abstract</h3>
<p>BACKGROUND: The stimulating effect of red and near-infrared (NIR)  laser phototherapy on bone regeneration and growth has been shown in a  number of in vitro and animal studies. However, the effect of NIR  phototherapy on the bone regeneration of hydroxyapatite (HA) -treated  extraction sockets has not been previously demonstrated.</p>
<p>MATERIALS AND METHODS: An investigational Biolux extraoral light  emitting diode phototherapy device was used daily for 21 days  postextraction and socket grafting with HA (Osteograf LD300)  unilaterally. Bone regeneration of the phototherapy-treated and  nontreated side was compared in same-mouth extraction sockets.</p>
<p>RESULTS: Histologic evaluations showed enhanced bone formation and  faster particle resorption associated with the phototherapy-treated  socket graft compared with the non-phototherapy-treated socket.</p>
<p>CONCLUSIONS: The accelerated bone healing in the phototherapy-treated  HA socket graft may provide faster implant placement compared to  non-phototherapy-treated socket grafts.</p>
<p>J Oral Maxillofac Surg. 2007 Feb;65(2):168-76.</p>
<h1>Low-level laser effect on mandibular osteogenesis.</h1>
<p>Miloro M, Miller JJ, Stoner JA.</p>
<p>Section of Oral and Maxillofacial Surgery, University of Nebraska Medical Center, Omaha, NE 68198-5180, USA. <a href="mailto:mmiloro@unmc.edu">mmiloro@unmc.edu</a></p>
<p>Abstract</p>
<p>PURPOSE: The purpose of this study was to determine whether low-level  laser (LLL) application during distraction osteogenesis could  accelerate bone regeneration and decrease the length of the  consolidation phase and thereby reduce potential patient morbidity.</p>
<p>MATERIALS AND METHODS: Nine adult female New Zealand white rabbits  underwent bilateral mandibular corticotomies and placement of  unidirectional distraction devices (KLS-Martin LP, Jacksonville, FL).  Each rabbit served as its own internal control. After a latency of 1  day, distraction progressed bilaterally at 1 mm per day for 10 days.  Immediately after each device activation, the experimental side, chosen  randomly, was treated with real LLL (Laser Medical Systems, Hedehusene,  Denmark) of 6.0 J x 6 transmucosal sites in the area of the distraction  gap. Radiographs were taken presurgically, immediately postsurgically,  and weekly until sacrifice, and the bone was analyzed using a  semiquantitative 4-point scale (Bone Healing Score [BHS]). Three animals  each were sacrificed at 2, 4, and 6 weeks postdistraction, and each  hemimandible was prepared for histologic examination in a blinded  fashion.</p>
<p>RESULTS: Ten millimeters of distraction was achieved in each rabbit  bilaterally. Radiographically, the BHS was higher for the LLL-treated  group at all time periods. Histologically, the area of new bone  trabeculation and ossification was more advanced for the LLL-treated  group, with less intervening fibrovascular intermediate zone in the bony  regenerate, at all time periods. The formation of a complete inferior  border occurred sooner in the treatment group than in the controls.</p>
<p>CONCLUSIONS: LLL accelerates the process of bone regeneration during  the consolidation phase after distraction osteogenesis. The adjunctive  use of LLL may allow a shortened period of consolidation and therefore  permit earlier device removal, with the avoidance of morbidity  associated with prolonged device retention.</p>
<p>Minerva Stomatol. 2007 Jan-Feb;56(1-2):27-30.</p>
<h1>Effect of superpulsed laser irradiation on bone formation in a human osteoblast-like cell line.</h1>
<p>[Article in English, Italian]</p>
<p>Martinasso G, Mozzati M, Pol R, Canuto RA, Muzio G.</p>
<p>Department of Medicine and Experimental Oncology, Turin University, Turin, Italy.</p>
<h3>Abstract</h3>
<p>AIM: The effect superpulsed of low-level laser therapy (SLLLT) on  bone regeneration has been the focus of recent research. This  preliminary study investigated the effect of superpulsed laser  irradiation on proliferation and bone formation in human osteoblast-like  cells MG-63.</p>
<p>METHODS: Human osteoblast-like cells MG-63 were exposed every 24 h to  superpulsed low-level laser produced by the device Lumix 2 HFPL Dental  (Fisioline s.n.c., Verduno, Cuneo, Italy); the experimental protocol  comprised 4 days of treatment. At each experimental time, cell  proliferation and some markers of osteoblast activity were evaluated.</p>
<p>RESULTS: Numbers of laser-treated cells increased starting from day 2  of treatment. The ability of SLLLT irradiation to stimulate bone  production was evaluated by determining the expression of osteocalcin  and alkaline phosphatase, proteins involved in calcium nodule formation.  These proteins increased markedly after 3 days of laser treatment.</p>
<p>CONCLUSIONS: These preliminary results show that repeated SLLLT  irradiation stimulates cell proliferation in human osteoblast-like cells  and, importantly, increases the expression of proteins essential for  bone formation.</p>
<p>Photomed Laser Surg. 2006 Oct;24(5):642-5.</p>
<h1>Effects of 830-nm laser light on preventing bone loss after ovariectomy.</h1>
<p>Renno AC, de Moura FM, dos Santos NS, Tirico RP, Bossini PS, Parizotto NA.</p>
<p>Department of Physiotherapy, Federal University of São Carlos, São Carlos, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to investigate the effects of  low-level laser therapy (LLLT; infrared, 830 nm) on the bone properties  and bone strength of rat femora after ovariectomy (OVX).</p>
<p>BACKGROUND DATA: Osteoporosis affects 30% of postmenopausal women,  and it has been recognized as a major public health problem. Based on  the stimulatory effects of LLLT on proliferation of bone cells, we  hypothesized that LLLT would be efficient in preventing bone mass loss  in OVX rats. Methods: Forty female rats were divided into four groups:  sham-operated control (SC), OVX control (OC), sham-operated irradiated  at a dose of 120 J/cm(2) (I120), and OVX irradiated at a dose of 120  J/cm(2) (O120). Animals were operated at the age of 90 days. Laser  irradiation was initiated 1 day after the operation and was performed  three times a week, for 2 months. Femora were submitted to a  biomechanical test and a physical properties evaluation.</p>
<p>RESULTS: Maximal load of O120 was higher than in control groups. Wet  weight, dry weight, and bone volume of O120 did not show any difference  when compared with SC.</p>
<p>CONCLUSION: The results of the present study indicate that LLLT was  able to prevent bone loss after OVX in rats. However, further studies  are needed to investigate the effects of different parameters,  wavelengths, and sessions of applications on OVX rats</p>
<p>J Oral Rehabil. 2006 Aug;33(8):619-924.</p>
<h1>Effect of low intensity laser irradiation on surgically created bony defects in rats.</h1>
<p>Nissan J, Assif D, Gross MD, Yaffe A, Binderman I.</p>
<p>Department of Oral Rehabilitation, The Maurice and Gabriela  Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv,  Israel. <a href="mailto:nissandr@post.tau.ac.il">nissandr@post.tau.ac.il</a></p>
<h3>Abstract</h3>
<p>Low intensity lasers have been used by clinicians to improve healing  and reduce pain in humans. Lasing also results in new bone formation  around hydroxyapatite implants and a significant increase in the total  bone area. However, the exact mechanism of cell biostimulation by laser  is still unclear. This study biochemically assessed the effects of low  intensity laser (Gallium-Arsenide) using 4 and 22.4 mW cm(-2) power  density on the bone healing process after surgically creating bony  cavities in rat mandibles. Rats (n = 24) were divided into two groups  each treated with specific energy, 4 or 22.4 mW cm(-2), for 3 min each  day post-surgery. Surgical cavities were created on both sides of the  mandible: the left served as an untreated control, the right was treated  with laser. All rats were sacrificed after 1, 2 and 4 weeks of  treatment. In the newly formed callus, accumulation of radiocalcium and  alkaline phosphatase activity was measured to indicate osteogenic  activity. One-way anova with repeated measures showed that the low  intensity laser using 4 mW cm(-2) power density significantly increased  radiocalcium accumulation from 2 weeks post-surgery, whereas 22.4 mW  cm(-2) had no effect. No changes were noted in the activity of alkaline  phosphatase with the laser treatment. These results suggest that laser  therapy of low power density is effective on the bone healing process in  artificially created osseous cavities by affecting calcium transport  during new bone formation.</p>
<p>Acta Biomed. 2006 Aug;77(2):109-17.</p>
<h1>Bone necrosis of the jaws associated with biphosphonate treatment: a report of twenty-nine cases.</h1>
<p>Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E,  D’Aleo P, Corradi D, Corcione L, Sesenna E, Ferrari S, Poli T,  Bonaninil M, Vescovi P.</p>
<p>Unit of Oral Pathology and Medicine, Section of Odontostomatology,  Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences,  University of Parma, Parma, Italy. <a href="mailto:elisabetta.merigo@unipr.it">elisabetta.merigo@unipr.it</a></p>
<p>Bone necrosis of the jaws is often related to head and neck  radiotherapy, to surgical procedures at maxillary or mandibular level  but also to various local and systemic factors such as haematological  diseases, haemoglobinopathies and systemic lupus eritematosus; its  pathogenesis maybe associated with defects of vascularization.  Bisphosphonate are synthetic analogues of pyrophosphate used for the  treatment of hypercalcemia in patients with malignancies and bone  metastasis and for the treatment of many other disorders such as  metabolic bone diseases, Paget’s disease, and osteoporosis; their  pharmacological activity is related to the inhibition of the  osteoclastic function which leads to resorption and reduction of bone  vascularization. Since the end of 2003 Bisphosphonate-associated  Osteonecrosis (BON) has become an increasing problem and the test of  that is the increase of the relative published case report and case  series. Here we report 29 cases of bone necrosis of the jaws in patients  treated with pamidronate (Aredia), zoledronate (Zometa) and  alendronate: 15 underwent surgical procedures and 14 occurred  spontaneously. Among these patients (21 females, 8 males; mean age  between 45 and 83 years); 14 were treated for bone metastasis, 12 for  multiple myeloma and 3 for osteoporosis. Bone necrosis involved only  maxilla in 7 patients, only mandible in 20 patients and both in 2  patients. Six patients had multiple osteonecrotic lesions, 3  contemporary lesions and 3 non contemporary. In these patients we  performed 3 kinds of therapy, associated or not: medical therapy (with  antibiotic drugs, antimycotics and antiseptic mouthwashes), surgical  therapy with curettage or sequestrectomy and Nd:YAG laser  biostimulation.</p>
<p>Acta Cir Bras. 2006;21 Suppl 4:63-8.</p>
<h1>Effect of 650 nm low-power laser on bone morphogenetic protein in bone defects induced in rat femors.</h1>
<p>Carvalho Pde T, Silva IS, Reis FA, Belchior AC, Facco GG, Guimarães RN, Fernandes GH, Denadai AS.</p>
<p>Department of Physiotherapy, UNIDERP, Brazil.<a href="mailto:ptpaulo@terra.com.br">ptpaulo@terra.com.br</a></p>
<h3>Abstract</h3>
<p>PURPOSE: To investigate the influence of 650 nm GaAlAs laser on the  action of bone morphogenetic protein (BMP) in bone defects produced in  rat femurs.</p>
<p>METHODS: The sample consisted of 12 male albino Wistar rats (Rattus  norvegicus). The animals were randomly divided into four experimental  groups. After undergoing anesthesia, the fur was removed from the  lateral face of the right thigh and surgical dissection was performed to  view the femur region. A bone defect was created using a spherical  diamond-tipped drill bit. In groups 1 and 2, the defect was filled with a  paste of Gen-Tech bone-inducing substance. The animals were treated  with GaAlAs laser, at a predetermined dose of joules/cm(2) for 80  seconds, over an area of 1 cm(2). Groups 2 and 4 were used as controls.  Bone samples were removed to perform histological procedures and  morphometric analyses on the 7th, 14th and 21st days after the  operation. The results obtained were subjected to statistical analysis  using ANOVA variance according to two criteria, with four repetitions,  followed by the post hoc t test. The rejection level for the nullity  hypothesis was 0.05 or 5% (alpha &lt; or = 0.05).</p>
<p>RESULTS: In comparisons between G1, G2, G3 and G4, p = 0.024 was  observed. In statistical comparisons using the t test for paired  samples, only G1 vs. G4 presented a statistically significant result (p =  0.021).</p>
<p>CONCLUSION: The association of low-power laser application and  Gen-Tech bone-inducing substance achieved a better result than laser  application alone or BMP use alone.</p>
<p>Photomed Laser Surg. 2005 Aug;23(4):382-8</p>
<h1>Assessment of bone repair associated with the use of organic bovine bone and membrane irradiated at 830 nm.</h1>
<p>Gerbi ME, Pinheiro AL, Marzola C, Limeira Júnior Fde A, Ramalho LM, Ponzi EA, Soares AO, Carvalho LC, Lima HV, Gonçalves TO.</p>
<p>School of Dentistry, Federal University of Bahia, Salvador, Brazil.</p>
<p>OBJECTIVE: The aim of the present investigation was to assess  histologically the effect of LLLT (GaAIAs, 830 nm, 40 mW, CW, (Phi)  approximately 0.6 mm, 16 J/cm(2) per session) on the repair of surgical  defects created in the femur of the Wistar Albinus rat. The defects were  filled to lyophilized bovine bone (Gen-ox), organic matrix) associated  or not to GTR (Gen-derm).</p>
<p>BACKGROUND DATA: A major problem on modern Dentistry is the recovery  of bone defects caused by trauma, surgical procedures or pathologies.  Several types of biomaterials have been used in order to improve the  repair of these defects. These materials are often associated to  procedures of GTR. Previous studies have shown positive effects of LLLT  on the repair of soft tissue wounds, but there are a few on its effects  on bone healing.</p>
<p>METHODS: Surgical bone defects were created in 42 animals divided  into five groups: Group I (control, 6 animals); Group II (Gen-ox, 9  animals); Group III (Gen-ox + Laser, 9 animals); Group IV (Gen-ox +  Gen-derm, 9 animals); Group V (Gen-ox + Gen-derm + Laser, 9 animals).  The animals on the irradiated group received 16 J/cm(2) per session  divided into four points around the defect (4 J/cm(2)) being the first  irradiation immediately after surgery and repeated seven times at every  48 h. The animals were humanly killed after 15, 21, and 30 days.</p>
<p>RESULTS: The results of the present investigation showed histological  evidence of improved amount of collagen fibers at early stages of the  bone healing (15 days) and increased amount of well organized bone  trabeculae at the end of the experimental period (30 days) on irradiated  animals compared to non irradiated ones.</p>
<p>CONCLUSIONS: It is concluded that a positive biomodulative effect on  the healing process of one defect associated or not to the use of  organic lyophilized bone and biological bovine lyophilized membrane on  the femur of the rat.</p>
<p>Photomed Laser Surg. 2008 Aug;26(4):401-4</p>
<h1>Evaluation of low-level laser therapy of osteoblastic cells.</h1>
<p>Pires Oliveira DA, de Oliveira RF, Zangaro RA, Soares CP.</p>
<p>Laboratório de Dinâmica de Compartimentos Celulares, Instituto de  Pesquisa e Desenvolvimento (UNIVAP), São José dos Campos, São Paulo,  Brazil.</p>
<p>Abstract Objective: The purpose of the present study was to evaluate  the effect of biomodulation on osteoblastic cells using a  gallium-aluminium-arsenide diode laser. Background Data: Low-level laser  therapy (LLLT) is a non-pharmacological therapeutic resource to which  biological tissues respond well, producing such effects as the  acceleration of bone formation and bone repair.</p>
<p>Materials and Methods: Osteoblastic cell cultures (OFCOL II) were  irradiated with a gallium-aluminium-arsenide diode laser (GaAlAs lambda =  830 nm; 50 mW; 3 J/cm(2); 600-mum-diameter optical fiber) and divided  into two groups: group 1-irradiated cells, and group 2-non-irradiated  cells. Irradiation occurred at 24-h intervals for a total of 3 d. After  each interval, the cells were marked with Mito Tracker Orange dye to  assess the biostimulatory effect on mitochondrial activity and cell  proliferation using an MTT assay.</p>
<p>Results: Intense grouping of mitochondria in the perinuclear region  was observed at 24 h and 48 h following irradiation. Changes from a  filamentous to a granular appearance in mitochondrial morphology and  mitochondria distributed throughout the cytoplasm were observed 72 h  following proliferation. Such changes led to an in vitro proliferation  process, as confirmed by the MTT assay.</p>
<p>Conclusion: LLLT has shown itself capable of altering mitochondrial activity and the population of OFCOL II cells.</p>
<p>Wien Klin Wochenschr. 2008 Feb;120(3-4):112-117</p>
<h1>Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells.</h1>
<p>Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D, Baghestanian M, Turhani D.</p>
<p>Department of Cranio-Maxillofacial and Oral Surgery, Medical University of Vienna, Austria.</p>
<p>Low-level laser therapy is a clinically well established tool for  enhancement of wound healing. In vitro studies have also shown that low  level laser therapy has a biostimulatory effect on cells of different  origin. The aim of this in vitro study was to investigate the initial  effect of low-level laser therapy on growth and differentiation of human  osteoblast-like cells. SaOS-2 cells were irradiated with laser doses of  1 J/cm(2) and 2 J/cm(2) using a diode laser with 670 nm wave length and  an output power of 400 mW. Untreated cells were used as controls. At 24  h, 48 h and 72 h post irradiation, cells were collected and assayed for  viability of attached cells and alkaline phosphatase specific activity.  In addition, mRNA expression levels of osteopontin and collagen type I  were assessed using semi-quantitative RT-PCR. Over the observation  period, cell viability, alkaline phosphatase activity and the expression  of osteopontin and collagen type I mRNA were slightly enhanced in cells  irradiated with 1 J/cm(2) compared with untreated control cells.  Increasing the laser dose to 2 J/cm(2) reduced cell viability during the  first 48 h and resulted in persistently lower alkaline phosphatase  activity compared with the other two groups. The expression of  osteopontin and collagen type I mRNA slightly decreased with time in  untreated controls and cells irradiated with 1 J/cm(2), but their  expression was increased by treatment with 2 J/cm(2) after 72 h. These  results indicate that low-level laser therapy has a biostimulatory  effect on human osteoblast-like cells during the first 72 h after  irradiation. Further studies are needed to determine the potential of  low-level laser therapy as new treatment concept in bone regeneration.</p>
<p>Lasers Med Sci. 2008 Feb 29 [Epub ahead of print]</p>
<h1>Low-level laser therapy modulates cyclo-oxygenase-2 expression during bone repair in rats.</h1>
<p>Matsumoto MA, Ferino RV, Monteleone GF, Ribeiro DA.</p>
<p>Department of Oral Maxillofacial Surgery, School of Dentistry, University of the Sacred Heart (USC), Bauru, SP, Brazil.</p>
<p>The goal of this study was to analyze the role of cyclo-oxygenase-2  following bone repair in rats submitted to low-level laser therapy. A  total of 48 rats underwent surgery to inflict bone defects in their  tibias having been randomly distributed into two groups: negative  control and laser exposed group, i.e., the animals were treated with  low-level laser therapy by means of gallium arsenide laser at 16  J/cm(2). The animals were killed after 48 h, 7 days, 14 days, or 21  days. The tibias were removed for morphological, morphometric, and  immunohistochemistry analysis for cyclo-oxygenase-2. Statistical  significant differences (P &lt; 0.05) were observed in the quality of  bone repair and quantity of formed bone between groups 14 days after  surgery in the laser exposed group. In the same way, cyclo-oxygenase-2  immunoreactivity was more intense in bone cells for intermediate periods  evaluated in this group. Taken together, such results suggest that  low-level laser therapy is able to improve bone repair in the tibia of  rats after 14 days of surgery as a result of an up-regulation for  cyclo-oxygenase-2 expression in bone cells.</p>
<p>Photomed Laser Surg. 2007 Dec;25(6):487-94</p>
<h1>Effect of lower-level laser therapy on rabbit tibial fracture.</h1>
<p>Liu X, Lyon R, Meier HT, Thometz J, Haworth ST.</p>
<p>Musculoskeletal Functional Assessment Center, Medical College of Wisconsin, Milwaukee, Wisconsin.</p>
<p>Objective: The purpose of the study was to demonstrate the biological  effects of low-level laser therapy (LLLT) on tibial fractures using  radiographic, histological, and bone density examinations.</p>
<p>Methods: Fourteen New Zealand white rabbits with surgically induced  mid-tibial osteotomies were included in the study. Seven were assigned  to a group receiving LLLT (LLLT-A) and the remaining seven served as a  sham-treated control group (LLLT-C). A low-energy laser apparatus with a  wavelength of 830 nm, and a sham laser (a similar design without laser  diodes) were used for the study. Continuous outflow irradiation with a  total energy density of 40 J/cm(2) and a power level of 200 mW/cm(2) was  directly delivered to the skin for 50 seconds at four points along the  tibial fracture site. Treatment commenced immediately postsurgery and  continued once daily for 4 weeks.</p>
<p>Results: Radiographic findings revealed no statistically significant  fracture callus thickness difference between the LLLT-A and LLLT-C  groups (p &gt; 0.05). However, the fractures in the LLLT-A group showed  less callus thickness than those in LLLT-C group 3 weeks after  treatment. The average tibial volume was 14.5 mL in the LLLT-A group,  and 11.25 mL in the LLLT-C group. The average contralateral normal  tibial volume was 7.1 mL. Microscopic changes at 4 weeks revealed an  average grade of 5.5 and 5.0 for the LLLT-A group and the LLLT-C group,  respectively. The bone mineral density (BMD) as ascertained using a grey  scale (graded from 0 to 256) showed darker coloration in the LLLT-A  group (138) than in the LLLT-C group (125).</p>
<p>Conclusion: The study suggests that LLLT may accelerate the process  of fracture repair or cause increases in callus volume and BMD,  especially in the early stages of absorbing the hematoma and bone  remodeling. Further study is necessary to quantify these findings.</p>
<p>Photomed Laser Surg. 2007 Aug;25(4):275-80.</p>
<h1>The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro.</h1>
<p>Renno AC, McDonnell PA, Parizotto NA, Laakso EL.</p>
<p>Physical Therapy Department, Federal University of Sao Carlos, Sao Carlos, Brazil. <a href="mailto:a.renno@unifesp.br">a.renno@unifesp.br</a></p>
<p>OBJECTIVE: The aim of this study was to investigate the effects of  670-nm, 780-nm, and 830-nm laser irradiation on cell proliferation of  normal primary osteoblast (MC3T3) and malignant osteosarcoma (MG63) cell  lines in vitro.</p>
<p>BACKGROUND: Some studies have shown that laser phototherapy is able  to stimulate the osteogenesis of bone tissue, increasing osteoblast  proliferation and accelerating fracture consolidation. It has been  suggested that laser light may have a biostimulatory effect on tumor  cells. However, the mechanism by which the laser acts on cells is not  fully understood.</p>
<p>MATERIALS AND METHODS: Neonatal, murine, calvarial, osteoblastic, and  human osteosarcoma cell lines were studied. A single laser irradiation  was performed at three different wavelengths, at the energies of 0.5, 1,  5, and 10 J/cm(2). Twenty-four hours after laser irradiation, cell  proliferation and alkaline phosphatase assays were assessed.</p>
<p>RESULTS: Osteoblast proliferation increased significantly after  830-nm laser irradiation (at 10 J/cm(2)) but decreased after 780-nm  laser irradiation (at 1, 5, and 10 J/cm(2)). Osteosarcoma cell  proliferation increased significantly after 670-nm (at 5 J/cm(2)) and  780-nm laser irradiation (at 1, 5, and 10 J/cm(2)), but not after 830-nm  laser irradiation. Alkaline phosphatase (ALP) activity in the  osteoblast line was increased after 830-nm laser irradiation at 10  J/cm(2), whereas ALP activity in the osteosarcoma line was not altered,  regardless of laser wavelength or intensity.</p>
<p>CONCLUSION: Based on the conditions of this study, we conclude that  each cell line responds differently to specific wavelength and dose  combinations. Further investigations are required to investigate the  physiological mechanisms responsible for the contrasting outcomes  obtained when using laser irradiation on cultured normal and malignant  bone cells.</p>
<p>Lasers Surg Med. 2007 Jul;39(6):551-9.</p>
<h1>Low-intensity laser irradiation stimulates bone nodule formation via  insulin-like growth factor-I expression in rat calvarial cells.</h1>
<p>Shimizu N, Mayahara K, Kiyosaki T, Yamaguchi A, Ozawa Y, Abiko Y.</p>
<p>Department of Orthodontics, Nihon University School of Dentistry, 1-8-13 Kanda, Surugadai, Chiyoda-Ku, Tokyo101-8310, Japan. <a href="mailto:shimizu-n@dent.nihon-u.ac.jp">shimizu-n@dent.nihon-u.ac.jp</a></p>
<h3>Abstract</h3>
<p>BACKGROUND AND OBJECTIVE: We previously reported that low-intensity  laser irradiation stimulated bone nodule formation through enhanced  cellular proliferation and differentiation. However, the mechanisms of  irradiation are unclear. Thus, we attempted to determine the  responsibility of insulin-like growth factor (IGF)-I for the action  observed.</p>
<p>STUDY DESIGN/MATERIALS AND METHODS: Osteoblast-like cells were  isolated from fetal rat calvariae and cultured with rat recombinant (r)  IGF-I, IGF-I-antibody (Ab), and/or the cells were irradiated once (3.75  J/cm(2)) with a low-intensity Ga-Al-As laser (830 nm). The number and  area of bone nodules formed in the culture were analyzed, and IGF-I  expression was also examined.</p>
<p>RESULTS: Treatment with rIGF-I significantly stimulated the number  and area of bone nodules. This stimulatory effect was quite similar to  those by laser irradiation, and this stimulation was abrogated  dose-dependently by treatment with IGF-I-Ab. Moreover, laser irradiation  significantly increased IGF-I protein and gene expression.</p>
<p>CONCLUSION: The stimulatory effect of bone nodule formation by  low-intensity laser irradiation will be at least partly mediated by  IGF-I expression.</p>
<p>Photomed Laser Surg. 2006 Dec;24(6):735-40.</p>
<h1>Comparative study of how low-level laser therapy and low-intensity pulsed ultrasound affect bone repair in rats.</h1>
<p>Lirani-Galvao AP, Jorgetti V, Da Silva OL.</p>
<p>Bioengineering Department, University of Sao Paulo, Sao Paulo, Brazil.</p>
<p>Objective: This study aimed to compare the consequences of low-level  laser therapy (LLLT) and low-intensity pulsed ultrasound (LIPUS) on bone  repair.</p>
<p>Background Data: Many studies have assessed the effects of LLLT and LIPUS on bone repair, but a comparison of them is rare.</p>
<p>Methods: Male Wistar rats (n = 48) with tibial bone osteotomy were  used. One group had the osteotomized limb treated with LLLT (GaAlAs  laser, 780 nm, 30 mW, 112.5 J/cm(2)) and the second group with LIPUS  (1.5 MHz, 30 mW/cm(2)), both for 12 sessions (five times per week); a  third group was the control. After 20 days, rats were sacrificed and had  their tibias submitted to a bending test or histomorphometric analysis.</p>
<p>Results: In the bending test, maximum load at failure of LLLT group  was significantly higher (p &lt; 0.05). Bone histomorphometry revealed a  significant increase in osteoblast number and surface, and osteoid  volume in the LLLT group, and a significant increase in eroded and  osteoclast surfaces in the LIPUS group.</p>
<p>Conclusion: LIPUS enhanced bone repair by promoting bone resorption  in the osteotomy area, while LLLT accelerated this process through bone  formation.</p>
<p>Photomed Laser Surg. 2006 Oct;24(5):642-5</p>
<h1>Effects of 830-nm Laser Light on Preventing Bone Loss after Ovariectomy.</h1>
<p>Renno AC, Moura FM, Santos NS, Tirico RP, Bossini PS, Parizotto NA.</p>
<p>Department of Physiotherapy, Federal University of Sao Carlos, Sao Carlos, Brazil.</p>
<p>Objective: The aim of this study was to investigate the effects of  low-level laser therapy (LLLT; infrared, 830 nm) on the bone properties  and bone strength of rat femora after ovariectomy (OVX).</p>
<p>Background Data: Osteoporosis affects 30% of postmenopausal women,  and it has been recognized as a major public health problem. Based on  the stimulatory effects of LLLT on proliferation of bone cells, we  hypothesized that LLLT would be efficient in preventing bone mass loss  in OVX rats.</p>
<p>Methods: Forty female rats were divided into four groups:  sham-operated control (SC), OVX control (OC), sham-operated irradiated  at a dose of 120 J/cm(2) (I120), and OVX irradiated at a dose of 120  J/cm(2) (O120). Animals were operated at the age of 90 days. Laser  irradiation was initiated 1 day after the operation and was performed  three times a week, for 2 months. Femora were submitted to a  biomechanical test and a physical properties evaluation.</p>
<p>Results: Maximal load of O120 was higher than in control groups. Wet  weight, dry weight, and bone volume of O120 did not show any difference  when compared with SC.</p>
<p>Conclusion: The results of the present study indicate that LLLT was  able to prevent bone loss after OVX in rats. However, further studies  are needed to investigate the effects of different parameters,  wavelengths, and sessions of applications on OVX rats.</p>
<p>J Craniofac Surg. 2006 Mar;17(2):297-301.</p>
<h1>Repair of bone defects treated with autogenous bone graft and low-power laser.</h1>
<p>da Silva RV, Camilli JA.</p>
<p>Department of Anatomy, Institute of Biology, State University of Campinas, UNICAMP, São Paulo, Brazil.</p>
<h3>Abstract</h3>
<p>Because bone healing at the graft site is similar to a fracture  repair, the purpose of the present study was to evaluate the effects of  low-power laser irradiation on the repair of rat skull defects treated  with autogenous bone graft. A defect measuring 3 mm in diameter was  produced in the left parietal bone and filled with an autogenous bone  graft obtained from the right parietal bone. The animals were divided  into 3 groups of 20 rats each: nonirradiated control, irradiated with  5.1 J/cm, and irradiated with 10.2 J/cm. The laser (2.4 mW, 735 nm, 3.4 x  10 W/cm, 3-mm spot size) was applied three times per week for 4 weeks.  Greater volume of newly formed bone was observed in the irradiated group  with 10.2 J/cm. In both irradiated groups, a greater volume of newly  formed bone occurred only in the first 2 weeks. The results demonstrated  that laser irradiation at the grafted site stimulated osteogenesis  during the initial stages of the healing process in a skull defect of  the rat and that this effect was dose dependent.</p>
<p>Photomed Laser Surg. 2006 Feb;24(1):38-44.</p>
<h1>Laser therapy improves healing of bone defects submitted to autologous bone graft.</h1>
<p>Weber JB, Pinheiro AL, de Oliveira MG, Oliveira FA, Ramalho LM.</p>
<p>School of Dentistry, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.</p>
<p>OBJECTIVE: The aim of the present study was to assess histologically  the effect of low-level laser thrapy (LLLT) (lambda 830 nm) on the  healing of bone defects associated with autologous bone graft.</p>
<p>BACKGROUND DATA: LLLT has been used on the modulation of bone healing  because of the photo-physical and photochemical properties of some  wavelengths. The use of correct and appropriate parameters has been  shown to be effective in the promotion of a positive biomodulative  effect on the healing bone.</p>
<p>METHODS: Sixty male Wistar rats were divided into four groups: G1  (control), G2 (LLLT on the surgical bed), G3 (LLLT on the graft), and G4  (LLLT on both the graft and the surgical bed). The dose per session was  10 J/cm(2), and it was applied to the surgical bed (G2/G4) and on the  bone graft (G3/G4). LLLT was carried out every other day for 15 days  (lambda 830 nm, phi = 0.5 cm(2), 50 Mw, 10 J/cm(2)). The dose was  fractioned in four points. The animals were sacrificed 15, 21, and 30  days after surgery; specimens were taken and routinely processed (wax,  cut, and stain with H&amp;E and Sirius red stains). Light microscopic  analysis was performed by a pathologist.</p>
<p>RESULTS: In the groups in which the LLLT was used trans-operatively  on the surgical bed (G2/G4), bone remodeling was both quantitatively and  qualitatively more evident when compared to subjects of groups G1 and  G3.</p>
<p>CONCLUSION: The present study indicates that the use of LLLT  trans-operatively resulted in a positive biomodulative effect on the  healing of bone defects associated with autologous bone grafts.</p>
<p>Photomed Laser Surg. 2006 Apr;24(2):169-78</p>
<h1>Photoengineering of bone repair processes.</h1>
<p>Pinheiro AL, Gerbi ME.</p>
<p>Laser Center, School of Dentistry, Department of Propedêutica and  Clínica Integrada, Universidade Federal da Bahia, Canela Salvador, BA,  Salvador, Brazil. <a href="mailto:albp@ufba.br">albp@ufba.br</a></p>
<p>OBJECTIVE: This paper aims to report the state of the art with respect to photoengineering of bone repair using laser therapy.</p>
<p>BACKGROUND DATA: Laser therapy has been reported as an important tool  to positively stimulate bone both in vivo and in vitro. These results  indicate that photophysical and photochemical properties of some  wavelengths are primarily responsible for the tissue responses. The use  of correct and appropriate parameters has been shown to be effective in  the promotion of a positive biomodulative effect in healing bone.</p>
<p>METHODS: A series of papers reporting the effects of laser therapy on  bone cells and tissue are presented, and new and promising protocols  developed by our group are presented.</p>
<p>RESULTS: The results of our studies and others indicate that bone  irradiated mostly with infrared (IR) wavelengths shows increased  osteoblastic proliferation, collagen deposition, and bone neorformation  when compared to nonirradiated bone. Further, the effect of laser  therapy is more effective if the treatment is carried out at early  stages when high cellular proliferation occurs. Vascular responses to  laser therapy were also suggested as one of the possible mechanisms  responsible for the positive clinical results observed following laser  therapy. It still remains uncertain if bone stimulation by laser light  is a general effect or if the isolate stimulation of osteoblasts is  possible.</p>
<p>CONCLUSION: It is possible that the laser therapy effect on bone  regeneration depends not only on the total dose of irradiation, but also  on the irradiation time and the irradiation mode. The threshold  parameter energy density and intensity are biologically independent of  one another. This independence accounts for the success and the failure  of laser therapy achieved at low-energy density levels.</p>
<p>Lasers Med Sci. 2005 Dec;20(3-4):138-46. Epub 2005 Nov 16.</p>
<h1>Low level laser irradiation stimulates osteogenic phenotype of mesenchymal stem cells seeded on a three-dimensional biomatrix.</h1>
<p>Abramovitch-Gottlib L, Gross T, Naveh D, Geresh S, Rosenwaks S, Bar I, Vago R.</p>
<p>Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel. <a href="mailto:liata@bgu.ac.il">liata@bgu.ac.il</a></p>
<h3>Abstract</h3>
<p>Mesenchymal stem cells (MSCs) seeded on three-dimensional (3D)  coralline (Porites lutea) biomatrices were irradiated with low-level  laser irradiation (LLLI). The consequent phenotype modulation and  development of MSCs towards ossified tissue was studied in this combined  3D biomatrix/LLLI system and in a control group, which was similarly  grown, but was not treated by LLLI. The irradiated and non irradiated  MSC were tested at 1-7, 10, 14, 21, 28 days of culturing via analysis of  cellular distribution on matrices (trypan blue), calcium incorporation  to newly formed tissue (alizarin red), bone nodule formation (von  Kossa), fat aggregates formation (oil red O), alkaline phosphatase (ALP)  activity, scanning electron microscopy (SEM) and electron dispersive  spectrometry (EDS). The results obtained from the irradiated samples  showed enhanced tissue formation, appearance of phosphorous peaks and  calcium and phosphate incorporation to newly formed tissue. Moreover, in  irradiated samples ALP activity was significantly enhanced in early  stages and notably reduced in late stages of culturing. These findings  of cell and tissue parameters up to 28 days of culture revealed higher  ossification levels in irradiated samples compared with the control  group. We suggest that both the surface properties of the 3D crystalline  biomatrices and the LLLI have biostimulatory effects on the conversion  of MSCs into bone-forming cells and on the induction of ex-vivo  ossification.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Arq Bras Endocrinol Metabol. 2005 Dec;49(6):891-6. Epub 2006 Mar 16.</td>
<td></td>
</tr>
</tbody>
</table>
<h1>Evidences of physical agents action on bone metabolism and their potential clinical use.</h1>
<p>[Article in Portuguese]</p>
<p>Lirani AP, Lazaretti-Castro M.</p>
<p>Departamento de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP. <a href="mailto:analirani@fcr.epm.br">analirani@fcr.epm.br</a></p>
<p>The action of physical agents such as low level laser therapy,  low-intensity pulsed ultrasound and electrical and electromagnetic  fields on bone have been often studied, showing that they are able to  promote osteogenesis, accelerate fracture consolidation and augment bone  mass. The use of these therapeutic modalities was first based on the  finding that bone is a piezoelectric material, that means it can  generate polarization when deformed, transforming mechanical energy into  electric energy, and this has widen therapeutic possibilities to bony  tissue. The present work aims to present evidences of physiologic  effects and mechanisms of action of these physical agents on bone  metabolism, based on articles published in international scientific  literature.</p>
<p>Photomed Laser Surg. 2005 Aug;23(4):382-8.</p>
<h1>Assessment of bone repair associated with the use of organic bovine bone and membrane irradiated at 830 nm.</h1>
<p>Gerbi ME, Pinheiro AL, Marzola C, Limeira Júnior Fde A, Ramalho LM, Ponzi EA, Soares AO, Carvalho LC, Lima HV, Gonçalves TO.</p>
<p>School of Dentistry, Federal University of Bahia, Salvador, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of the present investigation was to assess  histologically the effect of LLLT (GaAIAs, 830 nm, 40 mW, CW, (Phi)  approximately 0.6 mm, 16 J/cm(2) per session) on the repair of surgical  defects created in the femur of the Wistar Albinus rat. The defects were  filled to lyophilized bovine bone (Gen-ox), organic matrix) associated  or not to GTR (Gen-derm).</p>
<p>BACKGROUND DATA: A major problem on modern Dentistry is the recovery  of bone defects caused by trauma, surgical procedures or pathologies.  Several types of biomaterials have been used in order to improve the  repair of these defects. These materials are often associated to  procedures of GTR. Previous studies have shown positive effects of LLLT  on the repair of soft tissue wounds, but there are a few on its effects  on bone healing.</p>
<p>METHODS: Surgical bone defects were created in 42 animals divided  into five groups: Group I (control, 6 animals); Group II (Gen-ox, 9  animals); Group III (Gen-ox + Laser, 9 animals); Group IV (Gen-ox +  Gen-derm, 9 animals); Group V (Gen-ox + Gen-derm + Laser, 9 animals).  The animals on the irradiated group received 16 J/cm(2) per session  divided into four points around the defect (4 J/cm(2)) being the first  irradiation immediately after surgery and repeated seven times at every  48 h. The animals were humanly killed after 15, 21, and 30 days.</p>
<p>RESULTS: The results of the present investigation showed histological  evidence of improved amount of collagen fibers at early stages of the  bone healing (15 days) and increased amount of well organized bone  trabeculae at the end of the experimental period (30 days) on irradiated  animals compared to non irradiated ones.</p>
<p>CONCLUSIONS: It is concluded that a positive biomodulative effect on  the healing process of one defect associated or not to the use of  organic lyophilized bone and biological bovine lyophilized membrane on  the femur of the rat.</p>
<p>Photomed Laser Surg. 2005 Apr;23(2):212-5.</p>
<h1>Effect of low-intensity laser irradiation on the process of bone repair.</h1>
<p>Merli LA, Santos MT, Genovese WJ, Faloppa F.</p>
<p>School of Dentistry, Uníversidade Cruzeiro Do Sul, São Paulo, Brazil. <a href="mailto:luizmerli@uol.com.br">luizmerli@uol.com.br</a></p>
<h3>Abstract</h3>
<p>The effect of low-intensity laser (GaAsAl) irradiation on bone repair  in the femurs of mice was investigated. An experimental model of hole  injury with surgery drills was used in 20 mouse femurs followed by a  study of the effect of low-energy laser irradiation on bone repair. The  experimental model was divided into two groups. The first (10 left  femurs) received laser irradiation immediately after injury and was  followed for different time intervals (24, 48, and 72 h). The right  femurs (control group) underwent hole injury but no laser irradiation.  The rats were sacrificed after 14 days and the results were analyzed  using a quantitative histometrical method. The Mann-Whitney test was  used to perform the statistical analysis. Histometrical analysis  revealed a more rapid accumulation of reparative new bone in the hole  injury of the laser-irradiated legs. We conclude that GaAsAl laser  irradiation after injury was effective on bone repair when compared to  results in the control group.</p>
<p>Photomed Laser Surg. 2005 Apr;23(2):161-6.</p>
<h1>Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro.</h1>
<p>Stein A, Benayahu D, Maltz L, Oron U.</p>
<p>Department of Zoology, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel.</p>
<h3>Abstract</h3>
<p>OBJECTIVES: The aim of the present study was to investigate the  effect of low-level laser irradiation on proliferation and  differentiation of a human osteoblast cell line.</p>
<p>BACKGROUND DATA: It was previously found that low-level laser therapy (LLLT) enhances bone repair in experimental models.</p>
<p>MATERIALS AND METHODS: Cultured osteoblast cells were irradiated  using He-Ne laser irradiation (632 nm; 10 mW power output). On the  second and third day after seeding the osteoblasts were exposed to laser  irradiation. The effect of irradiation on osteoblast proliferation was  quantified by cell count and colorimetric MTT (dimethylthiazol  tetrazolium bromide) assay 24 and 48 h after second irradiation.</p>
<p>RESULTS: A significant 31-58% increase in cell survival (MTT assay)  and higher cell count in the once-irradiated as compared to  nonirradiated cells was monitored. Differentiation and maturation of the  cells was followed by osteogenic markers: alkaline phosphatase (ALP),  osteopontin (OP), and bone sialoprotein (BSP). A two-fold enhancement of  ALP activity and expression of OP and BSP was much higher in the  irradiated cells as compared to non-irradiated osteoblasts.</p>
<p>CONCLUSION: We conclude that LLLT promotes proliferation and  maturation of human osteoblasts in vitro. These results may have  clinical implications.</p>
<p>Photomed Laser Surg. 2005 Feb;23(1):27-31.</p>
<h1>Infrared laser light reduces loading time of dental implants: a Raman spectroscopic study.</h1>
<p>Lopes CB, Pinheiro AL, Sathaiah S, Duarte J, Cristinamartins M.</p>
<p>IP&amp;D and Department of Dentistry, FCS, UNIVAP, S. J. Campos, São Paulo, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to assess, through near-infrared  Raman spectroscopy (NIRS), the incorporation of hydroxyapatite of  calcium (CHA; approximately 960 cm(1))–on the healing bone around dental  implants submitted or not to low-level laser therapy (LLLT) (lambda830  nm).</p>
<p>BACKGROUND DATA: The process of maturation of the bone is important  for the success of dental implants, as it improves the fixation of the  implant to the bone, allowing the wearing of a prosthesis. LLLT has been  suggested as a mean of improving bone healing because of its  biomodulatory capabilities.</p>
<p>METHODS: Fourteen rabbits received a titanium implant on the tibia;  eight of them were irradiated with lambda830-nm laser (seven sessions at  48-h intervals, 21.5 J/cm(2) per session, 10 mW, phi approximately  0.0028 cm(2), 85 J/cm(2) treatment dose), and six acted as control. The  animals were sacrificed at 15, 30, and 45 days after surgery. Specimens  were routinely prepared for Raman spectroscopy. Twelve readings were  taken on the bone around the implant.</p>
<p>RESULTS: The results showed significant differences in the  concentration of CHA on irradiated and control specimens at both 30 and  45 days after surgery (p &lt; 0.001). Conclusion: It is concluded that  LLLT does improve bone healing, and this can be safely assessed by Raman  spectroscopy.</p>
<p>Swed Dent J Suppl. 2005;(172):1-63.</p>
<h2>The effect of low level laser irradiation on implant-tissue interaction. In vivo and in vitro studies.</h2>
<p>Khadra M.</p>
<p>Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Norway.</p>
<p>Low-level laser therapy (LLLT) is increasingly used in medicine and  dentistry. It has been suggested that LLLT may be beneficial in the  management of many different medical conditions, including pain, wound  healing and nerve injury. The present thesis is based on a series of in  vivo and in vitro experimental studies investigating whether LLLT has  the potential to enhance titanium-implant interaction. Information about  LLLT effect on bone healing is fundamental to understand whether LLLT  may improve implant-tissue interaction. Thus in the initial study (I),  the effect of LLLT on bone healing and growth in rat calvarial bone  defects was investigated. It was found that LLLT may accelerate  metabolism and/or mineralization during early bone healing. Based on  these findings, study II explored the hypothesis that LLLT can enhance  implant integration in the rabbit tibial bone. It was shown that LLLT  stimulated the mechanical strength of the interface between the implant  and bone after a healing period of 8 weeks. Histomorphometrical and  mineral analyses showed that the irradiated implants had greater  bone-to-implant contact than the controls. In the in vitro experiments,  cellular responses to LLLT were studied in two cell types: primary  cultures of human gingival fibroblasts and human osteoblast-like cells,  with special reference to attachment, proliferation, differentiation and  production of transforming growth factor beta1 (TGF-beta1). The  objectives of studies III &amp; IV were to develop a standardized,  reproducible in vitro model for testing a GaAlAs diode laser device and  to document the influence of single or multiple doses of LLLT, as a  guide to defining the optimal laser dose for enhancing cell activity. A  further objective was to investigate the effect of LLLT on initial  attachment and subsequent behaviour of human gingival fibroblasts  cultured on titanium. While both multiple doses (1.5 and 3 J/cm2) and a  single dose (3 J/cm2) enhanced cellular attachment, proliferation  increased only after multiple doses (1.5 and 3 J/cm2). Study V concerned  the response to LLLT of osteoblast-like cells, derived from human  alveolar bone cultured on titanium implant material. In this study LLLT  significantly enhanced cellular attachment. Greater cell proliferation  in the irradiated groups was observed first after 96 h indicating that  the cellular response is dose dependent. Osteocalcin synthesis and  TGF-beta1 production were significantly stimulated on the samples  exposed to 3 J/cm2. The following conclusions are drawn from the results  of these five studies: LLLT can promote bone healing and bone  mineralization and thus may be clinically beneficial in promoting bone  formation in skeletal defects. It may be also used as additional  treatment for accelerating implant healing in bone. LLLT can modulate  the primary steps in cellular attachment and growth on titanium  surfaces. Multiple doses of LLLT can improve LLLT efficacy, accelerate  the initial attachment and alter the behaviour of human gingival  fibroblasts cultured on titanium surfaces. The use of LLLT at the range  of doses between 1.5 and 3 J/cm2 may modulate the activity of cells  interacting with an implant, thereby enhancing tissue healing and  ultimate implant success.</p>
<p>Photomed Laser Surg. 2004 Jun;22(3):249-53</p>
<h1>Molecular structure of the bony tissue after experimental trauma to the mandibular region followed by laser therapy.</h1>
<p>Rochkind S, Kogan G, Luger EG, Salame K, Karp E, Graif M, Weiss J.</p>
<p>Department of Neurosurgery, Division of Peripheral Nerve  Reconstruction, Tel Aviv Sourasky Medical Center, Tel Aviv University,  Israel. <a href="mailto:rochkind@zahav.net.il">rochkind@zahav.net.il</a></p>
<p>OBJECTIVE: We investigated the therapeutic efficiency of laser  irradiation and Bio-Oss, both and separately, on the post-traumatic  regeneration of bone tissue in rats using infrared spectroscopy as an  informative and accurate measuring method.</p>
<p>BACKGROUND DATA: The therapeutic effect of low-power laser  irradiation on bone tissue regeneration processes in animal models has  been studied using morphogenic, biochemical, roentgenographic and  electron microscopic measurements. Natural bone minerals, such as  Bio-Oss collagen, were recommended for the reconstruction of bone  defects in the alveolar process.</p>
<p>MATERIALS AND METHODS: 29 male Wistar rats, divided into four random  groups in a blinded manner were operated on the right alveolar process. A  bone defect was made by penetrating the right alveolar process of the  mandible bone using a 3-mm drill. The rats were divided into four groups  as follows: Group I, left side served as intact bone and right injured  side as the control; Group II, right injured side was treated by organic  bovine bone (Bio-Oss); Group III, right side bone defect was treated by  HeNe laser (632.8 nm, 35 mW) applied transcutaneously for 20 min to the  injured area daily for the following 14 consecutive days; and Group IV,  Bio-Oss was placed loosely in the right side defect followed by laser  treatment. After 2 weeks, the intact bone and bone replicas of the  trauma area were removed and analyzed by infra-red spectroscopy  technique. The composition and the structure of the bone tissue mineral  substances were determined and compared among the four groups. For  quantitative analysis of the regenerative bone process, the  Mineralization index was used. An increase in this index indicates  regenerative bone processes.</p>
<p>RESULTS: The normal state analysis of the IR spectra of the normal  alveolar bone tissue within the intervals of 400 to 4000 cm(-1) revealed  characteristic absorption bands for the inorganic bone component in  spectrum regions 450-1480 cm(-1), and the organic component at 1540-3340  cm(-1). In the case of trauma, the intensity of absorption of the  inorganic component was decreased by 54%, and the absorption band became  narrow, which can be interpreted as quantitative changes of the bone  tissue mineral content. The wavelength characteristics of the inorganic  component remained unchanged; that is, the induced trauma under these  experimental conditions did not provoke alterations in the structure of  the phosphate framework. The organic component showed decreased  absorption by 10-15%, compared to the normal bone, and slight  displacement of the wavelength, which can be interpreted as changes  occurring in the quality of the organic content of the bone tissue. In  the Bio-Oss-treated group, the intensity of absorption of the inorganic  component increased by 43%, compared to the control injured area;  however, there was a decrease of 22.6% in the normal bone. The  wavelength characteristics of the inorganic component remained  unchanged. The organic component showed similar absorption results in  the injured non-treated group and absorption was 10-15% less than in the  normal bone. Mineralization Index in the Bio-Oss-treated group was  0.93, compared to 0.63 in the control group and 2.04 in the normal bone.  In the laser-treated group, the intensity of absorption of the  inorganic component increased by 62, compared to the control injured  area, and decreased only 11.4% in the normal bone. The wavelength  characteristics of the organic component remained unchanged; that is,  the organic component was similar to that of normal bone. Mineralization  Index in the laser-treated group increased significantly to 1.86,  compared to 0.63 in the control group and 2.04 in the normal bone. In  the combined laser and Bio-Oss-treated groups, the intensity of  absorption of the inorganic component and organic component was similar  to that of normal bone. Mineralization Index in this group increased  significantly to 1.98, compared to 0.63 in the control group and 2.04 in  the normal bone.</p>
<p>CONCLUSION: The results suggest that low-power laser irradiatults  suggest that low-power laser irradiation alone and in combination with  Bio-Oss enhances bone healing and increases bone repair.</p>
<p><strong><em>Used by the kind permission of the Czech Society for the Use of Laser in Medicine, www.laserpartner.org</em></strong></p>
<h1>Bone Stimulation by Low Level Laser – A Theoretical Model for the Effects</h1>
<p>Philip Gable, B App Sc P.T. G Dip Sc Res (LLLT) MSc, Australia</p>
<p>Jan Tunér, D.D.S., Sweden</p>
<p><strong> </strong></p>
<h1>Abstract</h1>
<p>The anecdotal and researched evidence for the effects of Low Level  Laser Therapy (LLLT) on the stimulation of bone have been reported for  over 20 years. This has been in the form of local as well as systematic  effects – including contra-lateral effects. Reports of stimulation of  rabbit radii fractures and mice femurs were made as early as 1986 and  1987 with irradiated bones healing faster than controls and  contra-lateral non-treated fractures similarly demonstrating faster  healing times. Over the following decade and a half, further studies  have also investigated and demonstrated that LLLT is effective for the  stimulation of bone tissue.</p>
<p>***</p>
<p>The reasons for this have been attributed to the general effects of  LLLT and its ability to increase the rates of healing through  mitochondrial ATP production and alteration in the cellular lipid  bi-layer. Additional hypothesis include the subsequent capacity of  irradiated cells to alter their ion exchange rate and thus influence the  catalytic effects of the specific enzymes and substrates. These in turn  initiate and promote the healing process completing the cascading cycle  of events.</p>
<p>In the area of bone specific research, Dr. Tony Pohl of the Royal  Adelaide Hospital in South Australia, has provided a new theory that  postulates that the majority of fluid transfer and exchange within  living bone is predominantly influenced by the lymphatic circulation.</p>
<p>LLLT is well documented and known as having effects that influence  the lymphatic circulation and wound healing process. A coupling of these  two areas of theory can demonstrate a positive description and  explanation of the predominant effects of LLLT in bone stimulation. In  reality, LLLT’s effects on bone may well be a further consequence of its  actions on the lymphatic circulation.</p>
<p>Reports of stimulation of Rabbit radii fractures were made by Tang in  1986 and similar reports by Trelles in 1987 on mice femurs. In both  situations the irradiated bones healed faster than the controls. In  another study by Hernandez-Ros, in 1987, LLLT demonstrated stimulation  of fresh fractures on Sprague-Dawley rats that were fractured  bilaterally. The unexpected results of this study were that the  contra-lateral fractured non-treated limb also healed faster than the  control group. Over the following decade and a half further studies  (Yamada 1991; Pyczek, Sopala et al. 1994; Ozawa 1995; Horowitz 1996;  Yaakobi 1996; Saito and Shimizu 1997) have also investigated and  demonstrated that LLLT is effective for promoting the stimulation of  bone healing. Recently Nicolau and colleagues (2002) from Brazil  demonstrated the positive effect of LLLT on the stimulation of bone in  mice with latent promotion of bone remodulation at injury sites without  changes in bone architecture, increased bone volume and increased  osteoblast surface through increased resorption and formation of bone  with higher apposition rates. A positive effect on bony implants has  been demonstrated by Dörtbudak (2002) and Guzzardella (2003). The effect  of laser irradiation on osteoblastic cells has been reported by  Yamamoto (2001) and Guzzardella (2002).</p>
<p>The reasoning for this amelioration in all experimental  circumstances, based on electron microscopy as well as macroscopic  histological evidence, was concluded to be due to i.a. improved  vascularisation as a consequence of blood vessel formation, absorption  of the haematoma, macrophage action, fibroblast proliferation,  chondrocyte activity, bone remodeling from increased osteoblastic  activity and deposition of calcium salts.</p>
<p>These changes and evidence based studies attribute the macro- and  microscopic effects to the known and accepted general actions of LLLT  and its ability to increase rates of healing through stimulation of ATP  production, (Karu 1989; Smith 1990) promoting repair and polarization of  the cellular lipid bilayer (Fenyo 1990) as well as LLLT’s capacity to  affect cells through alterations in their exchange rate of ions  (Robinson and Walters 1991) and influences the catalytic effects of the  specific enzymes and substrates (Pouyssegur 1985; Karu 1988) which in  turn initiate and promote the healing process.</p>
<p>More recent work by Dr. Tony Pohl, an internationally renowned  Orthopaedic Surgeon from the Royal Adelaide Hospital in South Australia  and lecturer at the Adelaide and South Australian Universities, has  given rise to a new theory on bone circulation through reconsideration  of fluid and protein transfer within bone (Pohl 1999). This theory  suggests that the general understanding of the circulatory action within  bone has been incorrect. Pohl postulates that the majority of fluid  transfer and exchange within the living bone is predominantly influenced  by the lymphatic rather than the vascular circulation. This is  justified through studies on bone fluid input and output levels that  have demonstrated that the venous and arterial aspect of circulation  alone cannot account for the demonstrated levels of output nor the  presence of free radical molecules which exceed those of the vascular  input. Furthermore, the diameter of large protein cells within the bone  exceed the diameter of the vessels that form the terminal aspects of the  circulatory system making it impossible for them to have been delivered  via this system. Consequently, an additional circulatory system must be  present that will account for both the increased output and the  presence of the large diameter protein cells as well as the free  radicals.</p>
<p>If LLLT is then considered within the context of this new theory on  bone circulation and the contribution of the lymphatic circulation then a  further logical reasoned deduction for the action of LLLT on bone  stimulation can be made. LLLT has a well documented and known effect  influencing the lymphatic circulation. This has been demonstrated from  the early works of Lievens, (1985) that demonstrated the influence of  “Laser Irradiation” on the motricity of the lymphatic system and on the  wound healing process. This is supported by several wound studies that  demonstrate that the levels of protein rich exudates in non-healing  wounds increase markedly from exposure to LLLT. This demonstrated action  is determined to be as a result of the increase in lymphatic  circulation (Robinson and Walters 1991; Gabel 1995). More recent work at  the Flinders Medical Center in Adelaide South Australia has been  completed and presented at the World Association of Laser Therapy  conference in Tokyo Japan (Anderson, Carati et al. 2002). This study has  demonstrated the positive effects of LLLT on the lymphatic circulation  and its consequential benefits to the post mastectomy patient.</p>
<p>An understanding of the existing knowledge of the effects of LLLT on  the lymphatic system combined with the hypothesis of bone fluid  transport provides a coupled theory that would demonstrate a positive  description and explain of the predominant effects of LLLT in bone  stimulation.</p>
<p>In the trauma situation of direct or indirect damage to the bone,  including fractures and periosteal induced damage such as stress  fractures, the tissue damage leads to compromises that include but are  not limited to, physical blockage from the trauma and waste / debris,  increased fluid and circulatory viscosity from added cellular content  within the lymphatics, lower speed motility and energy deficit in the  tissue and cells from the loss of ATP production as a general effect  from the trauma, cell changes and inability of mitochondria to function  at the normal higher level to promote self repair and regeneration.</p>
<p>LLLT with its known general effects and specific direct effects on  the lymphatic system would act to stimulate mitochondria ATP that  increases cellular and circulatory motility as well as directly  influencing lymphatic flow. LLLT also promotes increased permeability in  interstitial tissue and facial layers (Gabel 1995) reducing stagnation  and blockage. These actions would assist the increase in lymphatic flow  and consequently the circulation within the affected bone. There is also  a hypothetical potential that the presence of LLLT by increasing  lymphatic circulation does so by virtue of an increase in the diameter  of the lymphatic vessels, not just by increased flow rates within the  vessel at an unchanged diameter. This diameter increase, if definitively  present, would also explain the presence of large diameter protein  cells within the normal bone circulation that cannot be attributed to  the vascular circulation and would additionally explain a facilitated  process for removal of debris and larger protein cells passing out of  traumatized areas that is additionally stimulated by the use of LLLT.</p>
<p>Stimulation of bone healing by LLLT has till now has been generally  classified as a consequence of the general healing effects of LLLT. In  reality LLLT’s effect on bone may well be a further consequence of its  actions on the lymphatic circulation.</p>
<h4>References</h4>
<ul>
<li>Anderson, S, Carati, C et al. (2002). Low Level Laser Therapy (LLLT)  as a Treatment for Postmatestectomy Lymhoedema. WALT 2002, Tokyo Japan.</li>
<li>Coombe, A R et al (2001). The effect of low level laser irradiation on osteoblastic cells. Clin Ort Res. 4: 3-14.</li>
<li>Dörtbudak, O et al (2002). Effect of low-power laser irradiation on bony implant sites. Clin Oral Implants Res 13(3):288-292.</li>
<li>Fenyo, M. (1990). Theoretical and Experimental Basis of Biostimulation by Bioptron, Bioptron AG, Monchaltorf, Switzerland.</li>
<li>Gabel, C. P. (1995). “Does Laser enhance bruising in acute sporting injuries.” Aust. J. Physio. 41(4): 267-269.</li>
<li>Gabel, C. P. (1995). The effect of LLLT on slow healing wounds and ulcers. Health Sciences. Darwin, Northern Territory.</li>
<li>Guzzardella, G A et al (2002). Laser stimulation on bone defect healing: An in vitro study. Lasers Med Sci. 17(3): 216-220.</li>
<li>Guzzardella, G A et al (2003). Osseointegration of endosseous  ceramic implants after postoperative low-power laser stimulation: an in  vivo comparative study. Clin Oral Implants Res. 14: 226-232.</li>
<li>Horowitz, I. et al. (1996). “Infrared spectroscopy analysis of the  effect of low power laser irradiation on calvarial bone defect healing  in the rat (abstract).” Laser Therapy 8: 29.</li>
<li>Karu, T. I. (1988). “Molecular mechanism of the therapeutic effects  of low intensity laser radiation.” Lasers in Life Science 2: 53-74.</li>
<li>Karu, T. I. (1989). Photobiology of low-power laser therapy. London, Harwood Academic Publishers.</li>
<li>Lievens, P. (1985). The influence of “Laser Irradiation” on the  motricity of the lymphatical system and on the wound healing process.  International Congress on Laser in Medicine and Surgery., Bologna.</li>
<li>Nicolau, R A., Jorgetti, V, Rigau, J et al. “Effect of low power laser Ga-Al-As (660nm) in the bone tissue remodulation in mice”</li>
<li>Ozawa, Y. et al (1995). “Stimulatory effects of low-power laser  irradiation on bone formation in vitro.” SPIE Proc. 1995 Vol. 1984:  281-288.</li>
<li>Pohl, T. (1999). Bone circulation, the lymphatic system contribution. Personal Communication to C. P. Gabel. Adelaide Oct 1999.</li>
<li>Pouyssegur, J. (1985). “The growth factor-activatable Na+/H+  exchange system: a genetic approach. In Karu, T.I. 1988, ‘Molecular  mechanism of the therapeutic effects of low intensity laser radiation’,<em> Lasers in Life Science</em>, vol.2, p.53-74.” Trends in Biochemical Science 10: 453-455.</li>
<li>Pycek, M., Sopala, M et al. (1994). “Effect of low-energy laser  power on the bone marrow of the rat.”. Folia Biol (Krakow) 42(3-4):  151-156.</li>
<li>Robinson, B. and Walters, J (1991). “The use of low level laser  therapy in diabetic and other ulcerations.” Journal of British Podiatric  Medicine 46(10): 186-189.</li>
<li>Saito, S. and. Shimizu, N. (1997). “Stimulatory effects of low-power  laser irradiation on bone regeneration in midpalatal suture during  expansion in the rat.” Am J Ortod Dentofac Orthop 11(5): 525-.</li>
<li>Smith, K. C. (1990). Light and life: The photobiological basis of  the therapeutic use of radiation from lasers. International Laser  Therapy Association Conference, Osaka.</li>
<li>Yaakobi, T. et. al. (1996). “Promotion of bone repair in the  cortical bone of the tibia in rats by low energy laser (He-Ne)  irradiation.” Calcif Tissue Int. 59(4): 297-300.</li>
<li>Yamada, K. (1991). “Biological effects of low power laser  irradiation on clonal osteoblastic cells (MC3T3-E1).” Nippon Seikeigeka  Gakkai Zasshi 65(9): 787-799.</li>
<li>Yamamoto, M et al (2001). Stimulation of MCM3 gene expression in  osteoblast by low level laser irradiation. Laser in Med Sci. Abstract  issue. 16(3): 213-217.</li>
</ul>
<p>Photomed Laser Surg. 2005 Aug;23(4):382-8</p>
<h1>Assessment of bone repair associated with the use of organic bovine bone and membrane irradiated at 830 nm.</h1>
<p>Gerbi ME, Pinheiro AL, Marzola C, Limeira Júnior Fde A, Ramalho LM, Ponzi EA, Soares AO, Carvalho LC, Lima HV, Gonçalves TO.</p>
<p>School of Dentistry, Federal University of Bahia, Salvador, Brazil.</p>
<p>OBJECTIVE: The aim of the present investigation was to assess  histologically the effect of LLLT (GaAIAs, 830 nm, 40 mW, CW, (Phi)  approximately 0.6 mm, 16 J/cm(2) per session) on the repair of surgical  defects created in the femur of the Wistar Albinus rat. The defects were  filled to lyophilized bovine bone (Gen-ox), organic matrix) associated  or not to GTR (Gen-derm).</p>
<p>BACKGROUND DATA: A major problem on modern Dentistry is the recovery  of bone defects caused by trauma, surgical procedures or pathologies.  Several types of biomaterials have been used in order to improve the  repair of these defects. These materials are often associated to  procedures of GTR. Previous studies have shown positive effects of LLLT  on the repair of soft tissue wounds, but there are a few on its effects  on bone healing.</p>
<p>METHODS: Surgical bone defects were created in 42 animals divided  into five groups: Group I (control, 6 animals); Group II (Gen-ox, 9  animals); Group III (Gen-ox + Laser, 9 animals); Group IV (Gen-ox +  Gen-derm, 9 animals); Group V (Gen-ox + Gen-derm + Laser, 9 animals).  The animals on the irradiated group received 16 J/cm(2) per session  divided into four points around the defect (4 J/cm(2)) being the first  irradiation immediately after surgery and repeated seven times at every  48 h. The animals were humanly killed after 15, 21, and 30 days.</p>
<p>RESULTS: The results of the present investigation showed histological  evidence of improved amount of collagen fibers at early stages of the  bone healing (15 days) and increased amount of well organized bone  trabeculae at the end of the experimental period (30 days) on irradiated  animals compared to non irradiated ones.</p>
<p>CONCLUSIONS: It is concluded that a positive biomodulative effect on  the healing process of one defect associated or not to the use of  organic lyophilized bone and biological bovine lyophilized membrane on  the femur of the rat.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>J Clin Laser Med Surg. 2003 Dec;21(6):383-8.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of 830-nm laser light on the repair of bone defects grafted  with inorganic bovine bone and decalcified cortical osseous membrane.</h1>
<p>Barbos Pinheiro AL, Limeira Junior Fde A, Marquez Gerbi ME, Pedreira  Ramalho LM, Marzola C, Carneiro Ponzi EA, Oliveira Soares A, Bandeira De  Carvalho LC, Vieira Lima HC, Oliveira Goncalves T.</p>
<p>Laser Center, School of Dentistry, Federal University of Bahia, Salvador, Brazil. <a href="mailto:albp@ufba.br">albp@ufba.br</a></p>
<p>OBJECTIVE: The aim of this study was to assess histologically the  effect of LLLT (lambda830 nm) on the repair of standardized bone defects  on the femur of Wistar albinus rats grafted with inorganic bovine bone  and associated or not to decalcified bovine cortical bone membrane.</p>
<p>BACKGROUND DATA: Bone loss may be a result of several pathologies,  trauma or a consequence of surgical procedures. This led to extensive  studies on the process of bone repair and development of techniques for  the correction of bone defects, including the use of several types of  grafts, membranes and the association of both techniques. There is  evidence in the literature of the positive effect of LLLT on the healing  of soft tissue wounds. However, its effect on bone is not completely  understood.</p>
<p>MATERIALS AND METHODS: Five randomized groups were studied: Group I  (Control); Group IIA (Gen-ox); Group IIB (Gen-ox + LLLT); Group IIIA  (Gen-ox + Gen-derm) and Group IIIB (Gen-ox + Gen-derm + LLLT). Bone  defects were created at the femur of the animals and were treated  according to the group. The animals of the irradiated groups were  irradiated every 48 h during 15 days; the first irradiation was  performed immediately after the surgical procedure. The animals were  irradiated transcutaneously in four points around the defect. At each  point a dose of 4 J/cm2 was given (phi approximately 0.6 mm, 40 mW) and  the total dose per session was 16 J/cm2. The animals were humanely  killed 15, 21, and 30 days after surgery. The specimens were routinely  processed to wax, serially cut, and stained with H&amp;E and Picrosirius  stains and analyzed under light microscopy.</p>
<p>RESULTS: The results showed evidence of a more advanced repair on the  irradiated groups when compared to non-irradiated ones. The repair of  irradiated groups was characterized by both increased bone formation and  amount of collagen fibers around the graft within the cavity since the  15th day after surgery, through analysis of the osteoconductive capacity  of the Gen-ox and the increment of the cortical repair in specimens  with Gen-derm membrane.</p>
<p>CONCLUSION: It is concluded that LLLT had a positive effect on the repair of bone defect submitted the implantation of graft.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Lasers Med Sci. 2003;18(2):89-94.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of low-power GaAlAs laser (660 nm) on bone structure and cell activity: an experimental animal study.</h1>
<p>Nicola RA, Jorgetti V, Rigau J, Pacheco MT, dos Reis LM, Zangaro RA.</p>
<p>Vale of Paraiba University, Sao Jose dos Campos, SP, Brazil.</p>
<p><a href="mailto:renatanicolau@hotmail.com">renatanicolau@hotmail.com</a></p>
<p>Low-level laser therapy (LLLT) is increasingly being used in the  regeneration of soft tissue. In the regeneration of hard tissue, it has  already been shown that the biomodulation effect of lasers repairs bones  more quickly. We studied the activity in bone cells after LLLT close to  the site of the bone injury. The femurs of 48 rats were perforated (24  in the irradiated group and 24 in the control group) and the irradiated  group was treated with a GaAlAs laser of 660 nm, 10 J/cm2 of radiant  exposure on the 2nd, 4th, 6th and 8th days after surgery (DAS). We  carried out histomorphometry analysis of the bone. We found that  activity was higher in the irradiated group than in the control group:  (a) bone volume at 5 DAS (p=0.035); (b) osteoblast surface at 15 DAS  (p=0.0002); (c) mineral apposition rate at 15 and 25 DAS (p=0.0008 and  0.006); (d) osteoclast surface at 5 DAS and 25 DAS (p=0.049 and  p=0.0028); and (e) eroded surface ( p=0.0032). We concluded that LLLT  increases the activity in bone cells (resorption and formation) around  the site of the repair without changing the bone structure.</p>
<p>Lasers Med Sci. 2003;18(2):78-82.</p>
<h1>Effect of low-level laser irradiation on osteoglycin gene expression in osteoblasts.</h1>
<p>Hamajima S, Hiratsuka K, Kiyama-Kishikawa M, Tagawa T, Kawahara M, Ohta M, Sasahara H, Abiko Y.</p>
<p>Nihon University School of Dentistry at Matsudo, Chiba, Japan.</p>
<h3>Abstract</h3>
<p>Many studies have attempted to elucidate the mechanism of the  biostimulatory effects of low-level laser irradiation (LLLI), but the  molecular basis of these effects remains obscure. We investigated the  stimulatory effect of LLLI on bone formation during the early  proliferation stage of cultured osteoblastic cells. A mouse  calvaria-derived osteoblastic cell line, MC3T3-E1, was utilised to  perform a cDNA microarray hybridisation to identify genes that induced  expression by LLLI at the early stage. Among those genes that showed at  least a twofold increased expression, the osteoglycin/mimecan gene was  upregulated 2.3-fold at 2 h after LLLI. Osteoglycin is a small  leucine-rich proteoglycan (SLRP) of the extracellular matrix which was  previously called the osteoinductive factor. SLRP are abundantly  contained in the bone matrix, cartilage cells and connective tissues,  and are thought to regulate cell proliferation, differentiation and  adhesion in close association with collagen and many other growth  factors. We investigated the time-related expression of this gene by  LLLI using a reverse transcription polymerase chain reaction (RT-PCR)  method, and more precisely with a real-time PCR method, and found  increases of 1.5-2-fold at 2-4 h after LLLI compared with the  non-irradiated controls. These results suggest that the increased  expression of the osteoglycin gene by LLLI in the early proliferation  stage of cultured osteoblastic cells may play an important role in the  stimulation of bone formation in concert with matrix proteins and growth  factors.</p>
<p>J Clin Laser Med Surg. 2003 Oct;21(5):271-7.Links</p>
<h1>Effects of pulse frequency of low-level laser therapy (LLLT) on bone nodule formation in rat calvarial cells.</h1>
<p>Ueda Y, Shimizu N.</p>
<p>Department of Orthodontics, Nihon University School of Dentistry at Matsudo Chiba, Japan.</p>
<p>OBJECTIVE: The purpose of this study was to determine the effect of  pulse frequencies of low-level laser therapy (LLLT) on bone nodule  formation in rat calvarial cells in vitro.</p>
<p>BACKGROUND DATA: Various photo-biostimulatory effects of LLLT,  including bone formation, were affected by some irradiation factors such  as total energy dose, irradiation phase, laser spectrum, and power  density. However, the effects of pulse frequencies used during laser  irradiation on bone formation have not been elucidated.</p>
<p>MATERIALS AND METHODS: Osteoblast-like cells isolated from fetal rat  calvariae were irradiated once with a low-energy Ga-Al-As laser (830 nm,  500 mW, 0.48-3.84 J/cm2) in four different irradiation modes:  continuous irradiation (CI), and 1-, 2-, and 8-Hz pulsed irradiation  (PI-1, PI-2, PI-8). We then investigated the effects on cellular  proliferation, bone nodule formation, alkaline phosphatase (ALP)  activity, and ALP gene expression.</p>
<p>RESULTS: Laser irradiation in all four groups significantly  stimulated cellular proliferation, bone nodule formation, ALP activity,  and ALP gene expression, as compared with the non-irradiation group.  Notably, PI-1 and -2 irradiation markedly stimulated these factors, when  compared with the CI and PI-8 groups, and PI-2 irradiation was the best  approach for bone nodule formation in the present experimental  conditions.</p>
<p>CONCLUSION: Since low-frequency pulsed laser irradiation  significantly stimulates bone formation in vitro, it is most likely that  the pulse frequency of LLLT an important factor affecting biological  responses in bone formation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>J Photochem Photobiol B. 2003 May-Jun;70(2):81-9.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Low power laser irradiation improves histomorphometrical parameters  and bone matrix organization during tibia wound healing in rats.</h1>
<p>Garavello-Freitas I, Baranauskas V, Joazeiro PP, Padovani CR, Dal Pai-Silva M, da Cruz-Hofling MA.</p>
<p>Faculdade de Engenharia Eletrica e Computacao, Departamento de  Semicondutores Instrumentos e Fotonica, Universidade Estadual de  Campinas, Av. Albert Einstein N.400, 13 083-970 Campinas, SP, Brazil.</p>
<p>The influence of daily energy doses of 0.03, 0.3 and 0.9 J of He-Ne  laser irradiation on the repair of surgically produced tibia damage was  investigated in Wistar rats. Laser treatment was initiated 24 h after  the trauma and continued daily for 7 or 14 days in two groups of nine  rats (n=3 per laser dose and period). Two control groups (n=9 each) with  injured tibiae were used. The course of healing was monitored using  morphometrical analysis of the trabecular area. The organization of  collagen fibers in the bone matrix and the histology of the tissue were  evaluated using Picrosirius-polarization method and Masson’s trichrome.  After 7 days, there was a significant increase in the area of neoformed  trabeculae in tibiae irradiated with 0.3 and 0.9 J compared to the  controls. At a daily dose of 0.9 J (15 min of irradiation per day) the  7-day group showed a significant increase in trabecular bone growth  compared to the 14-day group. However, the laser irradiation at the  daily dose of 0.3 J produced no significant decrease in the trabecular  area of the 14-day group compared to the 7-day group, but there was  significant increase in the trabecular area of the 15-day controls  compared to the 8-day controls. Irradiation increased the number of  hypertrophic osteoclasts compared to non-irradiated injured tibiae  (controls) on days 8 and 15. The Picrosirius-polarization method  revealed bands of parallel collagen fibers (parallel-fibered bone) at  the repair site of 14-day-irradiated tibiae, regardless of the dose.  This organization improved when compared to 7-day-irradiated tibiae and  control tibiae. These results show that low-level laser therapy  stimulated the growth of the trabecular area and the concomitant  invasion of osteoclasts during the first week, and hastened the  organization of matrix collagen (parallel alignment of the fibers) in a  second phase not seen in control, non-irradiated tibiae at the same  period. The active osteoclasts that invaded the regenerating site were  probably responsible for the decrease in trabecular area by the  fourteenth day of irradiation.</p>
<p>J Clin Laser Med Surg. 2002 Apr;20(2):83-7.</p>
<h1>Computerized morphometric assessment of the effect of low-level laser therapy on bone repair: an experimental animal study.</h1>
<p>Silva Júnior AN, Pinheiro AL, Oliveira MG, Weismann R, Ramalho LM, Nicolau RA.</p>
<p>School of Dentistry, Postgraduate Programe on Oral and Maxillofacial  Surgery, Pontifícia Universidade Católica do Rico Grande do Sul, Porto  Alegre, Brazil.</p>
<h3>Abstract</h3>
<p>OBJECTIVE: The aim of this study was to evaluate morphometrically the  amount of newly formed bone after GaAlAs laser irradiation of surgical  wounds created in the femur of rats.</p>
<p>BACKGROUND DATA: Low-level laser therapy (LLLT) has been used in  several medical specialties because of its biomodulatory effects on  different biological tissues. However, LLLT is still controversial  because of contradictory reports. This is a direct result of the  different methodologies used in these works.</p>
<p>MATERIALS AND METHODS: In this study, 40 Wistar rats were divided  into four groups of 10 animals each: group A (12 sessions, 4.8 J/cm2 per  session, observation time of 28 days); group C (three sessions, 4.8  J/cm2 per session, observation time of 7 days). Groups B and D acted as  nonirradiated controls. The specimens were routinely processed to wax  and cut at 6-microm thickness and stained with H&amp;E. For computerized  morphometry, Imagelab software was used.</p>
<p>RESULTS: Computerized morphometry showed a significant difference  between the areas of mineralized bone in groups C and D (p = 0.017).  There was no difference between groups A and B (28 days; p = 0.383).</p>
<p>CONCLUSION: It is concluded that, under this experimental condition, LLLT increased bone repair at early bone healing.</p>
<p>Lasers Med Sci. 2002;17(3):216-20.</p>
<h1>Laser stimulation on bone defect healing: an in vitro study.</h1>
<p>Guzzardella GA, Fini M, Torricelli P, Giavaresi G, Giardino R.</p>
<p>Department of Experimental Surgery, Codivilla-Putti Research Institute/Rizzoli Orthopaedic Institute, Italy. gaetanoantonio.<a href="mailto:guzzardella@ior.it">guzzardella@ior.it</a></p>
<h3>Abstract</h3>
<p>The aim of this in vitro study was to evaluate whether low-power  laser (LPL) stimulation can accelerate bone healing. Bone defects of a  standard area were created in the distal epiphysis of 12 femora  explanted from six rats, and they were cultured in BGJb medium for 21  days. Six defects were treated daily with Ga-Al-As, 780 nm LPL for 10  consecutive days (lased group, LG), while the remainder were  sham-treated (control group, CG). Alkaline phosphatase/total protein  (ALP/TP), calcium (Ca), and nitric oxide (NO) were tested on days 7, 14  and 21 to monitor the metabolism of cultured bone. The percentage of  healing of the defect area was determined by histomorphometric analysis.  After 21 days significant increases were observed in ALP/TP in LG  versus CG (p&lt;0.001), in NO in the LG versus CG ( p&lt;0.0005) and in  Ca in CG versus LG ( p&lt;0.001). The healing rate of the defect area in  the LG was higher than in the CG ( p=0.007). These in vitro results  suggest that Ga-Al-As LPL treatment may play a positive role in bone  defect healing.</p>
<p>Int J Artif Organs. 2001 Dec;24(12):898-902.</p>
<h1>Laser technology in orthopedics: preliminary study on low power laser therapy to improve the bone-biomaterial interface.</h1>
<p>Guzzardella GA, Torricelli P, Nicoli Aldini N, Giardino R.</p>
<p>Experimental Surgery Department, Research Institute Codivilla Putti, Bologna, Italy. gaetanoantonio.guzzardella@ior.it</p>
<h3>Abstract</h3>
<p>Low Power Laser (LPL) seems to enhance the healing of bone defects  and fractures. The effect of LPL in other orthopedic areas such as  osteointegration of implanted prosthetic bone devices is still unclear.  In the present study, 12 rabbits were used to evaluate whether Ga-Al-As  (780 nm) LPL stimulation has positive effects on osteointegration.  Hydroxyapatite (HA) cylindrical nails were drilled into both distal  femurs of rabbits. From postoperative day 1 and for 5 consecutive days,  the left femura of all rabbits were given LPL treatment (Laser Group-LG)  with the following parameters: 300 Joule/cm2, 1 Watt, 300 Hertz,  pulsating emission, 10 minutes. The right femura were sham-treated  (Control Group-CG). At 4 and 8 weeks after implantation, histologic and  histomorphometric investigations evaluated bone-biomaterial-contact.  Histomorphometry showed a higher degree of osteointegration at the  HA-bone interface in the LG Group at 4 (p &lt; 0.0005) and 8 weeks (p  &lt; 0.001). These preliminary positive results seem to support the  hypothesis that LPL treatment can be considered a good tool to enhance  the bone-implant interface in orthopedic surgery.</p>
<p>Bull Exp Biol Med. 2001 Apr;131(4):399-402.</p>
<h1>Healing of bone fractures of rat shin and some immunological indices  during magnetic laser therapy and osteosynthesis by the ilizarov  method.</h1>
<p>Baibekov IM, Khanapiyaev UK.</p>
<p>Laboratory of Pathological Anatomy, V. Vakhidov National Surgery  Center; Institute of Traumatology and Orthopedics, Ministry of Health of  Uzbekistan, Tashkent.</p>
<h3>Abstract</h3>
<p>The effect of magnetic and laser therapy on healing of bone fractures  and blood levels of T and B lymphocytes was studied in rats during  osteosynthesis by the Ilizarov method. Laser therapy induced changes in  cells attesting to stimulation of reparative processes and normalization  of immunological parameters.</p>
<p>Lasers Med Sci. 2001;16(3):213-7.</p>
<h1>Stimulation of MCM3 gene expression in osteoblast by low level laser irradiation.</h1>
<p>Yamamoto M, Tamura K, Hiratsuka K, Abiko Y.</p>
<p>Department of Biochemistry, Nihon University School of Dentistry at Matsudo, Chiba, Japan.</p>
<h3>Abstract</h3>
<p>Biostimulatory effect of cell proliferation and bone formation by  laser irradiation has been reported, however, very little is known about  the molecular basis of mechanisms. We previously constructed the cDNA  library of mouse osteoblastic cells (MC3T3-E1) which enhanced gene  expression by laser irradiation using a subtracted gene cloning  procedure. In the present study, we focused on a gene clone, designated  as MCL-140, which exhibited the high homology of DNA sequence with mouse  minichromosome maintenance (MCM) 3 gene. MCM3 is involved in the  initiation of DNA replication as licensing factor in eukaryotic cells.  Nucleotide sequence of MCL-140 insert was determined and assessed in the  nucleic acid databases. The transcription level of MCL-140 was examined  by Northern blot analysis. The DNA sequences of clone MCL-140 insert  exhibited 96.2% homology with MCM 3 gene coding P1 protein. Higher MCM3  mRNA levels were observed in laser-irradiated cells compared to the  levels in non-irradiated cells: furthermore, radiolabelled thymidine  incorporation was increased by laser irradiation. These findings suggest  that low-level laser irradiation may enhance DNA replication and play a  role in stimulating proliferation of osteoblast through the enhancement  of the MCM3 gene expression.</p>
<p>Clin Orthod Res. 2001 Feb;4(1):3-14</p>
<h1>The effects of low level laser irradiation on osteoblastic cells.</h1>
<p>Coombe AR, Ho CT, Darendeliler MA, Hunter N, Philips JR, Chapple CC, Yum LW.</p>
<p>Discipline of Orthodontics, Faculty of Dentistry, University of  Sydney, New South Wales, Australia; Institute of Dental Research, United  Dental Hospital, New South Wales, Australia.</p>
<p>Low level laser therapy has been used in treating many conditions  with reports of multiple clinical effects including promotion of healing  of both hard and soft tissue lesions. Low level laser therapy as a  treatment modality remains controversial, however. The effects of  wavelength, beam type, energy output, energy level, energy intensity,  and exposure regime of low level laser therapy remain unexplained.  Moreover, no specific therapeutic window for dosimetry and mechanism of  action has been determined at the level of individual cell types. The  aim of this study was to investigate the effects of low level laser  irradiation on the human osteosarcoma cell line, SAOS-2. The cells were  irradiated as a single or daily dose for up to 10 days with a GaAlAs  continuous wave diode laser (830 nm, net output of 90 mW, energy levels  of 0.3, 0.5, 1, 2, and 4 Joules). Cell viability was not affected by  laser irradiation, with the viability being greater than 90% for all  experimental groups. Cellular proliferation or activation was not found  to be significantly affected by any of the energy levels and varying  exposure regimes investigated. Low level laser irradiation did result in  a heat shock response at an energy level of 2 J. No significant early  or late effects of laser irradiation on protein expression and alkaline  phosphatase activity were found. Investigation of intracellular calcium  concentration revealed a tendency of a transient positive change after  irradiation. Low level laser irradiation was unable to stimulate the  osteosarcoma cells utilised for this research at a gross cell population  level. The heat shock response and increased intracellular calcium  indicate that the cells do respond to low level laser irradiation.  Further research is required, utilising different cell and animal  models, to more specifically determine the effects of low level laser  irradiation at a cellular level. These effects should be more thoroughly  investigated before low level laser therapy can be considered as a  potential accelerator stimulus for orthodontic tooth movement.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Clin Oral Implants Res. 2003 Apr;14(2):226-32.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Osseointegration of endosseous ceramic implants after postoperative low-power laser stimulation: an in vivo comparative study.</h1>
<p><strong> </strong>Guzzardella GA, Torricelli P, Nicoli-Aldini N, Giardino R.</p>
<p>Department of Experimental Surgery/Codivilla-Putti Research  Institute, Rizzoli Orthopaedic Institute, Bologna, Italy.  gaetanoantonio.<a href="mailto:guzzardella@ior.it">guzzardella@ior.it</a></p>
<p>Stimulation with low-power laser (LPL) can enhance bone repair as  reported in experimental studies on bone defects and fracture healing.  Little data exist concerning the use of LPL postoperative stimulation to  improve osseointegration of endosseous implants in orthopaedic and  dental surgery. An in vivo model was used for the present study to  evaluate whether Ga-Al-As (780 nm) LPL stimulation can improve  biomaterial osseointegration. After drilling holes, cylindrical implants  of hydroxyapatite (HA) were placed into both distal femurs of 12  rabbits. From postoperative day 1 and for 5 consecutive days, the left  femurs of all rabbits were submitted to LPL treatment (LPL group) with  the following parameters: 300 J/cm2, 1 W, 300 Hz, pulsating emission, 10  min. The right femurs were sham-treated (control group). Three and 6  weeks after implantation, histomorphometric and microhardness  measurements were taken. A higher affinity index was observed at the  HA-bone interface in the LPL group at 3 (P&lt;0.0005) and 6 weeks  (P&lt;0.001); a significant difference in bone microhardness was seen in  the LPL group vs. the control group (P&lt;0.01). These results suggest  that LPL postoperative treatment enhances the bone-implant interface.</p>
<p>Clin Laser Med Surg. 2002; 20: 83-87</p>
<h1>Computerized morphometric assessment of the effect of low-level laser therapy on bone repair: an experimental animal study.</h1>
<p><strong> </strong>Silva Júnior AN, Pinheiro AL, Oliveira MG, Weismann R, Ramalho LM, Nicolau RA. J</p>
<p>The aim of this study was to evaluate morphometrically the amount of  newly formed bone after GaAlAs laser irradiation of surgical wounds  created in the femur of rats. Low-level laser therapy (LLLT) has been  used in several medical specialties because of its biomodulatory effects  on different biological tissues. However, LLLT is still controversial  because of contradictory reports. This is a direct result of the  different methodologies used in these works. In this study, 40 Wistar  rats were divided into four groups of 10 animals each: group A (12  sessions, 4.8 J/cm2 per session, observation time of 28 days); group C  (three sessions, 4.8 J/cm2 per session, observation time of 7 days).  Groups B and D acted as nonirradiated controls. The specimens were  routinely processed to wax and cut at 6-microm thickness and stained  with H&amp;E. For computerized morphometry, Imagelab software was used.  RESULTS: Computerized morphometry showed a significant difference  between the areas of mineralized bone in groups C and D (p = 0.017).  There was no difference between groups A and B (28 days; p = 0.383).</p>
<p>Laser Med Surg Abstract issue, 2002: 11.</p>
<h1>Effects of visible NIR low intensity laser on implant osseointegration in vivo.</h1>
<p>Blay A, Blay C C, Groth E B et al.</p>
<p>The effects of 680 and 830 nm lasers on osseointegration was studied  by Blay. 30 adult rats were divided into three groups; two laser groups  and one control. The rats in the two laser groups had pure titanium  Frialit-2 implants implanted into each proximal metaphysis of their  respective tibias, inserted with a 40 Ncm torque. The initial stability  was monitored by means of a resonance frequency analyser. Ten  irradiations were performed, 48 hours apart, 4 J/cm2 on two points,  starting immediately after surgery. Resonance frequency analysis  indicated a significant difference between frequency values at 3 and 6  weeks, as compared to control. At 6 weeks the removal torque in the  laser groups was much higher than in the control group.</p>
<p>Laser Surg Med. Abstract Issue 2002. abstract 303.</p>
<h1>Bone repair of the periapical lesions treated or not with low intensity laser (wavelength=904 nm).</h1>
<p>Sousa G R, Ribeiro M S, Groth E B.</p>
<p>The effect of bone repair in periapical lesions has been studied by  Sousa []. 15 patients with a total of 18 periapical lesions were divided  into two groups. One group received endodontic treatment and/or  periapical surgery. The patients in the other group were submitted to  the same procedure and in addition the lesions were irradiated by GaAs  laser, 11 mW, 9 J/cm2. This therapy was performed during 10 sessions  with an interval of 72 hours. Bone regeneration was evaluated through  X-ray examination. The results showed a significant difference between  the laser and the control group in favour of the laser group.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>J Clin Laser Med Surg. 2003 Dec;21(6):383-8.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of 830-nm laser light on the repair of bone defects grafted  with inorganic bovine bone and decalcified cortical osseous membrane.</h1>
<p>Barbos Pinheiro AL, Limeira Junior Fde A, Marquez Gerbi ME, Pedreira  Ramalho LM, Marzola C, Carneiro Ponzi EA, Oliveira Soares A, Bandeira De  Carvalho LC, Vieira Lima HC, Oliveira Goncalves T.</p>
<p>Laser Center, School of Dentistry, Federal University of Bahia, Salvador, Brazil. <a href="mailto:albp@ufba.br">albp@ufba.br</a></p>
<p>OBJECTIVE: The aim of this study was to assess histologically the  effect of LLLT (lambda830 nm) on the repair of standardized bone defects  on the femur of Wistar albinus rats grafted with inorganic bovine bone  and associated or not to decalcified bovine cortical bone membrane.</p>
<p>BACKGROUND DATA: Bone loss may be a result of several pathologies,  trauma or a consequence of surgical procedures. This led to extensive  studies on the process of bone repair and development of techniques for  the correction of bone defects, including the use of several types of  grafts, membranes and the association of both techniques. There is  evidence in the literature of the positive effect of LLLT on the healing  of soft tissue wounds. However, its effect on bone is not completely  understood.</p>
<p>MATERIALS AND METHODS: Five randomized groups were studied: Group I  (Control); Group IIA (Gen-ox); Group IIB (Gen-ox + LLLT); Group IIIA  (Gen-ox + Gen-derm) and Group IIIB (Gen-ox + Gen-derm + LLLT). Bone  defects were created at the femur of the animals and were treated  according to the group. The animals of the irradiated groups were  irradiated every 48 h during 15 days; the first irradiation was  performed immediately after the surgical procedure. The animals were  irradiated transcutaneously in four points around the defect. At each  point a dose of 4 J/cm2 was given (phi approximately 0.6 mm, 40 mW) and  the total dose per session was 16 J/cm2. The animals were humanely  killed 15, 21, and 30 days after surgery. The specimens were routinely  processed to wax, serially cut, and stained with H&amp;E and Picrosirius  stains and analyzed under light microscopy.</p>
<p>RESULTS: The results showed evidence of a more advanced repair on the  irradiated groups when compared to non-irradiated ones. The repair of  irradiated groups was characterized by both increased bone formation and  amount of collagen fibers around the graft within the cavity since the  15th day after surgery, through analysis of the osteoconductive capacity  of the Gen-ox and the increment of the cortical repair in specimens  with Gen-derm membrane.</p>
<p>CONCLUSION: It is concluded that LLLT had a positive effect on the repair of bone defect submitted the implantation of graft.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>J Clin Laser Med Surg. 2003 Oct;21(5):271-7.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of pulse frequency of low-level laser therapy (LLLT) on bone nodule formation in rat calvarial cells.</h1>
<p>Ueda Y, Shimizu N.</p>
<p>Department of Orthodontics, Nihon University School of Dentistry at Matsudo Chiba, Japan.</p>
<p>OBJECTIVE: The purpose of this study was to determine the effect of  pulse frequencies of low-level laser therapy (LLLT) on bone nodule  formation in rat calvarial cells in vitro.</p>
<p>BACKGROUND DATA: Various photo-biostimulatory effects of LLLT,  including bone formation, were affected by some irradiation factors such  as total energy dose, irradiation phase, laser spectrum, and power  density. However, the effects of pulse frequencies used during laser  irradiation on bone formation have not been elucidated.</p>
<p>MATERIALS AND METHODS: Osteoblast-like cells isolated from fetal rat  calvariae were irradiated once with a low-energy Ga-Al-As laser (830 nm,  500 mW, 0.48-3.84 J/cm2) in four different irradiation modes:  continuous irradiation (CI), and 1-, 2-, and 8-Hz pulsed irradiation  (PI-1, PI-2, PI-8). We then investigated the effects on cellular  proliferation, bone nodule formation, alkaline phosphatase (ALP)  activity, and ALP gene expression.</p>
<p>RESULTS: Laser irradiation in all four groups significantly  stimulated cellular proliferation, bone nodule formation, ALP activity,  and ALP gene expression, as compared with the non-irradiation group.  Notably, PI-1 and -2 irradiation markedly stimulated these factors, when  compared with the CI and PI-8 groups, and PI-2 irradiation was the best  approach for bone nodule formation in the present experimental  conditions.</p>
<p>CONCLUSION: Since low-frequency pulsed laser irradiation  significantly stimulates bone formation in vitro, it is most likely that  the pulse frequency of LLLT an important factor affecting biological  responses in bone formation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Lasers Med Sci. 2003;18(2):78-82.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of low-level laser irradiation on osteoglycin gene expression in osteoblasts.</h1>
<p>Hamajima S, Hiratsuka K, Kiyama-Kishikawa M, Tagawa T, Kawahara M,  Ohta M, Sasahara H, Abiko Y. Nihon University School of Dentistry at  Matsudo, Chiba, Japan.</p>
<p>Many studies have attempted to elucidate the mechanism of the  biostimulatory effects of low-level laser irradiation (LLLI), but the  molecular basis of these effects remains obscure. We investigated the  stimulatory effect of LLLI on bone formation during the early  proliferation stage of cultured osteoblastic cells. A mouse  calvaria-derived osteoblastic cell line, MC3T3-E1, was utilised to  perform a cDNA microarray hybridisation to identify genes that induced  expression by LLLI at the early stage. Among those genes that showed at  least a twofold increased expression, the osteoglycin/mimecan gene was  upregulated 2.3-fold at 2 h after LLLI. Osteoglycin is a small  leucine-rich proteoglycan (SLRP) of the extracellular matrix which was  previously called the osteoinductive factor. SLRP are abundantly  contained in the bone matrix, cartilage cells and connective tissues,  and are thought to regulate cell proliferation, differentiation and  adhesion in close association with collagen and many other growth  factors. We investigated the time-related expression of this gene by  LLLI using a reverse transcription polymerase chain reaction (RT-PCR)  method, and more precisely with a real-time PCR method, and found  increases of 1.5-2-fold at 2-4 h after LLLI compared with the  non-irradiated controls. These results suggest that the increased  expression of the osteoglycin gene by LLLI in the early proliferation  stage of cultured osteoblastic cells may play an important role in the  stimulation of bone formation in concert with matrix proteins and growth  factors.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Clin Oral Implants Res. 2002 Jun;13(3):288-92.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Effect of low-power laser irradiation on bony implant sites.</h1>
<p>Dortbudak O, Haas R, Mailath-Pokorny G. Department of Oral Surgery, Dental School, University of Vienna, Austria. <a href="mailto:orhun.doerbudak@univie.ac.at">orhun.doerbudak@univie.ac.at</a></p>
<p>This study was designed to examine the effects of low-energy laser  irradiation on osteocytes and bone resorption at bony implant sites.  Five male baboons with a mean age of 6.5 years were used in the study.  Four holes for accommodating implants were drilled in each iliac crest.  Sites on the left side were irradiated with a 100 mW low-energy laser  (690 nm) for 1 min (6 Joule) immediately after drilling and insertion of  four sandblasted and etched (Frialit-2 Synchro) implants. Five days  later, the bone was removed en bloc and was evaluated  histomorphometrically. The mean osteocyte count per unit area was 109.8  cells in the irradiated group vs. 94.8 cells in the control group. As  intra-individual cell counts varied substantially, osteocyte viability  was used for evaluation. In the irradiated group, viable osteocytes were  found in 41.7% of the lacuna vs. 34.4% in the non-irradiated group.  This difference was statistically significant at P &lt; 0.027. The total  resorption area, eroded surface, was found to be 24.9% in the control  group vs. 24.6% in the irradiated group. This difference was not  statistically significant. This study showed that osteocyte viability  was significantly higher in the samples that were subjected to laser  irradiation immediately after implant site drilling and implant  insertion, in comparison to control sites. This may have positive  effects on the integration of implants. The bone resorption rate, in  contrast, was not affected by laser irradiation.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Int J Artif Organs. 2001 Dec;24(12):898-902.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Laser technology in orthopedics: preliminary study on low power laser therapy to improve the bone-biomaterial interface.</h1>
<p>Guzzardella GA, Torricelli P, Nicoli Aldini N, Giardino R.</p>
<p>Experimental Surgery Department, Research Institute Codivilla Putti, Bologna, Italy. <a href="mailto:gaetanoantonio.guzzardella@ior.it">gaetanoantonio.guzzardella@ior.it</a></p>
<p>Low Power Laser (LPL) seems to enhance the healing of bone defects  and fractures. The effect of LPL in other orthopedic areas such as  osteointegration of implanted prosthetic bone devices is still unclear.  In the present study, 12 rabbits were used to evaluate whether Ga-Al-As  (780 nm) LPL stimulation has positive effects on osteointegration.  Hydroxyapatite (HA) cylindrical nails were drilled into both distal  femurs of rabbits. From postoperative day 1 and for 5 consecutive days,  the left femura of all rabbits were given LPL treatment (Laser Group-LG)  with the following parameters: 300 Joule/cm2, 1 Watt, 300 Hertz,  pulsating emission, 10 minutes. The right femura were sham-treated  (Control Group-CG). At 4 and 8 weeks after implantation, histologic and  histomorphometric investigations evaluated bone-biomaterial-contact.  Histomorphometry showed a higher degree of osteointegration at the  HA-bone interface in the LG Group at 4 (p &lt; 0.0005) and 8 weeks (p  &lt; 0.001). These preliminary positive results seem to support the  hypothesis that LPL treatment can be considered a good tool to enhance  the bone-implant interface in orthopedic surgery.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Stomatologiia (Mosk). 2001;80(2):33-5.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Prevention of inflammatory complications after mandibular  osteosynthesis by a combination of low-frequency ultrasound and laser  exposure.</h1>
<p>[Article in Russian]</p>
<p>Tarasenko SV, Agapov VS, Trukhina GM, Techiev SK, Artsibushev VI.</p>
<p>Clinical and laboratory study of the efficiency of separate and  combined use of low-frequency ultrasound and laser exposure of the  operative wound for prevention of pyoinflammatory complications during  mandibular osteosynthesis was carried out. Clinical parameters of wound  reparation in the course of healing and microbiological and cytological  findings in various methods of treatment are presented. The results  evidence a high efficiency of these physical methods, particularly of  their combination.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Bull Exp Biol Med. 2001 Apr;131(4):399-402.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>Healing of bone fractures of rat shin and some immunological indices  during magnetic laser therapy and osteosynthesis by the ilizarov  method.</h1>
<p>Baibekov IM, Khanapiyaev UK.</p>
<p>Laboratory of Pathological Anatomy, V. Vakhidov National Surgery  Center; Institute of Traumatology and Orthopedics, Ministry of Health of  Uzbekistan, Tashkent.</p>
<p>The effect of magnetic and laser therapy on healing of bone fractures  and blood levels of T and B lymphocytes was studied in rats during  osteosynthesis by the Ilizarov method. Laser therapy induced changes in  cells attesting to stimulation of reparative processes and normalization  of immunological parameters.</p>
<p>J Oral Sci. 2001 Mar;43(1):55-60.</p>
<h1>Pulse irradiation of low-power laser stimulates bone nodule formation.</h1>
<p>Ueda Y, Shimizu N.</p>
<p>Department of Orthodontics, Nihon University School of Dentistry at Matsudo, Chiba, Japan. <a href="mailto:ueda@mascat.nihon-u.ac.jp">ueda@mascat.nihon-u.ac.jp</a></p>
<h3>Abstract</h3>
<p>Although low-power laser irradiation provides many anabolic effects  such as acceleration of bone formation, the effects of different pulse  frequencies used during laser irradiation on bone formation have not  been elucidated. Osteoblastic cells isolated from fetal rat calvariae  were irradiated once with a low-power Ga-Al-As laser (830 nm, 500 mW) in  two different irradiation modes; continuous irradiation (CI), and 1 Hz  pulsed irradiation (PI). We then investigated the effects on cellular  proliferation, bone nodule formation, alkaline phosphatase (ALP)  activity, and ALP gene expression. Laser irradiation in both groups  significantly stimulated cellular proliferation, bone nodule formation,  ALP activity, and ALP gene expression, as compared with the  nonirradiation group. Notably, PI markedly stimulated these factors,  when compared with the CI group. Since 1 Hz pulsed laser irradiation  significantly stimulates bone formation in vitro, it is most likely that  pulse frequency is an important factor affecting biological responses  in bone formation. us for orthodontic tooth movement.</p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>Clin Orthod Res. 2001 Feb;4(1):3-14.</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong> </strong></p>
<h1>The effects of low level laser irradiation on osteoblastic cells.</h1>
<p>Coombe AR, Ho CT, Darendeliler MA, Hunter N, Philips JR, Chapple CC, Yum LW.</p>
<p>Discipline of Orthodontics, Faculty of Dentistry, University of  Sydney, New South Wales, Australia; Institute of Dental Research, United  Dental Hospital, New South Wales, Australia.</p>
<p>Low level laser therapy has been used in treating many conditions  with reports of multiple clinical effects including promotion of healing  of both hard and soft tissue lesions. Low level laser therapy as a  treatment modality remains controversial, however. The effects of  wavelength, beam type, energy output, energy level, energy intensity,  and exposure regime of low level laser therapy remain unexplained.  Moreover, no specific therapeutic window for dosimetry and mechanism of  action has been determined at the level of individual cell types. The  aim of this study was to investigate the effects of low level laser  irradiation on the human osteosarcoma cell line, SAOS-2. The cells were  irradiated as a single or daily dose for up to 10 days with a GaAlAs  continuous wave diode laser (830 nm, net output of 90 mW, energy levels  of 0.3, 0.5, 1, 2, and 4 Joules). Cell viability was not affected by  laser irradiation, with the viability being greater than 90% for all  experimental groups. Cellular proliferation or activation was not found  to be significantly affected by any of the energy levels and varying  exposure regimes investigated. Low level laser irradiation did result in  a heat shock response at an energy level of 2 J. No significant early  or late effects of laser irradiation on protein expression and alkaline  phosphatase activity were found. Investigation of intracellular calcium  concentration revealed a tendency of a transient positive change after  irradiation. Low level laser irradiation was unable to stimulate the  osteosarcoma cells utilised for this research at a gross cell population  level. The heat shock response and increased intracellular calcium  indicate that the cells do respond to low level laser irradiation.  Further research is required, utilising different cell and animal  models, to more specifically determine the effects of low level laser  irradiation at a cellular level. These effects should be more thoroughly  investigated before low level laser therapy can be considered as a  potential accelerator stimul</p>
<p>Bone. 1998 Apr;22(4):347-54.</p>
<h1>Low-energy laser irradiation stimulates bone nodule formation at early stages of cell culture in rat calvarial cells.</h1>
<p>Ozawa Y, Shimizu N, Kariya G, Abiko Y.</p>
<p>Department of Orthodontics, Nihon University School of Dentistry at Matsudo, Chiba, Japan.</p>
<h3>Abstract</h3>
<p>Although the acceleration of bone regeneration by laser treatment has  been reported, the mechanisms of action of laser on bone are unclear.  To determine the target cells responsible for the action of laser  irradiation and roles of irradiation on these cells during bone  formation, we investigated the effects of low-energy laser irradiation  at various cell culture stages on cellular proliferation, bone nodule  formation, alkaline phosphatase activity, and osteocalcin gene  expression, employing rat calvarial cells. Osteoblast-like cells  isolated from fetal rat calvariae were irradiated once with a low-energy  Ga-Al-As laser (830 nm, 500 mW) at various cell culture stages (days  1-16). Laser irradiation at early stages of culture significantly  stimulated cellular proliferation, ALP activity, and osteocalcin gene  expression thereafter. Furthermore, laser irradiation at earlier stages  of culture significantly stimulated a greater number (1.7-fold) and  larger area (3.4-fold) of bone nodules that had developed in the culture  dish on day 21. However, these effects could not be found by  irradiation at a later date. These results suggest that laser  irradiation may play two principal roles in stimulating bone formation.  One is stimulation of cellular proliferation, especially proliferation  of nodule-forming cells of osteoblast lineage, and the other is  stimulation of cellular differentiation, especially to committed  precursors, resulting in an increase in the number of more  differentiated osteoblastic cells and an increase in bone formation.  Both bone-formation-stimulating roles may be exhibited by laser  irradiation to immature cells only.</p>
<p>Lasers Surg Med. 1998;22(2):97-102.</p>
<h1>Effect of low-power laser irradiation on the mechanical properties of bone fracture healing in rats.</h1>
<p>Luger EJ, Rochkind S, Wollman Y, Kogan G, Dekel S.</p>
<p>Department of Orthopedic Surgery B, Tel Aviv Sourasky Medical Center, Israel.</p>
<h3>Abstract</h3>
<p>BACKGROUND AND OBJECTIVE: Low-power laser irradiation (LPLI) has been  found to have a positive effect on bone fracture healing in animal  models, based on morphogenic, biochemical, roentgenographic, and  electron microscopic measurements. We investigated the effect of LPLI on  bone fracture healing in rats using biomechanical methods.</p>
<p>STUDY DESIGN/MATERIALS AND METHODS: Two groups of male Wistar rats,  divided in a randomized block design in a blinded fashion, each  consisting of 25 animals, were subjected to anesthesia and tibial bone  fracture with internal fixation. The first group was treated with LPLI  (HeNe laser 632.8 nm, 35 mW), applied transcutaneously over 30 minutes  to the area of the fracture daily for 14 days. The second group served  as a control. After 4 weeks, the tibia was removed and tested at tension  up to failure (by a Lloyd LR 50K testing apparatus, U.K.) in 16 rats  from group I and 15 from group II. The maximal load at failure, the  structural stiffness of the tibia (callus stiffness), and the extension  maximal load were measured.</p>
<p>RESULTS: The maximal load at failure and the structural stiffness of  the tibia were found to be elevated significantly in the irradiated  group (P = .014 and P = .0023, respectively), whereas the extension  maximal load was reduced (P = .015). In addition, gross non-union was  found in four fractures in the control group, compared to none in the  irradiated group.</p>
<p>CONCLUSION: These results suggest that LPLI treatment may play a role in enhancing bone healing.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/low-intensity-laser-therapy-in-bone-healing-and-osteoporosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bone Healing / Osteoporosis</title>
		<link>http://www.cooperativemedicine.com/laser-articles/bone-healing-osteoporosis-2/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/bone-healing-osteoporosis-2/#comments</comments>
		<pubDate>Fri, 18 Nov 2011 23:24:55 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Bioelectromagnetic Articles]]></category>
		<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2228</guid>
		<description><![CDATA[by David Rindge, DOM, LAc, RN.  All rights reserved. Low intensity lasers, including laser needle therapy, as well as bio-electromagnetic therapy have been extensively documented to stimulate the function of osteoblasts, cells which lay down new bone.    In contrast, the biphosphonate drugs promoted for osteoporosis in standard practice do so not by stimulating the formation of new bone but [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p style="text-align: right;"><a href="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Rindge-David-2nd-cropped-Unity.jpg" rel="lightbox[2228]"><img class="alignleft size-thumbnail wp-image-2234" title="OLYMPUS DIGITAL CAMERA" src="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Rindge-David-2nd-cropped-Unity-150x150.jpg" alt="" width="150" height="150" /></a>by David Rindge, DOM, LAc, RN.  All rights reserved.</p>
<p><a href="http://www.cooperativemedicine.com/laser-articles/low-intensity-laser-therapy-in-bone-healing-and-osteoporosis/" target="_blank">Low intensity lasers</a>, including <a href="http://www.cooperativemedicine.com/laser-articles/laser-needle-acupuncture/" target="_blank">laser needle therapy</a>, as well as <a href="http://www.cooperativemedicine.com/bioelectromagnetic-articles/bio-electromagnetic-therapy-in-osteoporosis-and-bone-healing/" target="_blank">bio-electromagnetic therapy</a> have been extensively documented to stimulate the function of osteoblasts, cells which lay down new bone.    In contrast, the biphosphonate drugs promoted for osteoporosis in standard practice do so not by stimulating the formation of new bone but by inhibiting the normal activity of osteoblasts, cells which break down old bone.  The biphosphonates have even been documented to kill osteoblasts. </p>
<p style="text-align: center;"><strong>Which would you rather have, more new bone or more old bone?</strong></p>
<p>The new bone formed in response to laser and bio-electromagnetic therapy may be stronger and have greater flexibility than that resulting from biphosphonate treatment.  Biphosphonate drug treatment can also have serious consequences, including spontaneous fractures, esophageal cancer and osteonecrosis.   <a href="http://www.cooperativemedicine.com/laser-articles/laser-therapy-effective-treats-bronj/" target="_blank">Laser therapy has even been shown to effectively treat biphosphonate osteonecrosis of the jaw.</a></p>
<p>To see what researchers have reported in their own words regarding the effects of laser therapy in osteoporosis, arthritis and other bone-related conditions, visit:</p>
<ul>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/arthritis/">Arthritis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-healing-osteogenesis/">Bone Healing – Osteogenesis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/biphosphonate-related-osteonecrosis-of-the-jaw/">Biphophonate Related Osteonecrosis of the Jaw (BRONJ)</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-how-laser-therapy-ultrasound-promote-repair/">Bone – How laser therapy and ultrasound promote repair</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-healing-in-diabetes-diabetic-model/">Bone Healing in Diabetes</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-implant-interaction/">Bone – Implant Interaction</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/wp-admin/post.php?post=1242&amp;action=edit&amp;message=1">Epiphyseal Cartilage – Bone Lengthening</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/laser-needle-therapy-for-spontaneous-knee-osteonecrosis/">Laser-needle therapy for spontaneous osteonecrosis of the knee</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/osteochondrosis-2/">Osteochondrosis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/osteomyelitis/">Osteomyelitis</a></strong></li>
</ul>
<p>To see what researchers have reported regarding the effects of  in treating of bio-electromagnetic therapy in osteoporosis, arthritis and other bone-related conditions, visit:</p>
<ul>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/929/">Ankylosing Spondylitis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/982/">Arthritis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/mandibular-osteomyelitis/">Mandibular Osteomyelitis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/osteochondrosis/">Osteochondrosis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/osteoporosis-osteopenia-bone-healing/">Osteoporosis – Osteopenia – Bone Healing</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/pseudoarthrosis/">Pseudoarthrosis</a></strong></li>
</ul>
<p style="text-align: center;">From <em>Dem Bones, Dem Bones, Dem New Bones</em><br />
by David Rindge, <em>Acupuncture Today</em>, October 2010</p>
<p>“My doctors have told me that I should keep up whatever I am doing,” said my slim, 88 year old female patient.   “Joan” had stopped taking Boniva, the drug prescribed for her osteoporosis when she came to our clinic over two years earlier.  Since then she has treated herself at home with bioelectromagnetic therapy x 30 minutes daily.  Laser therapy has also been administered as needed for pain at office visits over her lumbar spine and hips, where bone loss was greatest.  Below are results from “Joan’s” bone density testing.  When she shared them with me, she also gave me a big kiss!</p>
<p style="text-align: center;"><strong>&#8220;Joan&#8217;s&#8221; Bone Densitometry Results L1-L4</strong></p>
<table border="1" align="center">
<tbody>
<tr>
<td>Measured<br />
Date</td>
<td>Measured<br />
Age</td>
<td>WHO<br />
Class</td>
<td>Young Adult<br />
T Score</td>
<td>Bone Mineral<br />
Density</td>
<td>% Change<br />
vs Previous</td>
</tr>
<tr>
<td>12/11/09</td>
<td>89.8</td>
<td>Osteoporosis</td>
<td>-2.7</td>
<td>0.854 g/cm2</td>
<td>+8.8%</td>
</tr>
<tr>
<td>1/30/08</td>
<td>88.0</td>
<td>Osteoporosis</td>
<td>-3.3</td>
<td>0.785 g/cm2</td>
<td>+0.5%</td>
</tr>
<tr>
<td>10/31/06</td>
<td>86.7</td>
<td>Osteoporosis</td>
<td>-3.3</td>
<td>0.781 g/cm2</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>By 1/30/08, approximately 3 months after beginning bioelectromagnetic and laser treatment, “Joan’s” bone density had increased by 0.5% at L1-L4, the area of severe osteoporosis.  <em><span style="text-decoration: underline;">By 12/11/09 she had gained another 8.8% bone density in her lumbar spine,</span></em><strong> </strong>It is important to understand that individuals with severe osteoporosis typically experience frequent, intermittent back pain due to “compression” fractures which can occur spontaneously in weakened bone.  “Joan” seldom has pain these days and has reported better overall health, energy and ability to exercise.</p>
<p style="text-align: center;"><strong>What is osteoporosis?</strong></p>
<p><strong><a href="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Osteoporosis-vs-normal-bone1.jpg" rel="lightbox[2228]"><img class="alignleft size-medium wp-image-2256" title="Osteoporosis vs normal bone" src="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Osteoporosis-vs-normal-bone1-300x213.jpg" alt="" width="300" height="191" /></a>Osteoporosis</strong> is “systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue, with consequent increase in bone fragility and susceptibility to fracture risk.”  According to estimates by the National Osteoporosis Foundation, 10 million Americans (8 million women and 2 million men) have osteoporosis, and almost 34 million more (55 percent of those over age 50) are at risk of developing it.  In 2005, osteoporosis-related fractures cost $19 billion, and costs are predicted to rise to approximately $25.3 billion by 2025.</p>
<p style="text-align: center;">
<p style="text-align: center;"><strong>Bone Mineral Density</strong></p>
<p>Twenty years ago osteoporosis was usually diagnosed only after a fracture.  Nowadays “bone mineral density” (BMD) can be measured by a type of x-ray technology called dexascan.  <strong><em>To qualify as osteoporosis, bone density must be </em></strong><em><span style="text-decoration: underline;">&lt;</span><strong> -2.5 standard deviations than that which is normal in a young adult of the same sex.</strong></em> The number itself is called a “T-score.”</p>
<p>“Joan’s” T-scores of -3.3 on 10/31/06 and 1/30/08 were far below the -2.5 level defining osteoporosis.  -3.3 is serious bone loss.  In contrast, her T-score of -2.7 on 12/11/09 two years later shows stunning improvement and is very close to the -2.5 borderline.   “Joan” has continued to treat herself daily with bioelectromagnetic therapy, and, based upon her progress, it is easy to believe that her bone density will be normal or nearly so on her next dexascan in two years.</p>
<p style="text-align: center;"><strong>Osteopenia – Marketing a “disease” and its treatment</strong></p>
<p><strong>Osteopenia </strong>is milder bone loss.  Defined as &#8220;1.00 to -2.49 standard deviations below the average peak adult bone mass as determined by a bone mineral density examination,&#8221;  few people had ever heard the word ‘osteopenia’ much less received treatment for it prior to 1995.  Yet today millions of women worldwide are taking biphosphonate drugs because they believe their condition requires it.  To learn how osteopenia became a popular medical diagnosis, visit <strong><em><a href="http://www.npr.org/templates/story/story.php?storyId=121609815"><em>How A Bone Disease Grew To Fit The Prescription</em>:<em>NPR</em></a></em></strong></p>
<p style="text-align: center;"><strong>Normal bone formation vs. biphosphonate effects</strong><strong> </strong></p>
<p>In normal bone formation, as a matrix of new connective tissue is laid down by <strong>osteoblasts</strong> and then mineralized, old bone is removed by <strong>osteoclasts</strong>.  Like in any living tissue, older cells are continually replaced by newer ones.   Biphosphonates disrupt this.  They suppress the resorption of old bone, inhibiting and even killing osteoclasts.  Without the normal actions of osteoclasts to remove old bone, the bony tissue resulting from long-term biphosphonate use, though denser on x-ray, is often weaker, less vascular and more prone to serious adverse events<strong> </strong>such as spontaneous stress fractures, esophageal cancer and biphosphonate related osteonecrosis of the jaw (BRONJ).   <strong> </strong></p>
<p>In biphosphonate related osteonecrosis of the jaw (BRONJ) the maxillo-facial bones become necrotic.  The effects aren’t pretty.  It is ironic and sad that so much destruction is wreaked upon bones by drugs intended to strengthen them.  And doubly ironic (but on positive note) that <a href="http://www.cooperativemedicine.com/laser-articles/laser-therapy-effective-treats-bronj/" target="_blank">laser therapy has been shown to effectively treat the consequences of BRONJ</a>.</p>
<p><em>&#8220;Of the 14 patients who underwent laser biostimulation, nine reported complete clinical success (no pain, symptoms of infection, or exposed bone or draining fistulas), and three improved their symptomatology only, with a follow-up of  between 4 abd 7 mo.  CONCLUSIONS: While the results reported in the study are not conclusive, they indicate that laser therapy has potential to improve management of BON (Biphosphonate-related osteonecrosis of the jaw).&#8221; [1]</em><em><br />
</em></p>
<p style="text-align: center;"><strong>Building bone safely and cost-effectively </strong></p>
<p>Laser and bioelectromagnetic therapies are <strong>osteogenic – </strong>they stimulate osteoblasts to form <strong><span style="text-decoration: underline;">new</span></strong> bone.   The resulting tissue may be stronger and more flexible than the original.  In contrast, biphosphonates inhibit normal breakdown of old bone.  When given a choice of new or old bone, which would you choose to have more of for yourself or your patients?</p>
<p><strong> </strong>“The percentage of newly formed bone was greater in the LLLT group (57.89%) than in the control group (46.75%) (p=0.006). Conclusion: The results suggest that LLLT had a positive effect on the percentage of newly formed bone.”<a>[2]</a></p>
<p>“With regard to bone synthesis, laser exposure has been shown to increase osteoblast activity and decrease osteoclast number, by inducing alkaline phosphatase (ALP), osteopontin, and bone sialoprotein expression.”<a>[3]</a></p>
<p>“There was histological evidence of improved collagen fiber deposition at early stages of the healing; increased amount of well-organized bone trabeculae at the end of the experimental period on irradiated animals. It is concluded that LPBM (laser photobiomodulation) has positive biomodulative effect on the healing process bone defects.”<a>[4]</a></p>
<p>“The results of the present investigation showed histological evidence of improved amount of collagen fibers at early stages of the bone healing (15 days) and increased amount of well organized bone trabeculae at the end of the experimental period (30 days) on irradiated animals …”<a>[5]</a></p>
<p>“Laser irradiation had significantly accelerated bone healing at 4 weeks and 8 weeks in comparison with that at the sites not irradiated. …. Our results have confirmed the positive effect of soft laser in accelerating bone regeneration.”<a>[6]</a></p>
<p>Laser therapy may be administered by probe treatment, laser needle acupuncture and other methods.  It may provide rapid pain relief and accelerate bone healing in specific areas targeted, even with severe bone loss. Yet whereas laser therapy is labor intensive, bioelectromagnetic therapy may be given over large areas, even the whole body, as an unattended treatment.  BT may also be the most cost-effective means for home treatment.  Both laser and bioelectromagnetic therapies are wonderful clinical tools which, in combined treatment, may complement and enhance one another.</p>
<p style="text-align: center;"><strong><a href="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Haxsen-et-al-graph.png" rel="lightbox[2228]"><img class="alignleft size-full wp-image-2310" title="Haxsen et al graph" src="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Haxsen-et-al-graph.png" alt="" width="150" height="150" /></a>Laser needles</strong></p>
<p>When laser light is given at relatively low average output powers but concentrated to achieve high intensities, it may significantly stimulate osteoblasts.</p>
<p style="text-align: center;">
<p style="text-align: left;">Haxsen et al compared the effects of dose and intensity of laser needles to stimulate alkaline phosphatase activity<a>[7]</a> and found that once threshold was achieved, the response was logarithmic and that intensity had greater relevance than dose.</p>
<p style="text-align: left;">Results. Primary osteoblasts showed no induction of alkaline phosphatase activity using single laserneedle stimulation with a laser power density of 51 mW/cm², an increase of about 43% at 102 mW/cm² power density (two needles per well) and a 9-fold (!) increase at 204mW/cm² laser power density (four needle stimulation per well).<a>[8]</a></p>
<p style="text-align: center;"><strong>Case Study &#8211; Osteonecrosis / Morbus Osgood-Schlatter<strong><a>[9]</a></strong></strong></p>
<p>The patient was a male, born 1993, who experienced sharp pain in the tibia during sports activity.  Radiology <a href="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Knee.png" rel="lightbox[2228]"><img class="alignright size-full wp-image-2309" title="Knee" src="http://www.cooperativemedicine.com/wp-content/uploads/2011/11/Knee.png" alt="" width="115" height="150" /></a>showed necrotic alterations at the tibial apophysis, and he was diagnosed with Morbus Osgood-Schlatter.</p>
<p><strong>Tre</strong><strong>atme</strong><strong>nt:</strong> Laser needles were place along the tibial apophysis and treatment was given x 30 minutes daily for two weeks.</p>
<p style="text-align: center;"><strong>Final s</strong><strong>tatus after 2 weeks: </strong>Morbus Osgood-Schlatter not detectable, pain-free under exertion.  Radiology:  negative</p>
<p>To view what scientists have had to say about the effects of laser therapy to build bone and treat bone-related disease, click on:</p>
<ul>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/arthritis/">Arthritis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-healing-osteogenesis/">Bone Healing – Osteogenesis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/biphosphonate-related-osteonecrosis-of-the-jaw/">Biphophonate Related Osteonecrosis of the Jaw (BRONJ)</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-how-laser-therapy-ultrasound-promote-repair/">Bone – How laser therapy and ultrasound promote repair</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-healing-in-diabetes-diabetic-model/">Bone Healing in Diabetes</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/bone-implant-interaction/">Bone – Implant Interaction</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/wp-admin/post.php?post=1242&amp;action=edit&amp;message=1">Epiphyseal Cartilage – Bone Lengthening</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/laser-needle-therapy-for-spontaneous-knee-osteonecrosis/">Laser-needle therapy for spontaneous osteonecrosis of the knee</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/osteochondrosis-2/">Osteochondrosis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/laser-research-library/osteomyelitis/">Osteomyelitis</a></strong></li>
</ul>
<p>To view what researchers have reported about the therapeutic effects of electromagnetic fields to build bone and treat bone-related diseases, click on:</p>
<ul>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/929/">Ankylosing Spondylitis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/982/">Arthritis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/mandibular-osteomyelitis/">Mandibular Osteomyelitis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/osteochondrosis/">Osteochondrosis</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/osteoporosis-osteopenia-bone-healing/">Osteoporosis – Osteopenia – Bone Healing</a></strong></li>
<li><strong><a href="http://www.healinglightseminars.com/bioelectromagnetic-research-library/pseudoarthrosis/">Pseudoarthrosis</a></strong></li>
</ul>
<p><strong> </strong></p>
<p style="text-align: center;"><strong>Some final thoughts</strong></p>
<p>Anyone treated for bone loss should have a Vitamin D level assessed by the 25(OH)D test at the outset.  Supplementation with higher dosages of D3 based on the results of this test is rapidly becoming the standard of care and may help your patients gain bone mass quickly.  If possible, assess bone mineral density before and after a treatment series.  Six months is the minimum time to expect significant change in bone density.</p>
<p>With good information, the right choices become easy.  Teach your patients about the effects of laser and bioelectromagnetic therapies – and also about the negative effects of biphosphonates.   Given the choice of new or old bone, which treatment do you think they will choose?</p>
<hr size="1" /><a>[1]</a> Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S, <em>Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases</em>. Photomed Laser Surg. 2008 Feb;26(1):37-46</p>
<p style="text-align: center;"><a>[2]</a> Kreisner PE, Blaya D, Gaião L, Maciel-Santos ME, Etges A, Santana-Filho M, de Oliveira MG. <em>Histological evaluation of the effect of low-level laser on distraction osteogenesis in rabbit mandibles.<strong> </strong></em>Med Oral Patol Oral Cir Bucal. 2009 Dec 29.</p>
<p><a>[3]</a> Saracino S, Mozzati M, Martinasso G, Pol R, Canuto RA, Muzio G. <em>Superpulsed laser irradiation increases osteoblast activity via modulation of bone morphogenetic factors</em>, Lasers Surg Med.<span style="text-decoration: underline;"> </span>2009 Apr;41(4):298-304</p>
<p><a>[4]</a> Márquez Martínez MEPinheiro ALRamalho LM, <em>Effect of IR laser photobiomodulation on the repair of bone defects grafted with organic bovine bone.</em> Lasers Med Sci. 2008 Jul;23(3):313-7. Epub 2007 Sep 20.</p>
<p><a>[5]</a> Gerbi ME, Pinheiro AL, Marzola C, Limeira Júnior Fde A, Ramalho LM, Ponzi EA, Soares AO, Carvalho LC, Lima HV, Gonçalves TO, <em>Assessment of bone repair associated with the use of organic bovine bone and membrane irradiated at 830 nm.</em> Photomed Laser Surg. 2005 Aug;23(4):382-8</p>
<p><a>[6]</a> AboElsaad NS, Soory M, Gadalla LM, Ragab LI, Dunne S, Zalata KR, Louca C.<em> Effect of soft laser and bioactive glass on bone regeneration in the treatment of bone defects (an experimental study). </em>Lasers Med Sci. 2009 Jun 23. [</p>
<p><a>[7]</a> The induction of alkaline phosphatase by osteoblasts is associated with bone formation.</p>
<p><a>[8]</a> Haxsen V, Schikora D, Sommer U, Remppis A, Greten J, Kasperk C.<em>Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures.</em><em> </em>Lasers Med Sci. 2007 Oct 31.</p>
<p><a>[9]</a> Case study courtesy of Detlef Schikora, University of .Paderborn; Faculty of Science.</p>
<p style="text-align: right;">Copyright 2010.  All rights reserved.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/bone-healing-osteoporosis-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laser therapy offers &#8220;faster resolution and fewer side effects&#8221;</title>
		<link>http://www.cooperativemedicine.com/laser-articles/laser-therapy-offers-faster-resolution-and-fewer-side-effects/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/laser-therapy-offers-faster-resolution-and-fewer-side-effects/#comments</comments>
		<pubDate>Sun, 21 Aug 2011 20:50:35 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2044</guid>
		<description><![CDATA[Dermatol Surg. 2004 Feb;30(2 Pt 1):139-46. Light therapy in the treatment of acne vulgaris. Elman M, Lebzelter J. Dermatology and Lasers Clinic, Tel Aviv Msq, Caesarea, Israel. BACKGROUND: Over the past decade, lasers and light-based systems have become a common modality to treat a wide variety of skin-related conditions, including acne vulgaris. In spite of [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p>Dermatol Surg. 2004 Feb;30(2 Pt 1):139-46.</p>
<p><strong>Light therapy in the treatment of acne vulgaris.</strong></p>
<p>Elman M, Lebzelter J.</p>
<p>Dermatology and Lasers Clinic, Tel Aviv Msq, Caesarea, Israel.</p>
<p>BACKGROUND: Over the past decade, lasers and light-based systems have become a common modality to treat a wide variety of skin-related conditions, including acne vulgaris. In spite of the various oral and topical treatments available for the treatment of acne, many patients fail to respond adequately or may develop side effects. Therefore, there is a growing demand by patients for a fast, safe, and side-effect-free novel therapy.</p>
<p>OBJECTIVES: To address the role of light therapy in the armamentarium of treatments for acne vulgaris, to discuss photobiology aspects and biomedical optics, to review current technologies of laser/light-based devices, to review the clinical experience and results, and to outline clinical guidelines and treatment considerations.</p>
<p>RESULTS: Clinical trials show that 85% of the patients demonstrate a significant quantitative reduction in at least 50% of the lesions after four biweekly treatments. In approximately 20% of the cases, acne eradication may reach 90%. At 3 months after the last treatment, clearance is approximately 70% to 80%. The nonrespondent rate is 15% to 20%.</p>
<p>CONCLUSIONS: Laser and light-based therapy is a safe and effective modality for the treatment of mild to moderate inflammatory acne vulgaris. Amelioration of acne by light therapy, although comparable to the effects of oral antibiotics, offers faster resolution and fewer side effects and leads to patient satisfaction.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/laser-therapy-offers-faster-resolution-and-fewer-side-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Blue light in inflammatory acne</title>
		<link>http://www.cooperativemedicine.com/laser-articles/blue-light-in-inflammatory-acne/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/blue-light-in-inflammatory-acne/#comments</comments>
		<pubDate>Sun, 21 Aug 2011 20:34:33 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2036</guid>
		<description><![CDATA[Hautarzt. 2005 Nov;56(11):1027-32. Light, laser and PDT therapy for acne [Article in German] Borelli C, Merk K, Plewig G, Degitz K. Klinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München. c.borelli@med.uni-muenchen.de In recent years, a number of studies have evaluated the treatment of acne using electromagnetic waves, such as lasers, photodynamic therapy, visible light or radio [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p><strong></strong>Hautarzt. 2005 Nov;56(11):1027-32.</p>
<p><strong>Light, laser and PDT therapy for acne</strong></p>
<p>[Article in German]</p>
<p>Borelli C, Merk K, Plewig G, Degitz K.</p>
<p>Klinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München. <a href="mailto:c.borelli@med.uni-muenchen.de">c.borelli@med.uni-muenchen.de</a></p>
<p>In recent years, a number of studies have evaluated the treatment of acne using electromagnetic waves, such as lasers, photodynamic therapy, visible light or radio waves. While the efficacy of laser treatment is still uncertain, photodynamic therapy shows promising results, but with marked side-effects, as destruction of sebaceous glands. Treatment with blue light (405-420 nm wavelength) also appears effective and can be regarded as an treatment option for inflammatory acne.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/blue-light-in-inflammatory-acne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combination blue and red promising in mild to severe acne</title>
		<link>http://www.cooperativemedicine.com/laser-articles/combination-blue-and-red-promising-in-mild-to-severe-acne/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/combination-blue-and-red-promising-in-mild-to-severe-acne/#comments</comments>
		<pubDate>Sun, 21 Aug 2011 20:05:52 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2027</guid>
		<description><![CDATA[J Cosmet Laser Ther. 2006 Jun;8(2):71-5. Combination blue (415 mm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. Goldberg DJ, Russell BA. Skin Laser &#38; Surgery Specialists of New York/New Jersey, and Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10022, USA. drdavidgoldberg@skinandlasers.com BACKGROUND AND [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p>J Cosmet Laser Ther. 2006 Jun;8(2):71-5.</p>
<p><strong>Combination blue (415 mm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris.</strong></p>
<p>Goldberg DJ, Russell BA.</p>
<p>Skin Laser &amp; Surgery Specialists of New York/New Jersey, and Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10022, USA. <a href="mailto:drdavidgoldberg@skinandlasers.com">drdavidgoldberg@skinandlasers.com</a></p>
<p>BACKGROUND AND OBJECTIVE: Acne vulgaris represents both a challenge to the treating dermatologist and a major concern for the patient. Conventional treatments have proved inconsistent with often unacceptable side effects and high rates of recurrence. Non-thermal, non-laser, phototherapy for acne with a combination of blue and red light has recently attracted attention. The present study was designed to assess the efficacy of this combination phototherapy.</p>
<p>METHODS: Twenty-four subjects, Fitzpatrick skin types II-V, with mild to severe symmetric facial acne vulgaris were recruited for the study. Subjects were well matched at baseline in terms of both age and duration of acne. Subjects were treated over eight sessions, two per week 3 days apart, alternating between 415 nm blue light (20 minutes/session, 48 J/cm2) and 633 nm red light (20 minutes/session, 96 J/cm2) from a light-emitting diode (LED)-based therapy system. Patients received a mild microdermabrasion before each session. Acne was assessed at baseline and at weeks 2, 4, 8 and 12.</p>
<p>RESULTS: Twenty-two patients completed the trial. A mean reduction in lesion count was observed at all follow-up points. At the 4-week follow-up, the mean lesion count reduction was significant at 46% (p=0.001). At the 12-week follow-up, the mean lesion count reduction was also significant at 81% (p=0.001). Patient and dermatologist assessments were similar. Severe acne showed a marginally better response than mild acne. Side effects were minimal and transitory. Comedones did not respond as well as inflammatory lesions.</p>
<p>CONCLUSIONS: Combination blue and red LED therapy appears to have excellent potential in the treatment of mild to severe acne. Treatment appears to be both pain- and side effect-free.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/combination-blue-and-red-promising-in-mild-to-severe-acne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Blue 405-420 nm appears effective in inflammatory acne</title>
		<link>http://www.cooperativemedicine.com/laser-articles/blue-405-420-nm-appears-effective-in-inflammatory-acne/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/blue-405-420-nm-appears-effective-in-inflammatory-acne/#comments</comments>
		<pubDate>Sun, 21 Aug 2011 20:01:08 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2024</guid>
		<description><![CDATA[1: Hautarzt. 2005 Nov;56(11):1027-32. Light, laser and PDT therapy for acne [Article in German] Borelli C, Merk K, Plewig G, Degitz K. Klinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München. c.borelli@med.uni-muenchen.de In recent years, a number of studies have evaluated the treatment of acne using electromagnetic waves, such as lasers, photodynamic therapy, visible light or [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p><strong>1: </strong>Hautarzt. 2005 Nov;56(11):1027-32.</p>
<p><strong>Light, laser and PDT therapy for acne</strong></p>
<p>[Article in German]</p>
<p>Borelli C, Merk K, Plewig G, Degitz K.</p>
<p>Klinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München. <a href="mailto:c.borelli@med.uni-muenchen.de">c.borelli@med.uni-muenchen.de</a></p>
<p>In recent years, a number of studies have evaluated the treatment of acne using electromagnetic waves, such as lasers, photodynamic therapy, visible light or radio waves. While the efficacy of laser treatment is still uncertain, photodynamic therapy shows promising results, but with marked side-effects, as destruction of sebaceous glands. Treatment with blue light (405-420 nm wavelength) also appears effective and can be regarded as an treatment option for inflammatory acne.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cooperativemedicine.com/laser-articles/blue-405-420-nm-appears-effective-in-inflammatory-acne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Red-blue light superior to blue light alone</title>
		<link>http://www.cooperativemedicine.com/laser-articles/red-blue-light-superior-to-blue-light-alone/</link>
		<comments>http://www.cooperativemedicine.com/laser-articles/red-blue-light-superior-to-blue-light-alone/#comments</comments>
		<pubDate>Sun, 21 Aug 2011 19:57:00 +0000</pubDate>
		<dc:creator>Cmdavid</dc:creator>
				<category><![CDATA[Laser Articles]]></category>

		<guid isPermaLink="false">http://www.cooperativemedicine.com/?p=2020</guid>
		<description><![CDATA[Am J Clin Dermatol. 2004;5(4):211-6. Phototherapy in the treatment of acne vulgaris: what is its role? Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Department of Dermatology, Faculty of Medicine, Hammersmith Campus, Imperial College, London, UK. e.charakida@imperial.ac.uk Acne vulgaris is a common dermatosis affecting 80% of the population. To date, different [...]]]></description>
			<content:encoded><![CDATA[
<!-- wp-jquery-lightbox, a WordPress plugin by ulfben --> 
<p>Am J Clin Dermatol. 2004;5(4):211-6.</p>
<p><strong>Phototherapy in the treatment of acne vulgaris: what is its role?</strong></p>
<p>Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC.</p>
<p>Department of Dermatology, Faculty of Medicine, Hammersmith Campus, Imperial College, London, UK. <a href="mailto:e.charakida@imperial.ac.uk">e.charakida@imperial.ac.uk</a></p>
<p>Acne vulgaris is a common dermatosis affecting 80% of the population. To date, different treatments have been used to manage this condition. Antibacterials and retinoids are currently the mainstay of treatment for acne, but their success rate varies. Phototherapy is emerging as an alternative option to treat acne vulgaris. Studies examining the role of different wavelengths and methods of light treatment have shown that phototherapy with visible light, specifically blue light, has a marked effect on inflammatory acne lesions and seems sufficient for the treatment of acne. In addition, the 
